<SEC-DOCUMENT>0001641172-25-015578.txt : 20250618
<SEC-HEADER>0001641172-25-015578.hdr.sgml : 20250618
<ACCEPTANCE-DATETIME>20250618160518
ACCESSION NUMBER:		0001641172-25-015578
CONFORMED SUBMISSION TYPE:	DEFC14A
PUBLIC DOCUMENT COUNT:		24
FILED AS OF DATE:		20250618
DATE AS OF CHANGE:		20250618

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONIM TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001178697
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				943336783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFC14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38907
		FILM NUMBER:		251056861

	BUSINESS ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		650-378-8100

	MAIL ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONIM TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001178697
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				943336783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFC14A

	BUSINESS ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		650-378-8100

	MAIL ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFC14A
<SEQUENCE>1
<FILENAME>formdefc14a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SONM="http://sonimtech.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_SONM_sonimtech.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001178697 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001178697</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011" name="dei:DocumentType">DEFC14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sonm-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000016" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000034 Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000034"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90B_edei--DocumentType_dxL_c20240101__20241231_zxtb5yvQMic3" title="::XDX::DEFC14A"><span style="-sec-ix-hidden: xdx2ixbrl0011">SCHEDULE
14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Statement Pursuant to Section 14(a) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Check
the appropriate box:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &#167;240.14a-12</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90A_edei--EntityRegistrantName_c20240101__20241231_z5lmEgQq9sA6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000012" name="dei:EntityRegistrantName">Sonim
Technologies, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Registrant as Specified In Its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check all boxes that apply):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><img src="formdefc14a_001.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
    Technologies, Inc.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
    Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, CA 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notice
of 2025 Annual Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
Proxy Statement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    and Time:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Friday,
    July 18, 2025<br/>
    9:00 a.m., Eastern Time</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participate
virtually at</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><img src="formdefc14a_001.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
    Technologies, Inc.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
    Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, CA 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
OF 2025 ANNUAL MEETING OF STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 3.5in; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    and Time:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Friday,
                                            July 18, 2025</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9:00
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.m., Eastern Time</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virtual
    Meeting:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participate
    online at</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
    Date:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Close
    of business on</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc. (&#8220;Sonim,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221;) will hold its 2025 Annual Meeting of Stockholders
(the &#8220;Annual Meeting&#8221;) on Friday, July 18, 2025, at 9:00 a.m., Eastern Time. To provide the opportunity for
participation by a broader group of stockholders and provide a consistent and convenient experience to all stockholders regardless of
location, the Annual Meeting will be held in a virtual-only meeting format. Stockholders will not be able to physically attend the Annual
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a registered stockholder or beneficial owner of our common stock at the close of business on June 9, 2025, the record
date of our Annual Meeting, you may attend the virtual meeting, submit questions and vote your shares electronically during the meeting
via live audio webcast by visiting <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span> and using the control number included on your proxy
card or voting instruction form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Annual Meeting, holders of our outstanding shares of common stock will be asked to consider and vote upon the following proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect the five (5) nominees as directors of the Company, each to hold office until the 2026 annual meeting of stockholders and until
    his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of Baker Tilly US, LLP (successor in interest of Moss Adams LLP following a merger) as our independent
    registered public accounting firm for the fiscal year ending December 31, 2025;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Sonim Technologies, Inc. 2019 Equity Incentive Plan, as amended, to increase the aggregate number of
    shares of common stock authorized for issuance by 600,000 shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    hold an advisory vote on the compensation of our named executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    hold an advisory vote on the frequency of future advisory votes to approve executive compensation; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact any other business properly brought before the Annual Meeting or any postponement or adjournment thereof.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may vote on these matters virtually or by proxy. Each outstanding share of our common stock is entitled to one vote. Whether or not you
plan to virtually attend the Annual Meeting, we ask that you vote by one of the following methods to ensure that your shares will be
represented at the meeting in accordance with your wishes (see &#8220;<i><a href="#a_011">How do I vote?</a></i>&#8221; on page <a href="#a_011">4</a> in the accompanying
proxy statement):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    online or by telephone, by following the instructions included with the proxy card; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    by mail, by completing and returning the enclosed proxy card in the enclosed addressed stamped envelope.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement and the form of proxy, along with our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, were first
sent or given to stockholders on or about June 18, 2025. Additionally, on the same date, said proxy materials were made available
to our stockholders at https://ir.sonimtech.com/.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Your
vote will be especially important at this year&#8217;s annual meeting.</b> As you may be aware, AJP Holding Company, LLC,
a Delaware limited liability company (&#8220;AJP&#8221;) and Orbic North America, LLC, a New York limited liability company (&#8220;Orbic,&#8221;
and together with AJP, the &#8220;Orbic Group&#8221;) nominated five (5) director nominees (Douglas B. Benedict, Joseph
M. Glynn, Gregory M. Johnson, Surendra Singh, and Michael Wallace, collectively, the &#8220;Orbic Nominees&#8221;) for election
as directors at the Annual Meeting on the blue proxy card in opposition to five (5) director nominees recommended by our board
(James Cassano, Peter Liu, Mike Mulica, Jack Steenstra, and George Thangadurai). Our board does not endorse the Orbic Nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
board does not endorse the Orbic Nominees and recommends that you vote &#8220;FOR&#8221; the election of James Cassano, Peter Liu, Mike
Mulica, Jack Steenstra, and George Thangadurai on the WHITE proxy card</b>. Our board also recommends that you, using the <b>WHITE
</b>proxy card, vote &#8220;FOR&#8221; the ratification of the appointment of Baker Tilly US, LLP as our independent registered
public accounting firm, the increase of the shares available under our equity incentive plan, and the advisory vote on compensation of
our named executive officers, as well as selecting &#8220;3 YEARS&#8221; as the frequency of future advisory votes to approve executive
compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may receive a proxy statement, blue proxy card, and other solicitation materials from the Orbic Group. Since the Orbic Group has the
option to choose which of our stockholders will receive its proxy solicitation materials, you may or may not receive them. We are not
responsible for the accuracy of any information provided by, or relating to, the Orbic Group or the Orbic Nominees contained in any proxy
solicitation materials filed or disseminated by, or on behalf of, the Orbic Group or any other statements that the Orbic Group may otherwise
make.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Board strongly urges you to discard and not to sign or return any blue proxy card sent to you by the Orbic Group.</b> If you have previously
submitted a blue proxy card sent to you by the Orbic Group, you have every right to change your vote and we strongly urge you to revoke
that proxy by voting for our board&#8217;s nominees and on the other matters to be voted on at the Annual Meeting by using the enclosed
<b>WHITE </b>proxy card. You may vote your <b>WHITE </b>proxy card by mail using the postage-paid return envelope enclosed or by voting
via the Internet by following the instructions on your <b>WHITE </b>proxy card or <b>WHITE</b> voting instruction form. Only your latest
dated proxy will be counted, and any proxy may be revoked at any time prior to its exercise at the Annual Meeting as described in the
accompanying proxy statement. Even if you would like to elect one or more of the Orbic Nominees, we strongly recommend you use the Company&#8217;s
<b>WHITE </b>proxy card to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Please
note that this year, your proxy card looks different. It has more names on it than there are seats up for election. Under &#8220;universal
proxy card&#8221; requirements, the Company&#8217;s WHITE proxy card is required to list the Orbic Nominees in addition to the
board&#8217;s nominees. Please mark your card carefully and only vote &#8220;FOR&#8221; the nominees recommended by our board.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you return a properly signed <b>WHITE</b> proxy card voting &#8220;FOR&#8221; fewer than five (5) director nominees, only the marked
nominees will be voted; if you vote &#8220;FOR&#8221; more than five (5) nominees on your <b>WHITE</b> proxy card, no votes will be cast
with respect to the election of any director nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strongly encourage you to read the accompanying proxy statement carefully and to use the enclosed <b>WHITE</b> proxy card to vote for
the board&#8217;s nominees and in accordance with the board&#8217;s recommendations on the other proposals, as soon as possible. It
is important that your shares be represented at the Annual Meeting, regardless of the number of shares you hold. If you have any questions
or require any assistance with voting your shares, please contact Sodali &amp; Co, our proxy solicitor assisting us in connection with
the Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdefc14a_003.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">430
Park Avenue, 14th Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
Call Toll-Free in North America: (800) 662-5200</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outside of North America Call Collect: (203)&#160;658-94000</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">E-mail:<span style="text-decoration: underline">SONM@investor.sodali.com</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><img src="formdefc14a_002.jpg" alt=""/></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San Diego, California</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
18,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Proxy Statement</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">Important Information Regarding Delivery of Proxy Materials</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Cautionary Note Regarding Forward-Looking Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Website Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">General Information about 2025 Annual Meeting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">When are this proxy statement and the accompanying materials scheduled to be sent to stockholders?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Why
    did I receive these proxy materials?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_001">What if I receive more than one set of proxy materials?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_002">Why might I be receiving proxy materials from the Orbic Group?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">Who is soliciting my vote?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">When is the record date for the Annual Meeting?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">How many votes do I have?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">How do I vote?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">How does the Board recommend that I vote on the proposals?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_003">Will other candidates be nominated for election as directors at the annual meeting in opposition to the Board&#8217;s nominees?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_004">Is the Company using a universal proxy
    card in connection with voting at the Annual Meeting?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_005">How many nominees can be elected as directors at the Annual Meeting?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">Are there any matters to be voted on at the Annual Meeting that are not included in this proxy statement?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">May I change or revoke my proxy?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">How is a quorum reached?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">What is the effect if I fail to give voting instructions to my broker, bank, or other nominee?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">What are my voting options with respect to each proposal and how many votes are required to approve each proposal?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_006">What happens if I return a WHITE proxy card but give voting instructions for fewer than five (5) candidates?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_007">What happens if I return a WHITE proxy card but give voting instructions for more than five (5) candidates?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><a href="#lpa_001">What happens if the Orbic Group withdraws or abandons its solicitation or fails to comply with the universal proxy rules and I already granted proxy authority in favor of the Orbic Nominees?</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">What are the costs of soliciting these proxies?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">How are votes counted?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">How do I attend the Annual Meeting?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">Will there be a question and answer session?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">9</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">How can I know the voting results?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_008">Background of the Solicitation</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">10</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">Directors, Executive Officers, and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">Board of Directors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">Current composition of our Board</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">Board Nominees and Composition of the Board after the Annual Meeting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029">Biographical information of our directors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">13</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030">Executive officers</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">14</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031">Biographical information of our executive officers</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">15</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_032">Corporate governance documents</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">15</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_033">Board composition considerations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">15</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_034">Board leadership structure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_035">Role of the Board in risk oversight</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_036">Director independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_037">Committees of the Board</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_038">Board, committees, and stockholders meetings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_039">Audit Committee</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_040">Compensation Committee</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_041">Nominating and Corporate Governance Committee</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_042">Director nominations process</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_043">Anti-hedging policy</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_062">Clawback policy (recoupment of erroneously awarded incentive-based compensation)</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_044">Communications with the Board of Directors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_045">Proposal 1 &#8212; Election of Directors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_046">Proposal 2 &#8212; Ratification of Appointment of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_047">Audit Committee Report</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">23</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_048">Proposal 3 &#8212; Increase of the Shares Available under the Sonim Technologies, Inc. 2019 Equity Incentive Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_049">Proposal 4 &#8212; Advisory Vote on Compensation of Our Named Executive Officers</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">35</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_050">Proposal 5 &#8212; Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_051">Executive and Director Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_052">Certain Relationships and
    Related Person Transactions</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_053">Policies and procedures for related party transactions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_055">Security Ownership of Certain Beneficial Owners and Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_056">Delinquent Section 16 Reports</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">49</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_057">Other Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_058">Householding of proxy materials</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_059">Stockholder
    proposals for the 2026 annual meeting of stockholders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_060">Annex A &#8212; Amended Sonim Technologies, Inc. 2019 Equity Incentive Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#ab_009">Annex B &#8212; Supplemental Information Regarding Participants in the Company&#8217;s Solicitation of Proxies</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">B-1</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><img src="formdefc14a_001.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
    Technologies, Inc.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
    Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, California 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PROXY
STATEMENT<br/>
FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS<br/>
To be held on Friday, July 18, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement contains information about the 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Sonim
Technologies, Inc. (&#8220;Sonim,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221;) which will be held on Friday, July 18,
2025, at 9:00 a.m., Eastern Time. The Annual Meeting will be held virtually via live audio webcast. You will be able
to virtually attend the Annual Meeting as well as vote and submit your questions during the live audio webcast of the meeting by
visiting <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span> and entering the control number included on your proxy card or in the
instructions that accompanied your proxy materials. You will not be able to attend the Annual Meeting physically in person. For
purposes of attendance at the Annual Meeting, all references in this proxy statement to &#8220;present in person&#8221; or &#8220;in
person&#8221; shall mean virtually present at the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified,
the proxies will be voted in accordance with the recommendation of our Board of Directors (the &#8220;Board&#8221;) with respect to each
of the matters set forth in the accompanying notice of meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have previously submitted a blue proxy card sent to you by AJP Holding Company, LLC, a Delaware limited liability company (&#8220;AJP&#8221;)
and Orbic North America, LLC, a New York limited liability company (&#8220;Orbic,&#8221; and together with AJP, the &#8220;Orbic Group&#8221;)
you have every right to change your vote and we strongly urge you to revoke that proxy by voting for the Board&#8217;s nominees and on
the other matters to be voted on at the Annual Meeting by using the enclosed <b>WHITE</b> proxy card and returning it in the postage-paid
return envelope. Only your latest dated proxy will be counted. Even if you would like to elect some or all of the director nominees of
the Orbic Group (the &#8220;Orbic Nominees&#8221;), we strongly recommend you use the Company&#8217;s <b>WHITE</b> proxy card to do so.
You may revoke your proxy at any time before it is exercised at the meeting by one of the methods described under the title &#8220;<i><a href="#a_014">May I change or revoke my proxy?</a></i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of our principal executive offices is Sonim Technologies, Inc., 4445 Eastgate Mall, Suite 200 San Diego, California 92121.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>IMPORTANT
INFORMATION REGARDING DELIVERY OF PROXY MATERIALS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the SEC rules, a company may select either of the following options for making proxy materials available to its stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    full set delivery option; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    option often referred to as the &#8220;notice and access&#8221; option or the &#8220;notice-only&#8221; option. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
company may use a single method for all of its stockholders or use full set delivery for some while adopting the notice-only option
for others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Full
set delivery option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the full set delivery option, a company delivers all proxy materials to its stockholders by mail. In addition to delivery of proxy materials
to stockholders, a company must post all proxy materials on a publicly accessible website and provide information to stockholders about
how to access the website. <b>In connection with the Annual Meeting, we have elected to use the full set delivery option.</b> Accordingly,
you will receive all proxy materials by mail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notice-only
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the notice-only option, which we have elected <b>NOT</b> to use for the Annual Meeting, a company must post all proxy materials
on a publicly-accessible website. Instead of delivering proxy materials to its stockholders, a company may deliver a notice of Internet
availability of proxy materials, which includes, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    regarding the date and time of the annual meeting of stockholders, as well as the items to be considered at the meeting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    regarding the website where the proxy materials are posted; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">various
    means by which a stockholder can request paper or e-mail copies of the proxy materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder requests paper copies of the proxy materials, these materials must be sent to the stockholder within three business days
and by first class mail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
the notice and access option in the future</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have elected to use the full set delivery option in connection with the Annual Meeting, we may choose to use the notice-only
option in the future. By reducing the amount of materials that a company needs to print and mail, the notice and access option provides
an opportunity for cost savings as well as conservation of paper products. We will evaluate the future possible cost savings as well
as the possible impact on stockholder participation as we consider future use of the notice-only option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause the actual results,
performance, or achievements of the Company and its subsidiaries to be materially different from any future results, performance, or
achievements expressed or implied by such forward-looking statements. The words or phrases &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;potential,&#8221; &#8220;seek,&#8221; &#8220;evaluate,&#8221;
&#8220;pursue,&#8221; &#8220;continue,&#8221; &#8220;design,&#8221; &#8220;impact,&#8221; &#8220;affect,&#8221; &#8220;forecast,&#8221;
&#8220;target,&#8221; &#8220;outlook,&#8221; &#8220;initiative,&#8221; &#8220;objective,&#8221; &#8220;priorities,&#8221; &#8220;goal,&#8221;
or the negative of such terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. These forward-looking statements include, but are not limited to statements concerning our
goals, commitments, strategies and mission, our plans and expectations regarding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    approach to corporate governance; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of the increase in the shares authorized for issuance under our equity incentive plan on our ability to retain qualified employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place
undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions, and expectations
disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could
cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks
and uncertainties described in the section titled &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K and documents
we have filed with the SEC thereafter. Other unknown or unpredictable factors also could have material adverse effects on our future
results, performance, or achievements. In light of these risks, uncertainties, assumptions, and factors, the forward-looking events discussed
herein may not occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date
stated, or if no date is stated, as of the date hereof. Except as required by applicable law, the Company does not undertake any obligation
to publicly update or revise any forward-looking statements because of new information, future events or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>WEBSITE
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Websites
throughout this proxy statement are provided for reference only. Websites referred to herein are not incorporated by reference into this
proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>GENERAL
INFORMATION ABOUT 2025 ANNUAL MEETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>When
are this proxy statement and the accompanying materials scheduled to be sent to stockholders?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or about June 18, 2025, we will begin mailing our proxy materials, including the Notice of the 2025 Annual Meeting of Stockholders,
this proxy statement, and the accompanying <b>WHITE</b> proxy card or, for shares held in street name (<i>i.e.</i>, held for your account
by a broker, bank, or other nominee), a voting instruction form, and the Annual Report on Form 10-K for our fiscal year ended December
31, 2024 (the &#8220;2024 Annual Report&#8221;). Additionally, our proxy materials will be made available to our stockholders on the
Internet at https://ir.sonimtech.com/ on or about the same date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>Why
did I receive these proxy materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have delivered printed proxy materials to you because the Board is soliciting your proxy to vote at the Annual Meeting, including at
any postponements or adjournments thereof. You are invited to attend the Annual Meeting online to vote on the proposals described in
this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply complete, sign
and return the proxy card, or follow the instructions below to submit your proxy over the telephone or via the Internet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
proxy materials include a <b>WHITE </b>proxy card for the Annual Meeting. <b>WHITE</b> proxy cards are being solicited on behalf of the
Board. The Company&#8217;s proxy materials include detailed information about the matters that will be discussed and voted on at the
Annual Meeting and provide updated information about the Company that you should consider in order to make an informed decision when
voting your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_001"></span>What
if I receive more than one set of proxy materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may receive more than one set of proxy materials for two independent reasons:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you hold shares of our common stock in more than one account, which may be in registered
                                            form or held in street name. Please vote in the manner described under &#8220;<i>How do I
                                            vote?</i>&#8221; for each account to ensure that all of your shares are voted.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may receive a proxy statement, blue proxy card, and other solicitation materials from the
                                            Orbic Group. In this instance, as described in detail under &#8220;<i><a href="#ab_002">Why might I be receiving proxy materials from the Orbic Group?</a></i>&#8221; the Board strongly urges you to discard
                                            and not to sign or return any blue proxy card sent to you by the Orbic Group and instead
                                            to use the enclosed <b>WHITE</b> proxy card.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_002"></span>Why
might I be receiving proxy materials from the Orbic Group? </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further described in the &#8220;<i><a href="#ab_008">Background of the Solicitation</a></i>&#8221; section of this Proxy Statement, the Orbic Group notified
the Company that it nominated the Orbic Nominees for election as directors at the Annual Meeting in opposition to the five (5) nominees
recommended by the Board. The Company&#8217;s <b>WHITE</b> proxy card, therefore, includes the names of the purported Orbic Nominees.
The Board does not endorse the Orbic Nominees and recommends that you vote &#8220;FOR&#8221; the election of the five (5) nominees proposed
by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may receive a proxy statement, blue proxy card, and other solicitation materials from the Orbic Group. Since the Orbic Group has the
option to choose which of our stockholders will receive its proxy solicitation materials, you may or may not receive them. We are not
responsible for the accuracy of any information provided by, or relating to, the Orbic Group or its nominees contained in any proxy solicitation
materials filed or disseminated by, or on behalf of, the Orbic Group or any other statements that the Orbic Group may otherwise make.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board strongly urges you to discard and not to sign or return any blue proxy card sent to you by the Orbic Group. A vote to withhold
with respect to either of the Orbic Nominees on the Orbic Group&#8217;s proxy card will revoke any <b>WHITE</b> proxy card you may have
previously submitted. This means that, if you have submitted a validly executed proxy on the Company&#8217;s <b>WHITE</b> proxy card
voting &#8220;FOR&#8221; the nominees recommended by the Board but later submit a validly executed proxy on the Orbic Group&#8217;s blue
proxy card withholding your votes from the Orbic Nominees, your prior vote in favor of the nominees recommended by the Board will not
be counted. If you have previously submitted a blue proxy card sent to you by the Orbic Group, you have every right to change your vote
and we strongly urge you to revoke that proxy by voting for the Board&#8217;s nominees and on the other matters to be voted on at the
Annual Meeting by using the enclosed <b>WHITE</b> proxy card and returning it in the postage-paid return envelope or by voting via the
Internet by following the instructions on your <b>WHITE</b> proxy card or <b>WHITE</b> voting instruction form. Only your latest dated
proxy will be counted. Even if you would like to elect some or all of the Orbic Nominees, we strongly recommend you use the Company&#8217;s
<b>WHITE</b> proxy card to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>Who
is soliciting my vote?</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is soliciting your vote for the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
as noted above, the Orbic Group may solicit your vote for the Annual Meeting (since the Orbic Group has the option to choose which of
our stockholders will receive its proxy solicitation materials, you may or may not receive them).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>When
is the record date for the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for the determination of stockholders entitled to receive notice of and to vote at the Annual Meeting has been set as the
close of business on June 9, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>How
many votes do I have?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of common stock outstanding on the record date entitles the holder thereof to one vote, without cumulation, on each matter to be
voted upon at the meeting. As of the record date for the Annual Meeting, there were 10,338,905 shares of common stock, issued,
outstanding, and entitled to vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>How
do I vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
of Record: Shares Registered in Your Name</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder of record, you may vote by proxy over the telephone, vote by proxy online, or vote by proxy using and mailing
the enclosed <b>WHITE</b> proxy card. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure
your vote is counted. You may still attend the Annual Meeting by following the instructions described below and vote online during
the Annual Meeting, even if you have already voted by proxy. The details for each method of voting available to stockholders of record
are set forth below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    Internet or by telephone.</b> Follow the instructions included in the <b>WHITE</b> proxy card to vote by Internet or telephone.
    Telephone and Internet voting facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m.
    Eastern Time on July 17, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    mail.</b> You may complete, sign, and return the <b>WHITE</b> proxy card in the postage pre-paid envelope accompanying the
    proxy materials so that it is received prior to the Annual Meeting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>At
    the meeting.</b> If you attend the Annual Meeting, you can vote using the control number on your proxy card or in the instructions
    that accompanied your proxy materials. In order to vote online you must pre-register by 9:00 a.m. Eastern Time on July
    17, 2025, at <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Beneficial
Owner: Shares Registered in the Name of Broker, Bank or Other Nominee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; (meaning the shares are held in the name of a bank, broker, or other nominee who is
the record holder), you should have received a <b>WHITE</b> voting instruction form from that organization rather than from us. Simply
follow the voting instructions to ensure that your vote is counted. Prior to the Annual Meeting, you will be able to vote by mail, via
the Internet or by telephone. You may also obtain a &#8220;legal proxy&#8221; from your broker, bank, or other nominee and register
in advance to attend and vote at the Annual Meeting by following the instructions described below. Even if you wish to attend the Annual
Meeting, we urge you to vote your shares in advance of the Annual Meeting by following the instructions on your <b>WHITE</b> voting instruction
form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may hold your shares in more than one account and may receive separate proxy cards or voting instruction forms for each of those accounts.
To ensure that all of your shares are represented at the Annual Meeting, we recommend that you submit every <b>WHITE </b>proxy card or
<b>WHITE </b>voting instruction form you receive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have obtained a legal proxy and wish to participate in the Annual Meeting, you must pre-register by 9:00 a.m. Eastern
Time on July 17, 2025, at <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Orbic Group has notified the Company that it intends to file its own proxy statement with the SEC in connection with the solicitation
of proxies from stockholders of the Company. Accordingly, you may receive solicitation materials from the Orbic Group seeking your proxy
to vote in favor of the Orbic Nominees. If you do receive any materials other than from the Company, our Board strongly urges you to
discard and <b>NOT</b> to sign or return any proxy card sent to you by the Orbic Group, even if the Orbic Group&#8217;s blue proxy card
provides an option to vote for the Board&#8217;s nominees. Our Board recommends you vote &#8220;FOR&#8221; the Board&#8217;s five (5)
nominees by submitting the enclosed <b>WHITE</b> proxy card. Even if you would like to elect some or all of the Orbic Nominees, we strongly
recommend you use the Company&#8217;s <b>WHITE</b> proxy card to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>How
does the Board recommend that I vote on the proposals?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends that you vote your shares as follows by using the enclosed <b>WHITE</b> proxy card and returning it in the postage-paid
return envelope:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
    Matter</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
                                            Vote</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recommendation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page
                                            Reference</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    More</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information</b>&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    1 &#8212; Election of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    each <b>Sonim</b> nominee: <b>James Cassano</b>, <b>Peter Liu</b>, <b>Mike Mulica</b>, <b>Jack Steenstra</b>, and <b>George
    Thangadurai</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -20pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_045">21</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    2 &#8212; Ratification of Appointment of Independent Registered Public Accounting Firm</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_046">22</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    3 &#8212; Increase of the Shares Available under our Equity Incentive Plan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_048">24</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    4 &#8212; Advisory Vote on Compensation of Our Named Executive Officers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_049">35</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    5 &#8212; Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    YEARS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_050">36</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_003"></span>Will
other candidates be nominated for election as directors at the annual meeting in opposition to the Board&#8217;s nominees?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
The Orbic Group has notified the Company that it intends to nominate five (5) Orbic Nominees for election as directors at the Annual
Meeting in opposition to five (5) director nominees recommended by our Board. The Board does not endorse any of the Orbic Nominees. If
you have previously submitted a blue proxy card sent to you by the Orbic Group, you have every right to change your vote and we strongly
urge you to revoke that proxy by voting for the Board&#8217;s nominees and on the other matters to be voted on at the Annual Meeting
by using the enclosed <b>WHITE</b> proxy card and returning it in the postage-paid return envelope. Only your latest dated proxy will
be counted. Even if you would like to elect some or all of the Orbic Nominees, we strongly recommend you use the Company&#8217;s <b>WHITE
</b>proxy card to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_004"></span>Is
the Company using a universal proxy card in connection with voting at the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
SEC rules require the use of a universal proxy card in contested director elections. These universal proxy rules are applicable to the
Annual Meeting. The Board&#8217;s nominees and the Orbic Nominees will be included on the universal proxy card. Each of the Company and
the Orbic Group will use its own version of a universal proxy card containing the names of both the Board&#8217;s nominees and the Orbic
Nominees. Although the Company is required to include all nominees for election on its universal proxy card, the Company does <b>NOT
</b>endorse any of the Orbic Nominees and strongly recommends you use the Company&#8217;s <b>WHITE</b> proxy card to vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_005"></span>How
many nominees can be elected as directors at the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
five (5) nominees can be elected to the Board at the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>Are
there any matters to be voted on at the Annual Meeting that are not included in this proxy statement?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the date of this proxy statement, we did not know of any matters to be properly presented at the Annual Meeting other than those referred
to in this proxy statement. If other matters are properly presented at the meeting or any postponement or adjournment thereof for consideration,
and you are a stockholder of record and have submitted a proxy card, the persons named in your proxy card will have the discretion to
vote on those matters for you.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>May
I change or revoke my proxy?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
You may change or revoke your previously submitted proxy at any time before the Annual Meeting or, if you attend the Annual Meeting virtually,
at the Annual Meeting before the polls close.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
of Record: Shares Registered in Your Name</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares as a record holder, you may change or revoke your proxy in any one of the following ways:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                            re-voting at a subsequent time by Internet or by telephone. Follow the instructions included
                                            in the <b>WHITE</b> proxy card to vote by Internet or telephone. Your Internet or telephone
                                            vote must be received by 11:59 PM Eastern Time on July 17, 2025, to be counted;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may submit another properly completed <b>WHITE</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    proxy card with a later date. Your proxy card must be received before the polls close to be counted;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    timely delivering a signed revocation letter to the following address: Sodali &amp; Co 430 Park Ave. 14<sup>th</sup> Floor
    New York, NY 10022; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    attending the Annual Meeting and voting virtually. Attending the Annual Meeting virtually will not in and of itself revoke a previously
    submitted proxy. You must specifically request at the Annual Meeting that it be revoked by voting at the Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
latest-dated proxy card, Internet, or telephone vote is the one that is counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Beneficial
Owner: Shares Registered in the Name of Broker, Bank, or Other Nominee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in the name of a bank, broker, or other nominee, you may change your voting instructions by following the instructions
of your bank, broker, or other nominee. In most cases, you will be able to do this by mail, via the Internet or by telephone.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
vote to withhold with respect to either of the Orbic Nominees on the Orbic Group&#8217;s proxy card will revoke any <b>WHITE</b> proxy
card you may have previously submitted. This means that, if you have submitted a validly executed proxy on the Company&#8217;s <b>WHITE
</b>proxy card voting &#8220;FOR&#8221; the nominees recommended by the Board but later submit a validly executed proxy on the Orbic
Group&#8217;s blue proxy card withholding your votes from the Orbic Nominees, your prior vote in favor of the nominees recommended by
the Board will not be counted. If you have previously submitted a blue proxy card sent to you by the Orbic Group, you have every right
to change your vote and we strongly urge you to revoke that proxy by voting for the Board&#8217;s nominees and on the other matter to
be voted on at the Annual Meeting by using the enclosed <b>WHITE</b> proxy card and returning it in the postage-paid return envelope
or by voting via the Internet by following the instructions on your <b>WHITE</b> proxy card or <b>WHITE</b> voting instruction form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>How
is a quorum reached?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws provide that the presence, in person, by remote communication, or by proxy of the holders of one-third of
the voting power of the outstanding shares of our common stock entitled to vote will constitute a quorum for the transaction of business
at the Annual Meeting. Thus, votes of stockholders of record who are present at the Annual Meeting virtually or by proxy, broker non-votes,
and abstentions will be counted for purposes of determining whether a quorum exists.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, as of the record date for the Annual Meeting, there were 10,338,905 shares of common stock, issued, outstanding,
and entitled to vote, which means that 3,446,303 shares of common stock must be present in person or represented by proxy at
the Annual Meeting to establish a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the General Corporation Law of the State of Delaware, shares that are voted &#8220;abstain&#8221; or &#8220;withheld&#8221; and &#8220;broker
non-votes&#8221; are counted as present for purposes of determining whether a quorum is present at the Annual Meeting. If a quorum is
not present, the meeting may be adjourned until a quorum is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>What
is the effect if I fail to give voting instructions to my broker, bank, or other nominee?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; by a broker, bank, or other nominee, your broker, bank, or other nominee is required
to vote your shares according to your instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;broker non-vote&#8221; occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because
the nominee does not have discretionary voting power with respect to that item and has not received instructions from the beneficial
owner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a proposal is routine and, therefore, a discretionary item, your broker, bank, or other nominee will be able to vote on such proposal
even if it does not receive instructions from you. If a proposal is a non-routine proposal and, therefore, a &#8220;non-discretionary&#8221;
item, in the event you do not instruct your broker, bank, or other nominee how to vote with respect to such proposal, your broker,
bank, or other nominee may not vote for this proposal, and those votes will be counted as &#8220;broker non-votes.&#8221; If you do not
give instructions to your broker, bank, or other nominee, the broker, bank, or other nominee will still be able to vote your shares with
respect to certain &#8220;discretionary&#8221; items on &#8220;routine&#8221; proposals but will not be allowed to vote your shares
with respect to &#8220;non-discretionary&#8221; items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table set forth below illustrates whether each proposal is routine or non-routine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
    Matter</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Routine
    or non-Routine </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    1 &#8212; Election of Directors<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-routine</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    2 &#8212; Ratification of Appointment of Independent Registered Public Accounting Firm</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Routine<sup>(2)</sup></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    3 &#8212; Increase of the Shares Available under our Equity Incentive Plan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-routine</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    4 &#8212; Advisory Vote on Compensation of Our Named Executive Officers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-routine</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    5 &#8212; Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-routine</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 40.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board does not endorse the Orbic Nominees and recommends that you vote &#8220;FOR&#8221;
                                            the election of the five (5) nominees proposed by the Board.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 40.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Typically,
                                            this proposal is considered to be a &#8220;routine&#8221; matter, and we would not expect
                                            any broker non-votes. Typically, if you hold your shares in street name and do not provide
                                            voting instructions to your broker, bank or other nominee that holds your shares, your broker,
                                            bank, or other nominee generally has discretionary authority to vote your shares on
                                            this proposal. However, to the extent that the Orbic Group provides a blue proxy card (or
                                            voting instruction form to stockholders who hold their shares in &#8220;street name&#8221;),
                                            the proposal included in this proxy statement will be a &#8220;non-routine&#8221; matter
                                            with respect to such stockholders, and brokers, banks, or other nominees will not
                                            have discretionary voting authority to vote on any proposal presented at the Annual Meeting.
                                            If, however, the Orbic Group does not provide a blue proxy card (or voting instruction form
                                            to stockholders who hold their shares in &#8220;street name&#8221;), then this proposal would
                                            be considered to be a &#8220;routine&#8221; matter with respect to those stockholders, and
                                            such stockholders&#8217; broker, bank, or other nominee would be able to vote upon
                                            the matter if the stockholders do not provide them with specific voting instructions. However,
                                            in that event, it is possible that a broker, bank, or other nominee may choose not
                                            to exercise discretionary authority with respect to this proposal. In that case, if you do
                                            not instruct your broker, bank, or other nominee how to vote with respect to this
                                            proposal, your broker, bank, or other nominee may not vote with respect to such proposal.
                                            To the extent there are broker non-votes, they will have no effect on this proposal. Therefore,
                                            we encourage you to instruct your broker, bank, or other nominee to vote your shares
                                            by filling out and returning the enclosed <b>WHITE</b> proxy card.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_018"></span>What
are my voting options with respect to each proposal and how many votes are required to approve each proposal?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table set forth below illustrates the voting options, vote required, and effect of abstentions and broker non-votes for each proposal,
assuming a quorum is present at the Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
    Matter</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
    Options</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
    Required</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker
    Discretionary Voting Allowed</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
    of Broker<br/>
    Non-Votes</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
    of Abstentions</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    1 &#8212; Election of Directors<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    or withhold with respect to each nominee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plurality
    of the votes cast by the holders of the shares entitled to vote on the matter (five (5) nominees receiving the highest number
    of affirmative FOR votes will be elected)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect<sup>(3)</sup></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    2 &#8212; Ratification of Appointment of Independent Registered Public Accounting Firm<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For,
    against, or abstain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affirmative
    vote of the holders of a majority of the voting power of the shares present in person or by proxy at the Annual Meeting and entitled
    to vote on the matter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Against</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    3 &#8212; Increase of the Shares Available under our Equity Incentive Plan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For,
    against, or abstain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affirmative
    vote of the holders of a majority of the voting power of the shares present in person or by proxy at the Annual Meeting and entitled
    to vote on the matter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Against</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    4 &#8212; Advisory Vote on Compensation of Our Named Executive Officers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For,
    against, or abstain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affirmative
    vote of the holders of a majority of the voting power of the shares present in person or by proxy at the Annual Meeting and entitled
    to vote on the matter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Against</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    5 &#8212; Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
    Year, Two Years, Three Years, or abstain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affirmative
    vote of the holders of a majority of the voting power of the shares present in person or by proxy at the Annual Meeting and entitled
    to vote on the matter</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    effect</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board does not endorse the Orbic Nominees and recommends that you vote &#8220;FOR&#8221;
                                            the election of the five (5) nominees proposed by the Board.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Typically,
                                            this proposal is considered to be a &#8220;routine&#8221; matter, and we would not expect
                                            any broker non-votes. Typically, if you hold your shares in street name and do not provide
                                            voting instructions to your broker, bank, or other nominee that holds your shares,
                                            your broker, bank, or other nominee generally has discretionary authority to vote
                                            your shares on this proposal. However, to the extent that the Orbic Group provides a blue
                                            proxy card (or voting instruction form to stockholders who hold their shares in &#8220;street
                                            name&#8221;), the proposal included in this proxy statement will be a &#8220;non-routine&#8221;
                                            matter with respect to such stockholders, and brokers, banks, or other nominees will
                                            not have discretionary voting authority to vote on any proposal presented at the Annual Meeting.
                                            If, however, the Orbic Group does not provide a blue proxy card (or voting instruction form
                                            to stockholders who hold their shares in &#8220;street name&#8221;), then this proposal would
                                            be considered to be a &#8220;routine&#8221; matter with respect to those stockholders, and
                                            such stockholders&#8217; broker, bank, or other nominee would be able to vote upon
                                            the matter if the stockholders do not provide them with specific voting instructions. However,
                                            in that event, it is possible that a broker, bank, or other nominee may choose not
                                            to exercise discretionary authority with respect to this proposal. In that case, if you do
                                            not instruct your broker, bank, or other nominee how to vote with respect to this
                                            proposal, your broker, bank, or other nominee may not vote with respect to such proposal.
                                            To the extent there are broker non-votes, they will have no effect on this proposal. Therefore,
                                            we encourage you to instruct your broker, bank, or other nominee to vote your shares
                                            by filling out and returning the enclosed <b>WHITE </b>proxy card.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
                                            are not applicable. Votes withheld will not be counted as votes cast and will have no effect.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_006"></span>What
happens if I return a WHITE proxy card but give voting instructions for fewer than five (5) nominees?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
undervote is an instance in which a stockholder returns a proxy card in a director election contest but does not exercise a vote with
respect to all the seats up for election at the Annual Meeting. To the extent an undervote (<i>i.e.</i>, voting &#8220;FOR&#8221; with
respect to fewer than the five (5) nominees on Proposal 1) occurs on a record holder&#8217;s <b>WHITE</b> proxy card, the shares will
only be voted &#8220;FOR&#8221; that nominee so marked. If you are a beneficial holder and you vote &#8220;FOR&#8221; fewer than five
(5) nominees on your <b>WHITE</b> voting instruction form (<i>i.e.</i>, an undervote), your votes on the election of directors will only
be voted &#8220;FOR&#8221; the nominee you have so marked.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_007"></span>What
happens if I return a WHITE proxy card but give voting instructions for more than five (5) nominees?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
overvote is an instance in which a stockholder returns a proxy card in a director election contest but exercises a vote &#8220;FOR&#8221;
more than the available seats up for election at the Annual Meeting. To the extent an overvote (<i>i.e.</i>, voting &#8220;FOR&#8221;
with respect to more than the five (5) nominees on Proposal 1) occurs on a record holder&#8217;s <b>WHITE</b> proxy card, such votes
on the election of directors will be invalid and will not be counted. If you are a beneficial holder and you vote &#8220;FOR&#8221; more
than five (5) nominees on your <b>WHITE</b> voting instruction form (<i>i.e.</i>, an overvote), your votes on the election of directors
will be invalid and will not be counted. In addition, depending on the broker, bank, or other nominee through which you hold your
shares, your votes on all other proposals before the Annual Meeting may also be invalid and not counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><span id="lpa_001"></span>What happens if the Orbic Group
withdraws or abandons its solicitation or fails to comply with the universal proxy rules and I already granted proxy authority in favor
of the Orbic Nominees?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders
are encouraged to submit their votes on the <b>WHITE</b> proxy card (or <b>WHITE</b> voting instruction form, if applicable). If the
Orbic Group withdraws or abandons its solicitation or fails to comply with the universal proxy rules after a stockholder has already
granted proxy authority, stockholders can still sign and date a later submitted <b>WHITE</b> proxy card (or <b>WHITE</b> voting
instruction form, if applicable). If the Orbic Group withdraws or abandons its solicitation or fails to comply with the universal
proxy rules (by, for example, failing to solicit the requisite number of holders of our outstanding common stock), any votes cast in
favor of the Orbic Nominees will be disregarded and will not be counted, whether such vote is provided on the Company&#8217;s <b>WHITE</b>
proxy card (or <b>WHITE </b>voting instruction form) or the Orbic Nominees&#8217; blue proxy card.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_019"></span><b>What
are the costs of soliciting these proxies, and who is paying for this proxy solicitation?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all of the costs of soliciting these proxies. We and our directors (including our director nominees), as well as other persons
who solicit proxies on our behalf, are considered to be &#8220;participants&#8221; in this proxy solicitation under applicable SEC regulations.
Please refer to <a href="#ab_009">Annex B</a>, Supplemental Information Regarding Participants in the Company&#8217;s Solicitation of Proxies, for information
about our directors (including our director nominees) as well as information about certain of our executive officers and other employees
who may solicit proxies on our behalf. Other than the persons described in <a href="#ab_009">Annex B</a>, none of our employees will be employed to solicit
proxies. However, in the course of their regular duties, employees may be asked to perform clerical or ministerial tasks in furtherance
of our solicitation of proxies. For example, in addition to these proxy materials, our directors and employees may solicit proxies
in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation
for soliciting proxies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have retained Sodali &amp; Co to aid in the solicitation of proxies and related advisory services for a fee of up to approximately $125,000,
plus reimbursement of expenses. We may incur additional fees if we request additional services. Sodali &amp; Co estimates that approximately
25 of its employees will assist in our proxy solicitation. We will request brokers, banks, or other nominees in whose names shares of
common stock are registered to furnish to the beneficial holders this proxy statement and the <b>WHITE</b> proxy card, and any other
materials related to the Annual Meeting, including our Annual Report on Form 10-K for the year ended December 31, 2024, and, upon request,
we will reimburse such brokers, banks, or other nominees for their out-of-pocket and other reasonable expenses in connection therewith.
Other than the fee paid to Sodali &amp; Co, as described above, our expenses in connection with our solicitation of proxies, excluding
normal expenses related to a non-contested solicitation of proxies and excluding salaries and wages of our officers and regular employees,
are expected to aggregate to approximately $350,000. Approximately $20,000 of the estimated solicitation costs have been expended
to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_020"></span><b>How
are votes counted?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes
will be counted by the independent inspector of elections appointed for the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_021"></span><b>How
do I attend the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will host the Annual Meeting live online via audio webcast. In order to attend the Annual Meeting, you must register in advance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholders
of Record</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were a stockholder of record as of the close of business on the record date, you may register to attend the Annual Meeting prior
to the deadline of July 17, 2025, at 9:00 a.m. Eastern Time by going to <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span>
and entering the control number provided on your <b>WHITE</b> proxy card.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you do not have your <b>WHITE</b> proxy card, you may still register to attend the Annual Meeting by going to <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span>,
but you will need to provide proof of ownership of shares of our common stock as of the record date during the registration process.
Such proof of ownership may include a copy of your <b>WHITE</b> proxy card received from the Company or blue proxy card received from
the Orbic Group, or a statement showing your ownership as of the record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Beneficial
Owners</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were the beneficial owner of shares (you held your shares in &#8220;street name&#8221; through an intermediary such as a broker,
bank, or other nominee) as of the record date, you may register to attend the Annual Meeting prior to the deadline of July 17,
2025 at 9:00 a.m. Eastern Time by going to <span style="text-decoration: underline">www.cesonlineservices.com/sonm25_vm</span> and providing evidence during
the registration process that you beneficially owned shares of our common stock as of the record date, which may consist of a copy of
the voting instruction form provided by your broker, bank, or other nominee, an account statement, or a letter or legal proxy
from such broker, bank, or other nominee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Generally</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
registering, you will receive a confirmation e-mail prior to the Annual Meeting with a link and instructions for entering the virtual
Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the meeting webcast will begin at 9:00 a.m. Eastern Time on July 18, 2025, we encourage you to access the meeting site
prior to the start time to allow ample time to log into the meeting webcast and test your computer system. Accordingly, the Annual Meeting
site will first be accessible to registered stockholders beginning at 8:45 a.m. Eastern Time on the day of the meeting.
All stockholders who register to attend the Annual Meeting will receive an e-mail prior to the Annual Meeting containing the contact
details of technical support in the event they encounter difficulties accessing the virtual meeting or during the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are encouraged to contact technical support if they encounter any technical difficulties with the meeting webcast. In the event of any
technical disruptions that prevent the chairperson of the Annual Meeting from hosting the Annual Meeting within 30 minutes of the date
and time set forth above, the meeting may be adjourned or postponed in the chairperson&#8217;s discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not you plan to attend the Annual Meeting, we urge you to sign, date and return the enclosed <b>WHITE</b> proxy card in the postage-paid
envelope provided, or vote via the Internet or by telephone as instructed on the <b>WHITE</b> proxy card. If you have any difficulty
following the registration process, please e-mail SONM@investor.sodali.com.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_022"></span><b>Will
there be a question and answer session?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
as of the close of business on the record date who register in advance and attend the Annual Meeting will have an opportunity to submit
questions live via the Internet during a designated portion of the Annual Meeting. We intend to answer appropriate questions that are
pertinent to the Company and the Annual Meeting matters, as time permits, and are submitted via the Annual Meeting virtual platform by
stockholders during the Annual Meeting. Questions should be succinct and only cover a single topic. We will endeavor to address as many
questions submitted by stockholders as time permits, and will not address questions that are, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">irrelevant
    to the business of the Company or to the business of the Annual Meeting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related
    to material non-public information of the Company, including the status or results of our business since our last Annual Report on
    Form 10-K and subsequent quarterly reports;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related
    to any pending, threatened, or ongoing litigation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related
    to personal grievances;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">derogatory
    references to individuals or those that are otherwise in bad taste;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantially
    repetitive of questions already submitted by another stockholder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    excess of the&#160;question limit;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    furtherance of the stockholder&#8217;s personal or business interests; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">out
    of order or not otherwise suitable for the conduct of the Annual Meeting as determined by the chairperson or secretary of the Annual
    Meeting in their reasonable judgment.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_024"></span><b>How
can I know the voting results?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
this is a contested election, we do not intend to announce voting results during the Annual Meeting. Final voting results will be published
in a Current Report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are
not available to us in time to file a Form 8-K within four business days after the Annual Meeting, we intend to file a Form 8-K to publish
preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the
final results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_008"></span>BACKGROUND
OF THE SOLICITATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
at least 2021, as part of the Company&#8217;s ongoing investor relations and stockholder engagement efforts, the Company&#8217;s management
has maintained regular dialogue with AJP and the Wang family of which Mr. Jeffrey Wang, Sonim&#8217;s current director, is a member.
In October 2021, Dr. Chuan Wang&#8212;Mr. Wang&#8217;s father&#8212;and other members of the Wang family, including individuals who later
formed AJP and became its sole equityholders, informally approached Mr. Peter Liu, then Executive Vice President for Global Operations
and Engineering at Sonim, regarding a potential investment in or acquisition of the Company. After negotiations and stockholder approval,
AJP and Sonim entered into a subscription agreement, resulting in AJP acquiring approximately 48% of the Company&#8217;s then-voting
power (the &#8220;AJP Shares&#8221;) and Mr. Wang joining the Board of Directors. Since then, AJP has been the Sonim stockholder
with the highest voting power. A detailed summary of this transaction is available in Sonim&#8217;s definitive proxy statement
filed with the SEC on May 23, 2022, under the heading &#8220;Background of the Transaction.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2024, Reliance Communications, LLC (&#8220;Reliance&#8221;), a competitor of Sonim and an affiliate of Orbic North America,
LLC (&#8220;Orbic&#8221;), filed a lawsuit in the United States District Court for the Eastern District of New York against Sonim,
Dr. Chuan Wang, and two entities controlled by Dr. Wang (<i>Reliance Communications, LLC v. Wang et al.</i>, 24-CV-4433 (&#8220;IP
Litigation&#8221;)), alleging misappropriation of trade secrets. Sonim regards the lawsuit as meritless and has asked the Court to
dismiss it with prejudice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2025, Orbic publicly announced that it had reached an &#8220;agreement in principle&#8221; to acquire a substantial block
of Sonim&#8217;s common stock from AJP. This announcement, made without prior notice to the Company, included Orbic&#8217;s stated intent
to pursue discussions with Sonim regarding a potential acquisition. In response, the Board formed a special committee of independent
directors not affiliated with AJP (the &#8220;Special Committee&#8221;) to evaluate strategic alternatives, including Orbic&#8217;s overture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On January 28,
2025, immediately following a meeting of the Board at which Mr. Wang was present (but Dr. Wang was not), Dr. Wang contacted Mr. Liu to
challenge his position on a vote relating to Sonim&#8217;s proposed financing initiatives. During this communication, Dr. Wang expressly
advocated for the resignation of the entire Board and for actions aligned with Orbic&#8217;s interests. He further asserted that Orbic
intended to pursue litigation against Sonim&#8217;s officers and directors in their individual capacities and demanded that Sonim cease
pursuing any additional financing unless the Board resigned. Dr. Wang also demanded that Sonim cease any efforts to secure additional
operational financing unless the Board resigns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 5, 2025, Reliance&#8217;s counsel in the IP Litigation asserted that Mr. Wang had shared Sonim&#8217;s material nonpublic information
with Reliance and Orbic.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 6, 2025, the Board notified Mr. Wang that his involvement in these disclosures appeared to constitute
a breach of fiduciary duty and Sonim&#8217;s Insider Trading Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2025, in contravention of Sonim&#8217;s Insider Trading Policy, AJP and Mr. Wang notified the Company that they had finalized
a stock purchase agreement with Orbic for a portion of the AJP Shares. The Insider Trading Policy required pre-clearance of all transactions
involving Company insiders and expressly prohibited transactions during designated blackout periods. AJP and Mr. Wang failed to comply
with both requirements. They stated, &#8220;AJP and Orbic have finalized and fully executed the stock purchase agreement. Orbic&#8217;s
lawyers should be following up with the Special Committee shortly with their proposal.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4, 2025, the Board determined that the purported transaction between AJP and Orbic occurred in violation of the Insider Trading
Policy and possibly involved trading on material nonpublic information. The Board further concluded that the transaction was inconsistent
with the prospectus in the registration statement covering the resale of the AJP Shares, which explicitly conditioned resales on compliance
with Sonim&#8217;s internal governance policies, including the Insider Trading Policy. In light of the violations and AJP&#8217;s failure
to respond to multiple inquiries regarding the Insider Trading Policy Compliance, the Company issued a stop transfer order with respect
to the AJP Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Around
the same time, on or about February 4, 2025, Orbic submitted a vague two-page &#8220;Proposal / Discussion Agenda&#8221; to Sonim. The
materials proposed a forced overhaul of the Company&#8217;s leadership and suggested a &#8220;collaboration&#8221; with Orbic to follow
such a change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, Dr. Chuan Wang, the father of Jeffrey Wang, sent an e-mail to the Board demanding the immediate resignation of Sonim&#8217;s
leadership and asserting that Orbic must take over Sonim. Dr. Wang further informed the Board that all transactions with Sonim and entities
controlled by him, directly or indirectly, would be discontinued immediately unless and until the leadership transition occurred. Despite
these threats, the Special Committee continued its search and assessment of strategic alternatives, including Orbic, and successfully
persuaded Dr. Wang to withdraw his threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2025, AJP and Orbic entered into an agreement and irrevocable proxy to provide Orbic with sole voting power over all AJP shares&#8212;1,946,345 shares of common stock&#8212;to use in connection with a contemplated proxy solicitation for the election of a slate
of nominees for election to Sonim&#8217;s Board at its 2025 annual meeting, which, in violation of Rule 13d-2 promulgated under the Exchange
Act, AJP failed to disclose within two business days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2025, the Orbic Group&#8212;comprising Orbic, AJP, and their affiliates&#8212;filed an amended Schedule 13D, disclosing the
existence of the Orbic Group and the irrevocable proxy. This was the first time Sonim received visibility into the actual terms of the
purported &#8220;fully executed&#8221; agreement previously referenced by AJP on February 3, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the evening of March 20, 2025&#8211;less than two business days before the nomination deadline&#8211;the Orbic Group submitted a
purported notice of nomination (the &#8220;Notice&#8221;) proposing a competing slate of directors for election at the Annual Meeting.
Orbic purported to submit the Notice pursuant to Section 5 (&#8220;Section 5&#8221;) of Sonim&#8217;s amended and restated bylaws (the
&#8220;Bylaws&#8221;). Section 5 of the Bylaws was adopted in connection with Sonim&#8217;s initial public offering in 2019 and has remained
unchanged since that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2025, the Orbic Group submitted a non-binding proposal (the &#8220;First Orbic Proposal&#8221;) to acquire Sonim for $4.00
per share in cash. Simultaneously, the Orbic Group served a books and records demand (the &#8220;220 Demand&#8221;) under Section
220 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) seeking documents in connection with the proxy contest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2025, the Special Committee, through its financial adviser, ROTH Capital Partners, responded to the First Orbic Proposal, among
other things, requesting documentation evidencing Orbic&#8217;s ability to fund and consummate the proposed transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2025, the Special Committee reiterated the above-mentioned request in a letter to Orbic and expressed hope to move forward with
the First Orbic Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 7, 2025, the Board concluded that the Notice was missing information required by the Bylaws. Because this information was missing,
the Board concluded that the Notice was not submitted in compliance with the Bylaws, and the Board determined to reject the Notice. On
the same day, Sonim advised Orbic that the Notice was defective due to the missing information and that it had been rejected by the Board
and Sonim.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 10, 2025, Orbic responded, disputing the Company&#8217;s conclusion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 24, 2025, AJP, on behalf of itself and Orbic, filed a complaint (the &#8220;Complaint&#8221;) in the Delaware Court of Chancery
against Sonim and directors Mike Mulica, James Cassano, Peter Liu, and Jack Steenstra (the &#8220;Director Defendants&#8221;).
The Complaint alleged that the individual defendants breached their fiduciary duties and sought, among other relief, a declaration to
that effect and an injunction prohibiting enforcement of certain provisions of Sonim&#8217;s Bylaws in connection with the Notice. Orbic
and AJP also filed a motion for expedited proceedings with the Complaint.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2025, AJP, Orbic, and related parties filed a preliminary proxy statement soliciting votes for the Orbic Nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 2, 2025, the Delaware Court of Chancery granted the motion for expedited proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2025, the Board determined it was advisable and in the best interests of Sonim to waive the deficiency in the Notice rather than
to engage in a protracted litigation. On the same day, Sonim&#8217;s counsel notified Orbic&#8217;s counsel of the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company&#8217;s counsel sent an e-mail to the Orbic Group, providing the Orbic Group with the required notification
of the Company&#8217;s nominees for election at the Annual Meeting, pursuant to Rule 14a-19(d) under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2025, Sonim produced the stocklist materials requested in the 220 Demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
same day, Orbic submitted a revised, preliminary, and conditional non-binding proposal (the &#8220;Second Orbic Proposal&#8221;) to acquire
Sonim for $1.81 per share in cash. The Second Orbic Proposal included a letter of interest from Capstone Project Finance, LLC, marked
&#8220;confidential,&#8221; which was preliminary, non-binding, subject to extensive conditions, and dated as of April 11, 2025 (well
before Orbic&#8217;s formal submission).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 19, 2025, following a review of publicly available information regarding Orbic&#8217;s financial condition, the Special Committee
concluded that Orbic had failed to demonstrate the financial wherewithal to consummate the Second Orbic Proposal and communicated to
Orbic as such. The Special Committee also informed Orbic that it observed that the proposal was replete with criticisms of the Special
Committee and Board and offered little substantive information in connection with the transaction proposed by Orbic. The Special Committee
replied that it determined that the Second Orbic Proposal was not a genuine effort to engage in constructive negotiations but rather
a tactical maneuver to further Orbic&#8217;s proxy campaign, and expressed its disappointment with Orbic&#8217;s conduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 2, 2025, we, AJP,
Orbic and the Director Defendants entered into a Stipulation of Dismissal pursuant to which AJP and Orbic dismissed the Complaint without
prejudice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_025"></span>DIRECTORS,
EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_026"></span>Board
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is managed under the direction of our Board, which is currently composed of five (5) members. Four (4) of our five (5) directors
are independent within the meaning of the independent director requirements of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has selected four (4) of the incumbent directors for re-election and one (1) new director for election at the Annual Meeting. Each
director to be elected and qualified will hold office until the next annual meeting of stockholders and until his or her respective successor
is elected, or, if sooner, until the director&#8217;s death, resignation, or removal. The entirety of our incumbent directors were elected
at the Company&#8217;s 2024 annual meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_027"></span>Current
composition of our Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names, ages as of April 30, 2025, and certain other information for each of our current directors with
terms expiring at the Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            First</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Became</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Governance</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano<i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu <i><br/>
    Director, Chief Executive Officer</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica <i><br/>
    Director, Chairman of the Board</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra <i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang <i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Audit Committee Financial Expert</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_028"></span>Board
Nominees and Composition of the Board after the Annual Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
recommendation of our Nominating and Corporate Governance Committee, we nominated four (4) of the incumbent directors and one (1) new
director, who, if elected and qualified, will hold office until the next annual meeting of stockholders and until his or her respective
successor is elected, or, if sooner, until the director&#8217;s death, resignation, or removal. The following table sets forth the names,
ages as of April 30, 2025, and certain other information on the composition of our Board, assuming all the director nominees are elected:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            First</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Became</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
    Governance</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano<i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu <i><br/>
    Director, Chief Executive Officer</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica <i><br/>
    Director, Chairman of the Board</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra <i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai<i><br/>
    Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Audit Committee Financial Expert</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_029"></span>Biographical
information of our directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>James
Cassano</i></b> has served as a member of our Board since July 2022. Mr. Cassano currently is the Vice Chairman and Lead Independent
Director of Ideanomics, Inc., where he is Chairman of the Audit Committee and a member of the Compensation, Acquisition Oversight and
Risk and Disclosure Committees. Mr. Cassano has been on the Board of Directors of Ideanomics since 2008. From December 2009 through December
2021, Mr. Cassano served as a Partner &amp; Chief Financial Officer of CoActive Health Solutions, LLC, a worldwide contract research
organization, supporting the pharmaceutical and biotechnology industries. From 2005 through 2009, Mr. Cassano was a partner in Jaguar
Capital Partners, a private equity company, which formed Jaguar Acquisition Corporation (OTCBB: JGAC), a blank check company. Mr. Cassano
served as executive vice president, chief financial officer, secretary, and director of Jaguar Acquisition Corporation. In June 1998,
Mr. Cassano founded New Forum Publishers, an electronic publisher of educational material for secondary schools, and served as its chairman
of the Board and chief executive officer until it was sold to Apex Learning, Inc., a company controlled by Warburg Pincus, in August
2003. He remained with Apex until November 2003 in transition as vice president of business development and served as a consultant to
the company through February 2004. In June 1995, Mr. Cassano co-founded Advantix, Inc., a high volume electronic ticketing software and
transaction services company which handled event related client and customer payments, that was renamed Tickets.com and went public through
an IPO in 1999. From March 1987 to June 1995, Mr. Cassano served as senior vice president and chief financial officer of the Hill Group,
Inc., a privately-held engineering and consulting organization, and from February 1986 to March 1987, Mr. Cassano served as Vice President
of Investments and Acquisitions for Safeguard Scientifics, Inc., a public venture development company. From May 1973 to February 1986,
Mr. Cassano served as partner and director of strategic management services (Europe) for the strategic management group of Hay Associates.
Mr. Cassano received a BS in Aeronautics and Astronautics from Purdue University and an MBA from Wharton Graduate School at the University
of Pennsylvania. The Board believes that Mr. Cassano&#8217;s extensive financial and executive experience with multiple private and public
companies qualifies him to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Peter
Liu</i></b> has served as a member of our Board since July 2022. Mr. Liu has served as our Chief Executive Officer since April 2022.
Mr. Liu previously served as our Executive Vice President for Global Operations from September 2010 to April 2022. From 2007 to 2010,
Mr. Liu served as Global Quality Director for LOM/Perlos, an international VI supplier of mobile phones. From 2005 to 2007, Mr. Liu was
the Head of Quality for the Strategic Growth Engine business at Motorola Solutions, Inc., a multinational telecommunications company.
Mr. Liu received an M.B.A. from Lawrence Technological University and a Bachelor&#8217;s in Engineering from Tianjin University. The
Board believes that Mr. Lui&#8217;s experience as our Executive Vice President for Global Operations and his knowledge of our Company
qualifies him to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mike
Mulica</i></b> has served as the Chairman of the Board since November 2023, having previously served as a Board member since April 2021.
Mr. Mulica currently serves as an operating partner at the venture capital firm Avataar Venture Partners.&#160;From May 2018 to present,
Mr. Mulica has served as the Global Management Advisor at Mulica Consulting, advising public and private companies on global mobile Internet
and application platforms. From March 2018 to May 2024, Mr. Mulica served as Chairman at AlefEdge, a global edge API platform company
that empowers enterprises to create, customize, and control their own private mobile network. Mr. Mulica also served as AlefEdge&#8217;s
Chief Executive Officer from August 2021 to May 2024. From May 2016 to August 2018, Mr. Mulica served as Chief Executive Officer
and President of Actility Technologies, Inc., an IoT communications and software company. From June 2014 to May 2016, Mr. Mulica served
as the President, Worldwide Sales and Business Development at Real Networks, Inc., a content and Internet software company. From October
2011 to July 2014, Mr. Mulica served as the Chief Executive Officer and President of Openwave Systems, Inc., a mobile Internet software
company. Prior to his service at Openwave Systems, he held various leadership positions at Motorola, Inc., a communications systems company,
Synchronoss Technologies, an Internet software and services company, FusionOne, Inc., a mobile Internet software company, BridgePort
Technologies, Inc., a mobile Internet software company, Phone.com, Inc., inventor of the mobile Internet, California Microwave, Inc.,
a microwave and satellite systems company, and Tandem Computers, a fault tolerant computer manufacturer. Mr. Mulica holds a BS in Finance
from Marquette University and an MBA from the Kellogg School of Management at Northwestern University. The Board believes that Mr. Mulica&#8217;s
extensive operational, executive and board experience with numerous private and public companies at various Internet, mobile and software
companies qualifies him to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jack
Steenstra</i></b> has served as a member of our Board since July 2022. Mr. Steenstra has served as the Chief Technology Officer of Meta
Technologies Inc., a software and hardware company in the wellness space, since August 2017. From November 2015 to August 2017, he was
a freelance technology consultant with various startups including VRx Medical, an immersive digital therapeutics company, contributing
to the technical, business, and product innovation of new products, services, and associated businesses developing new wireless devices.
From July 1995 to November 2015, Mr. Steenstra was Vice President of Engineering at Qualcomm, a technology company, where he led a cross-functional
department developing new products to support new business opportunities. Prior to that, he was an engineer at Abbott Laboratories, a
medical devices and healthcare company, where he developed digital surveillance systems, software, and medical devices. From January
2012 to December 2023, he served as a board member of Stepping Stone San Diego, a drug and alcohol rehabilitation and treatment program
specializing in the Gay, Lesbian, Bisexual and Transgender community. Mr. Steenstra holds a BS in Electrical and Electronics Engineering
from the University of Michigan and an MS in Electrical and Electronics Engineering from the University of Southern California. The Board
believes that Mr. Steenstra&#8217;s extensive leadership and business consulting experience qualifies him to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>George
Thangadurai</i></b> is expected to serve on our Board. Since 2019, Mr. Thangadurai has served as a founding partner at Avataar Venture
Partners, a growth-stage venture capital firm with over $800 million under management. Mr. Thangadurai also currently serves on the boards
of Chef Robotics, Inc., an AI-powered robotics company, Chalo Mobility Ltd., an international transportation technology company, and
Capillary Technologies Ltd., an international SaaS technology company. From September 2020 to October 2023, Mr. Thangadurai served as
Chief Executive Officer and a director of Heal Software, Inc., an AIOps company. From November 2014 to December 2020, Mr. Thangadurai
was Executive Vice President and Head of Global Business at Borqs Technologies, Inc., an E2E IoT solutions company, where he played a
key role in Borq&#8217;s initial public offering and listing on Nasdaq. Earlier in his career, Mr. Thangadurai held various executive
and board advisory roles, including roles at Mobiliya Technologies which was acquired by Quest Global, BR.Droid (Brazil), VitalTech,
and spent over two decades at Intel Corporation in multiple senior leadership positions, including General Manager of PC Client Services
and Strategy &amp; Product Management for the Mobile PC Group. During his tenure, Mr. Thangadurai helped grow Intel&#8217;s Mobile PC
business from approximately $7 billion to over $20 billion and received the Intel Achievement Award for his leadership on graphics strategy.
Mr. Thangadurai holds a Master of Science in Electrical Engineering from the University of Rhode Island. The Board believes that Mr.
Thangadurai&#8217;s extensive executive and board experience in enterprise technology, semiconductors, and venture capital, as well as
his leadership in both public and private technology companies, qualifies him to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_030"></span>Executive
officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the name, age, and position of each of our executive officers as of April 30, 2025. Mr. Liu first became an
officer pursuant to a contractual arrangement in connection with an equity investment by a certain stockholder, owned and controlled
by a current member of the Board, Jeffrey Wang. For more information about the arrangement, please see &#8220;<i><span style="text-decoration: underline"><a href="#a_052">Certain Relationships and Related Person Transactions</a></span></i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            First</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Became</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officer</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Commercial Officer and General Manager of North America</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_031"></span>Biographical
information of our executive officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
information about Peter Liu, please see &#8220;<i><span style="text-decoration: underline"><a href="#a_029">Biographical information of our directors</a></span></i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clay
Crolius</i></b> has served as our Chief Financial Officer since July 2022. From September 2021 to July 2022, he served as our Chief Accounting
Officer. From December 2016 to August 2021, Mr. Crolius served as Principal Accounting Officer and Controller for 4Front Ventures Corp.,
a national manufacturer and retailer. From 2015 to 2016, Mr. Crolius was the Controller at Ethology Corporation, a digital advertising
agency startup. From 2005 to 2014, Mr. Crolius was a Senior Management Consultant with the David Lewis Company, a professional services
consulting company. He also served as Vice President of Financial Operations for Warner Bros. Studios, a division of Time Warner from
2000 to 2005. Mr. Crolius holds a BA in Economics and Business from the University of California, Los Angeles, and is a certified public
accountant in the state of California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Chuck
Becher</i></b> has served as our Chief Commercial Officer and General Manager of North America since 2022. From April 2022 to August
2022, Mr. Becher served as Senior Vice President of Carrier Solutions at Inseego Corporation, a leader in mobile hotspots and fixed wireless
devices. From June 2020 to April 2022, Mr. Becher served as Chief Commercial Officer and EVP of OnwardMobility, a startup created to
bring BlackBerry devices back to the market. From December 2016 to January 2020, Mr. Becher served as Sonim Technologies&#8217; Chief
Sales and Marketing Officer. From 2000 to 2016, Mr. Becher also served in increasing positions of responsibility at Kyocera Communications,
Inc., a wireless phone original equipment manufacturer headquartered in Yokohama, Japan, culminating in the role of Senior Vice President
and General Manager of Sales and Marketing. Mr. Becher holds a BBA from the University of Michigan School of Business in Ann Arbor, Michigan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_032"></span>Corporate
governance documents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
Governance Guidelines</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board adopted Corporate Governance Guidelines, which set forth a flexible framework within which the Board, assisted by its committees,
directs the affairs of the Company. The Corporate Governance Guidelines address, among other things, the composition and functions of
the Board, director independence, compensation of directors, Board membership criteria, Board leadership, and composition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Code
of Ethics</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Business Conduct and Ethics, or the Code of Conduct, applicable to all of our employees, executive officers, and
directors. The Nominating and Corporate Governance Committee of our Board is responsible for overseeing the Code of Conduct and must
approve any waivers of the Code of Conduct for employees, executive officers, and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insider
Trading Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have <span id="xdx_905_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240101__20241231_zeNqiuBp2O7h" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000013" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">adopted</ix:nonNumeric></span> an Insider Trading Policy that governs the purchase, sale, and/or other transactions of our securities by our directors,
officers, and employees, and the Company itself. We believe that the Insider Trading Policy is reasonably designed to promote compliance
with insider trading laws, rules and regulations, and the listing standards of Nasdaq. The foregoing summary of the Company&#8217;s Insider
Trading Policy does not purport to be complete and is qualified in its entirety by reference to the full text thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Committee
Charters</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
standing committee of the Board is governed by a charter adopted by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Availability
of Governance Documents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Guidelines, the Code of Conduct, and each of the Audit, Compensation, and Nominating and Corporate Governance Committee
charters are available on the Company&#8217;s investor relations website, ir.sonimtech.com. We expect that any amendments to the Code
of Conduct, or any waivers of its requirements, will be disclosed on our website to the extent required by the applicable rules of the
SEC and The Nasdaq Stock Market LLC. A copy of our insider trading policy was filed as Exhibit 19.1 to our Annual Report on Form 10-K
for our fiscal year ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_033"></span>Board
composition considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
selection of directors and officers is conducted on the basis of outstanding achievement in their professional careers, broad experience,
personal and professional integrity, ability to make independent and analytical inquiries, financial literacy, mature judgment, high
performance standards, familiarity with our business and industry, ability to work collegially, and, in the case of our Chief Executive
Officer, the initial selection was made based on the contractual arrangement in connection with an equity investment by a certain stockholder.
Please see &#8220;<i><span style="text-decoration: underline"><a href="#a_052">Certain Relationships and Related Person Transactions</a></span></i>&#8221; and &#8220;<i><span style="text-decoration: underline"><a href="#a_036">Director independence</a></span>.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_034"></span>Board
leadership structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that having an independent Chairperson of our Board creates an environment that is more conducive to objective evaluation
and oversight of management&#8217;s performance, increasing management accountability and improving the ability of the Board to monitor
whether management&#8217;s actions are in the best interests of the Company and its stockholders. Therefore, our current policy (as set
forth in our Corporate Governance Guidelines) is that the positions of Chief Executive Officer and Chairperson be held by different individuals,
except in unusual circumstances as determined by the Board. As a result, the Board believes that having an independent Chairperson can
enhance the effectiveness of the Board as a whole. Notwithstanding the above, our Board believes that it is important to retain the flexibility
to combine or separate the responsibilities of the offices of Chairperson of our Board and Chief Executive Officer, as from time to time
it may be in our best interests to either combine or separate the roles and may amend our Corporate Governance Guidelines to that effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has an independent chairperson, Mike Mulica. As Board Chairperson, Mr. Mulica has broad authority, among other things,
to call and preside over Board meetings, including meetings of the independent directors, to set meeting agendas and to determine materials
to be distributed to the Board. Accordingly, the Board Chairperson has substantial ability to shape the work of the Board. Peter
Liu, the Company&#8217;s Chief Executive Officer, currently serves as our principal executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board meets regularly in executive sessions of the directors without those directors who are also our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_035"></span>Role
of the Board in risk oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is responsible for the oversight of risk management related to the Company&#8217;s business and accomplishes this oversight through
the regular reporting to the Board by its committees. The Audit Committee periodically reviews our accounting, reporting, and financial
practices, including the integrity of our financial statements, the surveillance of administrative and financial controls, and the Company&#8217;s
compliance with legal and regulatory requirements. Through its regular meetings with management, including the finance, legal, internal
audit, and information technology functions, the Audit Committee reviews and discusses all significant areas of the Company&#8217;s business
and summarizes for the Board all areas of risk and the appropriate mitigating factors. In addition, the Compensation Committee and the
Nominating and Corporate Governance Committee review and report to the Board with regard to areas of risk management that such Board
committees oversee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_036"></span>Director
independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by applicable rules of Nasdaq and our Corporate Governance Guidelines, a majority of the members of our Board qualify as &#8220;independent,&#8221;
as affirmatively determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making these determinations, our Board considered certain relationships and transactions that occurred in the ordinary course of business
between the Company and entities with which some of our directors are or have been affiliated. The Board determined that such transactions
would not impair the particular director&#8217;s independence or interfere with the exercise of independent judgment in carrying out
director responsibilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board undertook a review of the independence of each director and considered whether any director has a material relationship that could
compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities as a director. After review
of all relevant transactions or relationships between each director, or any of his or her family members, and the Company, its senior
management and its independent registered public accounting firm, the Board affirmatively determined that all of our directors are independent
directors within the meaning of the applicable Nasdaq listing standards, except for Mr. Liu, who serves as our Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_037"></span>Committees
of the Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board directs the management of the Company&#8217;s business and affairs, as provided by Delaware law, and conducts its business through
meetings of the Board and its standing committees. We have a standing Audit Committee, Compensation Committee, and Nominating and Corporate
Governance Committee, each of which operates under a written charter. In 2025, our Board has also established a Special Committee consisting
of three independent members of the Board to review strategic alternatives for the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, from time to time, special committees may be established under the direction of our Board when the Board deems it necessary
or advisable to address specific issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_038"></span>Board,
committees, and stockholders meetings</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Board held eight (8) meetings (including regularly scheduled and special meetings);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Audit Committee held seven (7) meetings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Compensation Committee held two (2) meetings; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Nominating and Corporate Governance Committee held zero (0) meetings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our incumbent directors attended at least 75% of the aggregate of (i) the total number of meetings of our Board held during the period
for which he or she served as a director and (ii) the total number of meetings held by all committees of our Board on which he or she
served during the periods that he or she served during the fiscal year ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we do not have a formal policy regarding the attendance of our annual meetings of stockholders by the members of our Board, we encourage
them to do so. Four (4) of our five (5) current directors attended our 2024 annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_039"></span>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee consists of James Cassano, Mike Mulica, and Jack Steenstra, with Mr. Cassano serving as Chairman. Following the Annual
Meeting (and assuming all director nominees are elected) our Audit Committee will consist of James Cassano, Mike Mulica, and Jack Steenstra,
with Mr. Cassano serving as Chairman. Our Board has determined that each Audit Committee member is &#8220;independent,&#8221; as defined
under the applicable Nasdaq listing rules and the applicable requirements of Rule 10A-3 of the Exchange Act. Our Board has further determined
that each of the members of the Audit Committee satisfies the financial literacy and sophistication requirements of the Nasdaq listing
rules and that each of Mr. Cassano and Mr. Mulica qualifies as an &#8220;audit committee financial expert,&#8221; as that term
is defined under SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee&#8217;s responsibilities include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    and retaining an independent registered public accounting firm to serve as independent auditor to audit our financial statements,
    overseeing the independent auditor&#8217;s work and determining the independent auditor&#8217;s compensation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    in advance all audit services and non-audit services to be provided to us by our independent auditor;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls,
    auditing or compliance matters, as well as for the confidential, anonymous submission by our employees of concerns regarding questionable
    accounting or auditing matters;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">overseeing our risk assessment and risk management processes;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and ratifying all related party transactions, based on the standards set forth in our related-person transactions policy;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with management and our independent auditor the results of the annual audit and the independent auditor&#8217;s review
    of our quarterly financial statements; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conferring
    with management and our independent auditor about the scope, adequacy and effectiveness of our internal accounting controls, the
    objectivity of our financial reporting and our accounting policies and practices.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_040"></span>Compensation
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee consists of Mike Mulica, James Cassano, and Jack Steenstra, with Mr. Mulica serving as the Chairman. Following
the Annual Meeting (and assuming all director nominees are elected) our Compensation Committee will consist of Mike Mulica, James Cassano,
and Jack Steenstra, with Mr. Mulica serving as the Chairman. Each of these individuals is a non-employee director, as defined in
Rule 16b-3 promulgated under the Exchange Act. Our Board has determined that each Compensation Committee member is &#8220;independent,&#8221;
as defined under the applicable Nasdaq listing rules, including the standards specific to members of a compensation committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee&#8217;s responsibilities include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    and approving, and making recommendations to the Board regarding, performance goals and objectives relevant to the compensation of
    our chief executive officer, evaluating the performance of our chief executive officer in light of those goals and objectives and
    setting, or recommending to the full Board for approval, the chief executive officer&#8217;s compensation, including incentive-based
    and equity-based compensation, based on that evaluation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
    the compensation of our other executive officers, and may incorporate recommendations from the chief executive officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercising
    administrative authority under our equity incentive plan and employee benefit plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    policies and making recommendations to our Board regarding director compensation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    risks and exposures associated with executive and director compensation plans and arrangements; reviewing and discussing with management
    the compensation discussion and analysis that we may be required from time to time to include in SEC filings; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing
    a compensation committee report on executive and director compensation as may be required from time to time to be included in future
    annual proxy statements or annual reports on Form 10-K filed with the SEC.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Compensation Committee&#8217;s charter, the Compensation Committee may form and delegate authority to subcommittees to the extent
permitted by applicable law, as it deems appropriate from time to time under the circumstances, pursuant to the terms set forth in the
Compensation Committee&#8217;s charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
compensation consultant</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Compensation Committee&#8217;s charter, the Compensation Committee shall have the authority to retain, obtain advice and assistance
from internal or external legal counsel, accounting or other advisors and consultants (referred to collectively as &#8220;advisors&#8221;)
it deems necessary or appropriate in carrying out its duties. The Compensation Committee has sole authority to (i) determine appropriate
compensation for any such advisor retained by the Compensation Committee, which reasonable compensation shall be funded by the Company
and (ii) retain and terminate any compensation consultant to assist in the evaluation of director, principal executive officer or senior
executive compensation, including sole authority to approve such consultant&#8217;s reasonable fees and other retention terms, which
reasonable compensation shall be funded by the Company. Compensia, Inc. (&#8220;Compensia&#8221;), a compensation consulting firm, has
served as the Compensation Committee&#8217;s compensation consultant since 2023 to advise the Compensation Committee regarding, among
other things, the amount and types of compensation that we provide to our executives and directors, our compensation philosophy and how
our compensation practices compare to the compensation practices of other similar and peer companies. Compensia does not provide any
services to us other than the services provided to the Compensation Committee. The Compensation Committee believes that Compensia does
not have any conflicts of interest in advising the Compensation Committee under applicable SEC rules or Nasdaq listing standards. The
Compensation Committee has assessed the independence of Compensia pursuant to SEC rules and Nasdaq listing standards and concluded that
no conflict of interest exists that would prevent Compensia from independently representing the Compensation Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_041"></span>Nominating
and Corporate Governance Committee</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee consists of Jack Steenstra and Mike Mulica, with Mr. Steenstra serving as the Chairman.
Following the Annual Meeting (and assuming all director nominees are elected) our Nominating and Corporate Governance Committee will
consist of Jack Steenstra and Mike Mulica, with Mr. Steenstra serving as the Chairman. Our Board has determined that each of these
individuals is &#8220;independent&#8221; as defined under the applicable listing standards of Nasdaq and SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee&#8217;s responsibilities include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
    the need for new directors and identifying individuals qualified to become directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to the Board the persons to be nominated for election as directors and to each of the Board&#8217;s committees overseeing an evaluation
    of our Board and its committees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
    individual director performance, participation and qualifications;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing,
    recommending, overseeing the implementation of and monitoring compliance with our corporate governance guidelines, and periodically
    reviewing and recommending any necessary or appropriate changes to our corporate governance guidelines;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    the effectiveness of the Board and the quality of the relationship between management and the Board; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    an annual evaluation of the Board&#8217;s performance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_042"></span>Director
nominations process</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee is responsible for identifying and recommending candidates to serve on the Board and its
committees. To identify suitable director candidates, the Nominating and Corporate Governance Committee may solicit current directors
and executives of the Company for the names of potentially qualified candidates or ask directors and executives to pursue their own business
contacts for the names of potentially qualified candidates, or consider director candidates recommended by our stockholders. In addition,
the Nominating and Corporate Governance Committee has the authority to consult with outside advisors or retain search firms to assist
in the search for qualified candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
considering whether to recommend any particular candidate to serve on the Board or its committees or for inclusion in the Board&#8217;s
slate of recommended director nominees for election at the annual meeting of stockholders, our Nominating and Corporate Governance Committee
considers the criteria set forth in the Nominating and Corporate Governance Committee charter and our Corporate Governance Guidelines,
including consideration of any potential conflicts of interest as well as applicable independence, experience, and other requirements.
Our Nominating and Corporate Governance Committee gives the same consideration to candidates recommended by stockholders as those candidates
recommended by search firms, members of our Board, and management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board considers recommendations for nominees from the Nominating and Corporate Governance Committee. The Board determined the appropriate
characteristics, skills, and experience for the Board as a whole and for its individual members. The Board will consider the minimum
general criteria set forth below, and may add any specific additional criteria with respect to specific searches, in selecting candidates
and existing directors for service on the Board. An acceptable candidate may not fully satisfy all of the criteria, but is expected to
satisfy nearly all of them. In considering candidates recommended by the Nominating and Corporate Governance Committee, the Board intends
to consider such factors as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">possessing
    relevant expertise upon which to be able to offer advice and guidance to management,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    sufficient time to devote to the affairs of Sonim;</span></td></tr>

</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">demonstrated
    excellence in his or her field;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of our
    stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">current
    composition of the Board; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversity,
    age, skills, and such other factors as it deems appropriate given the current needs of the Board and Sonim to maintain a balance
    of knowledge, experience, and capability.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, the Nominating and Corporate Governance Committee does not have a policy with regard to the consideration of director candidates
recommended by stockholders. The Nominating and Corporate Governance Committee believes that it is in the best position to identify,
review, evaluate, and select qualified candidates for Board membership, based on the comprehensive criteria for Board membership approved
by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_043"></span>Anti-hedging
policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted an Insider Trading Policy, which applies to all of our directors, officers, and employees. The policy prohibits our
directors, officers, and employees from engaging in hedging transactions and all other forms of monetization transactions: no officer,
director, employee, or consultant to Sonim may engage in short sales, transactions in put or call options, hedging transactions, margin
accounts, pledges, or other inherently speculative transactions with respect to our stock at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_062"></span>Clawback
policy (recoupment of erroneously awarded incentive-based compensation)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Nasdaq Listing Rules and Rule 10D-1 under the Exchange Act, our Board has adopted a Clawback Policy For Incentive-Based
Compensation (the &#8220;Clawback Policy&#8221;) that applies to our current and former executive officers. Under the Clawback Policy,
we are required to recoup the amount of any Erroneously Awarded Compensation (as defined in the Clawback Policy) without regard to any
taxes paid within a specified lookback period in the event of any Accounting Restatement (as defined in the Clawback Policy), subject
to limited impracticability exceptions. Covered restatements include both a restatement to correct an error that is material to previously
issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left
uncorrected in the current period. The amount required to be recovered is the excess of the amount of incentive-based compensation received
over the amount that otherwise would have been received had it been determined based on the restated financial measure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_044"></span>Communications
with the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
stockholder or any other interested party who desires to communicate with our Board, our non-management directors, or any specific individual
director may do so by directing such correspondence to the attention of the Secretary, Sonim Technologies, Inc., 4445 Eastgate
Mall, Suite 200, San Diego, CA 92121. Following its clearance through normal security procedures, the Secretary will forward such
communication to the pertinent director or directors, as appropriate. In that regard, the Board has requested that certain items unrelated
to the duties and responsibilities of the Board should be excluded or redirected, as appropriate, such as: business solicitations or
advertisements, junk mail and mass mailings, resumes and other forms of job inquiries, spam, and surveys. In addition, material that
is unduly hostile, threatening, potentially illegal or similarly unsuitable will be excluded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_045"></span>PROPOSAL
1 &#8212; ELECTION OF DIRECTORS</b>&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is currently composed of five (5) members and will be composed of five (5) members effective as of the completion of the Annual
Meeting. Our Board is elected each year at the annual meeting of stockholders for a term of one year. Each director&#8217;s term continues
until the election and qualification of such director&#8217;s successor, or such director&#8217;s earlier death, resignation, or removal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has nominated the incumbent directors, James Cassano, Peter Liu, Mike Mulica, and Jack Steenstra to stand for re-election to serve
as directors. The only nominee for director who is not already a member of the Board is George Thangadurai, who was recommended by a
non-management director. If elected, each of them will serve as director until the 2026 annual meeting of stockholders and until their
successors are elected and qualified, or their earlier death, resignation, or removal. For more information concerning the nominees,
see the section titled &#8220;<i><a href="#a_025">Directors, Executive Officers, and Corporate Governance</a>.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board anticipates that each of the nominees will serve, if elected, as a director. However, in the event that a director nominee is unable
or declines to serve as a director at the time of the Annual Meeting, the discretionary authority provided in the proxy will be exercised
by the proxy holders to vote for a substitute or substitutes nominated by the Board, or the Board, on the recommendation of the Nominating
and Corporate Governance Committee, may reduce the size of the Board and number of nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Orbic Group
has provided us with notice that it intends to nominate the Orbic Nominees for election as directors at the Annual Meeting. Although
the Company is required to include the Orbic Nominees for election on its <b>WHITE</b> proxy card under universal proxy rules, for additional
information regarding the Orbic Nominees and any other related information, please refer to the Orbic Group&#8217;s proxy statement if
and when it is provided to you by the Orbic Group. You can access Orbic Group&#8217;s proxy statement, and any other relevant documents,
without cost on the SEC&#8217;s website. The Board does NOT endorse the election of the Orbic Nominees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">You may receive
proxy solicitation materials from the Orbic Group, including a proxy statement and blue proxy card. <b>If you do receive such proxy materials
from the Orbic Group, our Board strongly urges you to discard and not to sign or return the Orbic Group&#8217;s blue proxy card or to
vote for any of the Orbic Nominees.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the director nominees proposed by our Board, with their breadth of relevant and diverse experience, are the most qualified
candidates up for election at the Annual Meeting. Furthermore, our Board believes that the director nominees recommended and proposed
by our Board would serve the interests of all of the Company&#8217;s stockholders better than the nominees proposed by one stockholder,
the Orbic Group, who is motivated to complete its hostile takeover of the Company. If you have any questions or require any assistance
with voting your shares, please contact Sodali &amp; Co, our proxy solicitor assisting us in connection with the Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="formdefc14a_003.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">430
Park Avenue, 14th Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Stockholders Call Toll-Free in North America: (800)&#160;662-5200</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outside of North America Call Collect: (203)&#160;658-9400</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">E-mail: <span style="text-decoration: underline">SONM@investor.sodali.com</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends a vote FOR the election of each of the Sonim director nominees: James Cassano, Peter Liu, Mike Mulica, Jack
Steenstra, and George Thangadurai.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_046"></span>PROPOSAL
2 &#8212; RATIFICATION OF APPOINTMENT<br/>
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has appointed Baker Tilly US, LLP (Campbell, CA, PCAOB ID: 23) (&#8220;Baker Tilly&#8221;) as our independent
registered public accounting firm for the fiscal year ending December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moss
Adams LLP (&#8220;Moss Adams&#8221;) had audited the Company&#8217;s financial statements since 2013. On June 3, Moss Adams notified
us that it merged with Baker Tilly effective on June 3, 2025.
The combined audit practices operate as Baker Tilly US, LLP. The Audit Committee and the Board seek
to have the stockholders ratify the Audit Committee&#8217;s appointment of Baker Tilly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we are not required to seek stockholder approval of this appointment, the Board considers the selection of the independent registered
public accounting firm to be an important matter of stockholder concern and is submitting the appointment of Baker Tilly for ratification
by stockholders as a matter of good corporate practice. If the appointment of Baker Tilly is not ratified by the stockholders,
the Audit Committee will consider the vote of our stockholders and may appoint another independent registered public accounting firm
or may decide to maintain its appointment of Baker Tilly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives
of Baker Tilly will be present at the Annual Meeting and will have the opportunity to make a statement, if they desire to do so,
and to respond to appropriate questions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Change in Auditor</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
reported on our Current Report on Form 8-K filed with the SEC on June 5, 2025 (the &#8220;Change in Auditor 8-K&#8221;), on June 3, 2025,
we were notified that Moss Adams, our independent registered public accounting firm, merged with Baker Tilly effective on June 3, 2025.
The combined audit practices operate as Baker Tilly US, LLP. In connection with the notification of the merger, Moss Adams has resigned
as the auditors of the Company, and the Audit Committee of the Board approved the appointment of Baker Tilly, as the successor to Moss
Adams, as the Company&#8217;s independent registered public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit reports of Moss Adams on the Company&#8217;s consolidated financial statements for the years ended December 31, 2024 and 2023,
and for each of the three years in the period ended December 31, 2024, did not contain an adverse opinion or a disclaimer of opinion,
nor were they qualified or modified as to uncertainty, audit scope or accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2024 and 2023, and the subsequent interim period through June 3, 2025, there were no (a) disagreements with
Moss Adams on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which,
if not resolved to Moss Adams&#8217; satisfaction, would have caused it to make reference to the subject matter of the disagreement in
connection with its reports on the Company&#8217;s financial statements, or (b) reportable events requiring disclosure pursuant to Item
304(a)(1)(v) of Regulation S-K, except for the material weaknesses disclosed:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under
                                            the heading &#8220;Item 9A. Controls and Procedures-Evaluation of Controls and Procedures&#8221;
                                            in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, as
                                            filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 20, 2023;
                                            and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under
                                            the heading &#8220;Item 4. Controls and Procedures&#8221; in the Company&#8217;s Quarterly
                                            Reports on Form 10-Q for the periods ended March 31, 2023, June 30, 2023, and September 30,
                                            2023, as filed with the SEC on May 8, 2023, August 14, 2023, and November 14, 2023, respectively.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2024 and 2023, and the subsequent interim period through June 5, 2025, neither the Company, nor anyone
on its behalf, consulted with Baker Tilly regarding: (i) either the application of accounting principles to a specified transaction,
either completed or proposed, or the type of audit opinion that might be rendered on the Company&#8217;s financial statements; or
(ii) any matter that was either the subject of a &#8220;disagreement,&#8221; as defined in Item 304(a)(1)(iv) of Regulation S-K and
the related instructions to that item, or a &#8220;reportable event,&#8221; as described in Item 304(a)(1)(v) of Regulation
S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided Moss Adams with a copy of the Change in Auditor 8-K prior to its filing with the SEC and requested that Moss Adams furnish
the Company with a letter addressed to the SEC stating whether it agrees with the above statements and, if it does not agree, the respects
in which it does not agree. A copy of Moss Adams&#8217; letter to the SEC, dated June 5, 2025, was filed as Exhibit 16.1 to the Change
in Auditor 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
paid to the independent registered public accounting firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees for professional audit services rendered by Moss Adams for the audit of our annual financial statements
for fiscal 2024 and fiscal 2023, and fees billed for other services rendered by Moss Adams LLP during fiscal 2024 and fiscal 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Type of Fees</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees for Fiscal 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees for Fiscal 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">782,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">724,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">220,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">63,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">57,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73,816</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">All Other Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fees</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,059,773</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">861,316</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees consist of fees for professional services rendered for the audit of our consolidated financial statements included in our annual
    report, and the review of our interim consolidated financial statements included in our quarterly reports.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services
    in connection with our Registration Statements on Form S-3 and Form S-8.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Fees consist of fees for tax compliance and tax advice.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee policy on pre-approval of audit and permissible non-audit services of independent registered public accounting firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee must pre-approve all audit related services and permissible non-audit services (unless in compliance with exceptions
available under applicable laws and rules related to immaterial aggregate amounts of services) provided by our independent registered
public accounting firm. However, the Audit Committee may delegate pre-approval authority to one or more committee members so long as
any such pre-approval decisions are presented to the full committee at the next scheduled meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
services rendered by Moss Adams LLP, our independent registered public accounting firm, during fiscal 2024 and fiscal 2023 were pre-approved
by the Audit Committee in accordance with the audit committee&#8217;s pre-approval policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the services described above was approved pursuant to the de minimis exception provided in Rule 2-01(c)(7)(i)(C) of Regulation S-X
promulgated by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends a vote FOR the ratification of the appointment of Baker Tilly as our independent registered public accounting
firm for our fiscal year ending December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_047"></span>AUDIT
COMMITTEE REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
information contained under this &#8220;Audit Committee Report&#8221; shall not be deemed to be &#8220;soliciting material&#8221; or
to be &#8220;filed&#8221; with the SEC, nor shall such information be incorporated by reference into any filings under the Securities
Act of 1933, as amended, or under the Exchange Act, except to the extent that we specifically incorporate this information by reference
into any such filing.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the performance of its oversight function, the Audit Committee of our Board has:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    and discussed with management the Company&#8217;s annual audited financial statements for the fiscal year ended December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussed
    with Moss Adams, our independent registered public accounting firm, the matters required to be discussed by the applicable requirements
    of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">received
    from Moss Adams the written disclosures and the letter required by applicable requirements of the PCAOB regarding Moss Adams&#8217;s
    communication with the Audit Committee concerning independence; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussed
    with Moss Adams its independence.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial
statements for the fiscal year ended December 31, 2024 be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year
ended December 31, 2024 for filing with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Audit Committee has the responsibilities set forth in its charter (including to monitor and oversee the audit processes), the Audit
Committee does not have the duty to plan or conduct audits or to determine that the Company&#8217;s financial statements are complete,
accurate, or in accordance with generally accepted accounting principles. The Company&#8217;s management and independent auditor have
this responsibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report is respectfully submitted by the members of the Audit Committee of the Board of Directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano (Chair)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 337.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 337.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_048"></span>PROPOSAL
3 &#8212; INCREASE OF THE SHARES AVAILABLE UNDER<br/>
THE SONIM TECHNOLOGIES, INC. 2019 EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2025, our Board approved an amendment to the Sonim Technologies, Inc. 2019 Equity Incentive Plan, as amended (the &#8220;EIP&#8221;
or &#8220;2019 Plan&#8221;), subject to stockholder approval, and accordingly, the Board directed that such amendment be submitted to
the stockholders for approval at the Annual Meeting. The amendment would increase the number of authorized shares of our common stock
available for issuance under the 2019 Plan as of the record date by 600,000 shares: from 1,874,054 shares to 2,474,054 shares. No other
changes are being made to the 2019 Plan. The proposed 2019 Plan, as amended and restated assuming this proposal is approved by our stockholders,
is included as <span style="text-decoration: underline"><a href="#a_060">Annex A</a></span> hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
approval of the amendment to the 2019 Plan is being sought in order to (i) meet Nasdaq listing requirements and (ii) allow for incentive
stock options to meet the requirements of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). For additional information
regarding our current officer and director compensation, see the section titled &#8220;<i><span style="text-decoration: underline"><a href="#a_051">Executive and Director Compensation</a></span></i><span style="text-decoration: underline">.</span>&#8221;
We also encourage you to review the section titled &#8220;<i><span style="text-decoration: underline"><a href="#a_061">Equity compensation plan information</a></span></i>&#8221; for more information
with regard to all our equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stockholders approve this proposal, the amendment to the 2019 Plan will become effective as of the date of the Annual Meeting. We
intend to file a Registration Statement on Form S-8 to register additional shares available for issuance under the 2019 Plan as a result
of the amendment. If our stockholders fail to approve this proposal, the 2019 Plan will remain as is without any changes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 9, 2025, the record date, the number of shares of our common stock authorized for issuance but unissued under the 2019
Plan was 24,276. As of the record date, the Company has outstanding stock options to purchase approximately 678,460 shares
of common stock and no shares of common stock subject to outstanding restricted stock units, all of which were granted under the 2019
Plan and various other prior plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
to vote approve the proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
awards are an important part of our compensation philosophy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that it is very important that our eligible employees, consultants, and directors (collectively, &#8220;Participants&#8221;)
receive part of their compensation in the form of equity awards to foster their investment in us, reinforce the link between their financial
interests and those of our other stockholders, and maintain a competitive compensation program. Equity compensation fosters a Participant
ownership culture, motivates Participants to create stockholder value and, because the awards are typically subject to vesting and other
conditions, promotes a focus on long-term value creation. The equity incentive programs we have in place have worked to build stockholder
value by attracting and retaining extraordinarily talented employees, consultants, and directors. The Board believes we should continue
to offer competitive equity compensation packages in order to attract and motivate the talent necessary for our continued growth and
success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
expect to expand our team and anticipate the eventual growth of our business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2019 Plan are to attract, retain, and motivate officers and key employees (including prospective employees), directors,
consultants, and other individuals who may perform services for the Company to compensate them for their contributions to the
long-term growth and profits of the Company and to encourage them to acquire a proprietary interest in the success of the Company. Therefore,
the remaining pool should always be sufficient if needed for new hires or other special circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
2019 Plan combines compensation and governance best practices designed to protect our stockholders&#8217; interests</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize that equity compensation awards dilute stockholder equity and must be used judiciously. Our equity compensation practices are
designed to be in line with industry norms, and we believe our historical share usage has been responsible and mindful of stockholder
interests. Certain provisions in the 2019 Plan are designed to protect our stockholders&#8217; interests and to reflect corporate governance
best practices including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Flexibility
in designing equity compensation schemes.</i> The 2019 Plan allows us to provide a broad array of equity incentives, including traditional
stock option grants, stock appreciation rights, restricted stock awards, restricted stock unit (&#8220;RSU&#8221;) awards, performance
stock awards, and performance cash awards. By providing this flexibility we can quickly and effectively react to trends in compensation
practices and continue to offer competitive compensation arrangements to attract and retain the talent necessary for the success of our
business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
discounted stock options or stock appreciation rights.</i> All stock options and stock appreciation rights granted under the 2019 Plan
must have an exercise price or strike price equal to or greater than the fair market value of our common stock on the date the stock
option or stock appreciation right is granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limits
on non-employee director compensation.</i> The maximum number of shares of common stock subject to awards granted under the 2019 Plan
or otherwise during any one calendar year to any non-employee director, taken together with any cash fees paid by us to the non-employee
director during that year for service on our Board, will not exceed $600,000 in total value (calculating the value of the awards based
on the grant date fair value for financial reporting purposes), or, with respect to the calendar year in which a non-employee director
is first appointed or elected to our Board, $1,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Awards
are subject to forfeiture/clawback.</i> Awards granted under our 2019 Plan are subject to recoupment in accordance with any clawback
policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our
securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable
law. In addition, we may impose other clawback, recovery, or recoupment provisions in a stock award agreement, including a reacquisition
right in respect of previously acquired shares or other cash or property upon the occurrence of cause. For more information about our
clawback policy see the section of this proxy statement titled &#8220;<i><span style="text-decoration: underline"><a href="#a_025">Directors, Executive Officers, and Corporate
Governance</a></span>&#8212;<span style="text-decoration: underline"><a href="#a_062">Clawback policy (recoupment of erroneously awarded incentive-based compensation)</a></span></i><span style="text-decoration: underline">.</span>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
single trigger accelerated vesting upon change in control.</i> The 2019 Plan does not provide for any automatic mandatory vesting of
awards upon a change in control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
liberal change in control definition.</i> The change in control definition in the 2019 Plan is not a &#8220;liberal&#8221; definition.
A change in control transaction must actually occur in order for the change in control provisions in the 2019 Plan to be triggered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination
of stock options and stock appreciation rights on a participant&#8217;s termination for cause.</i> If a participant&#8217;s service is
terminated for cause, as defined under the 2019 Plan (which includes the participant&#8217;s commission of any felony or any crime involving
fraud, dishonesty, or moral turpitude and the participant&#8217;s unauthorized use or disclosure of our confidential information or trade
secrets), the participant is prohibited from exercising his or her stock options and stock appreciation rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
manage our equity award usage carefully</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain additional information regarding our equity incentive plans as of the record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
                                            9,</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>
                                            2025</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Total number of shares of common stock subject to outstanding stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">678,460</td><td style="width: 1%; text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted-average exercise price of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.4633</td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average remaining term of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50
                                            years</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total number of shares of common stock subject to outstanding full value awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total number of shares of common stock available for grant under the 2019 Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,276</td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total number of shares of common stock available for grant under other equity incentive plans<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,824</td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total number of shares of common stock outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,338,905</td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Per-share closing price of common stock as reported on Nasdaq Capital Market</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.12</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares issuable pursuant to our 2019 ESPP.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides detailed information regarding the activity related to our equity incentive plans for fiscal years 2022, 2023,
and 2024, which has been retroactively adjusted to reflect the 1-for-10 reverse stock split that became effective on July 17, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Total number of shares of common stock subject to stock options granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">259,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">180,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">482,945</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total number of shares of common stock subject to full value awards granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,522</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,107</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average number of shares of common stock outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,718,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,278,694</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,007,669</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burn Rate <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burn
    rate is the summation of the total number of stock options granted and full value awards granted divided by the weighted-average
    shares outstanding.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2019 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material features of the 2019 Plan (as proposed to be amended and modified and assuming that the increase of the shares authorized under
the 2019 Plan is approved) are outlined below. This summary is qualified in its entirety by reference to the complete text of the 2019
Plan. Stockholders are encouraged to read the actual text of the 2019 Plan, which is included in this proxy statement as <span style="text-decoration: underline"><a href="#a_060">Annex A</a></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Awards.
</i>The 2019 Plan provides for the grant of incentive stock options (&#8220;ISOs&#8221;), nonstatutory stock options (&#8220;NSOs&#8221;),
stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock awards, and other stock awards,
or collectively, stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility</i>.
Employees, non-employee directors, and consultants are eligible to participate in the 2019 Plan. All of our 117 employees, four
non-employee directors, and 33 consultants are currently eligible to participate in the 2019 Plan and may receive all types of
stock awards, other than ISOs, under the 2019 Plan. ISOs may be granted under the 2019 Plan only to our employees in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Authorized
Shares.</i> If this proposal is approved, the total number of our common stock reserved for issuance under the 2019 Plan will not exceed
2,474,054, which number is the sum of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,851 shares that were approved in connection with the 2019 Plan&#8217;s initial adoption;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares subject to outstanding stock options or other stock awards that were granted under our 2012 Equity Incentive Plan,
    as amended, as of the initial adoption of the 2019 Plan, to the extent such awards are forfeited, terminated, expire, or are otherwise
    not issued;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000
    shares that were approved at our 2020 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000
    shares that were approved at our 2022 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000
    shares that were approved at our 2023 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    entirety of the shares added pursuant to the evergreen provision of the 2019 Plan;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000
    shares that were approved at our 2024 annual meeting of stockholders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600,000
    shares to be added pursuant to this proposal.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the number of shares of our common stock reserved for issuance under the 2019 Plan automatically increases on January 1 of each calendar
year for ten (10) years ending on and including January 1, 2029, in an amount equal to 5% of the total number of shares of our capital
stock outstanding on December 31 of the prior calendar year, unless our Board or compensation committee determines prior to the date
of increase that there will be a lesser increase or no increase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
subject to stock awards granted under our 2019 Plan that expire or terminate without being exercised in full, or that are paid out in
cash rather than in shares, do not reduce the number of shares available for issuance under our 2019 Plan. Additionally, shares become
available for future grants under our 2019 Plan if they were issued under stock awards under our 2019 Plan and we repurchase them or
they are forfeited. This includes shares used to pay the exercise price of a stock award or to satisfy the tax withholding obligations
related to a stock award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
Administration.</i> Our Board and our Compensation Committee administer our 2019 Plan. Our Board may also delegate to one or more of
our officers the authority to (i) designate employees (other than officers) to receive specified stock awards, and (ii) determine the
number of shares subject to such stock awards. Under our 2019 Plan, our Board has the authority to determine and amend the terms of awards,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recipients;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise, purchase, or strike price of stock awards, if any;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares subject to each stock award;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    fair market value of a share of our common stock in the event no public market exists for our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    vesting schedule applicable to the awards, together with any vesting acceleration; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    form of consideration, if any, payable upon exercise or settlement of the award.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2019 Plan, our Board also generally has the authority to effect, with the consent of any adversely affected participant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    reduction of the exercise, purchase, or strike price of any outstanding award;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cancellation of any outstanding stock award and the grant in substitution therefor of other awards, cash, or other consideration;
    or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other action that is treated as a repricing under generally accepted accounting principles.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Employee
Director Limitation.</i> The maximum number of shares of common stock subject to awards granted under the 2019 Plan or otherwise during
any one calendar year to any non-employee director, taken together with any cash fees paid by us to the non-employee director during
that year for service on our Board, will not exceed $600,000 in total value (calculating the value of the awards based on the grant date
fair value for financial reporting purposes), or, with respect to the calendar year in which a non-employee director is first appointed
or elected to our Board, $1,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Options.</i> ISOs and NSOs are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator
determines the exercise price for stock options, within the terms and conditions of our 2019 Plan, provided that the exercise price of
a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted
under our 2019 Plan vest at the rate specified in the stock option agreement as determined by the plan administrator. The plan administrator
determines the term of stock options granted under the 2019 Plan, up to a maximum of ten years. Unless the terms of an optionholder&#8217;s
stock option agreement provide otherwise, if an optionholder&#8217;s service relationship with us, or any of our affiliates, ceases for
any reason other than disability, death, or cause, the optionholder may generally exercise any vested options for a period of three months
following the cessation of service. The option term may be extended in the event that the exercise of the option following such a termination
of service is prohibited by applicable securities laws or our insider trading policy. If an optionholder&#8217;s service relationship
with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation
of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 12 months in the event of disability
and 18 months in the event of death. Except as otherwise provided in the applicable stock option agreement or other written agreement
between us or any of our affiliates and the participant, options terminate immediately upon the termination of the individual&#8217;s
employment for cause. In no event may an option be exercised beyond the expiration of its term. Acceptable consideration for the purchase
of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1) cash, check,
bank draft, or money order, (2) a broker-assisted cashless exercise, (3) the tender of shares of our common stock previously owned by
the optionholder, (4) a net exercise of the option if it is an NSO, and (5) other legal consideration approved by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Limitations on ISOs</i>. The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that
are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000.
Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the
time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates
unless (i) the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant
and (ii) the term of the ISO does not exceed five years from the date of grant. The maximum number of shares of our common stock that
may be issued upon the exercise of ISOs under our 2019 Plan is equal to three times the aggregate number of shares reserved under the
2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Unit Awards.</i> Restricted stock unit awards are granted pursuant to restricted stock unit award agreements adopted by the plan
administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable
to our Board and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock, a combination
of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted
stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit
award. Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited
once the participant&#8217;s continuous service ends for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Awards.</i> Restricted stock awards are granted pursuant to restricted stock award agreements adopted by the plan administrator.
A restricted stock award may be awarded in consideration for cash, check, bank draft, or money order, past services to us, or any other
form of legal consideration (including future services) that may be acceptable to our Board and permissible under applicable law. The
plan administrator determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#8217;s
service relationship with us ceases for any reason, we may receive any or all of the shares of common stock held by the participant that
have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance
Awards.</i> The 2019 Plan permits the grant of performance awards. A performance award is a stock or cash award that is payable (including
that may be granted, may vest, or may be exercised) contingent upon the achievement of pre-determined performance goals during a performance
period. A performance award may require the completion of a specified period of continuous service. The length of any performance period,
the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals
have been attained will generally be determined by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals under the 2019 Plan are based on any one or more of the following performance criteria: (1) earnings (including earnings per share
and net earnings); (2) earnings before interest, taxes and depreciation; (3) earnings before interest, taxes, depreciation and amortization;
(4) total stockholder return; (5) return on equity or average stockholder&#8217;s equity; (6) return on assets, investment, or capital
employed; (7) stock price; (8) margin (including gross margin); (9) income (before or after taxes); (10) operating income; (11) operating
income after taxes; (12) pre-tax profit; (13) operating cash flow; (14) sales or revenue targets; (15) increases in revenue or product
revenue; (16) expenses and cost reduction goals; (17) improvement in or attainment of working capital levels; (18) economic value added
(or an equivalent metric); (19) market share; (20) cash flow; (21) cash flow per share; (22) share price performance; (23) debt reduction;
(24) implementation or completion of projects or processes; (25) subscriber satisfaction; (26) stockholders&#8217; equity; (27) capital
expenditures; (28) debt levels; (29) operating profit or net operating profit; (30) workforce diversity; (31) growth of net income or
operating income; (32) billings; (33) the number of subscribers, including but not limited to unique subscribers; (34) employee retention;
and (35) other measures of performance selected by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates, or business segments,
and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant
indices. Unless specified otherwise by the plan administrator at the time the performance goals are established, the plan administrator
will appropriately make adjustments in the method of calculating the attainment of performance goals for a performance period as follows:
(1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes
to generally accepted accounting principles; (4) to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221;
as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures;
(7) to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance
period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of our common stock by reason of
any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange
of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude
the effects of stock based compensation and the award of bonuses under our bonus plans; (10) to exclude costs incurred in connection
with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (11)
to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting
principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights.</i> Stock appreciation rights are granted pursuant to stock appreciation grant agreements adopted by the plan administrator.
The plan administrator determines the purchase price or strike price for a stock appreciation right, which generally cannot be less than
100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under our 2019 Plan vests
at the rate specified in the stock appreciation right agreement as determined by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Stock Awards.</i> Our plan administrator may grant other awards based in whole or in part by reference to our common stock. Our plan
administrator will set the number of shares under the stock award and all other terms and conditions of such awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
to Capital Structure.</i> In the event that there is a specified type of change in our capital structure, such as a stock split or recapitalization,
appropriate adjustments will be made to (i) the class and the maximum number of shares reserved for issuance under our 2019 Plan, (ii)
the class and the maximum number of shares that may be issued upon the exercise of ISOs, and (iii) the class and the number of shares
and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Transactions.</i> Our 2019 Plan provides that in the event of certain specified significant corporate transactions including: (i) a sale
of all or substantially all of our assets, (ii) the sale or disposition of more than 50% of our outstanding securities, (iii) the consummation
of a merger or consolidation where we do not survive the transaction and (iv) the consummation of a merger or consolidation where we
do survive the transaction but the shares of our common stock outstanding prior to such transaction are converted or exchanged into other
property by virtue of the transaction, each outstanding award will be treated as the plan administrator determines unless otherwise provided
in an award agreement or other written agreement between us and the award holder. The plan administrator may take one of the following
actions with respect to such awards:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the assumption, continuation, or substitution of a stock award by a successor corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the assignment of any reacquisition or repurchase rights held by us to a successor corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accelerate
    the vesting, in whole or in part, of the stock award and provide for its termination prior to the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
    or arrange for the cancellation of the stock award, to the extent not vested or not exercised prior to the effective time of the
    transaction, in exchange for such cash consideration, if any, as the plan administrator may deem appropriate; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    a payment, in the form determined by the plan administrator, equal to the excess, if any, of the value of the property the participant
    would have received on exercise of the awards before the transaction over any exercise price payable by the participant in connection
    with the exercise, multiplied by the number of shares subject to the stock award. Any escrow, holdback, earnout, or similar provisions
    in the definitive agreement for the transaction may apply to such payment to the holder of a stock award to the same extent and in
    the same manner as such provisions apply to holders of our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
plan administrator is not obligated to treat all stock awards or portions of stock awards, even those that are of the same type, in the
same manner in the event of a corporate transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a change in control, awards granted under our 2019 Plan will not receive automatic acceleration of vesting and/or exercisability,
although this treatment may be provided for in an award agreement or in any other written agreement between us and the participant. Under
our 2019 Plan, a change in control generally will be deemed to occur in the event: (i) the acquisition by any person or company of more
than 50% of the combined voting power of our then outstanding stock; (ii) a merger, consolidation, or similar transaction in which our
stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined outstanding voting
power of the surviving entity or the parent of the surviving entity; (iii) a sale, lease, exclusive license or other disposition of all
or substantially all of our assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders;
or (iv) an unapproved change in the majority of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability.
</i>A participant generally may not transfer stock awards under our 2019 Plan other than by will, the laws of descent and distribution,
or as otherwise provided under our 2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term,
Termination, and Amendment.</i> Unless sooner terminated by our Board, the 2019 Plan will terminate on the tenth anniversary of the date
our Board originally adopted our 2019 Plan, or March 26, 2029. No award will be granted after termination
of the 2019 Plan (or if it is suspended by our Board), but awards outstanding upon termination of the 2019 Plan will remain outstanding
in accordance with their applicable terms and conditions and the terms and conditions of the 2019 Plan. Our Board has the authority to
amend, suspend, or terminate our 2019 Plan, provided that such action does not materially impair the existing rights of any participant
without such participant&#8217;s written consent. Certain material amendments also require the approval of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
federal income tax consequences</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal United States federal income tax consequences to Participants and us with respect to participation
in the 2019 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state, or foreign
jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject
to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each
participant should consult the participant&#8217;s tax adviser regarding the federal, state, local, and other tax consequences of the
grant or exercise of an award or the disposition of stock acquired under the 2019 Plan. The 2019 Plan is not qualified under the provisions
of Section 401(a) of the Code, and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our
ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement
of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of our tax reporting obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nonstatutory
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of
the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the
fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is
employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those
shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain
holding period for those shares will begin on that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Incentive
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2019 Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in
Section 422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of
an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was
granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the
difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax
basis in that share will be long-term capital gain or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred
to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition
equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price.
However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount
of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a
disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be
short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO
exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum
taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in
the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that
share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the
amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option
is exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not allowed an income tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise
of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled
to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness and
the provisions of Section 162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy
our reporting requirements with respect to that amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any,
of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock
is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to
sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize
ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid
by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days
following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal
to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for
the stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock
award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock
becomes vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Unit Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the recipient of a restricted stock unit award structured to conform to the requirements of Section 409A of the Code or an exception
to Section 409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair
market value of the stock received over any amount paid by the recipient in exchange for the stock. To conform to the requirements of
Section 409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following
events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another
date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section 409A
of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any
taxes owed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock
unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock
unit award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Appreciation Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date,
the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation
right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
on the Employer&#8217;s Compensation Deduction</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code limits the deduction certain employers may take for otherwise deductible compensation payable to certain executive
officers of the employer to the extent the compensation paid to such an officer for the year exceeds $1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
discussion above is intended only as a summary and does not purport to be a complete discussion of all potential tax effects relevant
to recipients of awards under the 2019 Plan. Among other items this discussion does not address are tax consequences under the laws of
any state, locality, or foreign jurisdiction, or any tax treaties or conventions between the United States and foreign jurisdictions.
This discussion is based upon current law and interpretational authorities which are subject to change at any time.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
plan benefits under 2019 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
of awards under the 2019 Plan to our executive officers, employees, and other eligible Participants are subject to the discretion of
our Board or Compensation Committee, as applicable. As of the date of this proxy statement, no awards have been granted under the 2019
Plan subject to the stockholder approval of the amendment to the 2019 Plan sought in this proposal. Therefore, it is not possible to
determine the future benefits that will be received by the participants under the 2019 Plan other than with respect to the value of RSUs
that will be received by our non-employee directors on the date of the Annual Meeting (assuming all incumbent directors are elected at
the Annual Meeting).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the table below provides information solely with respect to our non-employee directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar value ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Hao Liu, <i>Chief Executive Officer</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay Crolius, <i>Chief Financial Officer</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Becher, <i>Chief Commercial Officer and General Manager of North America</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All executive officers as a group (three persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Non-employee directors as a group (four persons)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">290,000</td><td style="width: 1%; text-align: left">&#160;<sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#8212; </td><td style="width: 1%; text-align: left"><sup>&#160;(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All employees as a group, other than executive officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    grant date fair value of award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with our non-employee director compensation policy, each non-employee director who will continue to serve as a non-employee
    director immediately following the Annual Meeting will automatically be granted an award of RSUs on the date of our Annual Meeting,
    with the number of RSUs determined by dividing (i) $60,000 by (ii) the closing trading price of our common stock on the grant date.
    Additionally, the non-executive chairman of the Board will also be entitled to receive additional RSUs determined by dividing
    (i) $50,000 by (ii) the closing trading price of our common stock on the grant date, which is the anniversary of the attainment
    of the status of the non-executive chairman of the Board.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    described in the footnote (2) above, for non-employee directors, the number of shares reflects the number of RSUs granted following the Annual Meeting or the date of the RSU grant to the chairman of the Board. Accordingly, the number
    of shares is not included in the table.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consequences
of failing to approve the proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the amendment to increase the number of shares authorized under our 2019 Plan is not approved by stockholders, the 2019 Plan will continue
in full force and effect in accordance with its terms. Once the share reserve under the 2019 Plan is exhausted, we may elect to provide
compensation through other means, such as cash-settled awards or other cash compensation, to assure that Sonim and its affiliates can
attract and retain qualified personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends a vote FOR the approval of an amendment to our equity incentive plan to increase the aggregate number of shares of common
stock authorized for issuance by 600,000 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_049"></span>PROPOSAL
4 &#8212; ADVISORY VOTE ON COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the requirements of Section 14A of the Exchange Act, we are asking stockholders to approve, on a non-binding, advisory
basis, the executive compensation of our named executive officers (or &#8220;NEOs&#8221;) as disclosed in the section titled &#8220;<i><a href="#a_051">Executive
and Director Compensation</a></i>&#8221; and the related notes, and narrative in this proxy statement. The Board and the Compensation
Committee believe that the policies and practices described and explained herein reflect our competitive pay strategy, emphasis on incentive-driven
pay, and effective use of goals aligned with our business strategy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
this advisory vote to approve the executive compensation of our NEOs is non-binding, the Compensation Committee values our stockholders&#8217;
opinions and will carefully assess the voting results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends a vote FOR the following resolution:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Resolved,
that the stockholders of Sonim Technologies, Inc. hereby approve, on a non-binding, advisory basis, the compensation paid to the Company&#8217;s
named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including in the Executive and Director Compensation section,
compensation tables and narrative disclosures.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_050"></span>PROPOSAL
5 &#8212; ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the requirements of Section 14A of the Exchange Act, we are asking stockholders to vote on whether future advisory votes
on executive compensation (such as the one described in Proposal 4 above) should occur every year, every two years or every three
years.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
note that stockholders are not voting to approve or disapprove the recommendation of the board of directors with respect to this proposal.
Instead, the proxy card provides four choices: a one, two or three-year frequency or stockholders may abstain from voting on the proposal.
The option that receives the highest number of votes will be deemed to be the frequency preferred by our stockholders. We expect that
the next stockholder vote on the frequency of non-binding, advisory votes on named executive officer compensation will occur at our 2031
annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
this advisory vote on the frequency of future advisory votes to approve executive compensation is non-binding, the Board will carefully
assess the voting results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends a vote for conducting future advisory votes on executive compensation every 3 YEARS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_051"></span>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_067"></span>Executive
compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
NEOs for the year ended December 31, 2024, consisted of three individuals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu, our current Chief Executive Officer, who served as our principal executive officer during the year ended December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius, our current Chief Financial Officer, who was serving as our executive officer at the end of the fiscal year ended December
    31, 2024; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher, our Chief Commercial Officer, who was serving as our executive officer at the end of the fiscal year ended December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_066"></span>Summary
compensation table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding compensation earned during the years ended December 31, 2024 and December 31, 2023 by
our NEOs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total <br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Peter Hao Liu</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 6%; text-align: center">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">450,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">175,630</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">47,288</td><td style="width: 1%; text-align: left"><sup> (2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">672,918</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">450,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">180,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,226</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">677,226</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Clay Crolius</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">93,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">89,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">503,021</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">323,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">96,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">157,520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">577,270</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Charles Becher</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">345,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">745,144</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Commercial Officer and General Manager of North America</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">275,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">675,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column reflects the full grant date fair value for stock awards or options, respectively, granted during the fiscal year as measured
    pursuant to ASC Topic 718 as stock-based compensation in our consolidated financial statements. The grant date fair value of stock
    awards was based on the closing price per share of our common stock on the applicable grant date. These amounts do not necessarily
    correspond to the actual value that may be recognized from the stock options and stock awards by the NEOs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    reported primarily consists of a housing and car allowance for Mr. Liu.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_065"></span>Outstanding
equity awards at December 31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables provide information about outstanding equity awards held by each of our named executive officers as of December 31,
2024. Awards for the named executive officers were granted under our 2019 Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="12" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards<sup>(1)</sup></b></span></td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%; text-align: left">Peter Hao Liu</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: right">6/30/2015</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">67</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">150.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: right">06/30/2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">12/2/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">248.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">12/01/2029</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/18/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,903</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,540</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">10/26/2032</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Clay Crolius</td><td>&#160;</td>
    <td style="text-align: right">1/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/27/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/24/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/24/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">4/8/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,000</td><td style="text-align: left"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">4/8/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Charles Becher</td><td>&#160;</td>
    <td style="text-align: right">11/18/2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: left"><sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">10/26/2032</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    vesting is subject to the recipient&#8217;s continued service through the applicable vesting date and is subject to accelerated vesting
    in certain circumstances. For additional discussion, please see &#8220;<i><a href="#a_063">Agreements with our Named Executive Officers</a></i>&#8221;
    and &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in 10 equal quarterly installments beginning on January 14, 2024, and ending on April 14, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in three (3) equal yearly installments beginning April 8, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in 11 equal quarterly installments commencing on February 29, 2024, and ending on August 29, 2026</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards<sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    Date</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Shares or</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
    of Stock that</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Have
    Not Vested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
                                            Value of Shares or Units of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    That Have Not Vested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup></sup></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    vesting is subject to the recipient&#8217;s continued service through the applicable vesting date and is subject to accelerated vesting
    in certain circumstances. For additional discussion, please see &#8220;<i><span style="text-decoration: underline"><a href="#a_063">Agreements with our Named Executive Officers</a></span></i>&#8221;
    and &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i><span style="text-decoration: underline">.</span>&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_063"></span>Agreements
with our Named Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are descriptions of our employment agreements with our named executive officers. For a discussion of the severance pay and
other benefits to be provided in connection with a potential termination of employment and/or a change in control under the arrangements
with our named executive officers, see &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i><span style="text-decoration: underline">.</span>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Liu</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2023, the Company entered an amended and restated employment agreement with Mr. Liu (the &#8220;Liu Employment Agreement&#8221;),
which superseded his previous employment arrangements. Under the Liu Employment Agreement, Mr. Liu receives an annual base salary of
$450,000. Additionally, Mr. Liu is eligible to participate in our EIP in connection with Mr. Liu&#8217;s equity awards. Mr. Liu received
stock option grants (subject to applicable vesting periods), to purchase in the aggregate a total of 401,443 shares of the Company&#8217;s
common stock (the &#8220;Options&#8221;) granted pursuant to the EIP. Each Option vests over four (4) years, with one-fourth (1/4th)
of the shares underlying such Option vesting on the one-year anniversary of the date of Mr. Liu&#8217;s appointment as CEO, and one-twelfth
(1/12th) of the shares underlying such Option vesting in quarterly installments thereafter. The Options will have a maximum term of ten
(10) years from each grant date and will terminate earlier upon the termination of employment prior to the ten-year period. The Liu Employment
Agreement has no specified term, is on an at-will basis, and contains, <i>inter alia</i>, customary confidentiality, non-disparagement,
and cooperation provisions. On April 2, 2025, the Company and Mr. Liu amended the Liu Employment Agreement, changing the terms of Mr.
Liu&#8217;s severance in the event of a change in control, as described below under the title &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential
Payments upon Termination or Change in Control</a></span>.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Crolius</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2023, the Company entered an amended and restated letter agreement with Mr. Crolius (the &#8220;Crolius Letter Agreement&#8221;),
which superseded his previous employment arrangements. The Crolius Letter Agreement delineates the terms of Mr. Crolius&#8217;s employment:
he is entitled to a base salary of $320,000 per year (the &#8220;Crolius Base Salary&#8221;), a discretionary bonus, and other benefits
generally applicable to all employees of the Company. The Crolius Letter Agreement provides for the at-will employment of Mr. Crolius,
references the Company&#8217;s policies, and contains other customary conditions. The Crolius Base Salary was conditioned to be retroactively
effective as of November 1, 2023, and Mr. Crolius was entitled to receive a lump sum payment of the difference between the Crolius Base
Salary and the base salary pursuant to his previous employment arrangements. On April 15, 2025, the Company and Mr. Crolius amended the
Crolius Letter Agreement, changing the terms of Mr. Crolius&#8217;s severance in the event of a change in control, as described below
under the title &#8220;<a href="#a_064">Potential Payments upon Termination or Change in Control.</a>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Becher</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2022, the Company and Mr. Becher entered into a letter agreement (the &#8220;Becher Letter Agreement&#8221;), delineating
the terms of Mr. Becher&#8217;s employment: he is entitled to a guaranteed cash compensation of $400,000 per year consisting of a base
salary and a guaranteed minimum cash incentive compensation program, a discretionary bonus, and to other benefits generally applicable
to all employees of the Company. The Becher Letter Agreement provides for the at-will employment of Mr. Becher, references the Company&#8217;s
policies, and contains other customary conditions. The Becher Letter Agreement provides for variable compensation and a cash bonus plan
and also entitles Mr. Becher to receive options to purchase shares of our common stock (the &#8220;Becher Options&#8221;) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to purchase shares of our common stock
    vesting with respect to 25% of such options on the one-year anniversary of August 29, 2022, and the remainder vesting in equal quarterly
    installments thereafter, each installment equal to 1/16 of the 40,000 options; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to purchase shares of our common stock
    per year over a four-year period, in the event that revenue targets are achieved, as determined by the board of directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Becher Options are subject to the terms and conditions of the EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_064"></span>Potential
payments upon termination or change in control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our NEOs is covered by arrangements that specify certain payments to be made in the event that the executive&#8217;s employment is
terminated in certain circumstances. These severance benefits are intended to reflect market practices and are designed to attract, retain,
and appropriately incentivize and further motivate them to contribute to our short- and long-term success for the benefit of our stockholders,
particularly during uncertain times. The severance benefits of all NEOs are subject to customary conditions and applicable tax and other
deductions and withholdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liu
Employment Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Liu&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) at any time
up to the twelve-month anniversary of the closing of a change in control, we must pay Mr. Liu a lump-sum cash severance payable within
30 days of his termination. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sum equivalent to one hundred fifty percent (150%) of his yearly base salary in effect as of his termination date, and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    guaranteed pro-rated bonus. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Crolius
Letter Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Crolius&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) at any
time up to the twelve-month anniversary of the closing of a change in control, we must pay Mr. Crolius a lump-sum cash severance payable
within 30 days of his termination. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            sum equivalent to six (6) months of his base salary in effect as of his termination date;
                                            and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            guaranteed pro-rated bonus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Becher
Letter Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Becher&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) outside
the context of a change in control, we must pay Mr. Becher a severance. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of salary continuation; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of COBRA reimbursement. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if we terminate Mr. Becher&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; at any time up to the thirteen-month
anniversary of the closing of a change in control, the severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">twelve
    (12) months of salary continuation; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of COBRA reimbursement; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accelerated
    vesting of all unvested equity awards under the EIP that would have otherwise vested within four years of the termination date. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers did not participate in, or otherwise receive any benefits under, any pension or defined benefit retirement
plan sponsored by us during 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified
deferred Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers did not participate in, or earn any benefits under, a nonqualified deferred compensation plan sponsored by us
during 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee
benefit plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our ability to grant equity-based awards is a valuable and necessary compensation tool that aligns the long-term financial
interests of our executive officers with the financial interests of our stockholders. In addition, we believe that our ability to grant
options and other equity-based awards helps us to attract, retain and motivate executive officers and encourages them to devote their
best efforts to our business and financial success. Vesting of equity awards (other than awards granted in lieu of cash salary or bonus)
is generally tied to continuous service with us and serves as an additional retention measure. Our executive officers generally are awarded
an initial new hire grant upon commencement of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our named executive officers currently employed by us holds equity awards under our 2019 Equity Incentive Plan that were granted subject
to the general terms thereof and the applicable forms of award agreement thereunder. The specific vesting terms of each named executive
officer&#8217;s equity awards are described under &#8220;<i><span style="text-decoration: underline"><a href="#a_065">Outstanding equity awards at December 31, 2024</a>.</span></i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our initial public offering, we granted all equity awards pursuant to our 2012 Equity Incentive Plan. We currently grant all equity
awards pursuant to our 2019 Equity Incentive Plan. All options are granted with a per share exercise price equal to no less than the
fair market value of a share of our common stock on the date of the grant. All options have a maximum term of up to 10 years from the
date of grant, subject to earlier expiration following the cessation of an executive officer&#8217;s continuous service with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
generally remain exercisable for three months following an executive officer&#8217;s termination, except in the event of a termination
for cause or due to disability or death. Restricted stock unit awards (&#8220;RSUs&#8221;) generally vest annually over 4 years (other
than awards granted in lieu of cash salary or bonus, which may be vested at grant), subject to the continued service with us through
each vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Health
and welfare benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
pay premiums for medical insurance, dental insurance, and vision insurance for all full-time employees, including our named executive
officers. These benefits are available to all full-time employees, subject to applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>401(k)
Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a
tax advantaged basis. Eligible employees may defer eligible compensation on a pre-tax, or after-tax, basis, up to the statutorily prescribed
annual limits on contributions under the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Contributions are allocated
to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217;
directions. Employees are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section
401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified
retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are
not taxable to the employees until withdrawn or distributed from the 401(k) plan. We currently provide a matching contribution under
the 401(k) plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding compensation earned during the year ended December 31, 2024, by our non-employee directors
who served as directors during such year. Mr. Liu, our Chief Executive Officer, serves on our board of directors but does not receive
compensation for his service as a director and the compensation paid to Mr. Liu for his service as an employee during the year ended
December 31, 2024, is set forth in the &#8220;<i><a href="#a_066">Summary compensation table</a></i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees earned or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid in Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>awards<sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>awards<sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Mulica<sup>(3)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">160,000</td><td style="width: 1%; text-align: left"><sup> &#8239;(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">260,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Wang<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Steenstra<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">115,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Cassano<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">115,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column reflects the full grant date fair value for stock awards granted during the year ended December 31, 2024 as measured pursuant
    to ASC Topic 718 as stock-based compensation in our consolidated financial statements. The grant date fair value of stock awards
    was based on the closing price per share of our common stock on the applicable grant date. These amounts do not necessarily correspond
    to the actual value that may be recognized from the stock awards by the non-employee directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    the 2024 annual meeting of the Company&#8217;s stockholders, each non-employee director was awarded 7,895 RSUs on June 20,
    2024 having a grant date fair value of $60,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, each non-employee director held the following number of unvested RSUs:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Mulica &#8212; 22,019; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Wang, Mr. Steenstra, and Mr. Cassano &#8212; 11,022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="a_068"></span>Non-employee
director compensation policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a non-employee director compensation policy pursuant to which our non-employee directors are eligible to receive compensation
for service on our board of directors and committees of our board of directors. Our board of directors or Compensation Committee may
amend the non-employee director compensation policy from time to time. Effective as of January 1, 2024, our board of directors amended
and restated the Non-Employee Director Compensation Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
new non-employee director who joins our Board of Directors is granted an initial award of RSUs under the EIP, having a grant date fair
market value of $60,000. If a non-employee director is appointed or elected to our board of directors other than in connection with an
annual meeting of stockholders, then such non-employee director shall be awarded the full initial grant upon such non-employee director&#8217;s
appointment or election, and the annual grant to be awarded to such non-employee director at the first annual meeting of stockholders
following such appointment or election shall be pro-rated for the number of months served prior to such annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our non-employee directors continuing to serve on the board of directors also receives an annual equity award of RSUs under the EIP.
On June 20, 2024, Messrs. Mulica, Cassano, Steenstra, and Wang each received an RSU grant of 7,895 RSUs, having a grant date fair value
of $60,000, vesting in one installment on the earlier of the first anniversary of the grant date or immediately prior to the 2025 annual
meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-executive chairperson of our board of directors receives an additional annual equity award of RSUs having a grant date fair market
value of $50,000 under the EIP. On January 9, 2024, Mr. Mulica received an RSU grant related to his November 12, 2023 appointment
to non-executive chairperson of the board of directors of 6,668, retroactively adjusted for the Reverse Stock Split, vesting in one installment
on the anniversary of his appointment, having a grant date fair value of $50,000. On November 12, 2024, Mr. Mulica received an RSU
grant of 14,124 vesting in one installment on the first anniversary of the grant date, having a grant date fair value of $50,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
RSU award granted under the policy will fully vest upon a change of control or the non-employee director&#8217;s death or disability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director receives an annual cash retainer of $35,000 for serving on our board of directors. The non-executive chairperson
of our board of directors receives an additional annual cash retainer of $50,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chairperson and members of the three principal standing committees of our board of directors are entitled to the following annual cash
retainers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Board Committee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; font-weight: bold">Chairperson Fee</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; font-weight: bold">Member Fee</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Audit Committee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">15,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Compensation Committee</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Nominating and Corporate Governance Committee</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,750</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
annual cash compensation amounts will be payable in equal quarterly installments in arrears, pro-rated based on the days served in the
applicable fiscal quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also reimburse all reasonable out-of-pocket expenses incurred by non-employee directors for their attendance at meetings of our board
of directors or any committee thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_061"></span>Equity
compensation plan information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain information with respect to all of Sonim&#8217;s equity compensation plans in effect as of December
31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Plan Category</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to be Issued upon</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining Available for Future</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance Under Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation Plans (Excluding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Reflected in Column (a))</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Equity compensation plans approved by security holders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">823,456</td><td style="width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6.4834</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">424,871</td><td style="width: 1%; text-align: left"><sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">823,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.4834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">424,871</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate number consists of the following:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,301
    shares subject to options to purchase common stock issued pursuant to our 2012 Equity Incentive Plan as of December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">754,193
    shares subject to options to purchase common stock issued pursuant to our 2019 Equity Incentive Plan as of December 31, 2024;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,962
    shares issuable upon vesting of outstanding RSUs issued pursuant to our 2019 Equity Incentive Plan as of December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    weighted average exercise price does not reflect shares that will be issued upon the vesting of outstanding RSUs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    404,047 shares authorized for future issuance under our 2019 Equity Incentive Plan and 20,824 shares authorized for future issuance
    under our 2019 Employee Stock Purchase Plan as of December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2019 Employee Stock Purchase Plan, the number of shares of common stock reserved for issuance automatically increases on January
1 of each calendar year for 10 years, starting January 1, 2020, and ending on, and including, January 1, 2029, in an amount equal to
the lesser of 1% of the total number of shares of capital stock outstanding on December 31st of the prior calendar year, and (ii) 5,000
shares, unless the Board of Directors or Compensation Committee determines prior to such date that there will be a lesser increase, or
no increase. Effective January 1, 2025, 5,000 additional shares were added to the 2019 Employee Stock Purchase Plan, provided that such
shares have not been registered by means of filing a Registration Statement on Form S-8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2019 Equity Incentive Plan, the number of shares subject to outstanding stock options or other stock awards that were granted under
the 2012 Option Plan that are forfeited, terminated, expire, or are otherwise not issued are available for issuance. Additionally, the
number of shares of common stock reserved for issuance under the 2019 Equity Incentive Plan automatically increases on January 1 of each
calendar year for 10 years, starting January 1, 2020 and ending on and including January 1, 2029, in an amount equal to 5% of the total
number of shares of capital stock outstanding on December 31 of the prior calendar year, unless the board of directors or Compensation
Committee determines prior to the date of increase that there will be a lesser increase, or no increase. Effective January 1, 2025, 249,193
additional shares were added to the 2019 Equity Incentive Plan. Subject to certain express limits of the 2019 Equity Incentive Plan,
shares available for award purposes under the 2019 Equity Incentive Plan generally may be used for any type of award authorized under
that plan, including options, stock appreciation rights, restricted stock, RSUs, performance-based stock or cash awards or other similar
rights to purchase or acquire shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
versus performance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are
providing information about the relationship between executive compensation actually paid to our PEO and the non-PEO NEOs (as calculated
in accordance with Item 402(v) of Regulation S-K) and certain financial performance of the Company for each of the last three completed
fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pay
versus performance table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000015" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total
    for PEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    Actually Paid to PEO <sup id="xdx_F5A_zoC5cfgHytsc">(2)(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Summary Compensation Table
    Total for non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Compensation Actually Paid to non-PEO NEOs<sup id="xdx_F53_z2S7G13evcl3">(2)(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment
    Based on Total Shareholder Return</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Income $(M)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">2024 <span id="xdx_F49_ztKsO747mKM5" style="display: none">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,918</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000017" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,334</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,083</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">513,490</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000020" format="ixt:numdotdecimal" decimals="2" unitRef="USD">34.23</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000021" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">33.65</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023 <span id="xdx_F42_z1MDmElWV8X8" style="display: none">(1)</span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,266</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,136,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">626,135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">688,442</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000026" format="ixt:numdotdecimal" decimals="2" unitRef="USD">79.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000027" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">0.09</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2022 <span id="xdx_F4F_z0K51fsW4TSd" style="display: none">(1)</span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,986,962</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,975,045</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420,553</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="2" unitRef="USD">46.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000033" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">14.09</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify; width: 48px"><span id="xdx_F0A_zPQXMzgQtuGl" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zMSvEzrWvW3e" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000034" xml:lang="en-US">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</ix:footnote></span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify; width: 48px"><span id="xdx_F0C_zhguKNClr2Sj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zwcOjN7hiTM" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000035" xml:lang="en-US">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</ix:footnote></span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify; width: 48px"><span id="xdx_F05_zCM3WG1VRqub" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z55mUfmXByJb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000036" xml:lang="en-US">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</ix:footnote></span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000038" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PEO in all reporting years is <span id="xdx_902_eecd--PeoName_c20240101__20241231_zLaRAxIJNNWa"><span id="xdx_90F_eecd--PeoName_c20230101__20231231_zJN3VjvnASK2"><span id="xdx_904_eecd--PeoName_c20220101__20221231_zoKdZEallga6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000039" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31" id="Fact000040" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000041" name="ecd:PeoName">Hao (Peter) Liu</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zSGEfxo4XKpi" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000043" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PEO: Liu, Hao (Peter)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember" id="Fact000045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,986,962</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember" id="Fact000046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,266</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember" id="Fact000047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,918</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000049" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,501,393</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,445,577</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000054" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,346</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">681,465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">610,049</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000062" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000065" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">801</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,407</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">197,203</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zLIFV5UcRD41" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,975,045</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,136,138</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember" id="Fact000079" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,334</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_z1PCABkBUfy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000081" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420,553</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">626,135</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,083</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000087" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,981</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000088" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">78,760</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000089" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">44,676</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,383</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,886</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,406</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000097" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35,262</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000103" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,049</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000105" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">50,540</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zzTNdSMsZ8ng" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,019</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">688,442</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">513,490</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zWpmt7CnJDWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000119" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and TSR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s cumulative indexed Total Shareholder
Return (&#8220;TSR&#8221;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdefc14a_004.jpg" alt=""/></span></p>

</ix:nonNumeric><p id="xdx_8A7_zNJbKpVQFbF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000121" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and net income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdefc14a_005.jpg" alt=""/></span></p>

</ix:nonNumeric><p id="xdx_8A1_ziH3R9BiXPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_052"></span>CERTAIN
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_053"></span>Policies
and procedures for related party transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a written Related-Person Transactions Policy that sets forth the Company&#8217;s policies and procedures regarding the identification,
review, consideration and approval or ratification of &#8220;related-persons transactions.&#8221; For purposes of the Company&#8217;s
policy only, a &#8220;related-person transaction&#8221; is a transaction, arrangement or relationship (or any series of similar transactions,
arrangements, or relationships) in which the Company and any &#8220;related person&#8221; are participants involving an amount that exceeds
$120,000. Transactions involving compensation for services provided to the Company as an employee, director, consultant, or similar capacity
by a related person are not covered by this policy. A related person is any executive officer, director, or more than 5% stockholder
of the Company, including any of their immediate family members, and any entity owned or controlled by such persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the policy, where a transaction has been identified as a related-person transaction, management must present information regarding the
proposed related-person transaction to the Audit Committee (or, where Audit Committee approval would be inappropriate, to another independent
body of the board of directors) for consideration and approval or ratification. The presentation must include a description of, among
other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to the Company of the transaction
and whether any alternative transactions were available. To identify related-person transactions in advance, the Company relies on information
supplied by its executive officers, directors and certain significant stockholders. In considering related-person transactions, the Audit
Committee takes into account the relevant available facts and circumstances including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risks, costs and benefits to the Company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on a director&#8217;s independence in the event the related person is a director, immediate family member of a director or
    an entity with which a director is affiliated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of other sources for comparable services or products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms available to or from, as the case may be, unrelated third parties or to or from employees generally.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the deliberations
and approval. The policy requires that, in determining whether to approve, ratify or reject a related-person transaction, the Audit Committee
consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, the best interests of the Company
and its stockholders, as the Audit Committee determines in the good faith exercise of its discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
party transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of transactions since January 1, 2022, to which we have been a participant and in which (i) the amount involved
exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets as of December 31, 2024, 2023, and 2022,
and (ii) any of our directors, executive officers or holders of more than 5% of our common stock, or any members of their immediate family,
had or will have a direct or indirect material interest, other than compensation arrangements which are described in the sections titled
&#8220;<i><span style="text-decoration: underline"><a href="#a_067">Executive Compensation</a></span></i>&#8221; and &#8220;<i><a href="#a_068">Non-Employee Director Compensation
Policy</a>.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Agreements and Corollary Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subscription
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company entered into a Subscription Agreement (the &#8220;Subscription Agreement&#8221;) with AJP Holding Company,
LLC, a Delaware limited liability company (the &#8220;Purchaser&#8221;), pursuant to which Purchaser agreed to purchase from the Company
an aggregate of 2,083,334 shares of the Company&#8217;s common stock for a purchase price of $17,500,000 (the &#8220;Purchased Shares&#8221;).
As of the date of the Subscription Agreement, Peter Liu, who then served as Sonim&#8217;s Executive VP for Global Operations and Engineering,
was appointed Chief Executive Officer of Sonim. The Subscription Agreement additionally provided for the issuance of a certain portion
of the Purchased Shares to Mr. Liu rather than the Purchaser. Jeffrey Wang, currently a member of the board of directors of the
Company, is the sole manager and the owner of 40% of the membership interests in the Purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Insider
Voting Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Subscription Agreement, all then-members of the board of directors of the Company and Robert Tirva, then President,
Chief Financial Officer, and Chief Operating Officer of the Company, each as stockholders of the Company, entered into a Voting and Support
Agreement, dated April 13, 2022, with the Company and Purchaser whereby such stockholders agreed, among other things, to vote the shares
of common stock of the Company owned and/or controlled by such stockholder in favor of the adoption of the Subscription Agreement and
the transactions contemplated thereby, as well as such other matters set forth in the Voting and Support Agreements. Each Voting and
Support Agreement also contained a restriction on the transfer of shares of common stock of the Company, subject to limited exceptions.
Each Voting and Support Agreement terminated upon the First Closing, as defined in and as consummated pursuant to the Subscription Agreement
on July 13, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Support
Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2022, the Company held its special meeting of stockholders (the &#8220;Special Meeting&#8221;), whereby the stockholders of
the Company approved the Subscription Agreement and the transactions contemplated thereby by approximately 71.98% of the votes cast.
Following the Special Meeting, on July 13, 2022, the Company and the Purchaser consummated the First Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the Subscription Agreement, on July 13, 2022, the Company and the Purchaser entered into a support agreement
(the &#8220;Purchaser Support Agreement&#8221;), whereby the Purchaser agreed, among other things, to vote the shares of common stock
owned by Purchaser in favor of the election of Alan Howe and Mike Mulica, as well as such other matters set forth in the
Purchaser Support Agreement. The Purchaser Support Agreement also required, as a condition to the Purchaser transferring any shares of
common stock owned by the Purchaser, that the acquirer of such shares of common stock agree to be bound by the terms of the Purchaser
Support Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the Subscription Agreement, on July 13, 2022, the Company and Mr. Liu entered into a support agreement (the
&#8220;Designee Support Agreement&#8221;). The terms of the Designee Support Agreement were analogous to the terms of the Purchaser Support
Agreement, provided that the Designee Support Agreement extended its requirements solely to 95,239 shares of our common stock issued
during the First Closing rather than the entirety of the shares of common stock owned by Mr. Liu.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the Purchaser Support Agreement and the Designee Support Agreement were terminated at the Director End Time (as such term defined in
the Subscription Agreement) due to the formal conclusion of certain investigation relating to the Company by the SEC</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the Subscription Agreement, on July 13, 2022, the Company and the Purchaser entered into a registration
rights agreement (the &#8220;Registration Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company is required
(among other things), within 30 days of the Second Closing (as defined in the Subscription Agreement), to file with the SEC a registration
statement to register the resale of all registrable securities held by Purchaser or any person that receives Registrable Securities (as
that term is defined in the Registration Rights Agreement) (each a &#8220;Holder&#8221;). The Company&#8217;s obligation to register
the Registrable Securities for sale under the Securities Act of 1933 terminates upon the first to occur of (i) the date that is five
years from the effective date of the shelf registration statement filed by the Company pursuant to the Registration Rights Agreement,
(ii) the date on which all Holders can sell shares of common stock of the Company under Rule 144 without volume restrictions, and (iii)
the date on which no registrable securities are held by any Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2024
Subscription Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 29, 2024, the Company entered into a subscription agreement (the &#8220;2024 Subscription Agreement&#8221;) with Jiang Liu, a greater
than five percent (5%) security holder of the Company, providing for the private placement of (i) 350,000 shares of the Company&#8217;s
common stock and (ii) warrants to purchase up to 350,000 shares of common stock (the &#8220;Warrants&#8221;) for an aggregate purchase
price of $3,850,000. Each Warrant has an exercise price of $11 per share, is immediately exercisable, will expire on April 29, 2029 (five
years from the date of issuance), and is subject to customary adjustments for certain transactions affecting the Company&#8217;s capitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2024
Registration Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the 2024 Subscription Agreement, the Company entered into a registration rights agreement (the &#8220;2024
Registration Rights Agreement&#8221;) with Mr. Liu. Pursuant to the 2024 Registration Rights Agreement, the Company agreed to prepare
and file a registration statement (the &#8220;Initial Registration Statement&#8221;) with the SEC by May 30, 2024 for purposes of registering
the resale of shares of common stock (i) issued and sold pursuant to the 2024 Subscription Agreement, (ii) issuable upon exercise of
the Warrants, (iii) issuable in connection with any anti-dilution provisions in the Warrants and (iv) any securities issued or then issuable
upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing. The Company agreed
to use commercially reasonable efforts to cause the Initial Registration Statement to be declared effective by the SEC by October
29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2025
Subscription Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company entered into a subscription agreement (the &#8220;2025 Subscription Agreement&#8221;) with Lytton-Kambara
Foundation (&#8220;LK Foundation&#8221;), an entity controlled by Laurence W. Lytton. Based on Schedule 13G/A filed with the SEC on
February 24, 2025, Mr. Lytton was a holder of more than 5% of our common stock before the consummation of the 2025 Subscription
Agreement. The Subscription Agreement provided for the private placement of (i) 800,000 shares of our common stock
and (ii) warrants to purchase up to 400,000 shares of common stock (the &#8220;LKF Warrants&#8221;) for an aggregate purchase price
of $1,000,000. Each LKF Warrant has an exercise price of $1.3864 per share, is immediately exercisable, will expire on May 12, 2030
(five years from the date of issuance), and is subject to customary adjustments for certain transactions affecting the
Company&#8217;s capitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2025
Registration Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the 2025 Subscription Agreement, the Company entered into a registration rights agreement (the &#8220;2025
Registration Rights Agreement&#8221;) with LK Foundation. Pursuant to the 2025 Registration Rights Agreement, the Company agreed to prepare
and file a registration statement (the &#8220;Initial Registration Statement&#8221;) with the SEC by July 11, 2025 for purposes of registering
the resale of shares of common stock (i) issued and sold pursuant to the 2025 Subscription Agreement, (ii) issuable upon exercise of
the LKF Warrants, (iii) issuable in connection with any anti-dilution provisions in the LKF Warrants and (iv) any securities issued or
then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing.
The Company agreed to use commercially reasonable efforts to cause the Initial Registration Statement to be declared effective by the
SEC by November 12, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Course of Business Transactions with Related Persons</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are the transactions with various entities, in which we believe Dr. Chuan Wang, the father of our director, Jeffrey
Wang, holds an indirect interest of approximately 40%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023-2024
ODM Arrangement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 15, 2023, in the ordinary course of business, the Company entered into an agreement pursuant to which the Company would execute
various statements of work and sell white label products under the ODM model arrangement (the &#8220;ODM Arrangement&#8221;). Pursuant
to the ODM Arrangement, the Company consummated various transactions as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
    Aggregate Dollar Amount</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">382,771</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,378,578</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Engineering
Services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into agreements to provide engineering services, all of which were executed in the ordinary course of business. Amounts
incurred under these agreements were and are expected to be capitalized as contract fulfillment assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    of the Agreement</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Dollar Amount Agreed Upon by Sonim</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    14, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into an agreement to purchase parts and components to be used in the manufacturing of the Company&#8217;s
products for the aggregate amount of approximately $1,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
of Liability and Indemnification of Officers and Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides indemnification for its directors and officers so that they will be free from undue concern about personal liability
in connection with their service to the Company. Under the Company&#8217;s bylaws, the Company is required to indemnify its directors
and officers to the extent not prohibited under Delaware or other applicable law. The Company has also entered into indemnity agreements
with its executive officers and directors. These agreements provide, among other things, that the Company will indemnify the officer
or director, under the circumstances and to the extent provided for in the agreement, for expenses, damages, judgments, fines and settlements
he or she may be required to pay in actions or proceedings which he or she is or may be made a party by reason of his or her position
as a director, officer or other agent of the Company, and otherwise to the fullest extent permitted under Delaware law and the Company&#8217;s
bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_054"></span>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_055"></span>Security
Ownership of Certain Beneficial Owners and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to the beneficial ownership of our common stock as of June 9, 2025,
the record date for the Annual Meeting, by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our named executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and director nominees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our current directors and executive officers as a group; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person known by us to be the beneficial owner of more than 5% of the outstanding shares of our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined beneficial ownership in accordance with the rules of the SEC, and thus it represents sole or shared voting or investment
power with respect to our securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table
have sole voting and sole investment power with respect to all shares that they beneficially owned, subject to community property laws
where applicable. The information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of
Sections 13(d) and 13(g) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have based our calculation of the percentage of beneficial ownership on 10,338,905 shares of our common stock outstanding as of June
9, 2025. In accordance with SEC rules, we have deemed shares of our common stock subject to stock options or warrants that are currently
exercisable or exercisable within sixty (60) days of June 9, 2025 and shares of our common stock underlying RSUs that are currently
releasable or releasable within sixty (60) days of June 9, 2025 to be outstanding and to be beneficially owned by the person holding
the common stock options or RSUs for the purpose of computing the percentage ownership of that person. We did not deem these shares outstanding,
however, for the purpose of computing the percentage ownership of any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, the address of each beneficial owner listed in the table below is c/o Sonim Technologies, Inc., 4445 Eastgate Mall,
Suite 200, San Diego, CA 92121. The information provided in the table is based on our records, information filed with the SEC, and information
provided to us, except where otherwise noted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Beneficially Owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Beneficial Owner Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Directors, Nominees, and Named Executive Officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">James Cassano</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">49,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Liu<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">489,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.64</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Mike Mulica</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Jack Steenstra</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,139</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">George Thangadurai</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Wang<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,968,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.04</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay Crolius<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Becher<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,668</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All current executive officers and directors as a group (7 persons)<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,773,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.15</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Five Percent Holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laurence W. Lytton<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,066,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.25</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AJP Holding Company, LLC<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,968,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.04</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orbic North America, LLC<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,968,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.04</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiang Liu<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.55</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    beneficial ownership of less than one percent (1%) of the outstanding shares of our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 220,050 shares of common stock exercisable within 60 days of June 9, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    solely on (A) a Schedule 13D/A filed with the SEC on May 19, 2025 (the &#8220;Orbic Group Report&#8221;), by the Orbic Group
    consisting of (i) Jeffrey Wang, (ii) AJP; (iii) Orbic; (iv) Ashima Narula, the sole member and manager of Orbic; and (v) Parveen
    Narula, the Chief Executive Officer of Orbic, and (B) Section 16 filings of Mr. Wang. Section 13(d) and Rule 13d-5 under the Exchange
    Act provide that, when two or more beneficial owners of a class of equity security registered under Section 12 agree to act together
    as a group for the purpose of voting equity securities of an issuer, the &#8220;group&#8221; will be deemed to have acquired beneficial
    ownership of all shares held by all members of the group. Consists of (i) 21,301 shares of common stock held directly by Mr.
    Wang (which were not disclosed in the Orbic Report), (ii) 1,946,346 shares of common stock held by AJP (to which the members of the
    Orbic Group share voting and dispositive power), and (iii) 1,000 shares of common stock held by Orbic (to which the members of the
    Orbic Group share voting and dispositive power). The 1,946,345 shares held by AJP are subject to a proxy agreement by and between
    AJP and Orbic that limits AJP&#8217;s dispositive power and grants the voting power to Orbic. Mr. Wang is the sole manager of AJP
    and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The principal office address
    or business of each member of the Orbic Group is as follows: (i) for AJP and Jeffery Wang&#8212;P.O. Box 2729, Sunnyvale, CA 94087
    and (ii) for Orbic, Ashima Narula, and Parveen Narula&#8212; 555 Wireless Blvd., Hauppauge, NY 11788.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 35,667 shares of common stock exercisable within 60 days of June 9, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 15,000 shares of common stock exercisable within 60 days of June 9, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 270,717 shares of common stock exercisable within 60 days of June 9, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="margin: 0; text-align: justify">Based solely on the Schedule 13G/A
                                            filed with the SEC by Mr. Lytton on May 16, 2025. Mr. Lytton has (i) the sole voting and
                                            dispositive power with regard to 866,916 shares of common stock and (ii) shared voting and
                                            dispositive power with regard to 1,200,000 shares of common stock held by Lytton-Kambara
                                            Foundation <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
                                            &#8220;Foundation&#8221;), of which Mr. Lytton is the President. Includes warrants to purchase
                                            400,000 shares of common stock exercisable within 60 days of June 9, 2025. The address
                                            of Mr. Lytton and the Foundation is 467 Central Park West, New York, NY 10025.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>

<tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 7%"><span style="font-size: 10pt">(7)</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify; width: 93%"><span style="font-size: 10pt">Includes warrants
    to purchase 350,000 shares of common stock exercisable within 60 days of June 9, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_056"></span>Delinquent
Section 16 Reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act, requires our directors and executive officers, among others, to file with the SEC an initial report of ownership
of our stock on Form 3 and reports of changes in ownership on Form 4 or Form 5. Based solely on a review of reports filed with the SEC
and on written representations from reporting individuals, we believe that all of our officers and directors filed the required reports
on a timely basis under Section 16(a) for the fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_057"></span>OTHER
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_058"></span>Householding
of proxy materials</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that permit companies and intermediaries (<i>e.g.</i>, brokers) to satisfy the delivery requirements for notices
or proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single notice
or proxy statement and annual report addressed to those stockholders. This process is commonly referred to as &#8220;householding.&#8221;
This process benefits both stockholders and Sonim because it can significantly reduce our printing and mailing costs and eliminates unnecessary
mailings delivered to your home. It also helps the environment by conserving natural resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
this procedure, we are delivering a single copy of the proxy materials to multiple stockholders who share the same address. Stockholders
who participate in householding will continue to be able to access and receive separate proxy cards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
written request, we will deliver promptly a separate copy of the proxy materials to any stockholder at a shared address to which we delivered
a single copy of any of these documents. To receive a separate copy of the proxy materials, stockholders may contact our Secretary by
written request to Sonim Technologies, Inc., 4445 Eastgate Mall, Suite 200, San Diego, CA 92121 or by oral request to our transfer agent
at 800-937-5449. The same phone number and addresses may be used to notify us that you wish to receive a separate set of proxy materials
in the future, or to request delivery of a single copy of our proxy materials if you are receiving multiple copies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_059"></span>Stockholder
proposals for the 2026 annual meeting of stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rule
14a-8 of the Exchange Act</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder would like us to consider including a proposal in our proxy statement for our 2026 annual meeting pursuant to Rule 14a-8
of the Exchange Act, then the proposal must be received by our Secretary at our principal executive offices on or before February
18, 2026. In addition, stockholder proposals must comply with the requirements of Rule 14a-8 regarding the inclusion of stockholder
proposals in company-sponsored proxy materials. Proposals should be addressed to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Secretary</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
Eastgate Mall, Suite 200</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92121</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
notice procedure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws also establish an advance notice procedure for stockholders who wish to present a proposal or nominate a
director at an annual meeting, but do not seek to include the proposal or director nominee in our proxy statement. In order to be properly
brought before our 2026 annual meeting of stockholders under the advance notice provisions of our amended and restated bylaws, the stockholder
must provide timely written notice that must be received by the Secretary at the principal executive offices of the Company, and any
such proposal or nomination must constitute a proper matter for stockholder action. The written notice must contain the information specified
in our amended and restated bylaws. To be timely, a stockholder&#8217;s written notice must be received by the Secretary at the principal
executive offices of the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    earlier than the close of business, on March 20, 2026; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    later than the close of business on April 19, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that we hold our 2026 annual meeting more than 30 days before or more than 30 days after the first anniversary of the Annual
Meeting, then written notice required by our amended and restated bylaws must be received by the Secretary at the principal executive
offices of the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    earlier than the close of business on the 120th day prior to the day of the 2026 annual meeting of stockholders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    later than the later of</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    close of business on the 90th day before the 2026 annual meeting of stockholders; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    close of business on the 10th day following the day on which the public announcement of the date of the 2026 annual meeting of stockholders
    was first made by us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Public
announcement&#8221; means disclosure in a press release reported by the Dow Jones News Service, Associated Press, or comparable national
news service or in a document publicly filed by the Company with the Securities and Exchange Commission pursuant to Section 13, 14 or
15(d) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to satisfying the foregoing requirements of our bylaws, to comply with Rule 14a-19 under the Exchange Act (the universal proxy
rules), stockholders who intend to solicit proxies in support of director nominees other than our nominees for our 2025 annual meeting
of stockholders must also comply with the additional requirements of Rule 14a-19 under the Exchange Act, including providing a statement
that such stockholder intends to solicit the holders of shares representing at least 67% of the voting power of the Company&#8217;s shares
entitled to vote on the election of directors in support of director nominees other than the Company&#8217;s nominees, as required by
Rule 14a-19(b) under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_060"></span>ANNEX
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Sonim
Technologies, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Amended
and Restated 2019 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adopted
by the Board of Directors: March 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: May 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
Date/Effective Date: May 9, 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: May 31, 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: September 29, 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated
to illustrate the effect of the reverse stock split: September 15, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: September 15, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: October 26, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: August 14, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: September 28, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: May 17, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: June 20, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: April 28, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: July 18, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>1.
General.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Successor to and Continuation of Prior Plan.</b> The Plan is the successor to and continuation of the Sonim Technologies, Inc. 2012 Equity
Incentive Plan (the &#8220;<b><i>Prior Plan</i></b>&#8221;). From and after 12:01 a.m. Pacific Time on the Effective Date, no additional
stock awards will be granted under the Prior Plan. All Awards granted on or after 12:01 a.m. Pacific Time on the Effective Date will
be granted under this Plan. All stock awards granted under the Prior Plan will remain subject to the terms of the Prior Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>Any shares that would otherwise remain available for future grants under the Prior Plan as of 12:01 a.m. Pacific Time on the Effective
Date (the &#8220;<b><i>Prior Plan&#8217;s Available Reserve</i></b>&#8221;) will cease to be available under the Prior Plan at such time.
Instead, that number of shares of Common Stock equal to the Prior Plan&#8217;s Available Reserve will be added to the Share Reserve (as
further described in Section 3(a) below) and will be immediately available for grants and issuance pursuant to Stock Awards hereunder,
up to the maximum number set forth in Section 3(a) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>In addition, from and after 12:01 a.m. Pacific Time on the Effective Date, with respect to the aggregate number of shares of Common
Stock subject, at such time, to outstanding stock awards granted under the Prior Plan that (1) expire or terminate for any reason prior
to exercise; (2) are forfeited or repurchased because of the failure to meet a contingency or condition required to vest such shares
or otherwise return to the Company; or (3) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection
with an award (such shares the &#8220;<b><i>Returning Shares</i></b>&#8221;) will immediately be added to the Share Reserve as shares
of Common Stock (as further described in Section 3(a) below) as and when such a share becomes a Returning Share, up to the maximum number
set forth in Section 3(a) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Eligible Award Recipients.</b> Employees, Directors and Consultants are eligible to receive Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Available Awards.</b> The Plan provides for the grant of the following Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options,
(iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, (vii)
Performance Cash Awards, and (viii) Other Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Purpose.</b> The Plan, through the grant of Awards, is intended to help the Company secure and retain the services of eligible award
recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide
a means by which the eligible recipients may benefit from increases in value of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>2.
Administration.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Administration by Board.</b> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or
Committees, as provided in Section 2(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Powers of Board.</b> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 57; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted;
(D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive
cash or Common Stock under the Award; (E) the number of shares of Common Stock subject to, or the cash value of, an Award; and (F) the
Fair Market Value applicable to a Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration
of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or
in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it will deem necessary or expedient
to make the Plan or Award fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>To settle all controversies regarding the Plan and Awards granted under it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or the time at which cash or shares of Common
Stock may be issued in settlement thereof).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination
of the Plan will not impair a Participant&#8217;s rights under the Participant&#8217;s then-outstanding Award without the Participant&#8217;s
written consent, except as provided in subsection (viii) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
</b>To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating
to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or to make the Plan or Awards
granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from, or compliant with, the requirements
for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required
by applicable law or listing requirements, and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company
will seek stockholder approval of any amendment of the Plan that (A) materially increases the number of shares of Common Stock available
for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially
increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may
be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available
for issuance under the Plan. Except as provided in the Plan (including subsection (viii) below) or an Award Agreement, no amendment of
the Plan will impair a Participant&#8217;s rights under an outstanding Award unless (1) the Company requests the consent of the affected
Participant, and (2) such Participant consents in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vii)
</b>To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy
the requirements of (A) Section 422 of the Code regarding &#8220;incentive stock options&#8221; or (B) Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(viii)
</b>To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not
limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to
any specified limits in the Plan that are not subject to Board discretion; <i>provided, however,</i> that a Participant&#8217;s rights
under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and
(B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have
been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially
impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of
any one or more Awards without the affected Participant&#8217;s consent (A) to maintain the qualified status of the Award as an Incentive
Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment
of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code;
(C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (D) to comply with
other applicable laws or listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ix)
</b>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests
of the Company and that are not in conflict with the provisions of the Plan or Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(x)
</b>To adopt such rules, procedures and sub-plans related to the operation and administration of the Plan as are necessary or appropriate
under local laws and regulations to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals
or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or
any Award Agreement made to ensure or facilitate compliance with the laws or regulations of the relevant foreign jurisdiction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(xi)
</b>To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of
any outstanding Stock Award; (B) the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1)
Option or SAR, (2) Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Stock Award, (5) cash and/or (6) other valuable
consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number
of shares of Common Stock as the cancelled Stock Award and (y) granted under the Plan or another equity or compensatory plan of the Company;
or (C) any other action that is treated as a repricing under generally accepted accounting principles (collectively (A) through (C),
an &#8220;<b><i>Exchange Program</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Delegation to Committee</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
General. </b>The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of
the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore
possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee
any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be
to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent
with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority
to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously
delegated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Rule 16b-3 Compliance. </b>The Committee may consist solely of two or more Non-Employee Directors, in accordance with Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Delegation to an Officer.</b> The Board may delegate to one (1) or more Officers the authority to do one or both of the following (i)
designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other
Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of shares of Common
Stock to be subject to such Stock Awards granted to such Employees; <i>provided, however</i>, that the Board resolutions regarding such
delegation will specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and
that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award
Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation
authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director)
to determine the Fair Market Value pursuant to Section 13(x)(iii) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Effect of Board&#8217;s Decision.</b> All determinations, interpretations and constructions made by the Board in good faith will not
be subject to review by any person and will be final, binding and conclusive on all persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>3.
Shares Subject to the Plan.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Share Reserve.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>Subject to Section 9(a) relating to Capitalization Adjustments, and the following sentence regarding the annual increase, the aggregate
number of shares of Common Stock that may be issued pursuant to Stock Awards will not exceed 2,474,054, which number is the sum
of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
18,851 shares that were approved in connection with the initial adoption of the Plan on the Effective Date; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
the number of shares that remained available for issuance under the Prior Plan&#8217;s Available Reserve as of the initial adoption of
the Plan on the Effective Date; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
the Returning Shares, if any, which become available for grant under this Plan from time to time; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)
30,000 shares that were approved at the Company&#8217;s 2020 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)
the entirety of the evergreen increases under the Plan; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)
500,000 shares approved at the Company&#8217;s 2022 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(G)
200,000 shares approved at the Company&#8217;s 2023 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(H)
300,000 shares approved at the Company&#8217;s 2024 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)
600,000 shares approved at the Company&#8217;s 2025 Annual Meeting of Stockholders</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(such
aggregate number of shares described in (A) through (H) above, the &#8220;<b><i>Share Reserve</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Share Reserve will automatically increase on January 1st of each calendar year, beginning on January 1 in the calendar
year following the calendar year in which the IPO Date occurs and ending on (and including) January 1, 2029 (each, an &#8220;<b><i>Evergreen
Date</i></b>&#8221;) in an amount equal to five percent (5%) of the total number of shares of Capital Stock outstanding on the last day
of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide
that there will be no increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser
number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant
to the Plan. As a single share may be subject to grant more than once (<i>e.g.</i>, if a share subject to a Stock Award is forfeited,
it may be made subject to grant again as provided in Section 3(b) below), the Share Reserve is not a limit on the number of Stock Awards
that can be granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or, if applicable, NYSE
Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the
number of shares available for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Reversion of Shares to the Share Reserve.</b> If a Stock Award or any portion thereof (i) expires or otherwise terminates without all
of the shares covered by such Stock Award having been issued or (ii) is settled in cash (<i>i.e.</i>, the Participant receives cash rather
than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that
may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or
repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant
or shares of Common Stock that are surrendered to the Company pursuant to an Exchange Program, then the shares that are forfeited, repurchased
or so surrendered will again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax
withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available
for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Incentive Stock Option Limit.</b> Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum
number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be a number of shares of
Common Stock equal to three (3) multiplied by the Share Reserve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Limitation on Compensation of Non-Employee Directors.</b> During any one calendar year, no Non-Employee Director may receive Stock Awards
under the Plan that, when combined with cash compensation received for service as a Non-Employee Director, exceeds $600,000 in a calendar
year, increased to $1,000,000 in the calendar year of his or her initial services as a Non-Employee Director (calculating the value of
any such Stock Awards based on the grant date fair value of such Stock Awards for financial reporting purposes). Stock Awards granted
to an individual while he or she was serving in the capacity as an Employee or Consultant but not a Non-Employee Director will not count
for purposes of the limitations set forth in this Section 3(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Source of Shares.</b> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>4.
Eligibility.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Eligibility for Specific Stock Awards.</b> Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent
corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code).
Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <i>provided, however</i>, that
Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221;
of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the stock underlying such Stock Awards is treated
as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to
a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that
such Stock Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has
determined that such Stock Awards comply with the requirements of Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Ten Percent Stockholders. </b>A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such
Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five
years from the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>5.
Provisions Relating to Options and Stock Appreciation Rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately
designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate
or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically
designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option
fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory
Stock Option. The provisions of separate Options or SARs need not be identical; <i>provided, however</i>, that each Award Agreement will
conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of
each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Term.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the
expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Exercise Price.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each
Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award
is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair
Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another
option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A
of the Code and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Purchase Price for Options.</b> The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the
extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment
set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise
restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method
of payment. The permitted methods of payment are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>by cash, check, bank draft or money order payable to the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the
stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions
to pay the aggregate exercise price to the Company from the sales proceeds;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce
the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does
not exceed the aggregate exercise price; <i>provided, however</i>, that the Company will accept a cash or other payment from the Participant
to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares
to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that
(A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered
to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exercise and Payment of a SAR.</b> To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company
in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable
on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of
the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant
is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike
price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined
by the Board and contained in the Award Agreement evidencing such SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Transferability of Options and SARs.</b> The Board may, in its sole discretion, impose such limitations on the transferability of Options
and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions
on the transferability of Options and SARs will apply:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Restrictions on Transfer. </b>An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or
pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant.
The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable laws or regulations. Except as explicitly
provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Domestic Relations Orders. </b>Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred
pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument
as permitted by Treasury Regulations Section 1.421-1(b)(2) or comparable non-U.S. law. If an Option is an Incentive Stock Option, such
Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Beneficiary Designation. </b>Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written
notice to the Company or to any third party designated by the Company, in a form approved by the Company (or the designated broker),
designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive
the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant,
the executor or administrator of the Participant&#8217;s estate or the Participant&#8217;s legal heirs will be entitled to exercise the
Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation
of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions
of applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
Vesting Generally.</b> The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic
installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when
it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem
appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option
or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
Termination of Continuous Service.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the
Participant and the Company, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s
death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise
such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date which
occurs three (3) months following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified
in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If,
after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable
time frame, the Option or SAR will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
Extension of Termination Date.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant
and the Company, if the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than
for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance
of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate
on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination
exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would
not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable
Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Award Agreement, if the sale of any Common Stock received
upon exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would
violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of the
period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the
Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not
be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in
the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Disability of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant
and the Company, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant
may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date
of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date which occurs 12 months
following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration
of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does
not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
Death of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and
the Company, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant
dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s
Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled
to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise
the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death,
but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period
specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If,
after the Participant&#8217;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable)
will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
Termination for Cause.</b> Except as explicitly provided otherwise in the applicable Award Agreement or other written agreement between
the Participant and the Company, if a Participant&#8217;s Continuous Service is terminated for Cause, the Option or SAR will terminate
immediately upon such Participant&#8217;s termination of Continuous Service, and the Participant will be prohibited from exercising his
or her Option or SAR from and after the date of such termination of Continuous Service. If a Participant&#8217;s Continuous Service is
suspended pending an investigation of the existence of Cause, all of the Participant&#8217;s rights under the Option or SAR will also
be suspended during the investigation period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
Non-Exempt Employees</b>. If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the U.S. Fair Labor
Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six
months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions
of the U.S. Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction
in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s
retirement (as such term may be defined in the Participant&#8217;s Award Agreement in another agreement between the Participant and the
Company, or, if no such definition, in accordance with the Company&#8217;s then current employment policies and guidelines), the vested
portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended
to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be
exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the U.S. Worker Economic Opportunity
Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under
any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to
all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>6.
Provisions of Stock Awards other than Options and SARs.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Restricted Stock Awards.</b> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as
the Board will deem appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common
Stock may be (x) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted
Stock Award lapse; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.
The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate
Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation
of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Consideration. </b>A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to
the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services)
that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Vesting. </b>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in
accordance with a vesting schedule to be determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Termination of Participant&#8217;s Continuous Service. </b>If a Participant&#8217;s Continuous Service terminates, the Company may receive
through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested
as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
Transferability. </b>Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the
Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine
in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the
Restricted Stock Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
Dividends. </b>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same
vesting and forfeiture restrictions as apply to the shares of Common Stock subject to the Restricted Stock Award to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Restricted Stock Unit Awards.</b> Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions
as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time,
and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award
Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of
each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Consideration. </b>At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid
by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid
(if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal
consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Vesting. </b>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the
vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Payment. </b>A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination
thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
Additional Restrictions. </b>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose
such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted
Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
Dividend Equivalents. </b>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit
Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such
dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner
as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents
will be subject to all of the same terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
Termination of Participant&#8217;s Continuous Service. </b>Except as otherwise provided in the applicable Restricted Stock Unit Award
Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination
of Continuous Service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Performance Awards.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Performance Stock Awards. </b>A Performance Stock Award is a Stock Award that is payable (including that may be granted, may vest or
may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award
may but need not require the Participant&#8217;s completion of a specified period of Continuous Service. The length of any Performance
Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance
Goals have been attained will be conclusively determined by the Board or Committee, in its sole discretion. In addition, to the extent
permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance
Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Performance Cash Awards. </b>A Performance Cash Award is a cash award that is payable contingent upon the attainment during a Performance
Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service.
At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the
Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined
by the Board or Committee, in its sole discretion. The Board may specify the form of payment of Performance Cash Awards, which may be
cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof
as the Board may specify, to be paid in whole or in part in cash or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Board Discretion. </b>The Board retains the discretion to adjust or eliminate the compensation or economic benefit due upon attainment
of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Other Stock Awards.</b> Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock,
including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the
Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under
Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete
authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares
of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions
of such Other Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>7.
Covenants of the Company.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Availability of Shares.</b> The Company will keep available at all times the number of shares of Common Stock reasonably required to
satisfy then-outstanding Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Compliance with Law.</b> The Company will seek to obtain from each regulatory commission or agency, as necessary, such authority as may
be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Stock Awards; <i>provided,
however</i>, that this undertaking will not require the Company to register under the Securities Act the Plan or other securities or
applicable laws, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts
and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for
the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved
from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Stock Awards unless and until such authority
is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant
to the Award if such grant or issuance would be in violation of any applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
No Obligation to Notify or Minimize Taxes. </b>The Company will have no duty or obligation to any Participant to advise such holder as
to the time or manner or tax treatment of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn
or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be
exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>8.
Miscellaneous.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Use of Proceeds from Sales of Common Stock.</b> Proceeds from the sale of shares of Common Stock pursuant to Stock Awards will constitute
general funds of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Corporate Action Constituting Grant of Awards.</b> Corporate action constituting a grant by the Company of an Award to any Participant
will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that
the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain
terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related
grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records
will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Stockholder Rights.</b> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of,
or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to
such Award has been entered into the books and records of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
No Employment or Other Service Rights.</b> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in
connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an
Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate
(i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the
terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the bylaws
of the Company or an Affiliate, and any applicable provisions of the corporate law of the state or foreign jurisdiction in which the
Company or the Affiliate is domiciled or incorporated, as the case may be. Furthermore, to the extent the Company is not the employer
of a Participant, the grant of an Award will be not establish an employment or other service relationship between the Company and the
Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Change in Time Commitment.</b> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services
for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company
and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after
the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction
in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date
of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule
applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award
that is so reduced or extended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
Incentive Stock Option Limitations.</b> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common
Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under
all plans of the Company and any Affiliates) exceeds U.S. $100,000 (or such other limit established in the Code) or otherwise does not
comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order
in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding
any contrary provision of the applicable Option Agreement(s).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
Investment Assurances.</b> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award,
(i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business
matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial
and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits
and risks of exercising the Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring
Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise
distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative
if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently
effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel
for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may,
upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate
in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
Withholding Obligations.</b> Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any
U.S. and non-U.S. federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination
of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common
Stock issued or otherwise issuable to the Participant in connection with the Stock Award; <i>provided, however, </i>that (A) no shares
of Common Stock are withheld with a value exceeding the maximum amount of tax that may be required to be withheld by law (or such other
amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes),
and (B) with respect to a Stock Award held by any Participant who is subject to the filing requirements of Section 16 of the Exchange
Act, any such share withholding must be specifically approved by the Compensation Committee as the applicable method that must be used
to satisfy the tax withholding obligation or such share withholding procedure must otherwise satisfy the requirements for an exempt transaction
under Section 16(b) of the Exchange Act; (iii) withholding cash from a Stock Award settled in cash; (iv) withholding payment from any
amounts otherwise payable to the Participant; (v) by means of a &#8220;cashless exercise&#8221; pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board, or (vi) by such other method as may be set forth in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Electronic Delivery.</b> Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document
delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet
(or other shared electronic medium controlled by the Company to which the Participant has access).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
Deferrals.</b> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common
Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish
programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with
Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still
an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and
in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination
of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with
applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
Compliance with Section 409A of the Code.</b> Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements
will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section
409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award
granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award
will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the
extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award
Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if
the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221;
under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment
of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to
alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s
&#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment
can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day
after such six month period elapses, with the balance paid thereafter on the original schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
Exchange Program.</b> Without prior stockholder approval, the Board may engage in an Exchange Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(m)
Clawback/Recovery</b>. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the
Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s
securities are listed or as is otherwise required by the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable
law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines
necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock
or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy
will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar
term) under any agreement with the Company or an Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>9.
Adjustments upon Changes in Common Stock; Other Corporate Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Capitalization Adjustments.</b> In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust:
(i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number
of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es)
and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and
its determination will be final, binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Dissolution or Liquidation.</b> Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation
of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not
subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such
dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture
condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous
Service; <i>provided, however</i>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested,
exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated)
before the dissolution or liquidation is completed but contingent on its completion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Corporate Transaction.</b> The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise
provided in the Stock Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless
otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate Transaction, then, notwithstanding
any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon
the closing or completion of the Corporate Transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)
to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award
to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant
to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised)
to a date prior to the effective time of such Corporate Transaction as the Board determines (or, if the Board does not determine such
a date, to the date that is five days prior to the effective date of the Corporate Transaction), which exercise is contingent upon the
effectiveness of such Corporate Transaction with such Stock Award terminating if not exercised (if applicable) at or prior to the effective
time of the Corporate Transaction; <i>provided, however</i>, that the Board may require Participants to complete and deliver to the Company
a notice of exercise before the effective date of a Corporate Transaction</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock
Award;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time
of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
</b>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the per share amount (or value
of property per share) payable to holders of Common Stock in connection with the Corporate Transaction, over (B) the per share exercise
price under the applicable Stock Award, multiplied by the number of shares subject to the Stock Award. For clarity, this payment may
be zero (U.S. $0) if the amount per share (or value of property per share) payable to the holders of the Common Stock is equal to or
less than the exercise price of the Stock Award. In addition, any escrow, holdback, earnout or similar provisions in the definitive agreement
for the Corporate Transaction may apply to such payment to the holder of the Stock Award to the same extent and in the same manner as
such provisions apply to the holders of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants.
The Board may take different actions with respect to the vested and unvested portions of a Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Change in Control.</b> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in
Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between
the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>10.
Termination or Suspension of the Plan.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier
of (i) the Adoption Date, or (ii) the date the Plan is approved by the stockholders of the Company. No Awards may be granted under the
Plan while the Plan is suspended or after it is terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>11.
Existence of the Plan; Timing of First Grant or Exercise.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan will come into existence on the Adoption Date; <i>provided, however</i>, no Stock Award may be granted prior to the IPO Date (that
is, the Effective Date). In addition, no Stock Award will be exercised (or, in the case of a Restricted Stock Award, Restricted Stock
Unit Award, Performance Stock Award, or Other Stock Award, will be granted) and no Performance Cash Award will be settled unless and
until the Plan has been approved by the stockholders of the Company, which approval will be within 12 months after the Adoption Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>12.
Choice of Law.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
law of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without
regard to that state&#8217;s conflict of laws rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>13.
Definitions. </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As used in the Plan, the following
definitions will apply to the capitalized terms indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
</b>&#8220;<b><i>Adoption Date</i></b>&#8221; means the date the Plan is adopted by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
</b>&#8220;<b><i>Affiliate</i></b>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of
the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times
at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
</b>&#8220;<b><i>Award</i></b>&#8221; means a Stock Award or a Performance Cash Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
</b>&#8220;<b><i>Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the terms
and conditions of an Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
</b>&#8220;<b><i>Board</i></b>&#8221; means the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
</b>&#8220;<b><i>Capital Stock</i></b>&#8221; means each and every class of common stock of the Company, regardless of the number of
votes per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
</b>&#8220;<b><i>Capitalization Adjustment</i></b>&#8221; means any change that is made in, or other events that occur with respect to,
the Common Stock subject to the Plan or subject to any Stock Award after the Adoption Date without the receipt of consideration by the
Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other
than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange
of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial
Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the
conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
</b>&#8220;<b><i>Cause</i></b>&#8221; will have the meaning ascribed to such term in any written agreement between the Participant and
the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence
of any of the following events: (i) such Participant&#8217;s commission of any felony or any crime involving fraud, dishonesty or moral
turpitude under the laws of the United States, any state thereof, or any applicable foreign jurisdiction; (ii) such Participant&#8217;s
attempted commission of, or participation in, a fraud or act of dishonesty against the Company or any Affiliate; (iii) such Participant&#8217;s
intentional, material violation of any contract or agreement between the Participant and the Company or any Affiliate or of any statutory
duty owed to the Company or any Affiliate; (iv) such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s or any
Affiliate&#8217;s confidential information or trade secrets; or (v) such Participant&#8217;s gross misconduct. The determination that
a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause shall be made by the Company in its
sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated by reason of dismissal
without Cause for the purposes of outstanding Stock Awards held by such Participant shall have no effect upon any determination of the
rights or obligations of the Company or such Participant for any other purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>&#8220;<b><i>Change in Control</i></b>&#8221; means the occurrence, in a single transaction or in a series of related transactions,
of any one or more of the following events:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the
combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.
Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the
Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof
or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the
primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C) on account of the acquisition
of securities of the Company by any individual who is, on the IPO Date, either an executive officer or a Director (either, an &#8220;<b><i>IPO
Investor</i></b>&#8221;) and/or any entity in which an IPO Investor has a direct or indirect interest (whether in the form of voting
rights or participation in profits or capital contributions) of more than 50% (collectively, the &#8220;<b><i>IPO Entities</i></b>&#8221;)
or on account of the IPO Entities continuing to hold shares that come to represent more than 50% of the combined voting power of the
Company&#8217;s then outstanding securities as a result of the conversion of any class of the Company&#8217;s securities into another
class of the Company&#8217;s securities having a different number of votes per share pursuant to the conversion provisions set forth
in the Company&#8217;s Amended and Restated Certificate of Incorporation; or (D) solely because the level of Ownership held by any Exchange
Act Person (the &#8220;<b><i>Subject Person</i></b>&#8221;) exceeds the designated percentage threshold of the outstanding voting securities
as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided
that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities
by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming
the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the
Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto
do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting
power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting
power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same
proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <i>provided,
however</i>, that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition
if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are
owned by the IPO Entities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets
of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated
assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which
are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities
of the Company immediately prior to such sale, lease, license or other disposition; <i>provided, however</i>, that a sale, lease, exclusive
license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute
a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined
voting power of the acquiring Entity or its parent are owned by the IPO Entities; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;<b><i>Incumbent Board</i></b>&#8221;)
cease for any reason to constitute at least a majority of the members of the Board; <i>provided, however</i>, that if the appointment
or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the
Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing or any other provision of the Plan, the term Change in Control will not include a sale of assets, merger or other transaction
effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous
term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition
with respect to Awards subject to such agreement; <i>provided, however</i>, that if no definition of Change in Control or any analogous
term is set forth in such an individual written agreement, the foregoing definition will apply. To the extent required for compliance
with Section 409A of the Code, in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#8220;change
in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets
of&#8221; the Company as determined under Treasury Regulations Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).
The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;Change in Control&#8221;
to conform to the definition of &#8220;Change in Control&#8221; under Section 409A of the Code, and the regulations thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
</b>&#8220;<b><i>Code</i></b>&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
</b>&#8220;<b><i>Committee</i></b>&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board
in accordance with Section 2(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
</b>&#8220;<b><i>Common Stock</i></b>&#8221; means, as of the IPO Date, the common stock of the Company, having one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(m)
</b>&#8220;<b><i>Company</i></b>&#8221; means Sonim Technologies, Inc., a Delaware corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(n)
</b>&#8220;<b><i>Consultant</i></b>&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate
to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors
of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will
not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is
treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either
the offer or the sale of the Company&#8217;s securities to such person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(o)
</b>&#8220;<b><i>Continuous Service</i></b>&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether
as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service
to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such
service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will
not terminate a Participant&#8217;s Continuous Service; <i>provided, however</i>, that if the Entity for which a Participant is rendering
services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service
will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from
an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.
To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine
whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive
officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their
successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award
only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement
or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance
with Section 409A of the Code, the determination of whether there has been a termination of Continuous Service will be made, and such
term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under
Treasury Regulation Section 1.409A-1(h) (without regard to any alternative definition thereunder).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(p)
</b>&#8220;<b><i>Corporate Transaction</i></b>&#8221; means the consummation, in a single transaction or in a series of related transactions,
of any one or more of the following events:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>a sale or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated
assets of the Company and its Subsidiaries;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>a sale or other disposition of more than 50% of the outstanding securities of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the
merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
required for compliance with Section 409A of the Code, in no event will a Corporate Transaction be deemed to have occurred if such transaction
is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial
portion of the assets of&#8221; the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative
definition thereunder).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(q)
</b>&#8220;<b><i>Director</i></b>&#8221; means a member of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(r)
</b>&#8220;<b><i>Disability</i></b>&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial
gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that
has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i)
of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(s)
</b>&#8220;<b><i>Effective Date</i></b>&#8221; means the IPO Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)
</b>&#8220;<b><i>Employee</i></b>&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director,
or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(u)
</b>&#8220;<b><i>Entity</i></b>&#8221; means a corporation, partnership, limited liability company or other entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>&#8220;<b><i>Exchange Act</i></b>&#8221; means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(w)
</b>&#8220;<b><i>Exchange Act Person</i></b>&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section
13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary
of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding
securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities
pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the
Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#8220;group&#8221;
(within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly,
of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(x)
</b>&#8220;<b><i>Fair Market Value</i></b>&#8221; means, as of any date, the value of the Common Stock determined as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share
of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange
or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported
in a source the Board deems reliable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then
the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a
manner that complies with Sections 409A and 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(y)
</b>&#8220;<b><i>Incentive Stock Option</i></b>&#8221; means an option granted pursuant to Section 5 of the Plan that is intended to
be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(z)
</b>&#8220;<b><i>IPO Date</i></b>&#8221; means the date of the underwriting agreement between the Company and the underwriter(s) managing
the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(aa)
</b>&#8220;<b><i>Non-Employee Director</i></b>&#8221; means a Director who either (i) is not a current employee or officer of the Company
or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered
as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under
Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;<b><i>Regulation S-K</i></b>&#8221;)), does not possess
an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in
a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is otherwise considered
a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(bb)
</b>&#8220;<b><i>Nonstatutory Stock Option</i></b>&#8221; means any Option granted pursuant to Section 5 of the Plan that does not qualify
as an Incentive Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(cc)
</b>&#8220;<b><i>Officer</i></b>&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(dd)
</b>&#8220;<b><i>Option</i></b>&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock
granted pursuant to the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ee)
</b>&#8220;<b><i>Option Agreement</i></b>&#8221; means a written agreement between the Company and an Optionholder evidencing the terms
and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ff)
</b>&#8220;<b><i>Optionholder</i></b>&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(gg)
</b>&#8220;<b><i>Other Stock Award</i></b>&#8221; means an award based in whole or in part by reference to the Common Stock which is
granted pursuant to the terms and conditions of Section 6(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(hh)
</b>&#8220;<b><i>Other Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of an Other Stock
Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms
and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>&#8220;<b><i>Own,</i></b>&#8221; &#8220;<b><i>Owned,</i></b>&#8221; &#8220;<b><i>Owner,</i></b>&#8221; &#8220;<b><i>Ownership</i></b>&#8221;
means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have
acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding,
relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(jj)
</b>&#8220;<b><i>Parent</i></b>&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with
the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power
of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after
the adoption of the Plan shall be considered a Parent commencing as of such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(kk)
<i>&#8220;Participant</i></b>&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person
who holds an outstanding Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ll)
</b>&#8220;<b><i>Performance Cash Award</i></b>&#8221; means an award of cash granted pursuant to the terms and conditions of Section
6(c)(ii).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(mm)
</b>&#8220;<b><i>Performance Criteria</i></b>&#8221; means the one or more criteria that the Board or Committee (as applicable) will
select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish
such Performance Goals may be based on any one of, or combination of, the following as determined by the Board or Committee (as applicable):
(1) earnings (including earnings per share and net earnings); (2) earnings before interest, taxes and depreciation; (3) earnings before
interest, taxes, depreciation and amortization; (4) total stockholder return; (5) return on equity or average stockholder&#8217;s equity;
(6) return on assets, investment, or capital employed; (7) stock price; (8) margin (including gross margin); (9) income (before or after
taxes); (10) operating income; (11) operating income after taxes; (12) pre-tax profit; (13) operating cash flow; (14) sales or revenue
targets; (15) increases in revenue or product revenue; (16) expenses and cost reduction goals; (17) improvement in or attainment of working
capital levels; (18) economic value added (or an equivalent metric); (19) market share; (20) cash flow; (21) cash flow per share; (22)
share price performance; (23) debt reduction; (24) implementation or completion of projects or processes; (25) subscriber satisfaction;
(26) stockholders&#8217; equity; (27) capital expenditures; (28) debt levels; (29) operating profit or net operating profit; (30) workforce
diversity; (31) growth of net income or operating income; (32) billings; (33) the number of subscribers, including but not limited to
unique subscribers; (34) employee retention; and (35) other measures of performance selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(nn)
</b>&#8220;<b><i>Performance Goals</i></b>&#8221; means, for a Performance Period, the one or more goals established by the Board or
Committee (as applicable) for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide
basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative
to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise
by the Board or Committee (as applicable) (i) in the Award Agreement at the time the Award is granted or (ii) in such other document
setting forth the Performance Goals at the time the Performance Goals are established, the Board or Committee (as applicable) will appropriately
make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude
restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally
accepted accounting principles; (4) to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221;
as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures;
(7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance
Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of common stock of the Company by
reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination
or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends;
(9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude
costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting
principles; and (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally
accepted accounting principles. In addition, the Board or Committee (as applicable) retains the discretion to reduce or eliminate the
compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria
it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding
to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(oo)
</b>&#8220;<b><i>Performance Period</i></b>&#8221; means the period of time selected by the Board or Committee (as applicable) over which
the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the
payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole discretion
of the Board or Committee (as applicable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(pp)
</b>&#8220;<b><i>Performance Stock Award</i></b>&#8221; means a Stock Award granted under the terms and conditions of Section 6(c)(i).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(qq)
</b>&#8220;<b><i>Plan</i></b>&#8221; means this Sonim Technologies, Inc. 2019 Equity Incentive Plan, as it may be amended from time to
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(rr)
</b>&#8220;<b><i>Restricted Stock Award</i></b>&#8221; means an award of shares of Common Stock which is granted pursuant to the terms
and conditions of Section 6(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ss)
</b>&#8220;<b><i>Restricted Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Restricted
Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject
to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(tt)
</b>&#8220;<b><i>Restricted Stock Unit Award</i></b>&#8221; means a right to receive shares of Common Stock which is granted pursuant
to the terms and conditions of Section 6(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(uu)
</b>&#8220;<b><i>Restricted Stock Unit Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a
Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award
Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vv)
</b>&#8220;<b><i>Rule 16b-3</i></b>&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in
effect from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ww)
</b>&#8220;<b><i>Securities Act</i></b>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(xx)
</b>&#8220;<b><i>Stock Appreciation Right</i></b>&#8221; or &#8220;<b><i>SAR</i></b>&#8221; means a right to receive the appreciation
on Common Stock that is granted pursuant to the terms and conditions of Section 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(yy)
</b>&#8220;<b><i>Stock Appreciation Right Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Stock
Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will
be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(zz)
</b>&#8220;<b><i>Stock Award</i></b>&#8221; means any right to receive Common Stock granted under the Plan, including an Incentive Stock
Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance
Stock Award or any Other Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(aaa)
</b>&#8220;<b><i>Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the
terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(bbb)
</b>&#8220;<b><i>Subsidiary</i></b>&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding
capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether,
at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening
of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company
or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or
capital contribution) of more than 50%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ccc)
</b>&#8220;<b><i>Ten Percent Stockholder</i></b>&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the
Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 77; Options: NewSection; Value: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ab_009"></span>Annex
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUPPLEMENTAL INFORMATION REGARDING PARTICIPANTS IN THE COMPANY&#8217;S SOLICITATION OF PROXIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, its directors (including our director nominees), as well as other persons who solicit proxies on its behalf, are considered
to be &#8220;participants&#8221; in the Board&#8217;s solicitation of proxies from its stockholders in connection with the Annual Meeting
under applicable regulations of the SEC. The following tables set forth the name, business address, present principal occupation and
address of any corporation in which such employment is carried on of such &#8220;participants&#8221; in the Board&#8217;s solicitation
of proxies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Nominees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
present principal occupations or employment, and principal business of any corporation in which such occupation or employment is carried
on, of the Company&#8217;s directors (including our director nominees) who are considered &#8220;participants&#8221; in the Board&#8217;s
solicitation are set forth under the section above titled &#8220;Proposal 1- Election of Directors&#8221; of this proxy statement. The
business address of each of the Company&#8217;s directors (including our director nominees) is c/o Sonim Technologies, Inc., 4445 Eastgate
Mall, Suite 200 San Diego, California 92121. The name, principal occupation and address of the organization of employment, of each of
the Company&#8217;s directors (including our director nominees) are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 39%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    Occupation or Employment</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 39%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
    Address/Address of Organization of Principal Occupation of Employment</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
    Chairman and Lead Independent Director of Ideanomics, Inc.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1441
    Broadway, Suite 5116<br/>
    New York, NY 10018</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer of Sonim Technologies, Inc.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">4445 Eastgate Mall, Suite 200 <br/>
    San Diego, CA 92121</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Partner at Avataar Venture Partners</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,
    Walton Rd, Shanthala Nagar, Ashok Nagar, Bengaluru, Karnataka 560001, India</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Streenstra</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Technology Officer of Meta Technologies Inc.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4660
    La Jolla Village Drive, Suites 100 &amp; 200, San Diego, CA 9122</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founding
    Partner and Director of Avataar Venture Partners</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,
    Walton Rd, Shanthala Nagar, Ashok Nagar, Bengaluru, Karnataka 560001, India</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    Engineer at Plaid Inc.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295 Lafayette St,</span></p>
                                                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10012</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers and Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal occupations of the Company&#8217;s executive officers and employees who are considered &#8220;participants&#8221; in the Board&#8217;s
solicitation of proxies (other than our Chief Executive Officer, who also serves as a director of the Company) are set forth below. The
principal occupation refers to such person&#8217;s position with the Company and the business address for each person below is c/o Sonim
Technologies, Inc., 4445 Eastgate Mall, Suite 200 San Diego, California 92121.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 79%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    Occupation</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Commercial Officer and General Manager of North America</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius, CPA</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
Regarding Ownership of Sonim Securities by Participants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of the Company&#8217;s common stock beneficially owned by its directors (including our director nominees) and executive
officers that are considered to be participants as of the Record Date is set forth under the &#8220;<a href="#a_055">Security Ownership of Certain Beneficial Owners and Management</a>&#8221; table and notes thereto elsewhere in this proxy statement. No other executive officers or employees
are deemed participants in our solicitation of proxies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
Regarding Transactions in Sonim Securities by Participants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding all securities of the Company purchased or sold by each of the participants listed above
under &#8220;Directors and Nominees&#8221; and &#8220;Executive Officers and Employees&#8221; during the past two years, except for unvested
performance-based awards that are not reportable under Section 16 of the Exchange Act. The table has been retroactively adjusted to reflect
the 1-for-10 reverse stock split that became effective on July 17, 2024. Unless otherwise indicated, all transactions were in the public
market or pursuant to the Company&#8217;s equity compensation plans, and none of the purchase price or market value of those securities
are represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities. Refer to &#8220;Key
to Transaction Descriptions&#8221; below the table for an explanation of transaction descriptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: middle; padding-bottom: 1pt; text-align: left; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction
    Date</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>#
    of Shares</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transaction
    Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/23/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/15/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,670*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Streenstra </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/28/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,953</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/28/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,953</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/28/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,953</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/28/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,953</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/24/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/26/2023</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/09/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,668</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/01/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/14/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/15/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
    Thangadurai</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/15/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/08/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,000</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/20/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,895</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/21/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,602</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/20/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,895</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/21/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,602</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/20/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,895</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/21/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,589</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/20/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,895</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/21/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,602</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/19/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,623</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/19/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,623</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/19/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,623</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/12/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,124</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2024</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,559</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/06/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,922</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/06/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,604</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/06/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,671</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,728</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,728</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,728</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">George Thangadurai</p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">04/04/2025</p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">568</p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">OMP</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Mulica</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,818</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Steenstra </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,381</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,326</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Wang</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,478</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Cassano</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,381</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/23/2025</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,634</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
to Transaction Descriptions<br/>
<br/>
</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OE
    &#8211; Exercise of Options </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMP
    &#8211; Open Market Purchase </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMS-TAX
    &#8211; Open Market Sale to cover tax withholding obligations as mandated by the Company pursuant to the EIP</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOG
    &#8211; Grant of Stock Options (Right to Buy) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUG
    &#8211; Grant of Restricted Stock Units </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Miscellaneous
Information Concerning Participants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described in this Annex B or otherwise disclosed in the proxy statement, to the Company&#8217;s knowledge:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant owns any securities of the Company of record that such participant does not own beneficially. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant is, or was within the past year, a party to any contract, arrangement or understanding with any person with respect to
    any securities of the Company, including, but not limited to joint ventures, loan or option arrangements, puts or calls, guarantees
    against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    associate of any participant owns beneficially, directly or indirectly, any securities of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant nor any associate of a participant is a party to any transaction, since the beginning of the Company&#8217;s last fiscal
    year, or any currently proposed transaction, in which (a) the Company was or is to be a participant, (b) the amount involved exceeds
    $120,000 and (c) any participant or any related person thereof had or will have a direct or indirect material interest. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant, nor any associate of a participant, has any arrangement or understanding with any person (a) with respect to any future
    employment by the Company or its affiliates or (b) with respect to any future transactions to which the Company or any of its affiliates
    will or may be a party. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    participant has any substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at
    the annual meeting. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
    of the participants or their associates has during the past ten (10) years, been convicted in a criminal proceeding (excluding traffic
    violations or similar misdemeanors). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLEASE
VOTE TODAY!</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEE REVERSE SIDE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THREE EASY WAYS TO VOTE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
you have any questions, require assistance in voting your WHITE proxy card, or need additional copies of the Company&#8217;s proxy materials,
please contact our proxy solicitor:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sodali
&amp; Co</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>509
Madison Avenue, 12th Floor</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
York, NY 10022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Call
toll-free (800) 662-5200 or (203) 658-9400</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Email: SONM@investor.sodali.com</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b>** TO VOTE BY MAIL, PLEASE DETACH HERE, SIGN AND DATE <b>WHITE</b> PROXY CARD, AND RETURN IN THE POSTAGE-PAID ENVELOPE PROVIDED
**</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
Meeting of Stockholders to be held on July 18, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27.95pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>This
WHITE proxy card is Solicited on Behalf of the Board of Directors of Sonim Technologies, Inc.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 19.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned stockholder(s) hereby appoint(s) Peter Liu, Clayton Crolius, and Katherine Schooler (the &#8220;Named Proxies&#8221;), and
each or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them, and each of them, to
represent and to vote, as designated on the reverse of this proxy card, all of the shares of common stock of Sonim Technologies, Inc.
that the undersigned stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 9:00 am ET on
July 18, 2025 via a live webcast at www.cesonlineservices.com/sonm25_vm, and any continuation, postponement, or adjournment thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Named Proxies are authorized to vote in their discretion (i) for the election of any person to the Board of Directors if any nominee
named herein becomes unable to serve or for good cause will not serve, (ii) on any matter that the Board of Directors did not know would
be presented at the Annual Meeting of Stockholders by a reasonable time before the proxy solicitation was made, and (iii) on such other
business as may properly be brought before the Annual Meeting of Stockholders or any continuation, postponement, or adjournment thereof.
<b>This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be
voted in accordance with the Board of Directors&#8217; recommendations. Proxies cannot be voted &#8220;FOR&#8221; more than five (5) nominees.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Annual Report are available
at https://ir.sonimtech.com/.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLEASE
MARK, SIGN, DATE AND RETURN THIS <b>WHITE </b>PROXY CARD PROMPTLY USING ENCLOSED REPLY ENVELOPE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(continued
and to be signed on the reverse side)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">YOUR
VOTE IS IMPORTANT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
take a moment now to vote your shares of Sonim Technologies, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
the upcoming Annual Meeting of Stockholders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">YOU
CAN VOTE TODAY USING ANY OF THE FOLLOWING METHODS:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in"><img src="proxy_001.jpg" alt=""/></td>
  <td style="width: 0.1in">&#160;</td>
  <td style="text-align: left; vertical-align: top"><b><i><span style="text-decoration: underline">Submit your proxy by Internet:</span></i></b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: justify">Please access <b><span style="text-decoration: underline">www.fcrvote.com/sonm</span></b> then, simply follow the easy instructions on the voting
  site. You will be required to provide the unique Control Number printed below.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="3" style="text-align: center"><span style="letter-spacing: -0.25pt">O</span>R</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><img src="proxy_002.jpg" alt=""/></td>
  <td>&#160;</td>
  <td style="vertical-align: bottom; text-align: justify"><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 3.55pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Submit
                                            your proxy by <span style="letter-spacing: -0.1pt">Telephone:</span></span></span></p></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: justify">Please call toll-free in the U.S. or Canada at <b>1-866-402-3905</b> on a touch-tone telephone. Then, simply follow the easy
voice prompts. You will be required to provide the unique Control Number printed below.</td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: right; width: 49%; vertical-align: middle">CONTROL
NUMBER</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 50%"><img src="proxy_003.jpg" alt=""/></td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 59.7pt 0 62.65pt; text-align: center; color: #221F1F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 59.7pt 0 62.65pt; text-align: center; color: #221F1F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                          may submit your proxy by telephone 24 hours a day, 7 days a <span style="letter-spacing: -0.1pt">week.</span></span></p>

<p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 1.1pt 59.7pt 0 61.1pt; text-align: center; color: #221F1F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
internet or telephone vote authorizes the Proxyholder(s) to vote your shares in the same manner as if you had marked, signed and returned
a proxy card.</span></p>
<p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 1.1pt 59.7pt 0 61.1pt; text-align: center; color: #221F1F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">O</span>R</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12.8pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in"><img src="proxy_004.jpg" alt=""/></td>
  <td style="width: 0.1in">&#160;</td>
  <td style="text-align: left; vertical-align: top"><b><span style="text-decoration: underline">Submit your proxy by Mail:</span></b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td><p style="font: 10pt/121% Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; color: rgb(34,31,31)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">If
      you do not have access to the internet or a touch-tone telephone, please complete, sign, date and return the proxy card in the
      </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enclosed envelope.</span></p>
</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.3pt">** TO VOTE BY MAIL,
PLEASE DETACH HERE, SIGN AND DATE PROXY CARD, AND RETURN IN THE POSTAGE-PAID ENVELOPE PROVIDED **</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>&#9746;
</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please mark vote as in this sample</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WITH
RESPECT TO PROPOSAL 1: Election of five directors to hold office until the 2026 annual meeting of stockholders, and until their respective
successors shall have been duly elected and qualified. While you may mark instructions with respect to any or all of the nominees, you
should mark a vote &#8220;FOR&#8221; only five nominees in total. If you vote &#8220;FOR&#8221; more than five nominees, all of your
votes on Proposal 1 will be invalid and will not be counted. You are permitted to vote for fewer than five nominees. If you vote &#8220;FOR&#8221;
fewer than five nominees, your shares will only be voted &#8220;FOR&#8221; the nominees you mark. If you sign and return your proxy card
and do not specify or direct how you want your shares to be voted, they will be voted &#8220;FOR&#8221; all of the Board of Directors&#8217;
recommended nominees.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.75pt; text-indent: 20.55pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 5.75pt; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
                   of Five Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Board of Directors recommends a
    vote FOR proposals 2, 3, 4 and 3 YEARS on proposal 5.</b></span></td>
                                                                                                                                                                                                                                     </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors recommends you vote FOR only the following five (5) Board nominees (1.01 through 1.05):</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAINST</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABSTAIN</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company Nominees:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WITHHOLD</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.01</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
                                            Cassano</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
    Ratification of the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for fiscal year
    2025.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
                   Liu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Amendment of our equity
    incentive plan to increase the number of available shares authorized for issuance by 600,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
                   Mulica</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Approval, on a non-binding,
    advisory basis, of the compensation of our named executive officers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1YR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2YR&#160;&#160;&#160;&#160;&#160;&#160;&#160;3YR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABSTAIN</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
                   Steenstra</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Approval, on a non-binding,
    advisory basis, of the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
                                            Thangadurai</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
                                                                                                                                                                              <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors recommends you vote WITHHOLD for the following five (5) Orbic Nominees (1.06 through 1.10):</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
                                                                       <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WITHHOLD</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
transact any other business properly brought before the Annual Meeting or any continuation, postponement or adjournment thereof.</span></p>

</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.06</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
                   B. Benedict</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date: _____________________________</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.07</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
                   M. Glynn</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.08</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory
                   M. Johnson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surendra
                   Singh</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature (If
    jointly held)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
                                                                  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
                   Wallace</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
                                                                  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________</span></td></tr>
                                                                  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title(s)</span></td></tr>
                                                                  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please sign
    EXACTLY as name appears at the left. Joint owners each should sign. When signing as attorney, executor, administrator, trustee or
    guardian, please give full related title. If a corporation or partnership, please sign in full corporate or partnership name by authorized
    officer.</span></td></tr>
                                                                  </table>
<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 82; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11.45pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>




















































































<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
<!-- Field: Set; Name: xdx; ID: xdx_088_labels -->
<!-- eJyFjzFPhEAQhXsT/8OEShPv9qIdHRoLkwtS0BmLAeaQuLtDlgHu/r27azzB5GI5b9778l6SNU0nHVvUsMeK9JDcJR8ifarUPM/bY+X0ll2r7ne7B+VYk9LBllxfJVQ3aTH1JVaaSjrKo+b608cLPME0QEHuwM6grQneogmCC6Lt/QwgLllQP7HpMyMh/vwKUYKgkR0w9IPM8GhlEctqGVHrU4Fds07/fCC8LlHGYdMi9mlO8mJrNrTnIYz3N3wLcBOkW8hEXFeNEicIe6qj3yY5W18m932m9s8S/9qEPnnoNJHDlv5ftuRF1GLmZewauNp/xn8BIhCn3w== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 !H# 2(  A$! Q$!_\0
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8A&-K E@V>^<#@]J** /70 .E+110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  7 !\# 2(  A$! Q$!_\0
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@RLX_+BBSU('<GU->C?L^?\AG7/\ KWB_]":BB@9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>proxy_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! 1H# 2(  A$! Q$!_\0
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MEZ^"W @GP?IG_ UZ*"" 0<@]#0QBT444@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ./\9_\
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C !1110 4444 36G_ !^0_P"^*].3_5K]***3 =1112&?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxy_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 !X# 2(  A$! Q$!_\0
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5L  "1QGC-=#6UI7_ !Z'_>- '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>formdefc14a_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdefc14a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" ,,# 2(  A$! Q$!_\0
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M4;2/"MW<1D^85"(1V).,UX=HNDW&OZO%8PGYY3EG/.T=R:]<^*7_ "*+<_\
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MJG_H"U] =J^?_B%_R.^H_5/_ $!:*WPG/P__ +R_3]4>L?#_ /Y$?3?]U_\
MT-JG\:_\B;JG_7$_TJ#X?_\ (CZ;_NO_ .AM4_C7_D3=4_ZXG^E7]CY' _\
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M+:.='2WA5O54 -%%#W*I_P -ER]ABEM]LD:.N1PR@BJMC:V\4^Z.")&P>50
MT44,4/X;-.LF[M+:2Z=WMXF8XR60$]***8J.Y=M42.WC1%54'15&!UIURB26
MTBNH92.0PR***70A_'\RC;V=K'<*R6T*L#P0@!K1D (Y&:**.AI4^)$E%%%,
#Q/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>formdefc14a_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdefc14a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H + # 2(  A$! Q$!_\0
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MV-)=2VA[FX?F.T0]V]6/852B\"M<>)X;F]CA^PVTOVLL/]9>77:23' 5>RT
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>formdefc14a_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdefc14a_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  H (X# 2(  A$! Q$!_\0
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M]HGPA^S3\-K[Q[XI#W<S2'3_  _HD#?Z3K>KO&SPVL8'*Q(J^9<S<B*,9/)
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MM[TR_;'F0JZK:F8N&#1Y!Q]J6MK!:6\%M;0Q6UK;Q+%!;11K##!#&H2..*)
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@484*5.A35H4H1IP3=WRQ5E=]7W?F%%%%0:A1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>formdefc14a_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdefc14a_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? G$# 2(  A$! Q$!_\0
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M9N^7?C;NXSGB@#YZ_P"&2?V9O^B&_#?_ ,)JP_\ C='_  R3^S-_T0WX;_\
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M(HH ^=_^&2?V9O\ HAOPW_\ ":L/_C='_#)/[,W_ $0WX;_^$U8?_&Z^B**
M/G?_ (9)_9F_Z(;\-_\ PFK#_P"-T?\ #)/[,W_1#?AO_P"$U8?_ !NOHBB@
M#YW_ .&2?V9O^B&_#?\ \)JP_P#C='_#)/[,W_1#?AO_ .$U8?\ QNOHBB@#
MYW_X9)_9F_Z(;\-__":L/_C='_#)/[,W_1#?AO\ ^$U8?_&Z^B** /G?_ADG
M]F;_ *(;\-__  FK#_XW1_PR3^S-_P!$-^&__A-6'_QNOHBB@#YW_P"&2?V9
MO^B&_#?_ ,)JP_\ C='_  R3^S-_T0WX;_\ A-6'_P ;KZ(HH ^=_P#ADG]F
M;_HAOPW_ /":L/\ XW1_PR3^S-_T0WX;_P#A-6'_ ,;KZ(HH ^=_^&2?V9O^
MB&_#?_PFK#_XW1_PR3^S-_T0WX;_ /A-6'_QNOHBB@#YW_X9)_9F_P"B&_#?
M_P )JP_^-T?\,D_LS?\ 1#?AO_X35A_\;KZ(HH ^=_\ ADG]F;_HAOPW_P#"
M:L/_ (W1_P ,D_LS?]$-^&__ (35A_\ &Z^B** /FZ?]D3]G8[I=*^&FE^$]
M0$92#6? ]_K7@G6[-_FV3VFJ>%]2TJ[AGC9BR2"1N>&#)E3S4>N>._V=O$?A
M_1_'7BG5/B-\$?%NLV7AK1O'GB5XI_'/PR\3:Q=BU\/Z1XXU:""WC\4^#]=O
M9K?1].\6WD2Z[H^KS6L/B.YU&RO5U*S^MJ\Y^+_A/3/'7PK^(GA#6(5GT_Q!
MX-\0Z=*K9!BDETRX:UNHF!!CN+*[6"\M95(:&Y@BE4AD!H ]&HK^6G_AYS\>
MO^@E_P".I_\ 'Z* /Z!/V._^36?@%_V2WPE_Z:X:^DJ^;?V._P#DUGX!?]DM
M\)?^FN&OI*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.A>-=1T!;I?">K>.]#LY3;:-XZU70;SQ=I4*0I8:U;BW@\L _GQ^/G_!4?\
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M5AJ6F>#?BXUC!KD6F1^+-%LM7U*%)X;*.TO6NY)]2M+RX"2K]Q4 ?RR?"O\
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ML^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\
M#9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?
M\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<
MT?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\
MG<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_
M /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQ
MO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PR
MGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\
MPRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C
M7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^
M-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\
MT,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O
M_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[
M/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9
M?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\
M#9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+
MG_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\
MN?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4
M=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]
M1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<
MT ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=
MS0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_
M /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&_
M_P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PR
MGQO_ /G<T ?4=%>!?#;]IWX*_%W6;30?AYXGUCQ!?7UIJ%[:3-X ^(VCZ//;
MZ6_EWY3Q#KWA/2_#YEMY=T)MSJ8N'GCE@BB>6&5$]E\0W.L66@:Y>>'=.@UC
MQ!::/J=SH>D7-TMC;:IK$%E/+IFG7%ZX*6<%]>I!;2W3 K;QRM,00AH V**_
MF(^$/[;7[5OPB_9 _;)_:!^)O[67A#Q_^T%H.B?#_P 4_%3]F3XT_ +6OA;X
MC_X)[?%_XC>-/!_PU\67-SHEGXLN?$/C;]D/X4:/J.H>,=+\1&TO=+\<V'@+
M7O%VD_$DP>(?$":?W/AW_@HY\?/ 7@S]LOX%Z%^U-\ OVX/C1\*M8_8Q\-_
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M'+]>:***\@]\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXUM\-+BP^+?P/^!OP\_9W\'_  2NO@3XH7Q_\"(O@A\#/#D_B;POX8TOX?\
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M?\5WE\1Z#X0N=&\%#Q'X-AGCU(Z1K#@ _2C]C[]IWQG^T!9_%[P9\9/A);?
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M./,U&[7ZXT5_ET?\-B?M5_\ 1P?Q5_\ "JO:/^&Q/VJ_^C@_BK_X55[7Y_\
M\1+R?_H S/[L'_\ -!^-_P#$=^%_^A1Q!_X#E?\ \VG^HO17^71_PV)^U7_T
M<'\5?_"JO:/^&Q/VJ_\ HX/XJ_\ A57M'_$2\G_Z ,S^[!__ #0'_$=^%_\
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M_1/+W_PX/Q-_^;*C_ABC]FC_ *)Y>_\ AP?B;_\ -E0!]4T5\K?\,4?LT?\
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M/]IGQI\:/C:G[,'[=GQZ_:W\=?M)_%W5? 7[(TOC?]I^^^&OQ\\:3?&#6/\
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M1&9'4J2#-17[3MJM&M4UHTUU1_4[2:::335FGJFGHTT[IIIM-----IIIM'X
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M%X9\+Z]XUOM&G\7+8Z'#;Z9)8:U9W5I;P0W"Q+]64 ?DI_P51\4?LV_#:Q^
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M_P!ALO\ TQA#^'/$?_DN^*?^QK/_ -1<O"BBBOG3XH*_T$?^"7/@W]I'4?\
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MM&I4]K42IMI4T^=I'])G_" _M:?]''_"_P#\1SO/_GST?\(#^UI_T<?\+_\
MQ'.\_P#GSU^*O_#]CXD_]&Z>!_\ PXNO?_,I1_P_8^)/_1NG@?\ \.+KW_S*
M5_5O_$N/BY_T3V!_\2')/_F@_0_^)T/H\?\ 17YI_P"(=Q/_ /,A^U7_  @/
M[6G_ $<?\+__ !'.\_\ GST?\(#^UI_T<?\ "_\ \1SO/_GSU^*O_#]CXD_]
M&Z>!_P#PXNO?_,I7;_#+_@M9\0O'OQ+^'7@.Z^ /@W3;;QQX\\'^#KC4K?Q]
MK=S/I\'B;Q#I^BS7T-M)X8ACN);2.]:XC@>:))7C6-I$5BPQQ'T=_%C"X?$8
MJMD&"C1PU"OB:TEQ!DLG&CAJ%;$5I*,:[E)QI8>K)1BG*3BHQ3E**.C"?3&^
MC_CL7A,#AN+<SGB<=B\+@L-"7"/$L(SQ.-Q6&P>'@YSPJA!3Q&,P\'.;4(*;
MG)J,)-?KG_P@/[6G_1Q_PO\ _$<[S_Y\]?#?[7__  2H?]M_38D^-OQ*^%0\
M86*)'H_Q3\&?L[GPU\2M,@C"JNGOXB7XLWBZSHI5 K:-KUIJ5C$,O9I9SGSJ
M_8:BOQS!8[&9=B:>,P&*KX/%47>G7P]65*I':ZO%VE"5K3ISC4ISC>,Z<T[+
M^DLQRS+\WP=;+\TP6%S#!8B/+6PN+HPKT9K6TN6:O"I%N].K2G2K4Y6E3JTY
M*[_C-\3_  O_ ."L7_!$4ZOJWP@\4K^T%^R2))YY"^A:IXK\$^&89)49K_Q'
MX &H2>)?A/J)R@N-<\+ZK=>#;J0@ZC=32G[.GZI_L,?\%*YOVZ+/3="\+?M8
M?"_X9_&>:U5]1^"_C[X!"UUVXG54\Z;P/K8^-$&E>/\ 3"Q:2)]&V:S! "^I
MZ+8A2[?NW+%%<12P3Q1S031O%-#*BR12Q2*4DBEC<,DD<B,4='!5E)5@02*_
M!7]NO_@@[\!_VA+S4?BG^S3?VG[,WQU%VVN1?V!;7-K\+O$NNI*;F.[U#P_H
M[07G@C6)+@B1?$W@?[,T$RBXN="U*<F0?<K/.'N*DJ7%.'649Q)*-/B?*L/%
M4J\[)1>=9932A5N[>TQ>%4:J5Y2CI8_,GPSQ9P,W7X'Q4L_X?@W.KP5GF*E*
MOA:=W*4>&\YJN52@XJ_LL!C7*@WRPC+5,_4S_A ?VM/^CC_A?_XCG>?_ #YZ
M/^$!_:T_Z./^%_\ XCG>?_/GK^;?X3?\%1/V]?\ @F+XXTC]G[_@I=\+O%_Q
M*^&XF73_  S\6(7AU3QB=(MW\K^T?"_CL-!X;^+^E6\1\V33-;N]*\=V:*L-
M]?>;$+$_TV_L[?M0_ ;]J[P):_$;X!_$CP_\0?#DHB2_33;AH-<\.WTL?F-I
M/BGP[>+;ZUX=U6+YE:SU6RMGD"&6V,]N4F?P<\X5S3(XPQ-2-+'957L\)G.7
M3^M9;B82;Y/WU/F^KU9;.AB52J*2E!.<HM+ZKAGCG).)IU<'1E7RS/,+=8_A
MW-Z3P.<8.<$O:?[-5Y%BJ,;W6)P;KTG!QG*-*,HRES7_  @/[6G_ $<?\+__
M !'.\_\ GST?\(#^UI_T<?\ "_\ \1SO/_GSU]145\T?8GR[_P (#^UI_P!'
M'_"__P 1SO/_ )\]'_" _M:?]''_  O_ /$<[S_Y\]?45% 'R[_P@/[6G_1Q
M_P +_P#Q'.\_^?/1_P (#^UI_P!''_"__P 1SO/_ )\]?45% 'R[_P (#^UI
M_P!''_"__P 1SO/_ )\]'_" _M:?]''_  O_ /$<[S_Y\]?45% 'R[_P@/[6
MG_1Q_P +_P#Q'.\_^?/1_P (#^UI_P!''_"__P 1SO/_ )\]?45% 'R[_P (
M#^UI_P!''_"__P 1SO/_ )\]'_" _M:?]''_  O_ /$<[S_Y\]?45% 'R[_P
M@/[6G_1Q_P +_P#Q'.\_^?/7DWQF\)?&;2_",-S\6OB]\-?''A8ZU811:-;_
M +$GB3XN2)J[Q79LK[_A%M$^)'B2\B6WB6Z0ZN=/6"R\X127,1ND63[[KA?B
M%XOUCP3H,>L:)\/O&'Q+O'U&UL6\.^"'\,)K,<%PD[R:FY\6>(O#&E_8;0PI
M'<!-2:[WW$/DVLR^:T8!\7?\$Z-1^'-S\%M*L?#7A!M(\<6-KJ0\<^*%^%.K
M^!+;Q09?&OBXZ4UMXDOM!L+'Q)%90B5%TNQUG6I/"Z.NF79MI4VM^A=?#O[
M_C#6==^!GA_0]0^'GC+PM9:')XHGL?$^OOX8;1/$\FI_$'QC<75MH:Z/XCU7
M5UGT63_1-3.L:5I41N.=/EOH/WU?<5 !17D/A'X__!'QXOQ4?P?\5O >OQ?
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M)9?\(+]L^&']H _\+'>?_A+/L7_"T_\ A'/L9'_$G^U?VE_;?GCRC8_8,7%
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M\+3680<\3BL9BL-AZ$%.#E6K4X\\+\T?P0_MC6O^@[KW_@\U;_Y,H_MC6O\
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M6D_$CPYH-AH\&FZ3XZTR_FDNK#Q59V\6N6DS;H+Y-J@;UC^S-^SII?QNU/\
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M'XJW_P 3[:U\2>)-4_:K\'^ /B3\4M8\427OPVU]M;3_ (50-;\.7_VSX6^
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M*;&D)J&GW4&F20MY\5LMKB.OTCH **** "BBB@ HHHH **** "BBB@ HHHH
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M743JVH74DT20V=K-(TJ!=P /S#BU+_@J3\,/"/A'XD7.A?\ !+;]O[X+>$]
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MCMI@2Q$L" 12 LQWH>3UK^43XH?M0?L"?\%*/VMOB?\ "ZU\,?\ !0#X)O\
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M5/%>HZQ\/[ZUT1Y[GXIZEX)T%M6\42:UXL\%:7XH\)ZS"EC]7?\ !-+]H/\
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MX)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"HOA/_P!$P^'G_A%>&_\ Y64
M<_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O^BZ?!S_PYW@G_P"7==!_PJ+X
M3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_ (17AO\ ^5E '/\ _#1/[/W_
M $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>"?\ Y=UT'_"HOA/_ -$P^'G_
M (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90!S__  T3^S]_T73X.?\ ASO!
M/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ+X3_ /1,/AY_X17AO_Y64?\
M"HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T73X.?^'.\$__ "[H_P"&B?V?
MO^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"HOA/_P!$P^'G
M_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O^BZ?!S_PYW@G
M_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_ (17AO\ ^5E
M'/\ _#1/[/W_ $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>"?\ Y=UT'_"H
MOA/_ -$P^'G_ (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90!S__  T3^S]_
MT73X.?\ ASO!/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ+X3_ /1,/AY_
MX17AO_Y64?\ "HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T73X.?^'.\$__
M "[H_P"&B?V?O^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"
MHOA/_P!$P^'G_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O
M^BZ?!S_PYW@G_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_
M (17AO\ ^5E '/\ _#1/[/W_ $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>
M"?\ Y=UT'_"HOA/_ -$P^'G_ (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90
M!S__  T3^S]_T73X.?\ ASO!/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ
M+X3_ /1,/AY_X17AO_Y64?\ "HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T
M73X.?^'.\$__ "[H_P"&B?V?O^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X
M17AO_P"5E'_"HOA/_P!$P^'G_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_
M ,NZ/^&B?V?O^BZ?!S_PYW@G_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"H
MOA/_ -$P^'G_ (17AO\ ^5E '/\ _#1/[/W_ $73X.?^'.\$_P#R[K\"/^"D
M?_!-OX,?MY_M()\?='_;W^!'PSC?X=>%? UUX9OKGPAXED:?PQ?^(;I-435;
M;XBZ-O6\AUQ(6@ELR\'V-0L\D;JL?]"__"HOA/\ ]$P^'G_A%>&__E91_P *
MB^$__1,/AY_X17AO_P"5E>KDV=9ED&,^OY5B%AL5[&KA_:.E2K+V5;D]I'DK
M0G#WO9PM*W,K:-7=_#XAX;R?BK+_ .RL\PLL9@?K%#%>RCB*^&:KX?VGLIJK
MAJE.I[OM:B<>;EDI>\G96_/G_@G7X"^!'["7[,?A_P#9\OOVLO@M\2;S2/%7
MC7Q1<>*+;Q=X,\,V\[^+M=N-86RATJ3Q?K$B)8QRI 9WO6:X</)Y42E4'W-_
MPT3^S]_T73X.?^'.\$__ "[KH/\ A47PG_Z)A\//_"*\-_\ RLH_X5%\)_\
MHF'P\_\ "*\-_P#RLKDQN,Q&88S$X_%U/:XK&5ZF(Q%10A!3K56I3DH0481N
MTO=C%16R1WY;EV$RG+\%E> I.C@LOPU+"82BZE2JZ="C%QIP=2K*52;BF[SG
M*4I-W;.?_P"&B?V?O^BZ?!S_ ,.=X)_^7='_  T3^S]_T73X.?\ ASO!/_R[
MKH/^%1?"?_HF'P\_\(KPW_\ *RC_ (5%\)_^B8?#S_PBO#?_ ,K*Y3M.?_X:
M)_9^_P"BZ?!S_P .=X)_^7='_#1/[/W_ $73X.?^'.\$_P#R[KH/^%1?"?\
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M7B'X7>%=:\)7=UIIMO!FCW_A[3[J\F6TU#Q5J)OO'5[8VD_BEX$ /TVHHHH
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M\4^)_"EII$UUJ%QINH_\))::C+>P1Z:^E"T>VU2XEBS/VM?V<K^\_;X_8B\
MZIX]M;SPG^VQH]KHW[;&B0^%+32[#X_ZO_P3YT*V^/'PEU]-'@O[BP\,'Q1X
MGO;CPM\0M.0ZFFL?#.WTCP7]I>QTJ%V /UI^.G[5W[-W[,GPVL/B_P#M!_&K
MX??![X;ZM-IMMI'BGQ[K]KX?L]8N]7A2YT^QTBVO"FHZK?S6C&]>PT^SN;RV
ML(;F^NH(;2TNIH>.^)O[>/[&'P9^%OPW^-OQ2_:@^"7@GX1_&&73X_A7\1-:
M^(/A^+PI\01J=HM_;7/A+5HKR:WURP2Q=+V^U&Q::PTNU9;C4[FSB8.?._V_
M_P!KS]E[]B3X=^%/C9^T!?\ PELO'3>(+[P-^SK!\3-<\'>$+K5?B;XTTN32
MIM*TCQ[XP\NU^'?AJXTHM+\3?'#W=II6@>"8+ZXU7^T)&T[1]2_$KX+^/OV%
M_P!CWQS^ROX^^*?[1'[/'Q,_8]N?V$/VO?AGX/\ CWX=OO#'BK]G'4OVE_'O
M[2FD_&#]I;X3?#O4M&&K^%='O?&>C:]=>%_AU\.(I[;7/$?@[P7=> M,LM7U
M&UNM+< _H!^.?[<_['/[,TWPZM_C_P#M,_!;X1R_%J2S7X;KXW\?:!HR^+K6
M_>"*TU?2I)[SRW\.2R75M&?$\[0^'HGN(%EU.,RQAH_B=^W7^QM\%_BUX"^!
M'Q7_ &F?@Q\/_C!\3QII\"?#[Q1X[T/2_$7B!=:G6UT)H;6>Z"6:^(;IEM?#
MK:E+9KX@NLVVC&^G!C'X-ZC\>OV<?V<?^"9/[(W[(_[2WC+]G?X&_M4?M<?L
M8V?P134/VGM5\">![OX1_LQZY9:Q'<ZO\4;_ ,=W5C>-H7PO\):__9W@CX2Z
MAJ+2>+/BO;Q>&;&P@MK+QCKF@9O_  4I^+W[)=E\ O 7P,^!G[6GP8\06/A?
MP/\ LSIXC_8ZN?!FGZM\:/\ @J!\/?#C_"W5_@#X;^$/QWTQ!X_UY]5T'24L
MM#^)'P?T7XB:)#JVJW6G^(M:\*:79ZU-  ?U2T5!:RR7%M;SRV\MI+-!#+):
M3F)IK622-7>WF:&26%I868QR&*62(NI,<CIAC/0 4444 %%%% !1110 4444
M !. 2>@Y-?F9X=_X++_\$L_%FOMX7\-_MR_ +6-<2Z-G)9V7BQI(X9UU*#2'
M\^]-FMA!!%J5S!:374UTEK!+(/-F10S#],)/]6_^XW\C7\Z'_!&G]F'XQ?%G
M_@FS\*-!^/G[1WA_XN_L>_'/]F7QI\/;#]EZ/]G[PGX/U#P9HGC'7M9TES+\
M;M-\6ZEXB\6W.E:4-8MK>ZO/#&EW$]]J5MK/FVU]I<'F '[\?\+-^'Y^)A^#
M0\6Z*WQ37P*OQ-D\"I=!_$,/@!]?;PK#XMN+%06M]&N?$23:/:74[1B[OK6]
MAM1*;*[,/C'AO]MC]D;QC^T%KG[*?A;]H[X/Z_\ M'>&[._O=:^#6E>.-#O/
M'=G'I,4=QK-N-&BNFENM3T2WD%SKFCV;7&K:+;)-<:I96D-O.\?P;_P1D\)>
M*=1^#?Q7^._Q9\<O\4OC3XN^+OC3]GK5?'D]BUA._P *_P!BOQ?XJ_9S^%.C
M&&6[OI#J&I0^%/$GQ,\9W@N!'JWQ$^(_BW4(X(+=[6&/PKXA_M)_L$_M _MU
M_"7]FSX7?';]DGX;>*?V,_CIX]\<Z?X?MO&WPN\*_$_XG_MM^/\ P1X\\ V/
MPM^&7@ZWO-/\2ZQ:Z3??$+Q#XH^._B+3+.X7QAX_'AOP(3K6J:?XX_L8 _7#
MX8?MF_LG_&GXG_%+X+?";]H?X2?$+XK?!,S?\+5\!>%?&VBZMXC\$):W;Z=J
M$VLV-M=,RVVD:G&VDZ[=6S7%OH6K[=)UB6QU%TMFB^ W[:?[)?[47B7X@>#O
MV=OVBOA'\9_%/PLNTL_'VA?#OQKHWB74?#AEN[BPAO;F#3[F5KG1KF]M+FTM
M=>T_[7HEU<PO!;ZA+(-I_GP_8;\=_ /Q_P"(?^"0WP4\ _\ "*7'QC_8_P#@
M?^U3I/[?_A2?2+6WUOX%Z3/\)[KP%\8_#O[14-_#;'PHOQ7_ &C9M-\56&F>
M,T2/XA-I-YX_T^/5-)LI-9?N=._:N^$7[6'Q8^,?QO\ ^"6_Q)_9$\>?M+?!
MS]E/QM^R/^PO^SQX=^+WPD\(>./&?AJY^(?@O5?BG\;/$/@^*=;GPS\*/AQ)
MX:TG_A0_@?Q+I,.DZA;^'_$7B>^M-%T;XC:"% /Z(/ OQO\ A#\3O&/Q4^'W
MP\^(WA+QGXU^!_B#2?"GQ=\-^'=8MM4U/X=^)M=T>/7]*T'Q3#:O(-,U:[T>
M5+X6,S?:(HRR3QQ3(\:^IU_.%_P19T7XN?##]K3_ (* ?!CQE^RAK'P#TKP]
MX9_95U+Q=KOB7]H/X<_&WQAJ_P 2V^&4\ESK_C[5_!=A9R^+_'WQM_MCQ'\5
MO%GC6)8[&TU@7.C7,$,MQ800?T>T %%%% !1110 4444 %%%% !1110 5\S_
M +:-Q\*;/]C[]JB\^.VA:WXI^"=G^SK\:+SXN^&?#4U_;^(_$/PTM?AUXCN/
M'&AZ#<:5<6>I6^L:KX:CU*QTV>QN[2ZAO)X9(;FW=1*GTQ7S1^V?\5=5^!7[
M(/[4GQKT/0O#7BC6OA)^SU\8_B3I/AKQG;SW7A#Q#J/@GX?>(/$=GH?BFVM;
MFSN)_#NK7&G1V&M107=M*^G7%RJ3Q,0X /Y*_CEH/QD^,_A7P9_P4+_:/_X(
MS?\ !*?XF_L^?"/X3^'/B3I5IKW[7MIK7[4D7[/W@OPY;ZWHNG>(O'ZVEO\
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M=1011W%X;:,Q6QNIT02W'V>(F*#S6?RHR4CVKQ5FBB@ HHHH **** "BBB@
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M_P".OC#6OV@/&/A&Z_8!T/X!?$S2_A#\0(X_B^]CXB_9K\+_ !$L=#L[#3_
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ME1B\#4RZO.AS86EAJG+*K/G]I[1-*:2_@CQ?\7/I6\.>(_%&2>'OAW6SK@W
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M?!_XH^ KM;/QC\/_ (A:%]KOK33M:T?SK/4H;S3]3U/0]:\/ZIH_B+1-4O\
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MC0SS2%%Q\-_\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
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8 !^,O_#I#XE_]!&V_P# R>BOZ/:* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>formdefc14a_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdefc14a_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? G$# 2(  A$! Q$!_\0
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MPUC2QK'A^^U#3SJ&EWL;VM_:"X\^TG4QSQHW%=O0!\[_ /#)/[,W_1#?AO\
M^$U8?_&Z/^&2?V9O^B&_#?\ \)JP_P#C=?0DDL46SS98X_,<1Q^8ZIOD;.U$
MW$;G;!PJY8X.!4E 'SO_ ,,D_LS?]$-^&_\ X35A_P#&Z/\ ADG]F;_HAOPW
M_P#":L/_ (W7T13))(X4:261(HUP6DD=4102 "S,0HR2 ,D<D#J: /GK_ADG
M]F;_ *(;\-__  FK#_XW1_PR3^S-_P!$-^&__A-6'_QNOH.2>&%!++-%%&2H
M$DDB(A+?= =B%);^'GGM39KJVMMOVBX@@WYV>=-'%NVXSMWLN[&1G&<9&>M
M'S]_PR3^S-_T0WX;_P#A-6'_ ,;H_P"&2?V9O^B&_#?_ ,)JP_\ C=?0ZLK*
MK*P96 964@JRD9#*1D$$$$$'!'(I: /G?_ADG]F;_HAOPW_\)JP_^-T?\,D_
MLS?]$-^&_P#X35A_\;KZ(J#[5;>6\OVB#RHF*22^;'Y<;J0&1WW;48$@%6((
M) (R10!\_?\ #)/[,W_1#?AO_P"$U8?_ !NC_ADG]F;_ *(;\-__  FK#_XW
M7T0"",@Y!Y!'0CUI@DC+M$)$,B*K/&&4NJMG:S(#N56P=I( .#C.#0!\]?\
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M(HH ^=_^&2?V9O\ HAOPW_\ ":L/_C='_#)/[,W_ $0WX;_^$U8?_&Z^B**
M/FZ?]D3]G8[I=*^&FE^$]0$92#6? ]_K7@G6[-_FV3VFJ>%]2TJ[AGC9BR2"
M1N>&#)E3S4>N>._V=O$?A_1_'7BG5/B-\$?%NLV7AK1O'GB5XI_'/PR\3:Q=
MBU\/Z1XXU:""WC\4^#]=O9K?1].\6WD2Z[H^KS6L/B.YU&RO5U*S^MJ\Y^+_
M (3TSQU\*_B)X0UB%9]/\0>#?$.G2JV08I)=,N&M;J)@08[BRNU@O+652&AN
M8(I5(9 : /1J*_EI_P"'G/QZ_P"@E_XZG_Q^B@#^@3]CO_DUGX!?]DM\)?\
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M?M=OYMO)=6HDMOM,2OO7R_\ 9V_X+,_MU^&?%'[$7C#]I:?X-_&GX=_MG_\
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M V@Z;X8\)>&=*21-.T/0=(MDM-.TVT$TDTQAMK>-$#S2RS2$&26621F<]C0
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MR?)-$C<5:_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??^AC\:_\
MAE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V??\ H8_&
MO_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??^AC\
M:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V??\
MH8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??
M^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V
M??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_
M &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^
M&R_V??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_
MX;+_ &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*
M^7/^&R_V??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCH
MKY<_X;+_ &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH
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M^-?_  RGQO\ _G<T ?4=%?+G_#9?[/O_ $,?C7_PRGQO_P#G<T?\-E_L^_\
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MG2;GX?P7/BZ-I[TVUM=_V3"[-8S7*7>VQ:Y8 'RG^QYK?QJN=5^*]GXA\ >
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M.N+FWM();J[GAM;:!&EGN+B5(((8T&6DEFE98XT4<L[LJ@<DBO@_XX?\%/\
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MV>V'AOQ+JO\ :7A_POJ^B77B&&2XG.@:SH=AJFGQ0QO<PK]H0#^+/]ISP?\
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M_!KXS:3\3]8_9^\86/A_PA%%'\,8M*\(Z7X=B^+>C/<O=W/B"[OK?PFL.G+
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M_P")_A3Q5<?![P-XQ'Q%T?X3_#[X7_#3PQ\*_A_X6U/X@QZ)X=L_&7B^_M=
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M;M*[7Z&45_EO67[9'[5TME:22?M"_%9Y)+6W=V/BJ\RSO$C,QQ@9+$DX '/
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M=6TJ[?QQ\0[Q+74-/\!ZY=6=PUI>^++BSN?(N(HY?(N[>>VE*!)X98F>-O\
M.L7[J_[H_E7YOQCQ3F/#^*P5#!4\).&)PU6M4>)I5*DE.&(5**@X5J24>75I
MIN^M[:'Y)XG^(.=\&YCE.$RJAEM6ECL!B,56>.P]>M.-2EC5AXJFZ6*PZC!T
MW=IQDW+522T/]!S_ (?W?\$OO^B\>(/_  S7QB_^8>C_ (?W?\$OO^B\>(/_
M  S7QB_^8>O\^6BOC_\ B)&??\^,L_\ ">O_ /-9^9?\1RXP_P"@/(/_  AQ
MG_SQ/]!K_A_=_P $OO\ HO'B#_PS7QB_^8>O9_V?/^"MW["7[4?Q:\,_ _X*
M_%G6?%'Q)\7P:[<Z#H=U\,_B5X?@NX?#>AZAXCUAY-7\0>%=-TFU^RZ1IE[<
M@75["9VB$$ DGDCC;_-^K]2O^"+G@GPQ\1?^"D?P#\'^,M-?5_#NJZ7\7'OK
M!-1U72GF>P^$OC&_LV6_T6^T[4H3#=V\,V(+R-9=GE3K+"[QMWY7Q_G6-S/+
M\'5H9<J6*QN&P]1PH5HS4*U6,)N#>)DE)1;Y6XR2>Z>QZ_#_ (R<59IGN399
MB<+DD</F&:8#!5Y4L'BHU8T<3B84:CIRECYQC449-PE*$TI6;C):'^B]17RM
M_P ,4?LT?]$\O?\ PX/Q-_\ FRH_X8H_9H_Z)Y>_^'!^)O\ \V5?L)_3AVO[
M0G[-/P/_ &J/A]??#'X\?#W0OB!X4NQ)):Q:I 8]5T'4'CV1ZSX9URV:'5O#
MNLV^$:+4=*N[:<A!%.9K=I(7_E]^*W_!.S]OS_@DQX[UG]H3_@G9X^\4_%[X
M*/.^I^,_A9<V3^(/$,.BVJF66U\>_#RT\C3_ (C:796?FQ0>,O!UOIGCG2((
MWN3:6J(]X_\ 2;_PQ1^S1_T3R]_\.#\3?_FRIR_L5?LU(P9/A]?*RG(9?B%\
M300?4$>,LBOI<BXIS+(XU,+%4<PRG$Z8W)<QA]8R[$QDUS-4Y<SPU9K6.(PS
MIU(S492C-Q4H_'<3\#Y/Q-.CC9O$93GV#L\NXCRBI]4S?!SBGR)UH<D<9AE>
MTL)C%6I2@YPA*DIRC+X,_P""?O\ P6D_9Y_;*;2OASX^^S? +]HB0I82?#_Q
M7J21^&O&&J1@QSCX=^*;]+*._NY9T?'A'6HM/\56K,+:"VU@127A_9JOPU_;
M2_X(1?LJ_M$Z!=:Y\$[%/V=/C3:O/J.G^+M!?5=7\+^*-3+?:(T\>Z!?:C/<
MW,LETJNGB70[S3_$%C(\ET[ZKA;5OQ)\$?&7XZ_\$QOB?:?!3_@I?^S]XK^+
M_P *=5U$Q>&_BWI7COX@7?B!-.4HC7O@'QG:^*M,\._$#1K:W*W-UX*\1)HO
MC+2B#&MW;X-G/[M3AW*.)J<\7P;6=#'J,JN)X4S"O!8R%DY5)9-BZDH4\QH1
MU<:$Y1Q$(65[I)_+T>+N(.#*M/+_ !#PZQ65RG&C@N.\IPU1Y?4YI*%*'$.7
MTHU*N4XF5XJ>)IPG@YSYI6:>G]P%%?G'^SY\//\ @GS^U/\ #[3_ (G_  '_
M +.^(/A*]"1W$^E?$GXG)JFAW[*6DT;Q-H=UXPAU?PYK5N5=9M-U>SM+DA?.
MA66V>*9_<_\ ABC]FC_HGE[_ .'!^)O_ ,V5?!5J%;#5JF'Q%&K0KT9RIU:-
M:G.E5ISB[2A.G4C&<9)[J45T:NFI/]2PV)P^,H4<5A*]'%8;$4XU:&(P]6G7
MH5J4U>-2E5I3G3G"2V<9/6Z:C)2C'ZIHKY6_X8H_9H_Z)Y>_^'!^)O\ \V5'
M_#%'[-'_ $3R]_\ #@_$W_YLJR-SZIHKY6_X8H_9H_Z)Y>_^'!^)O_S94?\
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MRQ>)P$<FA4Q>#P\JU"6%Q,<1BJV$QM%XNERUY4UA*M-4U-*MSN245^-OP/\
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MO_ZF(_E_Q[_Y'?#O_8GQO_JTB.HHHK\S/P<*_73_ ((3?\I2/V<_^P3\9_\
MU37C>OR+K]=/^"$W_*4C]G/_ +!/QG_]4UXWKU^'_P#D>Y-_V-,#_P"I$#Z3
M@W_DKN%_^R@RC_U.I'^AI1117],G]Z!1110 5YO\6?@_\+_CMX%UKX:?&'P+
MX<^(G@3Q!"8=4\-^)]/BO[&8A66*ZMV;;<Z=J-KO9['5=.GM-2L)2)K*[@F
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M%#6A:)&-JP0! ;<GRB$ 4%/E &*_SUOVM_%7[0_Q\_:NUSQM\$?^"/O[:O\
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M_P#B.=Y_\^>C_A ?VM/^CC_A?_XCG>?_ #YZ^HJ*^_/V0^7?^$!_:T_Z./\
MA?\ ^(YWG_SYZ/\ A ?VM/\ HX_X7_\ B.=Y_P#/GKZBHH ^7?\ A ?VM/\
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MO5O$$&F^+M(U$Z!X6MKF;PM\.-0CTSP5XV\36=O?-X<@TR"PN+C7QI3W<O\
M81^U+^TEI?[*_P -M+^)>K_"SXS_ !?M-4^(_P .?APOA7X%>!S\0/&EI=?$
M?Q58>%;3Q+>:&-1TL0^%/#L]^FH>)M4^U,]CIZ%H+:ZN9(;>3^/G]J_2?"L'
M[67[1WPDL?!__!PKIW[(/C[]HWQSXE^/7[(?P/\ V/=,\3_LR_&OQ?J'C>:^
M^)=_\-OBY-XYL_$^D_ OXY^)+:\\6^)-(TC1WM?$UCXBUJ[MI;2/7(AIP!_;
M%XNB\:1?#WQ'#\+KCPQ/\08_".J1?#^[\?MJ]SX.F\6II$R>&+CQD_A]TUVX
M\.R:L+*37FT:1-4ET\W1L'6Z:(C^4KP)X=_X+&_MLW/PE_X)[_'*X_;0_8Y\
M-_!;QC\>?B/^WC^WIX.U[PWX:N_C_++XS\0:C\$/A7^QKX\T='U,?#34/[=M
MIHDDL9-9T/P3X<TC1_$ EO-,:UUO^KGQ%X7TOQSX!UWP7>/KFA:+XP\'ZGX8
MNI/#^IWWACQ)H^E^(-%GTJ=]$UG2IH-2\/:YI]I=L=-U33;B&^TF_AAN[.:.
MXMXY%_'B+_@FK_P4/^'9G\-_L_\ _!;3]HW0/A<MO#IVB>'/VA_V=?@!^U#\
M0?#.EQK*HAM/C%XDL?!_BK7KNW5T@L]2\6VNNZE]G@A_M"^U&Y22YG /8O\
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MO;NW)>OM3_AH;Q]_T:3^T5_WU\%?_GPT ?45> ?M8?\ )K/[2O\ V0#XR?\
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MA@U5ELX0HI;,]H_X?.?MH_W/@Q_X;_6?_FUH_P"'SG[:/]SX,?\ AO\ 6?\
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MKZ[B#KXD\"!7$5S<2QAU#, P7< Q .":^?\ _AV+^W'_ -$,U/\ \*3P7_\
M-)7W!_P3[_9=_:J_9.^/=Y\5/B#^SKX\UO0;CX=^(_",=EX0UGX<WNK+J.L:
MOX:U"WN'@U;QQH]K]CCAT6Y29Q>&99)(-D+J79/AO$WQ4\,LW\/>,<KRKB_(
M,;F6/R'&8; X3#>W]OB,14G@G"E1YLGH1]I)4ZC5ZU->Z_?77]4\#_ 7QQX=
M\8/#;/<_\.N+\LR3*>+<MQV:9CC5A?JF#P5*GF:JXC$<G$F*G[*#K45+EPU9
MWG&U.6KC_2G17R[_ ,-#>/O^C2?VBO\ OKX*_P#SX:/^&AO'W_1I/[17_?7P
M5_\ GPU_G6?[*'T+XGM+Z_\ #NMV6F^(Y_"&H76F7D%EXIM;;2[VY\/W,L+K
M#J\%IK=M>:/<RV+D7"0ZG:7-E(R!;F&2(LI^#?V//"WC"S\5_&#4+[X^ZWXE
MTO3OV@?BQ8:KX-N/#OPUM;3QIJ8LM)C;Q;=WVD^'[;7K"ZDFEBOC9:#?6&BA
M[%(UL5MY+F.3UC7?C3XE\3Z-JGAWQ'^QI\>M<T'6[&YTS6-&U6W^!]]INJ:=
M>1-!=V-_9W/Q>D@NK6YA=XIX)D>.6-F1U*DBODW]DFV\'^'/&WC_ %C0OV,/
M%>FZ[!\?_'FA:3XXTOPU\'+23X6Z!J@T?3)_"]]?IX[AUBPL_#EC=W3:O8^&
M+;5]/%C=31Z6^HR220T ?K360-?T%M2U/1UUO2#J^B:?9:MK.E#4K,ZEI.E:
MDU^FG:GJ=B)OM5AI^H/I6II97MU%%;73:;?K!)(;.X$>O7X0^*/@E\5?VM_@
M!_P4@B^&.LV^E_%OXB_MS:QX&U_2]5\7^(_AHOQ3^!W[,'B/P!X.E_9NNOB7
MX-63Q;\._#'Q;^'7A7QCX>7Q5X>@DO='?XH:[J[PRV^I:A)( ?NAIFIZ;K>F
MZ?K.C:A8ZMH^K6-IJ>E:KIEW;W^FZGIM_!'=6.H:??6LDMK>V-[:RQ7-I=VT
MLMO<P2QS0R/&ZL;U?ST^$O@9\$/C'^P;XN^!'P8_9>_:7\1:C^RO\:=>\(>(
M_P#@G'XZ_;9\=_!AO#_Q'@TSP3JEY\,V^/>F^.=<?7_@CX,\->.M"^+/P?;3
M?&>I^";Z#5M#N+:QTZ^N(M"T?P;X ^&;?]K3X?\ _!+;]C;]H#XG_&GQG\*[
MWP!^WIK/QU\,:A\3OB?\._&OB#X[?LR?$KPA\.]#_9R\>^//#'C:R^)7BRR_
M9FF\?>*]*T[5&\<W47Q&G^%OA7X@ZC<:I:*L; ']1]%?A;\,/VB/C1X6_P""
M&_QI^-.C^./$GCCXI?!/X._MC^&OAQ\5]=OXO$'BSQ)IGP'\>?%WX=?#+XE:
MQK)26/Q)KUOX5\':%KVI:].DS>(=1T^XU>[\^6^F9_@;X\^#&_8EUN^_9N_9
MK^-WQQTOX7?M7_LR?LIZ]\<O&6K?'3Q]X]\4^%?$GQ._;6^"W[/?C[]I?PSX
MT\;^)/$>O_#[QE\8_AI\3_&>FZ[K'A6^T70)M9T#1_$6@:9I>I^'I+B@#^K;
M5==T30QIQUO6-*T<:OJMGH6DG5=0M-/&J:WJ+.NGZ/IQNYH?MNJW[1R+9Z?;
M>;=W3(X@A<JV-6OYM_$GPQT'X%> O^"P/[+?PG\0^-8/@W^RG\*OV??VK?V?
M]+\4>/\ Q5\3M5^ OQH'@CQI\6[G1O!_C'XAZYXJ\;6%A/XN^$'@[XC66B:K
MX@OCI5]XSUZ;31;Z3X@BLA_19X9U637?#?A[7)H1;3:SH>DZK+;@DBWDU&PM
M[MX06 8B)IC&"P!^7D T ?QC?MM?&/6_B5^VU\3O^">W[0'_  <1?#7X;>"?
MBS\7ET&__9R\(_\ !/OP5_;?P\\-^(?&=EX@\$?!BZ_:]LM$_L#P1\3]*L9=
M T2U\::WXKM/$^C:T=.U358(-6O(;*?^T^WA%O;P6XDEF$$,4(EG<R3RB)%0
M232$ R2OMW2.0"SDMCFOYV/VCO\ @@YJ?Q;GT+0?A[^TCH/@'P/XJ_:#_;C^
M*/[0-SJ_P/\ #_B;X@>._AE^W)XR^'OC'QK\-]!\13:Y#;6/B_PH/!5SX:\'
M?%_5;6Z\3>&]$N]#;1;.SF\-P1WO]$]M!':V\%K"&$-M#%!$'=Y'$<*+&@:1
MRSNP51N=V9V.68DDF@":L/Q/_P BUXA_[ >K?^D%Q6Y6'XG_ .1:\0_]@/5O
M_2"XH _A;HHHH _LN_8[_P"36?@%_P!DM\)?^FN&OI*OFW]CO_DUGX!?]DM\
M)?\ IKAKZ2H \B^/>B_&GQ'\'O'VB?L[>./!_P -OC;J.AM#\.?'/C_PK<>-
M_!OAS7Q=6TBWOB#PK::AI=SK-@]HEU:M;PWT#QRSQW(\WR##)_%]XH^)O_!1
M'X/1?%K]C3]M7_@O1_P3D_9O7QK\8?BK?_$^VM?$GB35/VJ_!_@#XD_%+6/%
M$E[\-M?;6T_X50-;\.7_ -L^%O@*_P!4TF[^&/A'5]&T%EL1IL21?W/5_!9_
MP43_ &2/V2/ _CRT^(WAK]L3]@;P=\5?VB?^"@7[:'P)\9?$/X]?!+QKXS\5
M >//C=\*OBE=ZCHWB?3_  SXEN;7]H;]C'QO:1>"/#?Q)U2;2/A/8^%O%6B>
M#M:UO2[.WU:"_ /[L+_2EUSPC>Z'9:WJ5DNL>'+G2K3Q'IUPJZQ:+J&F/:0:
MW8W95E&I0"9+^UN"A472)*5(XK^&/]N']G74/^"<_P"T?I7@?]JO_@K7_P %
MRO#?[-7C7X):5XH^&'Q]^'WC#Q!\5;'Q5\<+;Q=XML?&WPGUR3PEX9O(O"%Y
MH?@ZS\$ZWX>LK[293XD?Q%J][<ZYI%IHD<5[_<GXJ\.7?B;P-XC\)6'B?6?"
MU_X@\)ZQX<L_&?AIK6S\0^'+O5='N-,M_$^@.T,EE:ZSI$UPFJZ4QMY+6"^M
MX"87B78?Y&_^"H?B_P !_L2>*/V7_@5\2_\ @J?_ ,%M-<^,6C? +P%X,U'P
MQ^Q;:>&/'?B7Q_+=^./&NE^&OC#\81KEI;VT?Q#^*6O2ZCX+T*!=>U'7O$5I
MX'L+>&RO+BSNM2OP#]WO^".K?%2;_@F[^S'>_&B?XWWOC_5?#WC'6+K5?VD=
M5O\ 5?C=KWAS5_B5XSU'P%XE^(?]J-)?Z/K7B;P'<^&M?'A6YGNW\(V6I6OA
MA;R[BTI+B3],J_/+_@E-XXTGXD_L"_L^^.] ^(G[4/Q8T/Q/I'BW4])^(7[9
MMKHME^T?XFL'^('BN*WO/B';^'KF[TA?)2+[%X8>TN)/,\(6N@R7!%TTP'Z&
MT ?'/[9'[#_P<_;9\&Z'X<^)-YX^\'^)O"%_-?>!/BM\(OB#XS^%GQ3\$)JM
MQIJ>+--\/^-/ FO>'M9CT7QKHNG#P]XHT6ZN[G2M2T^5)I;/^T+'3KNT\Z^)
MO_!*K]@SXM>%/@[X&\4_ :ST_P )? GP9)\,O &A>!?&WQ'^&MF_PHN[K3]0
MUCX1^./^%?\ B_PW-\3_ (5^)-2TNPU7Q3X ^)$OBKPSXEU:"35-:TZ]O[R^
MN+K]"Z* /E'XC?L0?LN?%O6?B-K/Q&^%.G>*A\5_@7X>_9M\<Z'?:WXHA\(:
MG\'O"GB/5_%GAOPS8>#;'6[3PQX<OM#\0:W>:EI7BOPUI6D>+M/FATW[)KD*
MZ1I8M.*\+?\ !.']COPG^SU\1?V7[?X57.O_  H^+NNMXK^* \<^/_B1X_\
MB'X]\8QS:+/I?C7Q/\8?&?BW7/BQJ?C/PS)X:\,GP=XJE\9_VYX.'AKP^OAB
M^TH:/8>1]QT4 >!?LX?LQ?!;]DWX?3?#/X'>%KWP[X>U#Q)K/C/Q%J&O>*O%
MOC_QKXS\9^(7@;6_&/CSXA>/]<\3>.?''BG4H[6RM;C7O%7B#5M2^P6&G:;'
M<1Z?I]G;0=W\5+E+/P'KMQ)\3K?X.)&MAGXCW8\*&W\.;M3LT#2#QO;7GAC_
M (F18:0O]IV\@WWZ_9=M[]G=?0JX7XE?VE_PA6M?V1\/].^*6H[;+[/X%U;4
MM'TC3]=/]HVGF+<:CKUK>Z3;BPB\S4XS=VTHDELTBB"SR1.H!\"?L5ZI!-XN
M^(=LO[5FF>-7N/C5\:;E?AG"OP@%QX]1M49Q\18#H.FQ>*OL^H*/[<7_ (1Z
MXMO#6Q3]FMEL 5;]-:_-S]C'_A*/^$F^)'VW]G+PQX3TW_A>'QK%_P"/K/Q3
MX)O=1\&ZC_:[^9X&LM-TW1[?5[ZPLIL:0FH:?=0:9)"WGQ6RVN(Z_2.@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *Y/PKX(\->"Y?%,WAS3VL)/&GB
MS4?&_B-FN[RZ^W^)=6M-.L;_ %!1=SSBU6:VTJQC%I:""SC\DO% CR2L_644
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RGAOP3X:\):AXPU3
M0+!K*]\>^)CXO\4S&[O+D:CX@.AZ+X<-ZL=U/-'9K_9'A_2;7[-9);VN;8S^
M3Y\T\DG5T44 %4=4TO3-<TS4=%UK3K'5]'U>QN]+U;2=4M+?4-,U33-0MY+2
M_P!.U&PNXYK6]L;VUFEMKNTN8I;>YMY9(9HWC=E-ZBAI---)IIIII-------
M----IIIIIM---III---)IIIII-----------IIIIIM---I_. _8Y_9$4!5_9
M7_9P"@  #X'_  R   P  /#&  . !P!2_P##'7[(O_1K'[./_AC_ (9?_,Q7
MT=17-]3P?_0'A/\ PDPO_P S'%_9F6?]"W+?_#=E_P#\P'SC_P ,=?LC?]&L
M?LX_^&/^&7_S,5^-W_!03_@@9\'OCQ_;7Q0_9-?0O@-\7I5N-0O? RVIM?@U
MXYO5!E$8TC3X';X?:Q=2 HNI^'[6;09)&3[=X=#-+?K_ $/T5[>1YMCN',2\
M5DU2&"G42AB*5.C1^JXRE:2=#&X7V4:&+HRC.<>2O3FXQG/V<Z;E+F\C/.#N
M&>(L!4R[-,FP-6A.\H5*&&P^#Q6&JV:C7PN+PF'P]>A6A?249SA)+EJT:L&X
MG\(7A3_@H]^TS_P3I\6CX*_&G]B+]E#4?C]\([E(K3XB>)OACX<\'?%*TTO4
M-,:UTR^3Q=\--/M+#Q%;:KI$UPUAXPTTVEWKFEWLJ:C+=RO<2/\ UP_\$[/V
MI_$O[:'[(_PQ_:(\8>%-#\%>)/&LWC"UU3P]X;O;_4-#M)O#'C+7O#$<NGW&
MJ*+_ ,J\M])ANGBN6E>*:62-970*:^0OVT/^")W[/O[;/Q\UO]H3QW\4?C!X
M2\4^(/#GA?PYJ&C^$;KPC_8(@\)V,FG6%S;1:SX9U*^AGGM77[4K7DD3RH9(
MUC#E!^@/[(/[+O@S]C7]G_P1^SQX USQ+XD\,>")/$,]GK?BZ;3IM>OY_$OB
M/5?$U^]XVE6&F6"I'>ZM/#:QV]G&([6*%9&EE#RO]?Q)F'!&.R+!3R3*,)EG
M$5;$8?$9K# 9=6P.#C*6'K+&0HVJ_573>(]BZ:IX>#Y?A<8Q<7\%P'PYQYP]
MQ)F>%S;,98S@RCAL90R55L5E=7%591Q.%67XC%4L'EN$Q+Q*P4:U.M5Q%>M+
MW8QG*;E'D^F****_/C]B"BBB@ HHHH Y;QO,MOX/\33MXQB^'JQ:)J,C>.9_
M[$,/A(+;2$^()1XDAGT QZ7C[6PUF&73<1'[7&T.\'\[?V,-4@F\>?$VW7]J
M_3/&CW/QQ^*UPGPXB7X/BX^)2G3=.?\ X6#;?V'ID7B<6\X0ZF/^$6N+;PV5
MTMO+MEM/M:-^B_C'[7_PBOB+[!X7M/&U[_8]_P#9/"%_=V%A9>);C[/)Y6BW
M5[JD%SIUI!J+XMI+B^MYK6)9"\T;H"I_/K]C7_A*?^$U^*OVS]F_PQX4TX?'
M?XK_ -H^.K/Q5X(O-0\!:A_9^F;O!6GZ=INCP:KJ-E#)Y6GB_P!*NK;33'J,
ML@MQ#%,C@'Z4U\">)/V"_ ?Q#/[57@7XF21Z_P#!']HCX@^#_C=X<T'0M1\3
M>#?B!\*/CA8>%]-\.>*O'7@[Q[X8U;2M<T'4I=2\'^#/'/A'6?#VIZ5K&@^+
M)?%,ADDM+^%3]]T4 ?F=I'_!)/\ 8TLO@1X ^!NI>&?B-J$W@/7-5\;?\+IT
MGXW_ !G\"_M%^)_B;XLTK2]'^(OQ(\4?'GP%X]\-_%75_$?Q)LM'L++QC%>>
M+)])U+2+'2]"_L]-'T31K.P]"\;?\$T?V+O'?P(^%W[.%]\(I_#7PR^"6HWF
ML_",_#?X@_$OX7^/OA]K6KV^KVGB;6O#?Q9^'WB_PY\4;35_&UIXA\06WC_4
MI/%\UWX\CU[6&\72ZQ+?SR/]WT4 ?*_A7]B;]E[P/JWA+5/"?PET70[;P/\
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M.%\CSSZM<ZO<W !^P58?B?\ Y%KQ#_V ]6_](+BMRL/Q/_R+7B'_ + >K?\
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MZZ#_ (5%\)_^B8?#S_PBO#?_ ,K*/^%1?"?_ *)A\//_  BO#?\ \K* .?\
M^&B?V?O^BZ?!S_PYW@G_ .7='_#1/[/W_1=/@Y_X<[P3_P#+NN@_X5%\)_\
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M)_9^_P"BZ?!S_P .=X)_^7='_#1/[/W_ $73X.?^'.\$_P#R[KH/^%1?"?\
MZ)A\//\ PBO#?_RLH_X5%\)_^B8?#S_PBO#?_P K* .?_P"&B?V?O^BZ?!S_
M ,.=X)_^7='_  T3^S]_T73X.?\ ASO!/_R[KH/^%1?"?_HF'P\_\(KPW_\
M*RC_ (5%\)_^B8?#S_PBO#?_ ,K* .?_ .&B?V?O^BZ?!S_PYW@G_P"7='_#
M1/[/W_1=/@Y_X<[P3_\ +NN@_P"%1?"?_HF'P\_\(KPW_P#*RC_A47PG_P"B
M8?#S_P (KPW_ /*R@#G_ /AHG]G[_HNGP<_\.=X)_P#EW1_PT3^S]_T73X.?
M^'.\$_\ R[KH/^%1?"?_ *)A\//_  BO#?\ \K*/^%1?"?\ Z)A\//\ PBO#
M?_RLH Y__AHG]G[_ *+I\'/_  YW@G_Y=T?\-$_L_?\ 1=/@Y_X<[P3_ /+N
MN@_X5%\)_P#HF'P\_P#"*\-__*RC_A47PG_Z)A\//_"*\-__ "LH Y__ (:)
M_9^_Z+I\'/\ PYW@G_Y=T?\ #1/[/W_1=/@Y_P"'.\$__+NN@_X5%\)_^B8?
M#S_PBO#?_P K*/\ A47PG_Z)A\//_"*\-_\ RLH Y_\ X:)_9^_Z+I\'/_#G
M>"?_ )=T?\-$_L_?]%T^#G_ASO!/_P NZZ#_ (5%\)_^B8?#S_PBO#?_ ,K*
M/^%1?"?_ *)A\//_  BO#?\ \K* .?\ ^&B?V?O^BZ?!S_PYW@G_ .7='_#1
M/[/W_1=/@Y_X<[P3_P#+NN@_X5%\)_\ HF'P\_\ "*\-_P#RLH_X5%\)_P#H
MF'P\_P#"*\-__*R@#G_^&B?V?O\ HNGP<_\ #G>"?_EW1_PT3^S]_P!%T^#G
M_ASO!/\ \NZZ#_A47PG_ .B8?#S_ ,(KPW_\K*/^%1?"?_HF'P\_\(KPW_\
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M#S_PBO#?_P K* .?_P"&B?V?O^BZ?!S_ ,.=X)_^7='_  T3^S]_T73X.?\
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M3I<EQ-KEEX=GMKVW\07_ (:TM=0\1Z?H4]E?0:Q>Z5!ILUE>1W+6TO\ .?\
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MSXM\3:?\,/"EZT0^SW>O:_XLL_"VG-NN;[5X;1'F7Z*M/BGX$.FZS=ZUXO\
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M>UW]@^V&;[']J9KC[/Y?GL9=QKU;6/\ @DAX7_9#_9HO?AU^RI#\4?BWK_Q
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M26SMWCUJ^!/^'FW['/\ T4?5_P#P@?'/_P H*/\ AYM^QS_T4?5__"!\<_\
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MP)\0_BWXM\-_$#XT6-CX4\*>#[Z'7_A]\&--U.#76C\21"3^S_&WQ*UZS/\
M9.LZ[I$<AE\->'-$-UH/A^^8:P^J:OJL5I+8 'XR_P##I#XE_P#01MO_  ,G
(HK^CVB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>sonm-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeFibP9z5Z8+ekhvWB5belafyArZ0McpSjtD+KWUSUF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:SONM="http://sonimtech.com/20241231" elementFormDefault="qualified" targetNamespace="http://sonimtech.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sonimtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="SONM_HaoPeterLiuMember" name="HaoPeterLiuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" name="GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" name="FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" name="ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" name="FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" name="ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" name="FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>sonm-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sonimtech.com/role/Cover" xlink:href="sonm-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sonimtech.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:type="arc" order="50" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="loc_SONMHaoPeterLiuMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_SONMHaoPeterLiuMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>sonm-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="SONM_HaoPeterLiuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_HaoPeterLiuMember" xlink:to="SONM_HaoPeterLiuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_HaoPeterLiuMember_lbl" xml:lang="en-US">Hao (Peter) Liu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xml:lang="en-US">Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xml:lang="en-US">Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:to="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_lbl" xml:lang="en-US">Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:to="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_lbl" xml:lang="en-US">Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:to="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_lbl" xml:lang="en-US">Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:to="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_lbl" xml:lang="en-US">Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_HaoPeterLiuMember" xlink:to="SONM_HaoPeterLiuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_HaoPeterLiuMember_doc" xml:lang="en-US">Hao (Peter) Liu [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_doc" xml:lang="en-US">Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_doc" xml:lang="en-US">Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:to="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_doc" xml:lang="en-US">Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:to="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_doc" xml:lang="en-US">Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:to="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_doc" xml:lang="en-US">Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:to="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_doc" xml:lang="en-US">Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>sonm-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sonimtech.com/role/Cover" xlink:href="sonm-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sonimtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="loc_SONMHaoPeterLiuMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_SONMHaoPeterLiuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEFC14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sonim
Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total
    for PEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    Actually Paid to PEO <sup id="xdx_F5A_zoC5cfgHytsc">(2)(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Summary Compensation Table
    Total for non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Compensation Actually Paid to non-PEO NEOs<sup id="xdx_F53_z2S7G13evcl3">(2)(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment
    Based on Total Shareholder Return</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Income $(M)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">2024 <span id="xdx_F49_ztKsO747mKM5" style="display: none">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">672,918</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(134,334</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">624,083</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">513,490</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">34.23</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(33.65</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023 <span id="xdx_F42_z1MDmElWV8X8" style="display: none">(1)</span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">677,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,136,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">626,135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">688,442</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">79.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.09</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2022 <span id="xdx_F4F_z0K51fsW4TSd" style="display: none">(1)</span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,986,962</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,975,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">420,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">409,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46.08</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(14.09</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PEO in all reporting years is <span id="xdx_902_eecd--PeoName_c20240101__20241231_zLaRAxIJNNWa"><span id="xdx_90F_eecd--PeoName_c20230101__20231231_zJN3VjvnASK2"><span id="xdx_904_eecd--PeoName_c20220101__20221231_zoKdZEallga6">Hao (Peter) Liu</span></span></span>. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</span></td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 672,918<span></span>
</td>
<td class="nump">$ 677,266<span></span>
</td>
<td class="nump">$ 1,986,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="num">$ (134,334)<span></span>
</td>
<td class="nump">2,136,138<span></span>
</td>
<td class="nump">1,975,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PEO: Liu, Hao (Peter)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$1,986,962</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$677,266</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$672,918</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,501,393</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,445,577</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,346</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">681,465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(610,049</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,046</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(801</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">777,407</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(197,203</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zLIFV5UcRD41" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,975,045</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,136,138</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(134,334</td><td style="font-weight: bold; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 624,083<span></span>
</td>
<td class="nump">626,135<span></span>
</td>
<td class="nump">420,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="nump">$ 513,490<span></span>
</td>
<td class="nump">688,442<span></span>
</td>
<td class="nump">409,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$420,553</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$626,135</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$624,083</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(87,981</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(78,760</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(44,676</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">48,383</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">91,269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,886</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(35,262</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(10,049</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(50,540</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zzTNdSMsZ8ng" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; display: none; text-align: left">$</td><td style="border-bottom: Black 1pt solid; display: none; text-align: right">0</td><td style="display: none; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">409,019</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">688,442</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">513,490</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and TSR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s cumulative indexed Total Shareholder
Return (&#8220;TSR&#8221;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdefc14a_004.jpg"/></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and net income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdefc14a_005.jpg"/></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 34.23<span></span>
</td>
<td class="nump">79.72<span></span>
</td>
<td class="nump">46.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (33,650,000)<span></span>
</td>
<td class="num">$ (90,000.00)<span></span>
</td>
<td class="num">$ (14,090,000.00)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Hao (Peter) Liu<span></span>
</td>
<td class="text">Hao (Peter) Liu<span></span>
</td>
<td class="text">Hao (Peter) Liu<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 672,918<span></span>
</td>
<td class="nump">$ 677,266<span></span>
</td>
<td class="nump">$ 1,986,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(134,334)<span></span>
</td>
<td class="nump">2,136,138<span></span>
</td>
<td class="nump">1,975,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,501,393)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,445,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(610,049)<span></span>
</td>
<td class="nump">681,465<span></span>
</td>
<td class="num">(2,346)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(197,203)<span></span>
</td>
<td class="nump">777,407<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao (Peter) Liu [Member] | Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">624,083<span></span>
</td>
<td class="nump">626,135<span></span>
</td>
<td class="nump">420,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">513,490<span></span>
</td>
<td class="nump">688,442<span></span>
</td>
<td class="nump">409,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,676)<span></span>
</td>
<td class="num">(78,760)<span></span>
</td>
<td class="num">(87,981)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,886<span></span>
</td>
<td class="nump">91,269<span></span>
</td>
<td class="nump">48,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,262)<span></span>
</td>
<td class="nump">37,406<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(50,540)<span></span>
</td>
<td class="nump">12,392<span></span>
</td>
<td class="num">(10,049)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=SONM_HaoPeterLiuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>45</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="formdefc14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sonimtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formdefc14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formdefc14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEFC14A" isUsgaap="true" original="formdefc14a.htm">formdefc14a.htm</File>
    <File>sonm-20241231.xsd</File>
    <File>sonm-20241231_def.xml</File>
    <File>sonm-20241231_lab.xml</File>
    <File>sonm-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>formdefc14a_001.jpg</File>
    <File>formdefc14a_002.jpg</File>
    <File>formdefc14a_003.jpg</File>
    <File>formdefc14a_004.jpg</File>
    <File>formdefc14a_005.jpg</File>
    <File>proxy_001.jpg</File>
    <File>proxy_002.jpg</File>
    <File>proxy_003.jpg</File>
    <File>proxy_004.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="79">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formdefc14a.htm": {
   "nsprefix": "SONM",
   "nsuri": "http://sonimtech.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "formdefc14a.htm"
     ]
    },
    "schema": {
     "local": [
      "sonm-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sonm-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sonm-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sonm-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 7,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 45,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 102,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 79,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://sonimtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdefc14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r80",
      "r90",
      "r115"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]",
        "documentation": "Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]",
        "documentation": "Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]",
        "documentation": "Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]",
        "documentation": "Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]",
        "documentation": "Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]",
        "documentation": "Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_HaoPeterLiuMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "HaoPeterLiuMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hao (Peter) Liu [Member]",
        "documentation": "Hao (Peter) Liu [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r132"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r79",
      "r89",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r85",
      "r110"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r76",
      "r86",
      "r111"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r83",
      "r93",
      "r118"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r78",
      "r88",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001641172-25-015578-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-015578-xbrl.zip
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M.9_:[&=_&L"A_1R)(;ITX)M?PU$08T#Z%2C+@1=Q=@5[.&K1\C])=\2%S_Z
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M?:G9J8S&SW3.3QVSW)PC?SUCH8)#Q&[&SW123](!J3G'\Z9 D=L919X&;B1
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M03D]U:!Q><]],: W,E0J#%V*.2(D,!CP;@MVHF9/(L&_;/8%H#T ,Z%]U/L
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MRL]G03(SX74WL)$>O"NH-DAVV6J 'YH!IDFMOIW)O#S%/)"YGR;:DFFLK/?
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M4^&UB@2F$*Y*2BTL.>R."IH]VV[M[+QJ;7>VYXR>A0$9.LB8A8J4S_/],O;
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M$D?#=]!*'*MQIM;FT;3]M#:/]1(O5M6^82O 6(&B03MH!8K5.%,K4#1M/ZU
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MK>JV0AC\AU!"\81D2M\PGWO/O,W^4'&7R.1RI>*%BI%3GO[\ATSD1[8'O$S
M3/"W%GDI!0V$\U'.7?4LR*HH/D&,N#]HD0XR$_&D=8X)1\^&A(U)8J-\5 +U
MBM>"JEV5WS'LZO@(&/HP];F* '(N?"I^%8D!&M)"]HZS$7SX:>,?9//80[TW
M$%_9^W=;'#22JQ3&HCA N'Q/ ^2(:J9+8M>X)1<%$!5LLUSXJG1W#5 K5#2&
M%"7S81W>QUB*1VY_<?<+@S$UF"LB3,PT=Y?(DF%#78!#G3B=FH";,9S"F'1N
MJ)+<>79M=DZO92JP/G50KF(WDGT557G/%@=A(#+@S/QY46GUC5>XI9T,6[-
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M=#HM9^*G6']>COM(OJ8J,J8>!+&^E!#W@0T"=13P<(#("CK%K1+:T9Q8^-5
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M:.6.Q+(BIDOIQ%2 8QA)059#*_HT'RK+;U;N2'Y4?N.)* 0Y)HRF!"*5<L-
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ME]9B5^G;/&)W_^*#F^_HGR+RD8U/E<"JR*BO:@2MMM,L!2S"-[;#&\A?U?8
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MO"35$!U/H'MD4L;49L^)FSIA);J,]1V;%V!CEE/TZ(1QB5+&__WL&F8T0$G
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ML4VMX*R<>E5C3M5&C!AB?UUSN09+_)<WUTUY3<[+P-1BL?V7$E@JK#<IV9C
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M*/M"\2GJB2DI?OQFE,"4&/4.WBN!M$R2T1*RK ';Z!*F7LRD3-0K-@N;6J'
MZ[I$*LT-B(=JW^OZ>>@AU.4*TN>8:+#7<#K5$Y*E<(=-MOPF"XRI1[W361\O
MG27PPW$T!>LX+LH,+O))"B/#?9R[#]("H ^OJ'@$X4Z,2\DMT4$5%Z5R\3F'
MNYA/%6:-<T'CVN'E3'F][%Q+$]:G8;X(YIDB 0*H#DOJ7X' QYN8EZL^2;3
MX^QM4WMEW!!Z*7($SJ'LWXB,PU#];99FEZKNMXSB@3LEC\?'&K4"K('0T FZ
M,JP__@T.3B;(N0H: 4RL$#'C+-^):YGBVME ?)\QN4H1-BE*2HDW6 IF35;9
M[T:C5X27 A5ZUY.CB&?>43M*6\/$^HG$U&D!QU #+NH/#T 12F=@<L.K7EZ&
M^%RGX;3J"@7S55Y/U5F"/]$Q@BTLI)BP\S_A@ZOV')UK!1K :F>5K.F7>93
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M_1_/=NJ!^*7)%(V@2U^SX=\ $HMJ26N2RV\[T5B-2QMUUW]>!^X45TG*O<C
MZN':6M^7/QN 3)M/ IPK8,]1EH+>AF<KS7[TLU%_8V=[+]C9?17L[.\_7T0Q
M50?N%>:3+*:'7%"(X#X!E:4UR/5YJP_O_+WY--:24AJI:S[P^I47M7=(X7KV
M1A4\+WNKZ4,_?-TF_#$&A=&14W](I$0.-@6,@4I%/68ZO'T5;UJSQ87Z6WVV
M3>NRM?=B=_>F!U>Q%K<SY"+U"^MED_^I)F'UZ]7,6 V+MCK)TMO:W[Z7:,$H
M65[!V7VX7:MQ\/*%^SIY@8JU+F\DU]P#[YYV?]^V>M]0''_QDE:14#@XVV#
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M"Z;3GI#! @P*LXH%B(&.21 ,3VT4U3-3E7@YG2ZI^K"AF'W%'3"[8J@63\B
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MJLW,1<'**;O 2(%OMH@C%;#8E49)UN=0K/6V;]-2W->7#J;2H:?>(+\,6,;
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M^M/^U;XQ<C!PZ$G0200_I5-G7T'TTX_7FS3&:GT\FW!LIK!I7 N.99(I>Q>
M47"<V&P+F,=53-TW'CADU)X_I&R &5TR6ZZG6 4Q=Z'V:NSOXYBX.D])^%L1
MJYAXO$3F&MNX6]229)CR,E!^!HGHFZW-4NI)R,&\8&![6'\-2R+>B381[+_Q
M5Q*ZT=#-&5295BH" 1VCY%S"Z/H$2,>/2*@'$C $2H91BMD]"Q.$^Q4R(118
MS"J @O7\PB*X&RL?,3_#G^^;/SO4G)=E2L$IY#BU"-1/"9[.-W%[8=VH4O*7
M"-0-S"99T(1%I8;^?#2FX!05U'IQW@Q7_!ZG8@]O0<_$#*X;$& 2QD_L@MIV
M<0BX!T*WS:]"I"\(/(TP$P=3K@1A1N;,/J%.#P1B6@&,]WX.\E\0&<;SN*@Z
M?48+2,'05QPF,WNM]HZ]*^_+:3!T>#%B("T6)OP#V:'D)V<2(??2B6&NY/)X
MQX1RQ173]^8)XQ6VCP][I!D8LBLW-6Y"R 6F VZ:K2HR<$.'$A Y(@L!P7FQ
M43/"*S,U4(M8E*ULG"AMR/Y*NHS$MX8K[(!&)'01(:.I<37U*T(P1/R^3P'0
MV97*36L?='8F!9O&,8\49%EY2/"N.!1" 3(2$1=1-K\UW+CNTA_LDG,X$KC6
M21R$]P(M1_3=18-DPZ)_Z\YKW0OZ1?HEJ.,&BR(_(!Y EU&!H*A>*-Q2' VP
M-- OVXZGSF>2^O9,7^%,TD01P!>YN8G_>O<IRDEF#FA^[IN?IEIZA)43U,*$
M&P0W/C+( $41J1/,TA9(W3!*.QV734XBD.53-C([1!D:&4P9VA=JVS:3FA&I
M9@>B<@X]G;Z"0=-QKP5:"*U.6M2:&,+30-N)!#)V*A 0#"52G/"XV2,)VH<A
M4CSDN/KNP1X5;-3B&V(5.?;39I4"A.@&K$9#SE]!_X9".<I.#[L_R+:I1"E;
M=%FWCOM<I4IO3K<PGZA;E*H6=JEB81EW3D%K'PH'>*+#>U:QRC(2J3?EN8U0
MTXH:(C;$62E5!I1O/.U;I]%CZK8@=&L4H&C)+$&EO>C"1P/8UAT,; ?>H\&C
MP/@%760?MR2,/P%^CB@N"()*68F=CLZ11+A:MWY*(D2S9F2>I2 7RFMF&2/9
M@$UX=W51J%>@("6WSYBAQ46V::(K5$+1@R%H"]-8:'P7F/>.'<+6AL$DE?,S
MFLZ='1G*IP^\.!T"51@<8H$1TF('*XVP$FBF $//&J4,,)4J"20RC*$[$BB;
MJ9(G,PO(TSQ!J/2435-_$@EUIOP3Q-ISK@;VJM,VSE-CX&E#4ZG4,U*A\@+_
M9@]]^!F%!]_N!=&VF[OS4_D.FE2^%:;RM9M4OB:5KY:,HUE*%9?R;F2!67[G
MW&*J6E:;84G)GGRI:J0^^1)50\M0HV#%:+YPG]$(#-8(;'R[T.+P^YK4MF:T
MH5QJ8+G32$2J2'.1B1!EKS$6*0XJ]3#Q;JW"K63\*D]'NNNHUR2U.W2&W%9
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M$IV,JL!47@G#SZV,66ZH&4=C6=;3LJQ+[T'5P_5.I,:9-J?&F8[,+^.VI</
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M7J';C8N"+V,?SW0Z[0R_?'L;?8SO/EW&?[8.5GVP?\HFF>]$N^^W[E<PNWX
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M,LC@# 3,L'>&S6#FQ/5U.BT/X+<[/W;;/P+%MHL&6]'8G36.W2T<>Z5[?YJ
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M0=*'%O3.-U*'A^:,&',R@ R^2<>("F-FPJ'X%_4DA?[@YP3(:>Q.(L<;(<&
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M"U0-A/BH8^>GW2XEW(#"?$?HQR/?=RP5U3R5>T4^A5DT>:[2Q5.2\R<TE>V
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M6R'\ZH^]Z->-'%A!)_7T@4_JOK0G7AYTXH$_SD#<Q;9YD)-ZKXK]GQ_P7 .
M0A/6_/KKJ]%)^(%.PD-L_/MJELVC=\AR<;:27YHGX\8_^,8_C/.?2:_?Q-Z?
M/ZS5K^A-![&SIWLGM]?JJL#ED8-.GA!^Y@E-Y<FA]T::'WNM[XLMQXDZ#+9(
M\:.N$<,A]K%D8<T75B26A<;P1I.#OTSOHCYQF*+QIRVQ_1.70A/L8?B;]!9+
M!E,ZM K\;].$'QY*H^YDWSJ*3KU H'3B=#]8L#">V,$+PY_[Q!X^CA/["U06
MX.B@F!GJ>XIH<C:-DNC3_#)=M/(@'AR]_NM9H,  OOI;LHD.5 W1!#X CN'#
M_9\I2O!WC.7+R[RL&OS@X.=IK(J'K*_@ .92661UPXT!)MDTLI//L?R+_-/9
M/S_\#/\E_Q-_#_^XDG^6%L$JB=XE59LG5.R!Q=FK%,##F&98(8TJ$AGP+^&O
M$_GC#TEUE:8%#L)^PJO++%UV4:KZ"81EG?PRC;@@.CHXA75"\FCYI=^J/1SZ
MGOE<UTM_I)5=/#NQ*++/O\X!@T%MM<[FFA,;RY]B*-0HHN:Z1!9JX&+HF$58
ML13-\X2+7/Z[A1)RKI,'CNH+*' Q#0+UN Z):AO+U;$"[B*%>A <B)65"911
M<3F\^ZJ,=#M0X-9U"P58EFC@HU@:-/,[5^?)]V.Q7C)GDFXS1;I3G-HL4UA_
MF>98E 9_HCW7_ /XNKWH%4E7K63K\" ^VC_HNXCP>928RI'>6^XE#@#V,YI8
M?1JQ"BVKYWEIM;D@T2:YG[+D'L0OCT_CH^/3K>^4KX+(ZD0N!+T$NV8X,\)Q
MV.<+GV?S$LCQ$/.X7$GD))BRJ&8TD/W]WAM8#8*>?]?#H)(GM1(G_N[!S.$9
M5B%F F?@JT5RC[M<@& TU^K0XN_DWV@T6"N80]^)&C[1!/^=X>!O+E19IQXZ
M?2;?C8_;T\<8"K&,8C':1+Z#S@E-69Z^;%7WNBQU*U>3Y\T%6"X//C/(K^5)
M*C)H^)DA[7^-Q!%5FA6TB.LJ*^;9&AZ/:DD5M]$QJ71S4%WLQJJ03X6]<1EF
M7HG,N/X)3P<<=+6JH(73BK0P+N;ASQ_VWN]%OY1?H\/GAU+[?VJ+8G.5Y"D5
MMQWOOWBN5P1E'Q['*M/3U/ 5UK_\-WY%=')R$OV1026KG,0O^=5B+X[^D;3K
M==("><>[_XH.#IZ_>!$T!,5@+8PMT<F[>S(MPQ#6X+ZB&(18^F[SZD%]GZ.3
M^/3T^9-U?8;IY?Q9')H[/5S'C^]P'9QLLVK&PS4>KH&L/@'9!K7T-T?MGN_'
MSP_&JVL\74-??0*?W<72ZU2J3I#VV-T80;.B9Q@=,[&SO__U#$>QZ_\%XFP4
M?F",G8ZZG2KZ(^LS:!4'[IMV4XTW?JM!=%UE)C6\2"H,TKP@S%V?1M".GTOL
M>.?#.(@/"25R4SB#UN?9?R:K65(EMQK$&X#=)!@FNT,Y50&47?^/8V=F,":<
M*N=,,1I+$#A4\4&N20;I>B#)(B5O,5D9#7^KH1QO7_);W 88R+#C%KO^'P=7
M>;*JRYVU4W+^Q]+7>B6G7B4Y1!B^1'^D=1/C'OU767VA",*^<RFMAZ<:[R!>
M$ 09B^W<@[U#/MS9YW\>[/+N'(+GNRCK'=ZX#4#Q\NC&<72.!H[$==WO2N0?
MIB\VA%M^#!7R_>"1?MQ\'AQE=:^-"$_U!KU.\ZP ^M1&6,DKREC48Y_!X:#B
M>'?$P>DDT:@FE2B$)&&L.MK6@3X\W9(KI[]OC;388'*Z%B>(3"'M+GEU5B@2
M")I2:0S!""KF>"SDQ5NMHB-\(7V=5"0.$1I#NZ2?^.UCR%'@?TDSP#>A$_F8
MJTPND7R*>F#7+J:VRT5T74'_V\+PBB?DP6(?:?HY&)_ !7B5+=HD)U+0F3P!
MZ57*9)IYKG!A/;5I]'[JN,BY21Z:P!$W<ALA59C4TO;PLJNX=2IWNLQJ>==&
MFS2IX$HX?DBFO4=]TN[OFMI&X'T\$GC?(8'WRY' N\/1])T$WH_GT#V<QGB
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M8M](L:4/J-/$T2D ^,<T2F;E%8=.G3H )] ^%@$,<N??%L*TED4LDM/BDQH
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MO72T89)20KJQ[,68)AV2WDFGXE,IW<[41)\,.TBM8Q?H)7AJ05D#QN:P>*!
MHMK"Q(<LY]JV$RS"*J'=\-Z !Q^U4NH;6$;@'[!C/*-@/7RIZ/&>.,>&9D!5
MNQE+#P=VO).IO3UX\WRB]C5SYX[AX'*/W<^>@^%1R9%S)-5T/AZ3.+*,,A!A
MG0!5F9B7\KJ@T)?5^(F_ ^REV2(#0$/@>SJD#;<;7*;$Q .NPR)=HC5B,H)U
M='QX++4:IE#@/Y=3,[I%.MUSF( X_X(1YQTG+^<=I*"&]UD<U#=Q]+C#4-PN
MMW^/9E*B=\'-_PJCOFW9PK5+%IC:,=@<9U]XC3TJ>.36TTM-K(AZH3%!=KQ_
MHI95+GP+77ZD&)P!L[!J,)11K)WN$+PZ\HTB'W+M&T/J*N1[E4SPT#4=%#U)
M"<4-/3\G2^3!3^0*IK$.E'>(B6#AU();#K%(M!S*'\G/:P[\$@<_9LK7&9CE
M2_OC:4QI$&<E*3.)VV5RD\#H"RP^.1I4=9I+"4EJFP089:2[5#!@D].P.HSV
M+D7,V9GO&)?PQA780JNW#-,<N0WC^D8W7MD#NBQF4_%96E8?&/IE8UJ)1/ L
MZOG<X<17!VI;ER14$4[82:<\$+?)7P342R,E$M!C!P?[?U&BTV6@8M-PP; O
MAHYPS;QY&M6JXRO1I"6Z41J(RC'"[P$#A\YGS85S_K-'P7UX6_-D3WPP(=2/
M5LC480DDO;0&*%Q&&_H1>ZZ-QNF ],UY8DXY$?%K?S+C>Q9Y^C3[%^2R$_41
M6X!$_T4Y[6!;'*L!R1Y2F?F1[#J5=I#\%$EMF:9RL:VI]SO@.4N:%OGKO:[E
MA 5MLI51$S%1369+[&=.'4%2NL;)-X[!EN!!V-^!'+?S$[TZY%(O^U/RQGV6
M?[+#^HAEAF[*AEB3<0N>AN0.EPB.MM=E6^L[M#,R[V$[_A:C!<@\K& L+@,Q
M?4L P &Q,=2@;[-+*SY,F+CPJMH"'/!W 2KB(6BF5K;#WG2GGR'Q,[IY';V;
MEM0@<VD!#"FJ22<<*UC@&[D\<=/\9C$P-&@@@4=$+LA$U2X :[5VH& TUMC8
MC9IM#">WBA):*^2_R@ZPL$4/O2809E N!0ZO0_MJWCJ2O0Q$X7(TX+/4G+=(
M3AX#OM;P"_69AYAD"&OSH+4E7&NK88!^P-@"CX2,.06BKR_E096/6<N)E@NK
M&V^X?>]HJ/WPY-PV4,O!"&JY2U#+R0AJ>0)'\8&<_7-E&WX W_L^;@4?X.BU
M T/CIL<+ $.)HP1RUG FMCC_IH6)MH(]/G+W)7:T0-\9(M.IUAOKT(R5RT_T
MHL3<G:M_\CEU9@G-3=QV;EQ58S/31V8N/OPVD0[$2G.V45<5TS%M:;IVB5+/
MD(*XB>U38Q]S#]#\2@=-/UM!4RI=A'H,:G5M^JKT=16UHX7"#NLJ9\HNR##-
MMH\!264'%R/P,AVID@>J)/@[CJG'@X+@Y16 "GYH[^O'B$IZ JO$Z+X/"HN-
MRA'/!3MT)C_>Q6N[S?-4QGL;ULYH$E8AZR33S2G$S<TIJ"]KW== L+=_().L
M$Z#'6.+R=ZNTN2P7>"K6R09L:&$ '43E;[4ET'VPR)&T>Q*0W:[<8/1F%R4J
M=F[T:KGXQG?LOMZMY! 5]V.D%W)F4[X.,CP0,H$H$3]DJIHH!X;"*0I"R9@F
MF'8>DQ^:<$?:-D\J?K(PH^,8@-ZAP/@AW)/4/,?1)1Y042&5%,JS %"V.)I?
MIH!)F27%EVA127>56N 4*>2T(9PD=Q0/GEOA\EC=M*>XH[REKF&RIDHCJ22O
MI/Y:ZUZE'W7OY.@SEQBOVIQZZ[$6?9-"R4ZN2XI-1[[8Y1[0Q3>D1$3=;X9"
M-1-D7K'6*LT8@Y 2>G*-:HB*YR (#"(Y[2"A.C_(JBJ]*NE:R*Q>'( :E%+K
M(<>]M)M7L*6C,'4"O5*Q5WBZJ$<Q'Y"8&]6U2//L*JTV_BY.6+)F2)0!>%']
M33#RY6554^Y_VE\Y,&[Y<+;\BG;<S[$D_3DILO(4HJ9(=>X[53":I*J@%!.M
M%%ME&EX:)4UHYU%E;9A".E3R2K#1M9V'8D4F3:D+*#R]O@3#M/,PKN#ONOIL
M1::UL&CGM^FVG9JE.9.DSM&(0I<Z6!?I*V-.*T>[0-;M)<<]RXE/&XNED]RZ
M&OKU,";?$J@TS:SJ:]-K/?,)+&CY:-$$]92C!.&>*B7WMX61&E%>%A?8:=7A
MZ=""I?.NG+"RP_B-:=3JSAM!2T"EI2J)PR( YG#+:'YU-7D+X7M, 1&.E0Q#
MVWA%@("80%1RA)?W"\ZY:3A<OAJ;;SK78S._5\[3L,8WS:D+'^[,!FI_HY[:
M7T UCBIS*"I3:<S"ZB:ONO\IF)M=DVV7R9$6L(U]LOR0FL//.?7G3\?TTX#"
M.@LKY@W[^(%5.A7:GWWDR([5PAKEQJ(SDU_JLEBLY P4.U%T74$8H "]J8+<
MZF&N?280@:FZ]/:%0BW(:@?19&7I4WAW,3?X6CD9C$LX,=L%],+.9A3I95=6
M<"S<B4EU(O$7B,_E@'6 ,XZ>,,?>ETMF4[3ON>Y%/G$1>\(? T[\[..4QG.C
MM>&,Q'R[+ZSK<N_9-[FTJ( 10[N(:CECOA(;N(]! 7AVDBT0\AD\%94ZX*0#
M/@QF'$? L()7E[M0E"00.J"XXW3N:EQ=H1&.T%@Q2EA"OY2'PRBL< .Q16XQ
M'=3(CBZ.W9BF<&*:#/QJ$H5)#^3]@T=B5,;#4<;I5&"6:)E6*H@;Z/<<:%4=
M]\:TLQ64)-)VV_6(K&J:WM<)W5[: 1&B!M1"N!>]Y=M^5J>% 2M+]>1T2'7C
M[ZR20%RKI&+"/Q/M5L%L',6-XS1ML,E3D6;'9@PG#\;>S(#-R^PGR)T2<0;0
M^VECV\4RVY[392IG,F.?M*R,XWR-MQ_0%Z>,<7=4]*2LA.T^07I7U49A>0JW
M+,\,<:+=8M=V]!945XZOS9:I0K;ZUPI6%_'PK+_O">?8JJ2/FJ8+[E0+8B>*
MT1QG2*JTBBZS619,@=548*I"N?4>4$RA"P_W'7PS:_*-\%MQ0Q%K'!4<)3.N
M;X'E:U927XVX8MRM<U']P 3Q'4OP4SN0.V/0#D<,VEUBT$Y'#-IX7+\Y>?>Z
ME%^3@LSU/7!KO:],"9J'3Z-V#8F&$=!M@PI\T<I;R6(D>+]<2I^JZL=N66I>
M^/%'*CA!5W2A!ECI >+IC:$<-$-*CQ5P.R/IB":G3#J >GEK7Y5(O%"IF@$*
M\4+N#E$7/E/M9R!!::N-E;8TS!H'>\>'!\\.)K/IY'!*;(\K>"AHH:(LGOV^
M]VD/+LMNQ<>6D@Z[%H]7"0IK*'3;*8UPZR]"H5:UQ$_ZTGS\F*K[2EC^DA8I
M'A$I*Z^Y- BK:.[J9+MA.7 537X4+%D.S@D.SGD)4\KE(_#G,I,O ]3/QJYA
M<I/P%.?@,C75-L;+TT\X46\_I"J_I-4T-H55\B'V"Z\ORY@R)O3+I+D,6-TQ
M6>Q6+F9&#>60?K>Q8IA=(QOL?69J$AUPJ=9/;FR<3C(L(B; G,S)5L]8;_,N
MDU)AP#DH%-SMA72KP;U)\ ^=7^C&/)C,3A4P(O0-BOA?IEEEJNGZ%DST+E@7
MC?M-"_8/RD/&CK2@E\2.CKUR B^>F75Z@!\7Y%0>/(M"1YZ,5(FP'(S\:VW%
M(S2J39?P6Z_@_A)8?KD=H(N#<?VO,:XVH+C:<BK^OY2X[/\N)::"(DX31=O2
MPZ4'81XTEY T&DX%\Q#;40.I%:DV*YL+L&;D (@'0J?7F'M.I98A=$^!YZ!=
M9HT%I98Y6T(EP"J AH&*"O^W1N(ZU67">S,?QT4TH8 YO]$A=O.9GS^D%:A\
M3-K\O4SRVE( \GJ1,T^F;A@1G@IFDW#*D6&^5[Q1;L['8GCS:TAQ[:4""!6>
M.D1K)T!\XW?AD(>?2VEYA:T'7$!"HE#A'E"ZJW9ULZ DM4DW]!G6>IE'/3$@
M/7%!Q:!6@J9+'$1ZPT33#/6,'TS;H8+8\H%F:7.=4@FV<. 93-AA+*RE:]3I
MRSQ <F1U-IA8O$X0L7N%]#_P=.L#;8T$GB_80JFBUZ#5, X_#61^I8!KL\%B
MG72/P:2+DND\":@;0\:(L&IZ$IT15M6QS4T;.,4;G/>(*V;A=Z @4Z=#5YI4
M>49'75$WX5OP: MN2F:1^<I77=:1V][,&TZ?(1;8NXFJ[F58$K(;A.M\Q8T2
MQQ%MS<7D%1OS0,/QYZ3#7MF%=$@/.A:,?[II [HR ^ UFX=FF^ DM35-9R_-
MGP5NYK)*5ORR0(9!'XU1 P]( U\"'$6J!-7\Q5;'KVFS[EO[.M"'D/;M0$/\
M._[N-(#6S.*;5'844MG&K;$22);SA#GDW+12:2P@O^BW>NBI5UF9JPK2*KT@
M+Y5</XO]S/"0^$QYC<="$CRQHE\_NWHM8=O>T_(3O&YL[A$L=I(.MG1FIRYN
MQA*C=2D-?&LWA0%HTO,-<]:W[SGG%PU8Q0< >0L#JRX4@TK!Z\^O9:1LSR[<
M\8U@:=_NY5!$IOTH,YV%3V[8LO$>J$\AU&(H9+$CC(IS6[@HVP<ZK,:^XL,F
M[&/AMT_.*$("@6 T/M:E7,?-CD=ABZG2V5!AC@&;*M]Q$)[9*W6;@R"^]2"H
MS>X$FS3!>F>S>\X+3%8$SLMM=D?U]_K.HR.V7U6C;3(@VP0R<?H:Q;"'!>P8
M@%WR+5ZAEY'JTW=FWAWC7=R_PT<76><<68Z?V,GQBY%4#:$Y[#;@@[_=!U2-
MJ0\.6:,*<YMH4KZM8[J-E]?C>_6[=N*;+O*0:Q=]EVLG=G/M@JY<M-V5Z[J#
M/\JU^Q%,%5LA/$<CA.<N(3S/'P^$YT_?5&ELW_8-YLV_I'FC<M _SK*!NTSX
ME@W<O/=HW6"4Q#7I;0-GD7'UK1LSGF#5\69ZXP4=$?$^9P/)>KQMJ$ $)HJ\
M5-!%IH:?&N^3I]/C/_H)J*YEUF^4B5L9903)EF.9!I#0'DB!R[+ETL)DL(&#
M8@K"4!+6=MDY@.[$9C OJ97KALIIY'IDS,E:.4^W@"?;,2$WA]9BX5N4EH#L
M9D@>O @G#IP5O-E,%-]N)OI.:WAC;Y4"V'[0NBOMTM S6=QWVH)B#/,/]J[Y
MXB9:=;S,OVQ,J8*Y;<P%=(M[1Y6@=NX?$;A_OMVSAK8M2N 69EHW)Z%$MEJE
MBPQIUTGOX"D,O78')TS-P='C#.^R@OX(PK*J'Z5G)H*>&7X12=7T\5;J:3<W
MEQ"VNZ^BJ%NISPK8[C6K46SSA^"0"T=KI5\1E\5<<[3:%HE:Z)5XF]A9B,#.
M)'E="D3:J(%8E3_N0$@!C_IE0/HEGPKLVDC-@'33*- N'MC;7$!6ERF[*R38
M(D@I XAQ[BZDNGQ%H:Z/B"K'XNY?$^D!BT]0*(\=@<[F:(8>O#QZ@;6\\AXK
MD(&E1P8Y)K_,JMIMT4*,I)N^5%PK3U1NNL34V5>QU<1@,O%0@&B2Y,TETNB;
M*U^#W337EZZ5GNYA(Z[M2$F]2'^4U1=Y L_G)3"0SN6KH>% 6X"!C-E ,)04
MAZNU_'IOT#)'RVBY3*$1F!.H1%,'=6D/#:O0%>\!DX=-$J2&A3V:DYZ"_[0)
M8N'?5#FHWG0)[$%4"5XT59FS8W$UW8ZN@8)=RLRY7=U,D<'2+NW>(4U&)>6W
M\+LP/:/O/6A%*Q>_4-L+[^<4'CQX/B^KA4O3X.=.T .9MU6%M>>X:<2J!#D4
MV#IXYT6; 1J]2&L&$Q'5@-!M+Y862,^J]NWX,<K 1A](ROQVLYHZ%B%D4',8
M&SF%W<^D-H#C"4Y/N4Y1>.J2(M<P(@ %KV!?JHQ1[F$=05W%"@8AZL6R:9 5
MYC&4G^1[6]B-S:P0*M5XRO_E>:T3 $(Z'ITIF)&+]U>L"V77:LDU,3[?QDVG
M4YP1>C(MZK9*[WQ)8K,@E<,A:.D\O+R%84RP6J_9=;MZR?#Y_'YC"'07+_84
M5@!%FD^M4G-LC2?_X;:D U.I2K&]R&QC=2"A1;%[C2CM:8]?G^ 11?X#6FJ=
M.BVUY/;W=<<,\C*,&S8<*S QW /IPME&]C.!"CW\#:^QT/?UX$(?TZ'/2%=N
M'RY788>*3?R[=;:!*I-8==C"IYN86D[**NY8B-RJB2_/R==IA$QN<@*SLOP"
M@;YJ0S/T6%H#N C-IZH,3N3WL[@>*JL='3S#++7=ZC7BE!!829NIXJA1UX?5
M\"MF8\WZD]X<-0MWAY@TH9\*G/@8PG43RQM%@XR0.1E\=,M @ IFBT5(R@WO
M>[YJB]4CI?:+@HVR]FXCP3>VQE*F^8[ML7;LAA4-J1O6X'*TQV..]BYSM"_&
M'.TC,P.>1H+Y?GB37CF<.MQMN$?9*X9.^ <%"=S*6_#T@(+PUIS^;BX6R/G6
M&%.B4&T=J!>7BW"V7&9Y1IQ^%=+'[D8V.C%EN\NV ==2O6<J=B B[6=!@[L7
MW>"ZSI!\%T._;LGNDR9@>,S3430H7,++U @]M9=\ $QL_T;KJ%M2*T5TF68H
M?YYX9X7P U^)#E;4\E@M6I))#-B%3<Y'JEV?I%!EG8+/W5)4)(.WR6D95$J7
MW\#P3I!9GM@2J%V&B.$>NL,2@2*4UC4IKYZL +I(72 &1>^P6Q'X%QQ]_8:Z
M2NO,:6J@70[@>""&<R"N.@2D).G4+1Y38P3+Z4\][:QWE>ON<#R2?#H%T(BN
M,2GQOC[G6-CO8U1N&D2\C=Q4]%D3-;4*@-]^[^5#_1!J/]IB'Z ;HP/C 1K,
M ;J"$A$,8"WJ&RQVUP!15.DZE;)0CR%B:2ECG>>H ^3)3BV=8J%L$C@GUF7B
MA.<8+J6;Y-S,>[)%I&V"[0U%_D;(U5#B4MS<MK-UOQ=9LT-$W'SM[L+B(J1X
M.V'QVP1G0Z.\(4(K=HW0[OJV6X5IS2/$;6.UT:UBM5T\7#A6*X84JWU*!_KA
MXD.4#4(AMX$]R3;IBWLM(/S ZT% J/>8G5RXG$3 J4![S?16XS0 WC"WOF#,
M2$DC> UJS#@T(C\P(,3@[S2&K6OE=WO UH!V1$O<NGW.XXE:C4?R=C$J[S3"
M?]_^1(+PV$T<'!..H@+6G<4]DBU T0U'"JS K.F70;B4:^=6'@5N. (G)>Z#
M:KG<XVUT=1=1,.M8D*VEPRX BF-64?,_TV(G]CO:0*X C9!O:6<3W=S.9B<C
M;)3/X<BG=(?/F/>%V@5KS75W"C(F#=955+&E.D5 =;IZ$WMH2J^U>R:VN,9,
M9=P]&M,^@T)T!!>_@"M@BBLL]8T#WV82C>(^%'&W@C_1N6E$1J*N/[%;E+%"
MEI?M @MRLD(W+.LGVIJ7V,J3X%%!R1!\1NY'OT9\:CU3P2$E9YK\Q;9)EP7@
M1O#M< :,GKAYWC<-5@4>"/\EMN"_HC-Y277??8MWZ<U#SYMJ<?G8AJ8O E$[
M.W>3K/JC$? %] 'R#6B'W>(T/SHP]_"]!K8BKDY&Q-5=(JY>CHBK1P-:>DK7
M][V$R*^^#PYP2XZ,G>+!,5-4F6*HF^XC3N?75C9?Q^HY$Z2H\OKJR&R.RSX.
M[%%JAR*U\ZFP^?>M=,ZX2T,P43A:;^^14XK"@9N>SZGVV,FT<@M(A=&T0)-V
MM)G+F6-3KEM6PB^:G')9ZT6J8O:HI!KP"]!ZY*+WQ!G>!TV8!Z48D.;K-("0
MAG7?C&@0K<4[RO6(O?H(2Q2UDY%8A#N&NB^DE"%9((WN"^(T@G"4-21!LV#&
MNDX#"V[F-;_,TBNW^+^[$J;28X7=R#"8<7V94N5MP<EQ##" 7F=J!VLH]$K$
M8,V@-I<VP%+<JG/-%=!#]/ETP#8A'28H]4S[ KH>%Z]#_2.<SFINFD'/L)]L
MPP]:VUDD.7>,D+#\M37=B&O3;-Y>#J]2:U1B U%BGA9[!3O:K\3,QZ3#4 "2
MH K[!B4DOD$)62,"002*#T?W?*.>$?U9U_#;Z:3T:J;H&S63N'O-%'VK9A+?
MH)D^.^J#%G_#6 3*'X3UA2V(JD:0%(U F=,D0! :EK)"[,TVZHJ8U!Q0;$F3
MAK>7:UU"817>]VVM(NI2)COG1%R\BS5!.Y,>(2$%K ME4*#Y'=9R!*<QJL8!
MJ49HY8A;^]J2:%"*1JKE7Q'KB0D&$S?%X">,%'8XS3,F=E<**2WJ1,&_4\7%
M0'WO&FQN1[PC6EN*,M2/B\\ZD8B00J#:6-"?23YO5:6NIW)><?LNR+#46%:,
M"@CZ0O"AZ>B<42P'Y!PNIN*]SX_!6+_W.C7;93FX@A!I6!TY +.FC!U,F6X3
M%[L)9&'[*-3(5"H_DFM@X8?7*4T93=*]B[V8U2[Q^Q#//X'0J>K&;CI09=PR
MN*FR+^K?V&0">1H@OJFPU,C+]%M2?4D;B@,'.PHD@0M]ZCE649K1+9J7A5H@
M95C#$7'64X>!X- 0=8GF$]%7-*Q)NNCVOG/H1T[W(J\KK/]E>0YSD X/U(77
M&=ZYE%A 4R<5W#.VV9!ZL(%?1)?)S>R8 ,XLBVHE*-?*YE#J")NV%+1#"L_P
MF^B)GM2JGUA50C+E6U-MAMV<NF\@R,H"J9:FKUFBT.R7H3,S:K4'9F)YOB=>
ME5=ID4#:T.W/,<:W!G;1)%-Q=I5DN=4>@THT39]55?*&"N%+FJZCA'X!.JG!
MHTDJ):0@.NE@RK7*'V\,GU53"FI-BFY#\:QL&P WHTX=#_- )6<V1<XYFX/L
M5\2UAL2F3M,OH./+&;K\Q&":4)LKL&'+"A%I")GEDLD+::EL$ Q1R/NUKI-J
MPUD5<_<E"$L OD]+EMB1[]PA38FD9'212J.X%['@]2-R>-Y QNTG_QS]1_8W
M92;$XI)Z8?_'7[._Q1$W2\F8]:Q)OF!G)$41:8<P=$/KDAM_I55OMS5M*QC7
MLC9?*"OAM;0FO)\=BF8:2F?2N#0+S=R&_:*LRQDIW#S",[O%B#[6:90NH9:O
MQB(-T _V9_.R;MQ"6EP=!:ZVQ4._\081(<O4F$,8M"S;0NXPF&TV$0*#S;0\
M45?V*XN=$P,\R?6RS0V!'8H+-['J*9HTEILC]2B7.<9[A)Z3/#"L:^&%2ZE)
MN6#=$\Z=1=+?EEJU:H-'$<63>VP$1$-F%!#"6)M/-ZQZ2DN=DMDK8R)DA9$D
M58V"&(+&X?U3\0]G*DJJ!-O!'&KD>? K+/Y JYN[V_8+%G,P5! _GI/H=$3(
MW"5"YF!_A,B,$)FGH$D8;"#%^OTL5^3G4OF^*^'MH&M_RXIL)7\1?4Z^IK6)
M?SJ7&5--1(NVP1^5SL,P%^(&XO%FY=S$99EC#52MM+X*1JAPIKQ'DJ]1(P],
MHU(%%L-]U_)XTU9@^:SDR0I<O-O'*I]0""?\%1@JYH$4B;U#HE'YW6JMRS"!
M)IM4]<6Y)\U5;>XZ"$C1%:M;T7*)G)H$X8!ZAK]2NX7K*%<-FW^2>JJ= ?%:
MFQF9#NRC*_7P<9$7>^*WK(;+,RG2LAW!/D/3DLE4_$X=:#]4Y3Q-I2F-9OLG
M:?UWW$3R=-TO$A2<7(4>Y])VJKKQ5CC*Q$\OI'.35HGT85I@D^B$T4:I&8K4
M8"!$M2DXHW#_*[6/<'O\7;E-=AK'_(2:&IBM)\P$.4*<CM<T?:YR]RY=7:,
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M<0#(2F[LE@9/+MI R;^H@(G?&AK$C>I ,86NUV56((P. MYISORH$^0.UC"
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MK,G.IR@\NTE/$)3<1U+B","XUP/::[W9MRI6,KK?^.^Z/H B$VZ1D$=I,$K
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MAK[,[?R5#>KN46,J,O+#1DT_*@Z?HIZ)..PH<9CL,_.R.C-?Y9EY,:_.S#/
MBZ\R(VG1D*1'I/F+V2?:8R_]>2,E]I!'+97)=9KJ?) E K]?- -JTEIO,15/
M?I_JFSB)]4R/@W+E8% =<R=%2>#D"<+WMS5Y\ACW^<EK^_R*6IZ@EM&B(5#3
M[3&71]YGVFB**6&E^)2PC,=WM*2V[,L0VK.T%!S)LV@FCPP>#&-E&$WT%F=9
M;S*#2MY7;3[;V^0G6[$W:/"2*;\S;,7^L^U&=I1@3Q"=C1=U\U]&9R\7A).]
M1N;?^&P+=RG,<?/VZ86)VC1EVZ::J/]=-"+@&4<0XWEQ."7ZYL\VQ2'6I/YE
MOKNA)EIVY1[K;9A;&D9>^,O$)\L]0OBYF;S V?0 [.0ZVXU'47&"J)@NG"CP
M8F<BL823&:FK/2EUY^((/][A2<G6=%!E9V$;Z<D8V25E)+.%%E,-7=;D\-QX
M6Q0L,>4G' O'D,92DJ,*5)%#VZ?WO(NP"[_A5-NI.:686LJKSC$-\=9Q>0VR
M>&+'D:?/X?B!28>4J98VIBM7@1*> \E0BN:T6&5"F-8LDY]E1QAL&\.K3&/]
M8V8?SSF$MYO"7#*NC/BGJ57PEH!A=C6^LP\&.\.\,2W,WW9X%BNP\)A/7YB"
M;5GW*-[9:B9)712R1-.-GS?Z79L9_2[Z&L9&W7"IT^?C/F2+J!@HDQD9:Q*W
M858GJC*>H2:0@66YH<P2K3=M60F+:([(@C?"D@G<?$K%%$$IV9(@V:(O;#7>
M!G4%A@Q:54*O/*LS*_:MJ6/7)RP[-[U8CS?X=F'3^NUB;/:RAF._HO8!DY91
M$^(I3*31(TVCR+*F48O'<4>%95F*B+W&4L0I8?R([<5?]8SSV]U/TL+W/N(K
M):5%A[I%=:J[BE/=PKL_U8U(,H7Z9?6PH]K@#S.-/S_0SC_Y?"420E7;9@_:
M/BJ.="XNY1O3NFHTSFL7M<MV]9R<7A[5FQ?5]FG]DC1KQ]7FX>GE,6E4F^W3
M@]-&];+=@DM(^Z1&#NH7\/E&5D*T2*M^#I>TQ:WU(])HUK^=UEKIW58%=?(T
M>VIVH?/7:Q'^*UF,;6Z A^U>?2_FE,<:=SF!&_U L%;29LQ;Y^?*(X8%H]Y4
M*TN/^P1H0^DF3C1W'G@C!9N_H,/ZU.KF>-UH;$*AJ!R5[LAP$B'S8O7J4=%3
M5*<EWQ$%,L)W\1P'?-M4\?""&ES>/<&V _ J+ACCI;(BYCRIHI*%QE/!LE;M
M0/3 FQ1_<ZL'&U/XL;8*-L4X0%2@#O8B^-NP'4/X#WI9LO@5WHX5^-*[IK:A
MR2NC,O%8Y"+R\7E,0_1V$LW#/*)3US5%&XXPZ/$K*-4F*'U9-RF5-2 KEBSA
M/%916'$IN>SEY,V*P0\QG3GQ^!BO\C#CA 5%$&]R8<3X3[)QC/VGGAAC:@V/
MKZ:#&1'3_H#4YK)Y6OC^J(S0IL0N/FLB]28G=IZ4L[3C8+:#Z5N3-S5<9^AX
M@*'"!JE9\D)86\0#L4;]O.0-I1 VMZ ^/^#@PE>;E:N\JVFL7_FO8 GQON4L
M+;7+D>WM[1U2HYZ/F7G:!;4L(*/ ]!DIYO.D!01X:+*>DR,'.(71<6V3DDJQ
M4"P(Q2$TPS+Y'U\1C\+'&G7P5<9(;K)H[5<7S3N=3OKCO*K(3ZYP6Z1#)D&@
M>-!G-BCTPVN9B@DMC1U]P,A'+$#T_.?/AI)$9.N#C*1, DA/!<:>_\;'0E%[
MOZU8!V' :DH#^<;<TN3^1&N#5440%7^;[/:"6U\%*Z7*JK'2"(4,7T]]2M/4
M(D&B\#:+MWVI7OARJD(@;U4G@KD^(Y0C/$_AN/L(CGG ].=X>9YGGW_GZK!T
M!@PG\'- /8_:SB(*>HPTW@+H:U-G N8^=C2B0N.>,VJ :C<8-@I&RRNT17 +
M3PU&>8\@J?[3L,S"]G:!P['O.M08T7%HG^P4"N4_.NZ6@!(?>..X=SER>8.*
MI["7*0IM8*\7#LBY&:1AVP[Z)NMR0&H/3!<]\NJ3F<[+#-*76]J4H4MF#=T)
M(<5-WJHP=;-!0A?FG9 7%P&&A-) 1/6PT3@'IB&223 YI7I/?4I=<BV:*H8_
M>6E85*&4XV!\I9:/N9<&7-H'7[5/+4HN:8^Z.5+U^LY=^&&?V3UJ!6Z0(Y^I
M:\/*[RC9*>=!R"'3&";-E*@[ [-*<*+O,F9[OIL*6IT(O$BJC>,2[X+Y=$K@
MI48#;Y?+>:%Z*#E#WXU<F_!WCY%#%\2Z%*,>:EWROW0P_(02-3<K2 O%8J;(
M]!C;C@J!VL821HK]SLPT[.>1$XA$R"FA"K9CW%14$C;#$I9UNRX;2QS9O33L
M:<OI^B/J"H:KV3T,]7%3H&%1TWAI63J3R"-R?/)SF54KC=<5*SL@<;MTS'P?
M:T-R\= =^=D_;[*4.>>L&%O+-$_)M*MDAE!?X7QHQ>!&SI<F31%1-U&3HW1>
M\%PNS4>B;WA(M_!P;O$Y$(L<:R>^M^&8)&_E1V2QS(3XI%X\A>'6[[RKGQ,P
M6)Y#/.;R)O63)'YA:,16MCYS"-=AEC,29V0+3YA<UL5%RZG0,FLC0L_0$:W(
M)QD2\?HE7L(Q>_"&37;Y(93,">< 3)VA:4^>H<V%%AX[0\L.ZZF3I!]<T<KC
M_,\Y-7KM@P[YOMU7.PS*W-'$#*\EV$*?A_1-D#_/TV#AKC;00UU+'A?M@S;
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M\9S7S@I1(8]^,3PC8S\RF(.U\!3-E2F+,F,E6UB*==H^T9JU5J-VT$8] SH
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MEU4"QY$N=\Z]B]Z/'D+<-XCY>N@<\%(OZ93@I@)CX'[*,2]]9\0?,L+!,''
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M-RXOFN4%?*+W,$ZG#:<TAK5VL6FW&.4S/2_@\T4[8U+.YW/Y?/Z][)HB>X7
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MFRBUD4)Z3!Q R423$GL*?XG 7Y+51MOT+;;FK2O-D 622QQ R423DFP*?XG
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MR!8(M*GM2?R"E>$6N3"G[A#S&5*XSO67!X>_NE/.B/OR*"@(-)-L1R2K-D"
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M@(6%!7#GY *.%P F_[[^5^??)/_;'"S'70"^,P!Y0"8KRR7 *3X65CZ6XQX
M$ !@8?LO!\!_'Y93K*?9V#G.G.7D.G' \@).L;"RGCK-RL9V^O2)->;$#CC-
MQ\9_4=V(7<#.B^-2N*#&T^>OSL@8-W0+V8^1+VMZWX\[RRDL(BHF+GM%3EY!
M$:1U35M'5\_D;U,S\QL6E@Z.3LX0%U>HSUU?/_][L( '$9$/H^#1C^(3$E%)
MR2FIV3DO<M%Y+_,+7I>6E;^I>%M9U?B^"?L!U_RQ!4_HZ>WK_S0P.#XQ.34]
M,SLW3UPE?5M;W_B^N479/_CYB_J;]N?P7RX6 .O_H/]?N?A.N$Z=/LUZFN-?
M+I934?\Z\)UFNZC.SF]DQ^$5+G!)X^D90>/GKQJZS\IHVI.%O.^/<0I?!A%E
M*?^B_2?9_QM8W/\7V?^ _1^N>0 W*\M)\UCY &  DZFT$3KO24TA)^U,D.?I
M_1T*/%&:-R*. 3S?GVD?VN"JVX+(\WT<2OR*?_(T[U]*O[M_'6SR0W0TI%_R
M\>-]W<.H^JYZFG)=:8UVBB$O3*T]0C0BP^]P,3J],KQR]&'#[3YOCJ LJ=KV
M!O,++Y2-BW0Y]C'BS3,27=*2_D<6:/DAS7+;<T^'*NREQW.Y/7R2,_E+%,O$
MUUZ$C>4&#&K^EG(9<W#'V3,>=X6P#+794-P2:&#M>CU=,[!02J]?R6!]8[TG
M*_K.MI\0^86B:TMD0T"&'E\1! 0;:7H]^;K@SU_]8+(#>![7"V7TU;Z&3P-/
MPY1_J$2<X[ <7\.B^(TR9)L[W[<V?\P7NB[PI[(MV_+I<_=;QX X%'/67T.M
M+S@0=II$ER'\G>6-;&0!2&O^U.G7H@0T/WCWK.QNXH4?MS2Z'K,YQ,^&\6BI
M?34^KV'&8? @_OGF@F[_/^N=0]RV*4P9[^VIGAE2B6(N])<O-$2,ZF4IN1\\
M-#=.6(79E7,-6494XGF=T^]DF]--$\EJW6U2G*)00U$RI($PEJ@8TF'TI&?Z
MA<*^J5YSNJD>-O#S?MVC*44;AYP71?5*P!IP0^=N+=T&8<HH9_+3@'V>@J&_
MEKEH.;=;WTTW57\%FZ(DJN\UQ=AL.GDL6Z.^66RX]3AE1P)EGG9W,U./3*JE
M6 D%U \7M#G,QK"W':__$Q\601>KFQ8:-5%(NW.X(3FS[TD_]?08<"Z>#&3V
M59=.Z!\#O )-_D1)@?68[X\L:F"&TF0JKG:[4?'>O'->3$RU9L^$XJR;FX7*
MEWM.M]](6^J]Q!?34Y_'!=+[O]=B-J)GDHI<TT8.AF/!? FKW-:*HD<S8IY
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M>O8Y6(MABG+&&QY!>"=D(M( XDJ1[=%T?WD]0TS&RL6'F=YY9X^FO;?2>21
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MG%F%]=E]^XUI+*JL$-X<#.O4M'7^@;3L)/\=2I/[\/%D82(QDA RY*1^>^@
MQ:?W<.0516ZUZ)H(W]=9F(?"S"HN$23Q5_-OKI<_K56G1_"N"5F">19A9&TT
M 5S?9.<A:]E8:U_NNE!0MB;G>[=N*27"PE7-Y+N\72*GXW<'YT1YLR*!*$2#
M,R3&,VI=T,[4Z*V=J2#+\=Q_ %!+ P04    " "H@-):3DU"#M3F   L"0$
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MON+L$&V-Y_V?*,XB6<6?K)A8@5MMW+.^4STVMF$]POC\F3NY*7JH-?\5@1]
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MK\&DV1Z.I.S$[C(LG2LKW%!/Q4MF$6-KA?9ZL) PW".AWA#/#DW."NG3NU3
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M%>]Y,LB=)*M^H%K3#C05U]9#L/ 0V*!B!>67*&'"6;Z;> 6% ,^4PW?[E4!
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M73!!W7-K3^.<>VG"W_&KD34R)[*.U%O^!X?DM8*R#C:+ ''SPH@6C@ZY79H
M^T%42>L"*>,3$I H8:RF.#74<\!P9C/>E/R<0A+K:#WZ%"?(8"ROB=DNX#I<
M<+P48[+W)HLPN+!1_0M!3$<,AH_ J6"U8M7\07E)(U%(NA2Z'$:!.J*QEX0E
M451M,*%2K-(* C/:*25@.@BWB]IFUA AS%'W.:8I$:Q+H^B43A8O@G0O@95S
MG#2F[;*K[\EI,/?CN^^W-Q%?,2%5]3U;G*VBSTD)Y-*(2B ';Z+0H22D2Q^
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M7IUR!.+,X#<4* %M5"#HU:8;W%2,\B"HP6DZ(]&$55/4=3#MWN2H%DD-%CN
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M>S/6@L255N"&.%C-!"@!-TU(]:Y=P<>+GN*C.0L[\5D<V"]T8$P)0"L^TQ:
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MM&B:"]QE9F9&IKF65&9NJ9F9E,B4EJ2FW&EJ:4KEEKF0N68$*:AWF;F+8JE
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M"*A!*DQ',G4I'\2Q?A/=H.,SO**%:7LQD>@(>M[&Z!'&V?<)G2+;;B!X5(E
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MBN8V]GWO@]L<>J:C\T)PR@65CZZ%%;E4+&KAU\K>R78-1(_>RD=US2/)^7O
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M&G\FA;K4 GG+0!^T8$F.OH4 \J^X Q)7:4E@.?KN1<9KA.S9<UH+EFLLP+8
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M8+ST!6TA0):J^],;<QD)0\?ZQ-[5>;**Q]?)2NXU;MCDAUWMC#JAHE45<K[
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M]2BO]M&N>&:<.#B+0A3UKUQ3J$P9"1TM-#O;S+DY9OX'S@BTXPM7C.A=MZH
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MK?! AWF^2Y.1+,:;1FY=<BX?^)4<4-)355&<+3IE<WWXT1_:>[7>X:4O9U'
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M' ^>M?FK1V7/9P'^01;2%!Y%Y'X2^JE:H^D2S^<XT=_A]=GSP(3#Z@*/TW$
MF6^U ;H%#,@H? )TG&X(>O'PJ7@TW8[*E=K6HV$[;Y<$F9Z^5WONP5)I<W6$
MNOC<S9&A-R,M$8B@60 2KN&6TH(@J2I(T\[%S*+.$'1H6V=1B5LZ>;G^&1Z^
M@+4<>P/14(4=N1"0DPSK +5MW-H. 27=/*M$[ALB:-18 .V9C\9W[7;C5,DR
M-T<XFG>+_9I[-%O5S_&2G%QT(D/"PC>4)'.TSHOK[!2'5?OA2P":QU@<7H"%
M.L$JOMB,@X>F7W(60552L4D@#0M\9N*LH;P#C<! 2AW1@FD:+G+,>"2& M^/
M!R:UET9?<2EWP)[Z[JFGC.REKZ*_&<$"E(E()"</B&M8? 82)>HH$\.J$!@/
MD!3#X*]X8VJD,A&<;)VT^##>R-*/0EN&SZ+JT8H=9=!!3W);L%G+>]_^8GRR
MA\,#*BL(*$D-K><F.;^JT$RHKZGMU05(='K@)6.UQV&5T= _*BR-KLZD.T.=
MK>;3?&&BQA#Z0C<=#\0+)K6@(^/[Z\ +FL6@L'7N'9$!O%:S&0CK_Y$G-H5=
M^Z<\K=N;K#*>GB SBSZ&_7[RHRA8_8A+2<49T$*8RDAHL\H5CE8_HWN,<K2[
M.>OA'1 #V(Q;.>I"TL6M&!<55!3.=7-<1KL"1G:PEK+UBL=QFWJC+*_BM:"E
MPJ!>#[(L+TCK9&]YW;&>"R9?Y9]F45H8D9>R7]W .%O%I+NK;]'7:_["+)I%
MA>"7TJ+ZBG+DRA;@Z;B,)"#=X*Z #4(!#E:?BN&1=.!8T+R[1\I(@.TC90ZQ
M1\&!5&?U!H8)V1]GU1,EU.59W7L2W!$IVZ+I)E7G*)I5N^A=.)3Z+LY.@\"%
M%N,"1HNV-"6@#M*OI&UJA)J!&+EKJ[XV/WAA?74_>SU([&#I_\B/E+HR/2Q*
MS^?>#[9[#WM'EU*W\F=<6DQ*I*I.DD'8M,&UN-6@2J.K XPK+P/"B5<RB@7L
M#+7H:KIQCL!(9N2#(&JD[WOX.(!O%3TZ_YY:)F.TYQL&]D>L!283.2O&Z1N
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MK9 [S!\G]'ELE@W/)^8-;PL;L8#^4"K]/Y]HZMM;,$]E&:<Z!]N\4*>+E?\
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M%;E,$/U=+;#"RL-5_IJKR@AND5Z+*_<],"1R&;SF%G8O-@:^HU2][F^UOEB
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M(\[Q0,>74BZ+F<ZO,"O@A2VN@U5X3P>QR^7VF\7?2[=I";I"(C6$M!3&J3-
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M08C, D)4)I4A#@S*D*AL143,!E0F(2HBDQ 5D:@A46:(D.T$6Q B@B(R1(:
MC!'"L!61>0I*)A69I*,06M));O8YK\ZM.N?_ZN[[;KUZ]:I.4IVJI'^U>JWU
M^]9:W]?5D8Y).; -1P^['H;)R<G!SLC>,.D$S/GO;_]'K[^-_)_:D).^@:DI
MPMBK+LO+;86M4I.35Y.3ML,0,)C<FG]? /N_7G*KY%>O6:N@N$Y)6;: O@&V
M2DY>?M5J^35K5J^6G8V3G8>M5ENCOF77@;4:'F<5ME[6W'W[;H&BT<'*5BW/
M?L!XS[DK\>N4M'4VZNJ9F)IMV[[#VL;6;N\^>^??#AUV.>)ZU.O$R5/>/KY^
M0>>#+X2$AH5'7XVY%HN_?B,A,2DY)34M_=[]!P^SLO]\E/.TL.C9\^(7)2^K
MJFOHM76OZQO:F.T=G5U_O7TW,#@T/#(Z-L[B\OB?OWR=^C8](_CQ<W%)N S^
M6OD[+CF8_'^$_B_C4I/%M6KU:OG5"G_');<J]N\%:JO7;-FU5OV A\+9RQI;
M=]]6U#QXMZ"R=9W1'D] Z]R5?B5M8VNNB>#OT/XMLG\66/S_H\C^([#_&1<+
MMEY>3K9Y\FHP-$PRXAC&1QL2C@DFZX";G.^U^6I5P)UKER$_L#;KFE_Y5-)"
M3,1>VJ(4)H_7/SZTI6'@.W0Y^MGIB7!61<G+B4]A^=J#2(L](7&EV ZMI&[2
MN!'G1*NI("2)UF(RPR5_Q"?P*&F.!_@]YWY<4"VW&(A@9?0\<'28BV_K_#!@
MT//9OU/%1;2E,QLKYVC 7V?462Y 1=[DT5*C_-=&]$3P5!M?X#.O/[]8::H<
M,>&FN*'ZNG;6->',M?8G<;OV(QRD,*:QY#U[T9FH+X5Q;<Y*89W?I+!D5_$C
MQK=DR$X*:PMG2F$9H_V:ORM\D,* M^AJ._$&=K(4!KK[D 0-:.X]T@7<RA:&
MBNQDSBLIC!^S>$A3[B<#VHV9ZY'"?K/C,B0:IQ!0% 4\3QW/E:3BF"3(M P-
M?HI3.P0C+$AAZ^^+]I#Z54"<%)8XG"*%Z1=*=,V$%Z2PI_H 6PI;5PJ7V&%_
M\_AO9_^YLTI5[0O&;L:1QOZ.8\/#^<B=49A=<A:Y0]KN;Z+DC;92_W?<TV*"
MRKQ8)BD]YT)).6$7>)M#2VU I?$,_-OL1THY.,UO1(O!&HI6Z&X7[3IN^?'E
M RV,VE>C-6FF23&66V>.T.::OKEW-$58!]]R9/S79+G\EW!:4E_^#/3S?^5&
M+@W=E-%Z(7_;GQ5'/FJ-N^JN/K_^O-I^!/J?^MYWUWW]]-<#%EXN]^PZMO[U
MR.#P9XMZ@\XK.X["?K'_B2O-UQUC.6F.(7;,5"B8ZXO:XA^J!E;PWX3Q#+8T
MA2@D?6F2?""WW\<'X%3KM6];%4@2#%\)S8N=IE9V?'PD.3KS0GZ*])\W!_%?
M=GIE:WV 6U>@8G^3%Y<M/R/9!50\Y&-U)F;JB.H \1G/8&M7!VH;O>^)?U[4
M%+,%T=!$/C4ROW@SQ"WC5.3N@:].* 7?*-;&L5VP'XA_<K6[CT[Z/HI_&?_^
M_?Z3O^_V37L#@[D:<U3=803!/P-X8"$@A?%"F!0R"B%;5L<-H4 Z K,V!NM&
M?H9L#?)6D\=3/&._9+0_:I+I,]!9R17-.V/LD[-OZK/8+&4*:B!F5Z^>G=9$
MWS^&OO&]#NU>6Q_^STTNB#]G<C]?G/_MX^&IBYMV?,E47>/ZOU5O;XTS-<-,
M[F[-N.3G:N"AJ0ZS>'_PSCW8VTU_V.? ?LW^(XPFW,.?/6!1?4CS_ MUUZU;
MU=E7%<YI9DD,K\^[Y\RP)G LJ\T)Q&O7!UVTYU]_^#376'GW<8BN[JP,O*1_
MB-V9=^_*RG1]UI[R5*JZ^\>[PP=6;SB@L/K*]M!_B*DGHI-U63_$3^$[3+<;
MMUPDGHXJ6NL2-^%Q>[/6.47C5;ME_4S\3_O9*L6_]BG\X7+0*2S^2'?-P=]V
M;RUU//N@H30D8K=\_<E7U^[!]N[]H (C+/U#@P>O5UYOP3Q"Y%6__U%'R_TR
M%26%(1V$(1EC$_E[<N[=0L7^BY3T_POCM*?;GL#S9(G\SX"Y^E_3//LM?=L_
MS%WZ/^P/+:E/_]O7_[=\C:(*?Q/G94Y?I27G8!.7Y'2/V%#EV;.!ZT;FV%_'
MG9Z7<./<CC8FX\?)QO&'IY+7/_+J<:G +PBO"1 IBR0#?/$), -PZ6CHR4ZN
MP1GB'_*H7>CU3>YE 60L?-IP[_"3^$FT)H@.:,YANPPV^5]7GVU T6S*4$;U
M0Q=IWI[5*ZRF*9XL(8N]!@1S,(VK<DZ+BA$H)!"<BX^6_W'N7L!N;GG4TS,'
M,GGOYL\TT1\>"8TZDWYRRQ]ZL,5P\U]A4EC*8^B&%/8D6V)/A8CI,,EM=!#C
MEPWU%E;H1C"1PIZ_CIC>\:M.*.M<]WW!-5+8^;HV[$I$<LN])ZO2M_VOCWJ<
M@?$/O%GG+A;X%"[_"9U$.)@U:5TOVEX+),X735J@MKW6&6 &?<83#S;4,"[F
MF&.M^EOZ+2XM7!X:MG1S'Z27._S>OY2!ZCXU8!-A7FYW8F#)W >Y..]VO"7>
MS7\>_7ME0Z9_1+=Y=UAP70.]/OV(U>9[1RYD\*]YRD$R]UNMB@ $I-$E9(&6
MA<1^MG(9"BWIQ]9@DTEA>;&<94@S08@1-Q(B10?P""$'LQYT;F>KQ9P'1X$=
MHLZ59UGWRWWPGMNL<6MGH[_9K@07IU:<R;.>F"C5;3J)6]$2;95= HN.@F\"
M:9)UT8(NOFFA" 4."DE26'P=P1/D H-MV&HV$[,J@@5O9XR'HU/LDRO#N,@-
M3,'!V<Z&!<C*+?3^83/>LI 1[VB@D&S:?.?;%X_"-+0,Y2%4T*0.TN@6'@<K
MRPE7Q(])Y]'Q#$6B^6QM3B;U,A^CB/>UC#'8S?2^_W[8PM$<=]GI0RZGU/(W
MN37SQ0EE5\UOYNZT,,V8NU6GSU"4PCBYC%?4-[A,P\WB(B)<TLU8!\D)JF7$
M()[WL\M/-5$0$!:+LLKN%42.)BR2R:4457#M;,>][R3-3WA]%V!.8K2[5TPW
M ?+/;E;XF2?:36H]Q^ \#32582B&<!ZD\]CCL^VR:D%'T,!M4E@''#23PM(D
MFB"64]O,I>GXAMWPON/H]@2,X(V!]^W:FP]^F&C7<^_):WX\J?D*"!%:?J><
MC;P>\\*]-%RG.Z)5\H$$_+[ HK2U&(KS4;J2]\0-XC]((?,888DLNWV2CZ0J
MRIWOC@XB&39#\&8B>.O*A4=6=P5V7D!*HF,0EYQ!XH4'.N9TEK]T+9_NQU=,
M8?JONA\.L#M4]XBRV/]$MG6VC+,,95"&@\0:^'CWFY60%!2,<*5%_(RH&K83
MPS.*Y" S;V25V-)O"O1==L_><S.EHTH<LY\;''3KV65B_L5GJXM>D623S)W+
MDO9 -0:@7<QEC$^TVKO+^I841C&T%1<3Y*-QZ-0<S'KH!IBAU61H"V8'345<
M*9W-WYP^,&S%;?#/L-J%@X]?%47K_2$'#1-VR,R]DSGG%NEH 'CQ$;*<:DO>
MMU@#IK>EL#5W$8 KB6RH '2U8K7P#AT(G8LQ<=C?Z]"&<Y!7C ")'23JA[/6
M/&7Y3QO*#UB[1[L/%6>Z?0KQWT%L-:LGM8Z1*AES7_CH,?TN;"TEM071>UWD
M1C!M >$ @RN%M9>2=/&SQ^[O!]#D%A0^G-EN;P9M7<&F781T2C(.]G:T;+DU
MHU>7@J/[X^95A-E]3N6/$I;]$*!I]MQV')=,6LL4V>'UT.O])$.7B:R1E?W4
M=E((6?@\Y1*9O[M^=+VL1S_8VK@Y\?U5K,4OEZ.[N!&?2*&,<1HG9#X2*#P-
M&HA<"'O[)!8$,X&),*$DHD51L"GGP8WCS^*X&>'=[?8J'<PP;U;,]WD'W\$R
M&N]$PY%)_QC7 1]?_AGXE+^P$*PLE>5N:Z$X@<')D5W,#7TK?RNP"4U_((7I
M22QG4)N!J7@;+*NZ@Z4 ;2;J ,NID-<SR :,%E"%\>#)8OQ@I^&.AM=U#:-;
M1R6[0E="$AU-@FZ6A#:HEKSX-.'O/!"&!3QHX YX!\Y =J6]:-EX4<,K<TES
M!J(SDB$I3 4=BDV3P@R(QH1 $'=98(<!)I, C?:<$3)W?@\7TSJ+2%LY?/<%
MOIM7D50T!O(#^FPH:0U%@?)]]/*L6+^Z<<\9S"<V"R.T$6=+81?AJT 2ES&_
M'<"VRI! ,.%:GNMN1VVH&>4RZ,,$1,4T0/:/#&I#;>M'UM T07\/T6:10<?7
MV^5A/R?']XQ/.G64-KE_Q6J@.3GH5Y1.9 ))&25'."K.(2+ 8BZV52$+FVBO
M\M?H13HV1?V3COV=%C7!\X=E8_BIP]F^(4C:VS#>;Z0->UU&6&)^Q@/Y7YWB
M<AL&B\;-AK3O"^^#V8 S7Z$-K4J(_KO>5Z^B@\_XN#0B$K2+XV-4P/F6C803
M0Y O3\6N50*K$0C3<%P3,(T7H/I!JWD(\N#=)"GBKWU?F,L*-!IZ4AT]K8T&
M3O6"VQ#S!GSXN!L3*P\%  J<TPA#$N=.X!99;23B>:(.]MH8=OH _B:OZY9C
M0'G8C:_W.3>MP?M<&$LA[>N Y=6;_AAU=OCV)Z&QK*P*U<H*OS&_;K%RJTA.
MTF7;LGD(.HD#X*U_X!-\Q-F#0JLA^K9</]<H1O#KP6YL@J7Z3-LG1\MJI<!M
M0<-C:SZ5U YWDA+1'!G5J RY14>N"9=L$%,==0O"L:J,D+@0H3MP\E.19//U
MJ_#QT7:]C.^T,F@'7728OKN;*Q*[>3(:<R+HKX<3ZZ)_W;AG_O )_ TZ$0OX
MD"92A!-5XML256C#L&0UL5NVNR@G&:101#/)1_9&E"WD @:5$X[)NDH)M%W0
ME=ZB14EBJ#KJHMN1BH>*?&9;C %Z%QD*J9@)-!FE(Q7!@T+$7+=#R9QII','
M:KUD0D\*FQ>)XF0V&Q"UE PB8@)OUC&)%C^638.2V$ 3@)+B^6/9C=J.5B9L
M+P&1OD.$]2SRVQ>GOP5:4-M&;W0E<5[7-S3$,[V3.R-F^9K9HXC^V#LDS@,J
M<)R-@'3 0R(G/$/H 8:405M!9<-ZA5:V\I&6S?1Z,"Z(=[-4Q-8,"T0(W)/K
M(OB*UAC-TS/>--G.1Q+CC-J5=W24^09VK&FZ?%.[4;1!\E:V_XP+GX)^!Q6
M[RHN0A1#+V7N;73!M HW&O##5/I,_Q@'3=$JF"+GLT\_^8;EQ#7+)L_S3/Z!
M(<]W$_.L2.;!.S!T'F;\OD39010!'9"=CK\F&:)NH'(N5(ML9$DX1KI(3<56
M89(9P1@EO,+I@98]Q!ZA'R)M:6$=WH4GXX\=:83HE[+>S1RNF>A5/CU#TK&.
M=.$NIUS-4V+Z5%(.9XU_+[AI&"L,D-DN(+6Z,R[V3A1S<;+"7(U?X*8D05HE
MQ$$V7>$V(QQY^P9B[BX?KH^>RP,<A)%#WZW9RN&3N\1%-@@#7U"YTYXQ+_]R
M.AIO.N@QX!Z/CV[/>>=:%,H:],$\/2!>CU>0K&L4*1,L0"FLG#C$5I7"+L"3
M M5 4046G^#]&DQ[%GK%<I): =9NXPJPJ4W["GIBD$F0&0^CY;(1HXE/:6.9
M9I3CT\Z_UNL1?VNH_TE:@UHM2\(JTM^LCZ1/W(!/\0;K1&C(:9"H(1EF]<Z;
M\!BL4HZ.K'F%890D0^@:8L(+<*$CW[X)]!#(<\IROM\5[2+L[7<,,DO?*E/7
MF30(H9!FB;OJI-1FB3Y0E__3Z]XW>3YV_*=$B2G"@&;"$+%LHA+?DJH93'22
MK$^B(Q@L!8G2NILO F4$I*HN ?(*XE*5B3U4-=R97 P8)G(,_[M/K\4;=9+4
M"1="4DX(/M3QX.DY&"$RN3R*[NYP>'CA^6#9G.2SN!#-*6(#WHQ$*:P:/G=3
MD"TCPF^2Q)1%9;82(6"8%-5+ON$R-X6<]RTCP$<("KQF%R9#!3K$(]TRW 2R
MN0QU/))#:<>H^(U!^P6]F=:(#03G9I#0\*#!&+DG[%)+H\B?1FHUEQ5+_J0I
MJ%\@Z6%-S94#+!&G-TFR>58*TVK:SE7/66J2J($9O+SC4]X"!!DRXI6ZA\-U
M\=X^(S2:5:X'E2G9,GAJAA7RZMZ>8M[0 8&^9!U&!I@?8!V7DCBY'LP0F4,.
M N]DE (83EH#60\@GPFL=X;FKV^439-:&K2EQ#6(QOJ(;VQKR'^%/3'<Y,#?
MWG2@,)R56#T9?LK;6T?#=;/"%V](N[#+GM1.2:$"!VFI@88"8C9?!<[3@;1B
MA7#!A3P^6K&UY%O^)D'671YU/5CL0Q]=#-B]\IWO6=5G,QLQMN3D<'0XJN)[
MN47%F=J6K)NIY^^V>( R_;-&!HCX-()5O;@>93L]:27.CVI1D'3(^C0)3NQ4
M(VQM!BUIO7QJ.F(=%,$+D'>].B0Q80IV=V& "AK7 .F9'J?C,TA E'R:72D?
M*3:M-WB6D9D;$B-VADZ*'S!",!D-N-8X'5Y*&U(17WI8G-=B!)KQIEI5#/U=
M%YO-N=1V3++P)PNOT=ZB/7C5(6_WNW<X9;^//9&%8];JTZ=&YEZ1Y3==WG$=
MGL[@Y*)?C69 >P0)K2WFXL=-:N7X(/Y"IPC)<N%K4V+0J1TT"FIOV.CO@;[0
MH>'W]I\]N\J=8R+7M^FOLUCL"D9%)J09J\H!U+D\4:!DC%&'F'\K.C=M" ?O
M @D<^%RS:*UD:)>D)] 8-*\@;&8(V)WLS(5G8>H!LY)]PY(M@= A8)C:EJ'3
M'OO3GY+<4X@W:^^?R8E[]H.M3":?>ET/DB5*7MS>9 9="H.T9X67Q/&,J%Y]
MD-S&>%4HZ0BT!"<XF*0>@5L[59&((/8S:DXC-GQ?S)TWZLC?#$PV<_WGB3];
M#=</^OL-$!S6UFE]*IWNC0D'G$MF3JT4?U](1W/RT97>=QAA3CK"-P+XW#S'
MG,;"'&#TV41@R-J7PUFVS3=+P5/:=4!G-<_!2>?$X")2)P)E4&>.*YB1[!B(
MR7-QC3?'7[1ZDLGZ=&Z:$4X=(PN/BNN:MA?BS865H#S YQ>G0/M>O"W%1R'U
MO\5/G0!&"APC5#YUI3@>"K*DI-;(D]9?=B[I*@JO_7WF$G.U7V+LKE;U)PH_
MMLN0] >P/,?ET5836V4T%CE.Z: :H,PE/9-:X$F1)W&P;F5Y;D4*TY'"(BD(
MWQE#1:"W'9N$K3Y^-_H%85<V3R$C!KGF&ZG&+&TI$GZR81B)8!(UJH /#[G=
MG?3D3H=0""E\!#8#LQ*E0\]DO8X^N4?\E @C8,6E!*1 GFLVG\VA4;#5Q:WZ
MC=V(]$E[D JXO$$I =@[.A@ZA6?6=I-LW@SGP>.+!).E$3%\&MP][(GSE4V3
M1KG*C'ESCLN<BDA/\AZU3PI+NB]RDGQ@J[3 P3Z"^0!QW?-*3L#6 +6SH/_3
M63>>&U+1?SIKV<BEMBJ[/9S@_#)@8EHPD_.]T9C54D=Z$;ZG)]IL%P<.FM;-
M[0+J.F6T$64$R2:S(YQ+TH,V"98[D>D(Y9@>%+_] G85^),OR0LJ@H($"BF1
M5C%O%V=UFVX6A]7:-C3GL QLC>L.#\Z5%5G-R0ET(#6R,%!<@;Z _)N/M?<F
M,=0_"Q28<'5\ F^TBZ9#_(N]OL42? DG3YJ+<UH4P:J]:.XAR ZDE(_/-C1G
M,EZ 1W_HQO1$[W\E4/E$SPGW"D-$UM6+?M-FJ$@ZJ8 W92):R!!0YLB =ZN]
M71N92F'#90J,-E'(\X8TL6]RDM.TR2$A F_A#<'74L"(0V):V@7>/YW3S35@
MM%/2A=?\A'4E,[_/1#,YC2/U-<G#EE^O2DK,/Y/6$%M)E6PFPY#83](@Z(J<
M(,<^*%KD/_&)11S06_2+Z1FBZEC:R+^T+0[AD<U%W<V[RI;";,H](\\-8JHJ
MZX8KD,&OAPH;J.?3Y7[)J//J&^)&V2Q;8#GSX)V]\=@ZG3OEC@C12<@)("41
MKLO&Q;B=G_C!TL*M?%/PT/-9EI#V',7@D-*8O%&9ZEHCZ6.O7O(24X*X:$28
MF<O(5 /\\LOQCLB;YT?1G5V=U'2V#CJ$-#8E4>I^.GM#6%]!?"^3K)@)?6$K
MZ,&=-KE)K88VB:O0%V@L'!.A7N.F?_/;HZ*: :(CM*YAV+H4SSK2T9O6HM\J
M?S%Y<[ 4=H@T3A(JBBFD<R**=J#D/5;.40O(/B%HMP^FIM-[-H6OU*72(\T/
M[;$E<W\YNO#BO$Z/1C8A"YW:?X09:E4-63;M>]9M7346=NV'PZXO!%=9!OK%
MB00LX,+3D94=:;R0^[U.]J6NTS)(>$L@A3%GET9-!PC.@ESLL*5-7@AO4[:+
MCUXME:=R4/)N[>M<UZ&+ECTEU./^,8,5W^?-8) 2."K+BY]L'CS&B/P(L>)<
M*>PL8KPZ "PN(C(-]<79BW%>W*^/ "Q3@I+5B!3V$O( D"E-$3PW2BI;FW!
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MH#CNPAVL%BD8F28;T3Q"!+ 0?Y&H3^M IC"T6C:"(;SBVW2:.JAQI*$!D/5
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MQ!K=;&@O6H/TJXJV2?R4=+[W5OYZ,;7%'L]D&JH,+9+402_.5/N".GCS5)U
M"FM/>3VPU*/<:C]94C2STUABE;,VYYT,;5]-<K:?"TG[[6Z#^O,=[I[%GD7W
MP_/L'^J=:CPQ_:'PJ- [//?HO#D]SBHXL"ST]_) UW?6VT9H)OK1>_L+3]4\
MD.WLY4(3_9KZQU$#C=B"!]Z_<+[$<03]:NVI>ZZB@]"IZ\;TNM@@7NG[ZJ8C
M[[LVZEJX[H5%ORG% F-4.E:\"=&!A7;0(G[V@FG7[<2P"Z1K<"DL!]Z13=ED
M-4 :WW3@)8;[KJ%("OMF]UX*\[AA#C6@N97H<,;*7G0Z SP9V"^%J:2)3LH&
M42LD^VQ[*:3(3*'_PY2\Q(BA+(7U%::B@4TT*2P7LZ3SE!%/ 8VR.Q#IB!K2
M_!+ YR*[D&G4#:BMD-U(DXK Z\2PX_9R?!>V=G#!1D6^C?8B=-G3K8@]7=?F
MIMRAT5[YJ>@B>];ST!O$6$N]R)CX%K5QX'L,0QT\-\ID6>:D- XO]::3-ECG
M60W#7>H9#$%'<Y'23>NJ%RCZTKAVM'/J3HIN0D%J\9K4?%VO\HWV526*@_>_
M9*P[Z>[&ZCAD_K9&_(FV@E2Z'(7M&#]YFBWOHI7 ].@8;3N^=SDYZ9"CD[U-
MB,>[C+"!#"L_0<TS3\LK;[L?&O>^VD9KQ60BZ%.0FC_'M;EFI&5SF,1I="[O
MZ7TF6M$Q3(#C!3X?* G&9TAA*4W^=LF1GS/>N*HO8^FAW6LO5:;$0,\%HY#6
M?0Z.LI0-4.:"_NWO! D",VQ.]-J\.#XN#:%#)S_JKDS7Q;Y!KW=TKYB16UUH
M$D7PO9!Y1]NU/,"/<: ;-$N/WB;RTT7MR#3\V*M%^;W[4F4R]*.<DJ__T2TP
M^/A1UO,/ZR?:,Q7?/O_&>YVR)K4C^HJ+_,.&1YVVT<W-CR_]"G",$&:(7NXN
MUXG3<Q&F!48+=/@*;:1$O1,Y4QW8-*(\>+GHD,:[&+@^6.T,=%0_77MN<]RY
ME=[YW;:=:LPHDZQ3^D8N!$N2@1]F+E+&<4O$%3'Z<:X$M4B1,=[^^VD+G4 ;
M :(M]Z:Y?SQF87$/C[8)\FC1YF\V.+C-JHVR=.^>G$B?FP+I!X7PE$5H=>*(
M%$8OIJ",P_EA30,$A3!'DMGZD7YPEF<SFKY4?TY5*86\?]!YB\GFVVUWIZ6P
MEX^T RI(G?L"MG?Q6L];OYSZL[&<,^MUXM+.AXN-I=N*RUE^(&-V5..K9$$)
MO)XW6FRYY=%E=P)Z/<="^.+54K[1GA)E5,2.#??]0C]1&EILI;#6. 8G'[LN
MZ\=HV^1>@7>7^Y5/QFJ^!#.@_,MDADF;?.T^0@ O!)A*(=QKO?O=6M1S[/#A
M8\&Z/I*8&39PFCTQ(<QJ:NACG,6-.9RNCX_9-8$O].LCG!6<6AG&_DF+4KT=
MS,6M"N5OVCML(S[\]G+C_$75_A4^,"51K)8A8 S$%?N-3Q![6(@[R/E,/@^1
M&KA9X$VF3Z2T03]ZX\K*[^#/!*A_:!O9VUW5F;;Q-VSQU86Q:*%__]R6@1I<
M4O?3Z5.S5>RC_4TA F770<M!4=;*M3Q>=\1>#?&?3PX)"T78VU4]NS_H=4[%
M% *\UY2=5U_-EQ=5?:0?L!G->A;[G/+"(J']X^SIV3L_)O68O;PW0/*)4MZ#
M0.!ZY^4=]SQ=)U@>;>5QWQ;1>;7B5!*G&5U+77&9UQ =[0+D6V\TE&6CM,F=
M_?B80X7?SZX#=-Z(0BT_QR2[6K+@:OBGYH_MLO&F<..'B\6M%-"6(3P'#+^7
MB<;>.S)A9!=Q[[H7UG<:&0RPF75V<HGWNJX*/2,F+8<VGSN?D8_19#4]23OE
M<%UYN_A/V1C;)LY!?\L/E-'(5C!7"NMYB/C/C;HL KS=[OG, A7@)?_'64.J
M]U]5D!7V^Z)G^^&'IT^P_**/5MV?G"T^K-.6J981ROMYPY>J%?1T8:EE6T_E
M>/773Z_/!@=FKGWLW_@YV: U\MW *(*3#<F$B! ISCO4Q%!$7UA(RM<9FF\J
M1*16..[#\3#:UU_=,6D58-./TWG(&L/R'3-'VSDA<OM%<B=/'GRA]'+5RQ=R
M)_>_@:G"Y&\IP"Z9?R']YYGC(86M]Q!9D_H=FZ4P9H+ 3M9"=_S:=!RID_%R
M-FB7S^. D.;3)V^,_0_FWC2JB:UK%XW;!@4Q2"MM5$041%1:$1(5%1$A D*D
MC8A()T04)$I(J0B1-EL14! B;43$**U")$)HMB(BO8(2DHCT4J402]*=^(W[
MX][O?>\8[SEC?&.<'Q!"5:U::ZXYY_,\5:M)H786U'I7.;VQ9GPOG@=/K5WE
M=SC@QZPZ<ADEHW_7*5^T\IVZ' 'QJOD9SJ\2^LX?P2]%CG B%WN3AB1%04X=
MN)^A_O)P#-<.:)<9>&[6M-:Q9EX1#G1J&(RIF%SXLF=TWK4ISMGF/2\J/# B
M*@:3,]Z\]LZ><E$9"I39'#;XB7#HH"F=ON8@\F*D^2'U)6>O?L=$SG]"">)!
MQJRKT O.M =-!LJJ"\GO61MB(HSF1%'0.L@D1A'S^NKX0#[;VQ^NXKV?^.=%
MREY2:N.5N=)MRL2@Y )9!-JT"2LDDQ*/WZP-D$L@&WZBME;-=@LWF>U1Z<H+
M/5EN8'U&;=LC:\^2NU=B0LOF*^<*?QLF2S9.D+3OC5L??YSDXYF];]FM-D_B
MK-W5OO1CIP8H*6539YY-[XK^,AR5>7' T02YH"-+RK^ 9E/6)).8(+/Y4+NI
M)&#RW_US1O0[A$&5(F[=I@'=:;(873,C1?ST^ITC<MBY2XIX:"L[<W44301A
M/H1+4%]D,=PD111!/*3(#+^!]9O""!;3,&.5G&<Y<PY0.!NS7"(O\AHDN4*&
M;6!XO<TZ2@S8S<-1QAHI[*MZA3R[@*\#H@-</RO'6N'.VV7^GZ_'Q*W)+U+:
MOZ7@*)_PD\SH9\";)VZ0=D,:$GD'$-DLV=.'QX'?*TI%OG$S*_IC_+9_BT/>
M;-K-J@YB]1!JYHZI*,JXXQF%?P;]"D[.[-@)U9-Q';\'K<PZP9B0H+?9QMI)
M[/X+A=YF)RH]=^4E$.\;&*C_]DF[$T=_/@-*$6D//'*#7UIZ);=\O<W^IEFV
M?*7_R6?$1P/I.BY;5<-L+F:CH](/:UJM.:9RS#-RCS=J\M5A4N6_<V(,-P5S
MCKIDF,."+Y"WRDP8A']&ZZ.$"P^2NS#+I8@P*F6(LY9L2[+[T+21Z#;K:/#$
MNV25'>Y OY[=[1FTYI!)KJX/NZ&K:7U1?W1%8^@_!U2_A5^^HR'!DXV!YGT8
M0C>\I2-CD3:L(EGSB3^O*O*'M_ULHO,QB3F66!Y2B5TT7)[M@]<3V=;\,)=U
MY[!?%BU/56\/&--TGY^_>?7HUV'O(CN^%.'(^N^)A&XZZR&TT%^%I0R]?7M1
MD[R)Y+P"=<(AK<IXZN+.[>^JK/M;VES?[7G@<N]SSF[*X)[9XV>'S$Z.OP,'
M<@>MT\SH;F:N=XNMU+:)8E5 -+:UKS@]KS5HKV!=]TZ>;1%]P(RDPZ-MCBE\
MHW-.T[^W)5 MS"WAP2:C8Q?3FM9*$3?(,DP*Q0331K;7,"AHM-#JM>GPYH/9
MRB0,Y%]R&PYOURHYW6$-Q_+R%JHR)-^]>B"N;I@)ILWS2<NP0L3IPP9<<2Z#
MC1]QDJP^+#22]-BL''P)NK1A@K'IE@QT,1UN/!"/PX&L%(L]G)!TV[B'^#"S
MSY\[#7HKZ,G1^[HPK>I[;'-<EIZJ#["42>NA'#Y#I*+-BZ<W8^'MP*R8QTJ5
M(N1C_ ZU<5FI5W$9DHU^\'7S\6WI<6,HS6&XXC@XWZJH-?RYLFOH!O-0KFE:
M3=':\%A"0C"FT9UR,6,KW1:_:C!Z]_2>BF3N\1:F^AYU%P^#S#/3QU1_:JT?
M:+\YKG-H4U!<":VSA_=]X]C;FA]2A!(XHY;U-JKX!I])5W0=7]Q;4GA,QSZG
M-_W82Y>MN)2"K0\,$Q[\+CU70/N\4NUWAQ!-LI79D?1G8C^R1B9]I(AE4D1U
MTT;XV,*66)4IO#+9<&MY(:<J._,(9$F)X:^. =:%>X[[G>N+B=OG=$?C?6)0
M';$,N/3O4(>D%J;V;.!Q *0:]H%QY"+=,SWL4JGG ][<-I?\H^U1=^+*#T>'
M395C^I]]?(#>DZCCJ?Q*QU-[O8M%R)E=BZ%#A=YW!_AN6=[N^7M;G((U[2)S
MT^X6HQZ',+)8_Q(O#J+=#K,R G[HQR\I8AVRE2,Y7Z%_:3K7>)SP'\$(8JDL
MY;>/9$.Q($26H:[$R;*='(\@15B>!-BJY"[4 M84 ,=$SE+$M[?7T.5%39[_
M$<P^1/['U7VT_/^"VA:+CM@>BE8\33Q<<Q(ZT/>T@\)I#8W?>:VA_HY,,4><
ML=MSM%:C+[&=?;G.K>-BP.BF&)(6C!,<P%(#6SD;NI,CR>LQ"90Y.>@TL<O<
M":/5P0N&@C\N4'>+3/_HU"PD!?U%H*+C76(VC0K2"#MGML$K7JX5J-*8?<-]
M)7=J:!S&\>+/V&F[-/;CCX$3J62CF:N"AW5_,[N"BZ?4R;O#*YU<'QCFA 9%
MEH4GWS^3IAZ UR?_T[0<5N"9ZL'#'(DJI3UBGW<?VA:>.0E2;RV^TN;54;G4
M-:>(4='Y>/L/(H_'6-[*7A-;AP"[ZI)AW*VBAO[(R$B3'?.2#X89-@@QB?&&
MD<$"3Q"T29M N;E,*/48&)M$\AB;EV&9+EJ5_ :SPCP>YYWZNB&2 =6W-5!N
M, UYW3HD/SCKB84@>8R0(-&6214?]I+>2YYA[U<]U ?1,MXK#VX_P<))X:@4
MX14.#;4L 6W4Y40'B3P*Q'([F@E)+!03*)4,H$WA[D>B=7#7DR_$\&:.-GH9
MN4\K,@]:-^_8PW2\Q"5H3"[W'C3%< -@N2,)K?YZ [:&&K>8^E&E\/V()X96
MCY;)^+2X@17&^60L6=/#(PQ396E[%E\A.B1^2%:?RKD\:@'[R:+>$62EDE'$
MC([]'R8&:K$9#4"K0F>$C;"%MC)R842A*];5SZ=YR-\*?!G3PVE9*MFL&,8?
M9H4A1Y;S<M@*\Y_FN;&SXZ#V$?%#3 AGV-X1HJ:2#,:P:B3/U#&9HW(4X.5<
M.L5<$>#)I=M&0-H2)9;>M*?GY9R"'2#U)LF*/N6_>L#48EY%E@5]$DJF+!N>
ME@;_CB$(+26CPX!(N5IP"]8&1P3NX(+-K[FL2A*N!@X0&LYP:G@AP[C9]: 9
M']GBHZCM"(839]I'%5FIK=U<AJ[7M&0'"W;F.EOMEP%T AT:G[])VAX?5$*,
M4(K'\6E_249Q%(&%N(JT7FA,LL(.VX]AKDNL24B8)MP"4P4YO9N>04@V,H7?
MK#15L!',F5M.)^UK!&O\-W\0.8&9K\F[&WIK,2O9A%AN96!K$RIER>YB)S9[
M<ODL"D'^S%$4^0C73>/K,;=$^WC ,J)I"V:M1)\XS\-=M[@>$,\W_6N&)7<.
MVGD;LN>*WSQ_(7DW4"M%*!+KFR6;P%>E _EO3X7'6M8-U3'4*F</DW?4RY(S
M@X2#93V?'"YTD[1KT5LP:3(BN :]@71>7$!6@E%\'*5I6R?4R98BM-!;0X"5
M(@5PX@04WWV3B2P3H>&V(I('%'N#:0H9'LS#0H:)MON">(U(Y1#_G9#+_7#2
M)MIKUG/4W#9,(%9-AJ<8\F:9>%0( AW:I8A/X8+,@::=Y ]H;<B3(>A>*QD"
M:@S;D,K$]Q/-H\IPT*6'S5%/1%M!$$YX.BV+4.90=)?W=XS"5$-\!V6,YIGM
M!" @VJR[3/^N%E?^F7:J*=E'5!E#O:91\<N;%$1(.%9H3L38PQ45HA.@0RLK
ME;42$T) D'O)!G %'ZL:*I$'1XO',$D<%=$!D-&B)P<R$C(R_XS/<CC,@M0;
M>6MV$MQ:6BX@RVD2^960H(.K,6?XF'0"5N1R;D@1-8:S#CS:S29S\<,FU1#T
M7B"=O IBS([SK\LE+R(U2?KPO0(=F/#(S]]79%<-C>P?_G6]IB)?KH.&M'!6
M%A[O-X\;L?,&AE+#;^V<&VNLS3*L:T@R3KW"/]W3M>*?JL,[SEN?O6.)\]11
MV_B+\9IQ"[\."#T,RRRY4@46"@^3=O^9U4D%ZB<2FY3);_"K_NO-_%\B>VRJ
M&_'8ZTF;^>;NO]@,TO$^D04WPK2UR0#"I*&-X2'>JKHES^N$8AC[>IB<IS@^
MU[ITKMH6SR3K]:KL_V!N)[_7.[K'/-[LJ./GE:&9SE4WNH*"=%;]?5#G^NL=
M^Q\BN72)/$YX$&C>3;)@D(Z!U"32GSIYP)E<TT\.@IOB.MM Z#803* ,#M*J
M-=I,M<@]>KO!^F16&/X3^\^L,_7JLJY8+O5&+RQ%M"A/^5M7]YE7W.T;\H0,
M;DQ?K<R;NN,M P7,\Z$YCS',B.%8]FV(SNV^)I'=$!P8K2B'+Z+6D"[!@4])
M6Z OB>]OUB6;.7+MB/$/IY0[+B$%_A7!)NWY@-8_$<&!:U-H5$"=-5:- 8^C
M;N;F=+ ^8=M85;%SARO@ +0!R1?L:#==38P3J$&QMR1JI,/0Y7*^8A@F1>M+
MOR-=4:[#)C:#>2S&3V;95@W+V%W$%_C\,UX[[\#'I @&[3E]+AYL%'R!32.@
M1JX<!;T=QC4S>,Z$%J4IS :T]@Q+P=9/5P:B*W._O+4UY:UP8I?\4_^L,JEX
M?9Q/46:;]AJ3LG0$NO)_X%6;;2J?T\Y927Z/DF/&0YT\<_1VVFM90JBQA)#)
M@2#N9NV\+OQPJCPF(F2N&'9J$7AGO*K\[&#0?]$QHNR3K[-N0]?%Z6?-QHS?
M4L0,3:;<QFX -=WI:'-2!/93@F 67A3ZP#."3+CQ,:P@.)(C"^D:\2\VGEI@
MGL=?]5PFS]9Z+[8Q$J/GU\)R1Z&?;^A$N@], %;V ^OXV3/-WK?[^XZ??2E%
M'!Z6>#;M )J/2!'AF&M78^<2A<MA!\%9,?VKN$D4(W01!;X29T@VDS:+[XN,
M6-4%S\$9OD:;IJT?6,Q+>@DIOV5+E.9G3=<1PST>D"(AC;3H3BE"K:MR&"Z8
M<.W/*&K_Z8B0E-6 AQ/_MJPX<[CTF:71B<K[2@\M'[M_-8X$+LJ3;AIVMAM]
MP=4(L9],FH8#K&C!E+ESGW?56Z&]?W]#?'UQLY/9JI/]J3[J?5@;0M7U,$(5
M]P9?9SKW'%01;( CRD1.\#Q/T;-WJ!6M_QRD)S!17.2Z&;05G,JOO/Q53#]1
M!>*OD\R"RXG4UF!V[EH;:@K3:6=^@+F-:=)"NKW;JSM;,@QR'+S%=<!9#C)4
M1I/KZ!6D>#B*$"'T"6_: $[,#JEZ\_RG,9JUA T.X3L343?,4U=_C_%S>7^R
MJ<HF^\G@B2F;98VUSF3A\;A;6:_1)44O,"D85;(>216^PD>E8M1)@0]%&#A"
MAET'FR"K-&8P+WRRY@M21B;R4?=CXH&8[6-K2RS!0U5?_/V<5N8_T-"(56(;
MOM=;]V?A*$E[@:TX7T00>L*Q_.Y$&=.S)YF_8O4V;2;V^?<QW<>$W<O#<TG#
MT4@N2YUHV+:T+E%&#I!PV9)?L+TSLF68GEA)LN>9,6 2#!SO'_+K51R3^Q33
M"?=AH7,5W,IC[->C!GVVFWC);<]Z1?9/B%%,'WKHG.XXL_X(GSWS!(YGM+7=
M\?4^LHH1*K@2[/2DZ^L5Y=^,V9_"8R2DN(*LXT/R$M,D&T,YZVT5T,\KX,M\
MU]J^Q2Z%DSTDQX>^"GX$-GH[2$^I>:70-HJ$++.,#PU)="'/Q.(9SP^^G[XX
MG:FKS\YT9D%E?2TY'$5;IW ^($^L;Y=H9)ESYC!KB>KLUEQ:2HR%7R VSK7T
M(WSD6W>K69Y/6SVS02N^]=P^X[C[D5;>)9.O44:2#EG2[PA]+,+U6_QYXZ,^
M:+L]6+A?%/D<TJ#L:-KPICC,>SZYSR\DDF0?P-/G1QR(]K/AG]@LL%M9$^_Q
M\#JY-289X'/)8L9;_,<$!Q@C1V5&Q#X4;8+?%!(?C_ X[>%X)+$"+U-X0NP:
M.(YM3()&B,&ML4OME5'<3JRJ3^COON_G:SN]:A?Z5R==&?ZEC!IXC#!^C0E'
M_K:@#>,D_\BU8\4X?WT&P$"(GV"^#@*A>.%&E"9FT8^8\1("OK]@"%?*\'3:
M<B/_'?#5[Q[PD862(AY9]XFJ:N9_RWV4(H;R&9);QUZ>7/C_?,6_[0R:9&T!
M"IS^?,@"97?>TNG^-0G";6$F<55NQ8X:2<).S3UWM8A6_J=<@C[]6/$-F\TJ
M87R<D:Q.AXH% _!Z,)8OU]$]/-.VA&RAJ<!'^DZ INQM3T0X/DJ9&,YV_?+E
MDT_(/#(CI@*_ENC+O-P5M<([,KEBI&,%I)'A>6X$PHF4MFZCRYRV@&20$L+/
MW0H3($;TQ:)_*'JK<^YDR&<.W;%1WC>TM,;HL5&14='FQ$,GU#Q.!GB<1*B=
M_+. _2I$&Q!^@9;FE1W0K*GNDQ44O<?7Q9[2<K;JG<=Q2_33K06R([L(ZP_F
MDYH45N)4MCQ^>R(K[&]<Z9S1]KVH&AE#S'!N/74\,K[ LS*CN5,C^;7#UL3C
M_DBD4;]!8FO'^I3*F^T]Q ;?VG'G *.^D_V]E>^_WL7Q";+<#&^<%ZE4C_&&
M?6=0:V-HZ5>_5+5TN,'-/)\O<=B??$3-;2+6P4^NY8S5!=V-S)[YF]9_66E&
M<"H*5L!!()][^;;>=7#H-7HM#!0=>IQ< INR;:R2HD6;']\8;+#(>K!GKWQC
MR6TMAX"7G_)ROV]CF.UZ7TT:=KE2$$SML)SO3&[S+'?&?.^92%SM0S=9/5*,
M*;U8H,,5)<D7.-\9OW+&=?Q;\]BSA0K'B%">W0/(PW1H^ R=7)ZHZNH?,/?_
MGF",T@&:#V&^LC'G&4)+;#IKB6%[ /_-FA8%?,%_-19;RZ"D"/4C@%:'$^<9
MMG/$N(*-C)\ZV!>L[XP?:C GF?5CUUO6[%\L29G^;Z"#]5L7G!<G0ZREFEO3
MVXI89A@Y>7&TK']5@+=NF&",<(4H6(H8L.!?%:4RAK#P)BM1J;[@DA3Q#-L.
MB-W]K1AXB@PPXS*!CWW+I8AR)71F O#U*1<0;MM#%;N4 (6EJJ[X/L-?#_\,
MF,/EB;Q@#,CBUU^/8231-I 4_I^A?UMUW=EDPSX>Z_F]Q*"4Z2]Y$>_S'PW/
M!S\?B)Z:LS!><S3W[?<UUZ*F5#WZRMW2CWJ4ND4_[KL;[%*Y_6W^L4NI;FE<
MZV,J-WF]47>#-+<^S36K/)*Q.>O8AI23%1\JU[A5'JFU]BCV?,#CV\2$GDP\
M%K/)NE[SX(6[9_-SXS&9IL,*DC4J0F_):[P2@Q5F"AO$ME(UPY8\4K6_ &.M
M];>G_<U3CR8%7MI*4<^+ER*4,>EZRK=VJK ;Q W$E@%Y(*C["6=C([:.=1H/
M[V0TSP_+2Q$N\%ZAVY0 7QT[)[>R%R9[670T]$JTB*Q6I;=U59^\IFTFLN+&
M3-=W7KKW%<Q).YMFTG+/7!Q[HN#HG,JO]ZP=?P:&;J'-OA'&ABY1;M6F&Z U
M1)?4SYD8\TT3S&>L%_?]/G/0) *],>3L@0!^UR;KM/0C3O&7>]4.]5F,;"O^
M@9\/@=!>K:KE8]9#2)NLPI5."FT;Y"]XU:D9=+KL3=_6KOKSN+GYMTLIK4>,
M7*RR1D35*LU7AN1QE;E$0BK=">E64L%_H6]>Z>:USL:--!!T=^C!!$Z_O0M_
MVSVSQ87T_$Y:Q 9):87QXX8]#39)#FZ:7J>"O$XI:YY2.K#BQKH#;3:L#(8<
MN8\&NF'AS58I-=1$?*UI8BUJ6%]P)%L4BD9",4^+XQ^'#I-SMX[(DVS@A$?M
MO\A:_<77CZ>"C;Q=&2.1<(U"A7&L\V$IHFS^DY/@@S@?B$#]1<]H6@9+V*W/
M?;88\S#R_HF]S)BQQD^N&Z8D)F!E*^5$[[>U$E^K1SNCXP2X>%/WIN3C6?R)
M!]NI;Z;L44=*=4:VM.[C7GKRLN&C38I+3]*FG6'W= Y&'(G>O3OQL?_Z1U_O
M(@NY!39O7R2]\JU8[Z3R-[13S4>7?:75$[6K=%O%VS)EM_'B^P%:+M&0]=Z3
MKPRU,DLWU)]8*DC9QLA!?]Q6E(+X=S_MD-K3E_$/IP5DK8'9!:32YZFA"R$-
MHX4E^9<[CO67)&:_E\P?]K,_9E/ZZDF;079KF.?6<=4VP:/8*ZE@_6P"EY%6
M5V  =\8S2*Y_5BZ+0PYK\[IR4IAVP6"3,\H50B6O++NMDRO)XRWGQQ\@8>BO
M/F?G&!?6W7ZRIRW<Y/G @\_)#X48W@XM@^YKH@ "ST_%%S*D? ._5^A5/R2>
M&\&]@M95E[UZ4#3OW!-AKEFY6)'O\ET9_,0NQ:J),AM,:E*WNV',66?\4&.S
M*&517$PA"05W%<(%0WQ4FP]! :;Y@Q-MVE@%(IZ=X%A]5+27U_@ET)/&%O@;
M9/1\G]M2#:G5MC--=\[RKS3U&51ODYM9:=9Y8-/=S6N\U"TS0WYJ*E5OUFCG
MI;R??>RBVJBT+#!GZ!\I0DF*B&!= ];,84)-8GFFMYZ*#,<8G[PYS4HD-^@;
M_:P/VYDWCPH!PQLTV#1Y[>T[%P$UTOX(S"GPHE62>;I1_,'YD]#\37,[(SN'
M4_VC;S\OGTDQ_EG4)Y%_*50PG1T!A8)2"-D> ]+9G%O#61U)T51D6,%:Z%LI
M=+&SH\'NYE5*6I-N&+#*UI2;#_#N$#NY"^M^$N>=:\"LS_Y:?<5^P(D&*KO>
MTOM5=^F?58UN))';46N:5I LQ66VH9"P9;U(!>X0YZ)5B)TM@@)].,&PM6P@
MNK'KX@K0*E&""BG8!E%3MM3T1,\YX0:+>IAV5PPIT5VF[JRAH>.U?82@:\MG
MAXT30%J;*45O'QQ1*#H# ADRH6.:Z+\%S*JGFF-N73U7&QC%571HSLD]/7@:
M,M>:O'=*<</468Y3_(X>-B&RRHY]>/RHQKAI(AYT1WYTX./9W6EX-8F.I+=@
M^8",P?[5J])*4Q>Y/CG,,UWY$79HP5GFU _CTD=-M2?).J\&F<MY3GXV$NQJ
MXD]V70,K@7EV$'<"QOD,;KUQM'_Y]^",O?(:ARYI)^OO?-RV9=E=F[.Z3]7N
MV^_<L"K@@0J60;$UEHE7-7$6>K-('55CV,+1^T(Z!&/+1"=!>@M&=V881XGA
M*$YSY&4$]@M@#XY72A%MJ)6B \_ V'212G%H/=D0'"VMZ'X"7Q[]@5P;?AF]
MH_8Y$UQ(<&6\F%P.!XH;_B#>\ 3;-$VFD3RS0)QDW3;X^1.1'TCM8*G !#;P
MC'J#=1JE.'-UUCN+WJ;Q(0;SB=\,*'\7*3PY4$Y,9?]94KV%K TE5=4O>4@J
M2H?]PS/J-*QBGTD1%RW7S@>>_:%]8SXT\CU!/\.X:DY>W<KU\*VB%ULR;:.N
M:SF]=!__BY6%2AG5^//(QV]:BJBEB50O<8/;\HU?7R7,=@I=2-X@IV4>-CR7
M)50G8EHOB2["KF LSZ3[)J'6&<>[#4Z3W 9M+T%#![R8$5PI0@\^O*AKYD#Q
MK J/O_SV;8LXNGNZO3?X96W=BSL:=7?BB.?BKD1]V_^C_>F'-QE6K>]<H?9Q
M:]ZU'?\3:YN@]D@^7<V9.U LZ>1HQ6 ^ULOD((2;<PX:FYJ C;GS>I]/><-.
MGM!5CM>*FL'@@1@J<NIVZW!HO];':9O1^V>&.L/J8_\>J4G'M[!::;+ZJ8FP
MD*S'&#=EOYBL&J1(K7A,BFA&J1BV-J*&40<@*_8!(9K<8=AZNX.+@=UM#*\Q
M[84H7_@7V]\"S"XM-\S8"&47R_35TQW1KU".0_2!'2M;ZZNDB"(U $U3^_,P
M0J.6=4N*T$1O$,DXR0T[\C"^3J[%-(FCPHP!K?!P_</0)J4>B2X\U XHBNQC
MN<A;N>2$$F+VD)M-!R4:KQSZ:^E@6.P\856Q13[;,314Z^PU\GQX[KGB)[#*
MJ1[F>MXY,*GR,>QT0B:J^-O,.TV56(F+VG-ZX7[+6S],+K7/[?.-4/[FX^QI
M9W;2)*@\+ZBVZ9U*)XUW Q@VE*S>]S2LR>C%GV5"90X&NE.'3?FK,N/B2F!.
MASXO>*YP3!?%'C5XWK_S?.0YL/XZ)IB5-*H($\;R=RK,^-PS=S;B8/NC[UY'
M)/G9*^R5C#UY\"8H5-\[;VN<3ZSE<56+PI#;Z14KEBVK-WR["7'"?1QQAM7M
M(ZB7=1H2^BEX.F0; 3I(5@N%83*KFY=\0&]D+C'FW(5ZDDZ:GNTEH2O)*\%^
MT,!I[LC/%K3\4--?Y/<V3?F\SL!'K[HXK7&$%*T'@OKL\I4_#FYINKM\:4!F
M8#>B<8LC"$@TK%ZC1AH%^6)9N\YB4G/]GM!6F&.'<\UX&"V2#1,D-S)@;%O5
MY)]QEEYCW2M%IP?-==U/]![)CY#QP,NYUWNUC]@DW7[4O:YB1S69@7L+//O5
M:H?CT6:+06R[]WP2*P0E/U/OKY3J,#@+A $4/3W84;@_S+LCT91A:_R8R. 1
MV(PU6_PUP:97?)\Y+4##)(.BV'3?(*DV.":4L,)*05GLM1]UAP9ZH%3)72S%
M)V2$Z S<)SP,CP@LX"RPNLW?8H",( ]<Q;(KPWER;-I?1%HK6JL>G$@A+8,N
M88&U<,+KJSF)Z!TA&K<G.[E(]2]$'V_(^?U=#>ZOE 6,VE3V4.!/!T&#N []
MUZBD&P,>9:5CZC(20-:8QIQ'E/"(Y)T4H6O88V&:5&#P#'*XCEX[25,MH_""
M,TB;<QE),7@=DA4<SXO0/_J!B7\"XT[UGZ]-5=PIB]%>6V?=1<F][P"]6QG&
ML\EF/9$RI/TB=Q2RHLR/OG?ZHN'7-Q?CO/.[,WIIQ/U97)[V/V5U]Y\L:N]S
MFCEWQW*7W\B!*$VO,T?\AA$B7UFW94D^8!0D1B1D:C,&.0YAV_:QDG(XSY%S
M$(1J]E>"H_@TY<-\S,>?A\5TDBX/4)H95A5(=.)1;4,FW.[E1$IKCMY?O3L7
MD9I.I2$WO$0VFU@U/Z4(C&0+<9Y-TV6Z"EW)',[J&JHJ42@P^L"*Q,!;Y5H9
MZXE]; D"\AC(:2.L)'=FUZO34$T[B-CF'Y,GB,4=9#78*YY'0P"1,TODZV13
M2C.@Y%"F>["S)70+,*"KNNRWC!*N^ R1$Z!Z'D>DJB HA3W6%9K.CD-"_A![
MKT0!?CS!'J8E+C!2+I',Q#2)KF@??!O"M31$,@)*.6%HS2%F8'$7-PZE[A2H
M!1?PFZURZOK\/G:$QEA-TEK%^WCJA<5>* I-2;0;'%T:.N&UZ!?81I9'6_9]
MKVF_$>+9O@\#.]EN;(AG^W>&[^'4+OZS7<4[U6WHKY!71LPAGCB;^DAD"RD6
ML, F/G]GYIXI3CA,"*?#P2=IK0$6/IJ;3\V2 LHG1W5I0LOH5%S HVG/9O77
M;\Z?;3RZZ>_E7.0GUG[QPUIM(+5.HB4NE*A/7:0.(_GR^.'/(@V;\?;G%6R>
M<@Q>Z=03C'KTU(Z:+K<3D><76#(/$:(1FVU*IWFN"RS11DPM7:P#M$@1(H=]
MW1+2XH^A6:="V&BD?=3N51_KK-BI6>L5HQV3)L@-;OW$W M6]7)>>Q\+4U3%
MKRMC]3 ]XG@^VQ>$I$GGP(=3]1)=!\)6CNN=?VKXBWK7T'Y2Q$TY08T444R%
M\5+$K8DK4D1W 1,CR ,Q<XY_W@5]R-%BS2T'1]QZ'\*ZT+D()Y=:>%DLW9?S
MT6$,I63W);_I(4>#D-T>GA>U9;=?;=;'^EBO]!JN;9E8^7__J<FL?)[VGH>/
M\YPN/G;A/0XX_M='[5LZ*M<+7N@:?7'O8WU%!4H1_I=92YN,Q@%CDYPBT6W)
M%0<NM4CTMTR4MI-K98D0:3ZO&<8"7;L3!>AET)';8_.J3J"0K^ ULS21A&K7
MBJEEDI&WYT_G[*?Z@OS/;V)6_RA\$ ;&9U5ORKAP/$;<)6,0RX7>0$^'R%2*
M:+W$E"(FNO&M5)&2BL3M.I@I><-J[Q8?-& L*#$^DV0B_?9*O%"3QUH85)+4
M@%:2H[,X,?4G4GRDDYH#<)>)*S&3?(F,4?#VC@(_)XHE2JCA/DD&A@M(]/,G
MI CTU:64%.%/@?TX!]X/A&.7K/]K44LX(Y8F^CWY;WNGJ:CH_Z_CJ/]:QLRT
MT;;E_Z.%_V@4@"!NSBI(J$H>S"%OAG^!$SX?(J2(8&R:>[B-'?5U>+[6KY-]
M^J!ZP]"@>BZ3IK9XLO=[Y-S-9S[3<LY-0M4J@^Y/YW9?B9!$O_F%$_>($@$Z
M2J1J+SEN)G@K152?A4>DB,<_6]4D@<F_-,0#DH,L;<A*<D03)[YV!K.X&]4I
ML9,B_IFG +/8="EBH,3!];#:[_NP-6X:+UH?QFY;HHM4,\=TJ==MG4I@^S:S
M4$ #J&8>J(1#F?BRCR7 &ML@@VDL=V&0A/[%B#U;/=R\<6"._,:VYPL/,'P#
M=!X3QDG6=$(S;N+[F/.81):V.57Q%)%U DS/H4:,@1)ZN>^4.JZXE;P<0E*"
MKA#F3 C!B96;^PN^;\SNW5'5<AO=?SE@X;-&-M^L8!?W?+$I7>NCJ._611)K
MY3&/[3WIOOYFNL>2]!Y4>(1E;7O_A*_A5GSB!JDW=&MLT)51'[97-K[5JRV4
M6_6 HIWTWLSVL(U%E%GAM<[''6JIE6OM5K]]=<6]T.5BNM;N+._TB\U[S:D+
MV_[C'H1P$M1SR%"2WO?GR5I4S+PD2'8Q9?:/#"J.!C$2';\X*>+^,8E8BDB.
M@BY)DF>1DBU[#:4(<]1SH'4R7@\SR>C"0.MX@.0L)HSUG[C\G\'9_WH'#%>(
M4@8FO]@B94<U_*6(;VY4. >E@9DLD%6-9W\'^+G___"&<+=@C0PG,XGU@C;X
M)8^0)),:+=1UL'K??C@NGG^J-D*_S;N@,>I25"@/A0Q)I;\)CRL*?=ZQ]O:,
MVV>+EG??&02=,UN]-#,7&UB[>$TJW41CZ_*_(77U J19:5(+;^)@MC$R[49A
M.MWMJ1Z9H["])_)"J>58:9>"P98\A^\/EO&0\G ^^^Z+ZH2HQ>H=&4U6J)R^
MMC.[-KRK*WE^)2CLY.Z[HQHH>>*MQQ[A?6EAUC].ND7FA>WX'?NO3<'\2WL9
MCQXQ\M ?8'X[9CD0@KU%UARTU>#/IW&6B\)EA%QIV"[I%1=0E72R?3[$I&JN
M-@U_-)4C16R@U[Z\657QZ,Z>GG_*=QR_4V0C0WQ %QA+ FHZ9OMXVZ6(4!IL
M2&G_50?G/?3W#T>!%2*S@!AP])NNF00=:8Y!3-NP4FV]Z'#"\3SE0Y+ET!?^
M5/U@XWEN?^36$!/MI<ZB5Y^IMW[ZHRKVCH4?.75U)D<SY\S#YWLOVV3Z5M%3
M6DY^*T6'6*EYKD\,H7_OO^-+>1=EM?HL"7?P@9FM>6$J&TUB636?)-IR=E1J
M=,N_V!&OY[WP.\S ZLC%"DJ>_^*V-PV4'UG";4#S>;09L9ZG./$:&''@.=R0
M<5:9KS;8B?QU\>OA1D'\0##X;NDK?O+'%$OIS$LXG=O83?'N:GOMKKOX_A[)
M8.]=1\&<T:IT[,+Z "YR.,_C>?6 .6OX$G=K:5F8Y3-\Z%(Z9?:WQ7CZ8E:_
MDUWM>/X75GNYR??*R(#H7(5;6XAER8-'O]R^CO83$F0 9"%%G,.,=+*I!,BG
MA?,16']^AT$-* -HN;;0,EB*8$L1FX1VE0,SS0;UR2+TG9MF\*76$Z,?S<DA
MSR(LI_%UAC^?K_NSZJNYS&.5B"G[[/PU,:&TCV0_C\ ;8Y8546-?C :_NS7O
MF-<)NSKQNEO--@BBCZ8[<;]5DDHCO)=\NY#]MG0*_-*&N=?FBGK\EG%<$E3;
M^SHPS.LE$,"?KBG<V_CB]&X3BQCYB"VY<!8M*ACQX@-?/N8%+7&L?QN4X9-X
ML6O/,,Z5LM29]<$MZ^A!V\=EH0FI+N]+SXZ$2A$G /":9)"V$"5%*$@1D,X\
MYO?/'BEB-7).=M !!;*DB/7O9>R19G>E>Q;W7Q-/[[,B.?**^+'Y-.6^]JLQ
M#S3T3&!G'KVVE[R9Z(;S/?9+"S-LX!Q^Q.N $Z!,),<['<GWWF325=F?U(MI
M,.;NOK?#WR^Y(J$CH")@]\F@3L^DS0_*^Q,F?Y^MW/8F?$V+.]VZ=MO)!][!
MTYJ7@W*^P3::2;@T=B!XZM[/GK: L)9:K=3';@G,8(WO_70W\^F^W OEQQ[T
M)?^8_Q=NM0#\&^QW=?6EA_[G)^]'[?QW%,+A7XG<HIKJLO^Q<M^-KA)7S/'N
MR!)_*";Q@KVR^9TNJ]GY&!W7HK3J-_JBD).'3JPY=P:A<V<E:5%H(F,#VM\M
M.*F8LS $]D\-2A$U+.I7R.46;4U;>S'O=\2Y#^>@585%^ YHKS:[KF$@]][Y
M !MRDWEP^E/O&7??5A897AIMF6]&&]<-D'1-6^TL^?O[>4W@#O4&N]G1G;5Q
MCIX \G P3Z$+8_\RTR.MMJBY N]]ZFB00DR4ZN$'9(*DS5OC1D339M(19I\L
M@KN<FKUK:>V,E,$&3&NRC-8^'40FY9[JG74EZW7'%\-/?[9ZJAQ0Z"X5I[*]
M+].YXQ$>@=03X5Z1I;>6+]JP5C = D&#_PK%[QS!8PC3"E *M,%ZD2J[@VP]
M0-Y),OY PE; 0V/!J=%(==$N.$N(%IV_"\>RFW9D'NZ1Z$Y:TA1$!^)XP'KX
MDAMHD91\-IW7>(5D/?0$B M_5T-(D" ^V,9"&)YE3E$>L%YTMD]D$ #IV(U_
M:;_-<Q^K-';]8&YW<.;0BUR_/;JGB'$GG)>[]4=$%+X8J(DWM7_>[_W-1*_C
M+4*D P(BM8EFVFK663L<G]%!TR*9P5F,:4X--KUI&;D-7_.%PT:ID Q!JSDO
M[AM;@[%71TR'4:W>$53*HD_W7R3T!X+I(G8=Z334D7">DF#K8<HNCR3KA/9B
M;C&W<V\W$Y&\V%FJ<)LWT&PB<X9\8[X.2@4(F$]"K0,B,8EH?7'9 G8Y7/3K
M=9.&N!1M2:QX[6\[("(\"=5"4G8NHOX*&45#V"2R&:S/EF\XT5OC\R7.$;1X
M):*<>F[%Z7U/*9P<W=!C#B@2+QWK6S!%$N-D'W8*AWHC-C[KK8G7=JQ)8COU
MUG1JG\T8[L3VS4:,U537U&=8FU069FRXK7_8M7P_ZKT<>TTM:[TL?1I(C"6M
M>IK@KPSF)J&+Z(J8*D5$HH;WC=4W*SJ\UC/Z4!MO.@:TH=*D".5O,(&[KV*P
MAPO2$YGN\<6D(R! F6O2P8>KHXUZDZJ_ @'VX:5?7M6_Y=3(M9DNDWP:KIR?
M6R;<#JMTD*U@.:&QY VGRC)!>&PRUZH%HSD5^Y/.!D: L>X.C(;DW0Q7%\^^
MZE_+ U D-=@)_#/?180?4]1V'C@+OIWQ'-4[!=2*CB]%LX8.JRX3#<*9/ H;
M/VS*I8K4A8)GL(?YZ&;Q?;*)Y#WGSV"Q/3#5-"DF'\EF;6C:3;*"[?AB%1\(
ME7!ZJ.:5H2>TUAN93"* 0]P'Z"U^>Q^^@AP2=YJ;V$S/V5J@<L1:1$\3%^1:
MXD7%T/N+]Z)U]4R\OB0TAD5-":;([\<0[X:<MI]#K-KR]Z[P'#@/I#<#&\PC
M5-A-=GW?+=+E#D+U">B-]L65XO&"_')BPFLM,2V%N2-WL?+)\\.5DP(]_;[H
MKC-^2%>OA<:9+LLWC(BG^C>/Q&M=P]SD#'?P.CKR4"-4_GB^%-&.A8W)";*D
M?KP/$YH>=UQ,0:\D;?I@H<DZC5$6*5#:;X^0UFMEI.I$C,TKDS9"5NS*@[U"
M_GQJC% 8X> P^-06;S#W9,C[@)IXT$<[(2(RLM4I^O2MST]6IBE<",1;'\1/
M[%YCM;I3U+;+Y\$0Z">\+'.)_6.@1@=AV+"%M0H8J^: [L;S&0U6<]H\ZBIX
MG\ 9G)@MI7^$-\^W8:%(/SF)*O(:V7":O$KR[D;W'E^B_FL]"U:F3]W?;<73
M0][ +7[V40+ [++]Y_R.XYT7JO+V!1J-;AB>.[NK,*8A).M,^+5/*O<& O<D
M;2N\@%C9\#^QN!^7)LA%/<<E C*--+Q3P.$C13K:W/F;P]0Y8UZLN P(1WTJ
MYB65<S$RC2VS^2N?5J70IIV]%BH/B=[#WP@*).M^_3Y;-3Y!Q6N$8T79V+?Q
MV8L70^UW?UW\LUE"K>F<0:GD[9\Q3*SDJZR6;EFH:,Q98&])$>O(.J:)Y)5$
M'=%^J+1TJ!50.T7T[&NMS]W0'_T<F6B[SVXI3&_K +J_.Y!>&&+R].G9I%$L
M?T+ Z"49R\T%"1U(6Y[+TI6.,9W\#QHM+B9=XN&I^"J4C)]__'4<PLQV0HRV
M)4KZMR8X!P!'>%]']U9#Z$S0E$]+-F'8^O"<]8_VC ZU#J(W#SZ=*ZVA^MX*
M?8T:T4@M@DKP2)(#LF6&NA8+K<*LGKY-PC1"PK!?Z'5Y;>4EQPLVO( RX?@^
MOQ?@;.ZSJDS_"*U# P9]73W/9+UV2^+&7,/EP#L(<]679'9>,P^]Y0L^B#-(
M5J!/.T:/K"\9Q=33$VKG%>&P>;ZH"NYNU:(V(Q.!YPRJ>73\<9)Y/Z8^HBQY
MR_-,KP\B%6Z7O@.$R/YY/-R/L/02TDA<8.G <GZ@'W\F5SV5CY2;)F]HR&0O
MY?]*LG4LGB)O[ GNI<>K>/66);B!@I?T8;_G?3'.ECSMN:V2#9&SWS)XHWLU
M()XIO)4A4L5P/]'80/6?[7GZ!.D?T!HF3)O+R=SN890@!EXF/"$Z +[/T7I;
MI(U-\_]C[93:F<:8Z!O=;E#$T\;R^(+50(UIK?;=.]\N(,_(&*+]-+Y^L$*X
M,U0#4^_Q/N]*#,&RL%BDVP3%4IA>7& XTQ.4HS##^95RCI#<'+YX^@=*?ICD
M J%NUG!6A%=HW. F88PD2WBEFN%W5<< CW"NZ<<)P2Z(.MOUB-C9+D6H21'G
ML<,$ 1MNA%0<0<EM'E6#= %"I])AU)%JD#^*#0T%J\<8UZ,)2)$M'!Q\*>:1
MW^?IBU/9-AFO*MYL"<0-+:ZHJSM%GGNXMBO0NX=I1\=6S"S5W2^<LJR,S+$I
M> Z$EX4.SL=>4LPJPL;%[5#OL1@8;WM5VO#&Z/[3X*35;"<C_="AK[]$:H$"
M3VABSHYK>D,A %P2"C)@4["C@[P)BNW@?.0XP<T\U/6KK#D5;@5+P;F4Z/:+
M/;KO0PQKG3>'6#'V*]6@&I(BDDAR/(X23&B6[!DH3-*U;UU2KZ"'Q,;\KJR8
M E8"D>'Y%T9$9\2E"X1KF&J42+GC-1[%"C*Q]X.YD#OWS_#9-:13 \QPX7YB
MN.R+3I/!]%5"2DTEOHVC@5X5AOK+=M]8. 7.BN-)$<C)I02X6.C2?0JOU!5_
M<9GXL"L^!:C!M0,I,EV&&;LC151-I%DP-(AYW/DT3!@1,T8#D!)STF&03#=-
M$+ES,6O)?6@,;,'%I/EO_F#1M:LYBJOKY/Y!A'\Z5:?5=$]07Z"7XYORTZ6@
M=_K]FB*8PEN5' .B6FDU=)%*!Q?5BD]%JXFS%EDC/I(UA6 Y/Y7WBQK#TA+I
MPG%"WY%I;VH'-=%?7J:),>O# 66F<1%10I C7C4.,8".-]13L.VOPK#(T:FZ
MAL$')J\QCQY_)<6630^S$F/\,/;0JPEVNALW8B4C[<D.6[O'?I/M^V9"@T*>
MD#P"RB?-Q'6JF5B@_M0[?:>Z;$YGP]&SV"X6;&B9& [&\EAS,T)#(@H/76X$
M]0478 [X=F2LBY)N2^!A;BW1V!4HF8F6V2Z#K-KQ\C(EI$ED>0Z1W..X\PHP
MP[MQ:,'$L-7F/;V<2.YL-RZK' GMF0+9OP@=QOEV3$UQ<B5)&9+KJ)1KQ0D$
M6ATW%NPPS39/%%:6VU36%3_Y2)QO+=#NC=QA,C]KLN*@YO?OQ?U:O2=K5U-M
M]Z-V2#KT-*#X['H(Z]8$+U;"><>>P[^A!K8KZ-Q-:=(>_@0S3E*]0[9 B5V2
MVUPA0<GKB]_G]8_MLM/C@PI+BM_<:-[Q4YN<./05.]N(210ART4.$#X)$S"O
M^YE(.PX/0 3G'J8CEZ H4JX>8***NBOR#HQMZ2>0]4-QV0X'J@V/,9_U^D_8
MISM2L*\:ZPUFYK!P" $%])1(>O"_AIKQ$I+YLD4UHMQ<P)]W?,)C4L0G!/Q&
MBG@\TQKS'F#;$X62=$.!S'Q-3?)2Q$\N8S<\ MGSJ*V,!(P&6F>25D7MZ'0.
M[I BUI+BQRHWS[OGC7WVCGA*YS'DIX?5$ML+3>K;*BIN/0EH8*4XO329BSQW
M5/U(RIH2!>W Y#1Z4NO![6_=V3S]#97CVT\P-K1%5-PMRJ[PK/5YZAMMZ+X\
MG>ZR,\;H]/.[W)5,NKM<*GUU10UC^_OUN%#_8W,FN-_Y4YP?R.=2!&,?7JR4
M=9%U.@(SEL !72=-(AX"B5I[0R*XR2EP(WO<R4&K6,WPQ(H;!]KW6T^O/"5%
M4/X01 ?,9.84"O:$ 2DBVT+T_85#\A,65T.[2F@>9[J4@DG&472N!$D1&\H(
M55)$#M&_4U)FR*]5$ZK(\$]?EC$S@![#7@Q8"4H14L2.D']7K#GPV-99BCCH
M2Y L=Y B<BFR<.53,9-975($Z*\A1108_B/["]N=46#S9X>B,-,U)!\XTER?
M-Z?!UK/NG:4DFW]:C#><;1#<%%A]"]>.$UL&Y\@N<=T\NC%=<LYKE2?K83=,
MFI@K%G<GH&#"(DT2$?Z3S<6)UCM(Y#7&\%JGX$P/&!-Z*2@\J'S$UE+/&.S\
M8IY35[GBL'J\]^JWQG^?W;K_X-='@6WQ6%F[VL0OI(C)I#  =B/*M&&NS"D.
MHE.M ;D?5,7G+_!JNYC&B3ROJ,N7O--W;F;SC )'7=WE[CBLM'92U#F,>?RV
MUO9B2?YA ^M!IELHJ\W6GLLH+?.@N;&)P=<@JYW<3T'WC@T\$^U+Z;SP42[W
M_=,]UF^KZ;A=%XGE/4F*'MGOE8JRWPFH_ZT]?RS[GCR,^0SOEJ5=*<)+BO@V
MR,1+=%.%45)$S]I^F05+0+P487X78#^729&E3;DTB6J!@NR\.ZP2\LL%3RFB
MXL]F[$0I0G(.K2$TFYH;:6>)]@9A1*!=L02U5RB[QZ6Q#HFV.%B*R/,6;Y9U
M;Y!DE*,G182;IJ+6DS2@4-*J!DRB1,^'6.R$5@$'),G$F+U,IX"29PT%\_B!
MWO" \*CMZW?LMLIU%;W;[BF*D=7ZC.0SL&!O@1%MMY7U=9<!.1%HMOZS ]DP
M($##I=#R#I3,98)1MW*_Y_!8B!&B.[8./,< !R5+"C#I<% %\]?M&3W;GHU.
M]H3S4$5;E'G9F<<!JYVHR9"^VL(5VE^0N;63^(C,) 8Y;6=E\7OO_%F9C;R7
MOOMS!H+=D1N.T <&C;Z[.64.&W^ID!2./5T^E>S4YK*ZG*<A.HQ?--)LY<@J
M$,FOFG[IT(^I-HM!,?J*T\H]3Y)?@.HG;I;.Q:?69H8O;2]J\I.9/@GZ)=;"
MSLF //[/#(0)MH/(W(K*FNP%0AC"F3&&%('6DAAA^A*FC8S'.?\]V5C\E")>
M$ZAH3'43_ ,[.P4)VS#GQ0])05<WUS!A_,51=64XKOF1[7:B!2WELF/$%?H5
MX/R=H2-6#3NBIG?;E2[T.4;?1I!ON^)W2A'_FIV*)5K:'9R%4$P-3KP(XJ0(
MFB+B$AYT1?[>U3UB+.G*Y!,D%=U*N-\9AI_QOW"_91<=G1^FM>,UT'O)71@4
M>2WL(_" I^C$'!ZC68JX14-&*]K[OX0Q$45>X7H[P:?EA:'UWJ_:J&U^!W_H
M6HY^%VPGG*U]WOC"*>9V87WV_D< M53F-NN!9H>#CS!K%DB)"'[;**I]_P0*
MVCV%SXD2..5^N_>YH<SO6FO@]M[F0;IGM(=EX=XS=_F:EP9+OG/GC;=6#IP'
M,,0W+9\/T[Y],B#E&+9_B[[PZ9Q1^M5[IWKNAGH4!&@]HV-"4]BUV]U=PMXZ
MY5PNH/#;_K=2D@6(GZ:J !]RM*6(:SVR$"F&.+ LTTD1AY[*8N0&R!)!&-V*
MCY)EP!M/D".^.,A:Z 3P)1R0AX&W38B5XV4WDO^SD=Z/]D9.$AX\U UO(]Q@
M1I00,T_"!X(O!9[.O=&E2$T1F?\Z'KD@S#O*+*5Y)FU6=\RB1:?>7/'499EP
M7K[*=V@+M(_-G+!\C>O\\82>_B)P][OG'Q.= T"BCEY4$B.E#1<]XYE;>C#-
MP*TX4:O*-36*;O6=]8"/5" =[@!I*J<O^.KFGXFZ]XYBV<*]L# 5H'L,3H&-
M:B9[RDKOM\B0P_&(D?N-1MQ=3_J#'OQ5F<O\]]1 A2^;SLG0ZY"9NQ31DMD,
MB'IQ0GLI8GU%"[!D2I092RZ0]?L#L!9HK1)O!"9[HR@2E2"\6!FUTO4_+=#U
M7XI#03M81U%+Y@]DJ'OSD\Q/#U'Z /"0Z6\;ZBV.X, B38RU5<#WMP'6--"E
M^U.]H%C\M\2,6,W#M.(_=?/6-1:'<Q0)(LW@T+$O@=Q:0:DZ/99'4 QW_>S+
MKH!GCM3[J-7V/"V.S9CZIO(&H52E$2V^_^]B%]\RBH;6.;9*]'D_(_7>@2^;
M?-P-_KD MH^-NYTTP"O>;&.O=[2IV=4W4;RWQ>S5ELP[-26U^&E:#TI&1:^3
M-G3"0-H>6V#=1/0+6FI4UIYW;U4#4I(T=.\%+5Z(&==!FVIC/_&V]Y;;1. N
M1MU\62AW5E+TGZ<1D:\D%UU4Q+)&*XB(\/50WORPI;MP+_F#GKX&1SN]]Z./
M/\GT16;+<HE:,'L#P-5\1?6$Z<'AH9=M&7/SU9-NG"E,T)#).2%><',(M)]G
M@1]&T5)$L:.XB#7/N,$2P2'+IXVZ!VK2#?&]BXHJ?GWF<^&'!RH-^Q:=]3VK
MZOIK7AUKF;9,FNX\\8R9$N[4Z73O?E'!\+?MFW(MS][6=)3[]J_YK1NN%SP;
M(JWAXE6(G#9.U?S<FD(8V]R$&B1Y\.+#QLGKN@C%<!Q[..8]HS(L9[TWR>=%
M8[8NQKGZ96/V/I\KW_6LO4XG>1TK7N>;W-5Y^\#>ES\O_MAF:(4.[\C).MR9
MEVO+9 [YUKNZ-KOG/1XKW^8\$+,W/K>LT,JU?X)IEUM6-O'^P5[5SZ\&]*%B
M0=^?A_YY*)E]V3+BT6Q)"K@"HOB&%,99:&4.V]A4R9]XB8WS+GJ>Z]BD!5=I
M)@ZQYXYPVS%<5+_6SV:K;_9A#I19>_T??[9;T3#N -;8AOW9J-,(>VV1DTA;
M;VMG5Y<FXT9;P:[VOP.W/%&O!U1$^L%KDQ5+>R4"S"V]U4[SBF'KE\5NO1\:
MV1LF-[4@122D2A%C^3\V-X1QE+UT/62PW6)6LK8"<7(,3M,[(/>W(BE=Z <T
MN[+&9"?6S=_H2)#(9"!O5>65P!5ON 2]R5'M'G/J+?+J%WE15OX;('-OX6=[
M/<$>;/'T&N!AF*(4L4EQYX0\;GH7><N%;T%)I5E1!58[N\"3_%GP_BN=SF4Z
M4H1Q:H_-J?(SF!$0NGSWV<>7+FZ.C_H?Y ;S]F;X_?T5?OM[GN(;SK;%W!O(
MJ\S@BH[$9'<G7GIIXAM^NIA:ATO)90:DO6Y_$+#=T.@D[P%V2M:$42.P.\-V
M7S'<V%RPL8>)XQ*43K'+)_TW@X+2X"<AN4TTZZW:7?O<G^7&[>N\LFM_]IK\
M6.--F[*N<1@_*^!E4L1*!9F:%*G0>;4B3!6F8P#^)-P7YEW!<00[>4$WE[;F
M5X;^L&%6/(8C%;X<X;QN,CVY69]'6#[-""X_1@MA]46>/M>7N>0,&HITHH3*
M<$++L&<%WU2!Y L:)F^MHPB#V563#>HO0P/)9W OG$U]JX<>4G%]*Q*S!R5.
MNI97/JS*;OGT<T.WQ3\A 3^F']C?_O8;6 _6: ON#_KYIQ\=GS,P=-A;Z%)Z
M['Y$6-3=^)**(]8Q,9A0%^4TSH<+W2F?[1Z\?^KWX,PNW[T%7)4,8[G4=\\\
M+L[:I]^M&/?JLCWT;,.L[7SW:IL%:/?-.]'3+[HZ%G 2^1CS02GB6<Z<H@7S
MIT\7BF)K'9@[&KHQUTRFBB<2EVW?<?S.IHU9^TX%.;IG;4'Q@X6!WE+$P^^O
M9$[4Y2-%9!K_RN$[B-1H KR8)=$D5@MLQ7ESS#@>(5V*T'[RL,=V^<-I+<_$
M4N\P#8E>_PY1Q.,M2XD=M]Y9EJ^ZSLWWGB$EK/VPNN,=CX61(KA_=D\6*W7)
MZ*\\=J6,2CCB^S%'&,JVMO]8F]JT!#_P^OMTE >QH&YSEM&BF#E^8'QOC(&K
MD^*U=QN+I@]&N6:%'(,(GTKZ2T6[%UZ#(ZT85=(A[NQ/MHMVUXL^@]?@.911
M^S=?LY1.Z-X.R]"UOZS:L2O]2ZP35A2G9*BH)#&VV5P,2P^[.!'Z@Y'$JK-@
M+*V;X<"V ZS?>ZASZ>&2A(9?$J0%07*<\1+XUZHZB/9I"/A21)%FN:PECF,L
M2:CQDKY$W_0F?L'W0K?$%_AY2R([/?G\TB&@IX)/;91=UA, #@G::Z6( U_B
M9*B46R_3?[@94]%ZRHG^2."\LXMQ)?8D,U6B2LM O67V,Y[RUC5M 3?BUOM^
M=MH0L_;U+K_7NQ%CN;]E;/I?.7C6+SF1RKS 3_R8=7:>&DM30V^4O&^R'5S0
MIE+(_XN]-P]J*FOWA>.(BA"524 2E4D;(:V *(3$&1$Q*BT("&D;$4*$M (2
M)20",H-II06%%R(R23-$( &%D "!I)5&9);0D*D=F&1OA[ E S>>K^Y7M^YY
M[_V^?\Y_IXI5E:+VVI7UK&?]ANR]UF,)9%\/WC!"W3(YW?-DQHR7RM:-3TOV
M!05THF*?M#_J;)A):NB]XWL/30?E2CG>H ]_EY@_N?OEISK4G[N?YV&W"2X^
MW7?2I5D!91_UE/QKYYEW+SYXB#Q]G@S/^ 3/+(SBA]%PP$2(L "3^5<6L,!,
MUJ>_<G?*_FZV*+B\;SAEL0*^ZD3QY3]DN[?\RS.3T9!<>]0K7\]_\BI[?X1<
MO;/__[>RI!6%*7<DZ,KBO6:TRFOF>@ I_3V06A);$7PP5%88&.F@>,]?V-,Y
MH\]<5=$<>:/T[YY?_KE@Y5I4WOM[=F+4Q7O;7U+UU'2TO5P7:Z3Z>0C%Q<Q0
MK0>^S(MT9-VIU9)QNK[*F<T"*RIVL1Z,=S?'B7!I<^P9W2J;/#MYZ"/Q^?"2
MV;/.]8$W'$)R1YS%.1AK$)/S!SFNBU9?*:R-/C@R&Q73&W)L.%*C(R:T5!3=
M,#@8%T(+BP9O'G>HC;H8ETFV\;AS?NSN4-5VKK?Z7B0'*>TSUYJC\Z]Y(7"C
MJ999)%)UHX2 V3>@<@:N#>!26E8_<4K80],5XROO2$=V[5+M#XF+$;714^W9
M">CS$]Z(O,7L>YYZ,"IKY,#H%^,AMKM%;-O6Z44;1F@UT?7T4,VK\K*I@%Q\
M15'5]/7M)/9YPF+R5$"!?_#$42/V(*%Y9N4]<[=$1!MU U0JR>_&B\02'95A
M$BK5M9>;#Y)DJ+G>&K*YEJGQ)A!=^ECE UDH?R33VQ'Z^8JH%BA?,IS;S=-7
M[09)TM$42HCT+>B7]NC>@@<MT^QC'=!#JHK8='R9LJ0BXF94<\74XJN<)^>G
M19C:$$+55$#=PS@2K6+Z9J1JX\3Y:;.$KS7W1)-O)D4]1KWE$ZR&\;\[=D4?
MMA1,"[[2W#&;(%/@L!PY:RZ;3T2NQH;.B_!= ?19)E@9#*2E:_GM7U17=1,E
M#KC(P8((/<<.U_+W_+W00@7T_D("34)/1CO+:W5E?1V*04I8%62SJ!=X^%E3
M_2"S;OMK%FTUM$):2!,-2K6$L&E<L5?]"&.K(H",SE8QC#I9T"?$KX] &G!M
M56X@,QWC1OV+L8FS#9@_K/X7)U[>MYXLZI'Y9>WB729P$F1M=J>&S84N9RC'
M&%)2"G7KM(M9^>.:*\O4'OWX%-YZ;#@]!V&L%0GF*@(T6 K)NXKW0>4 3C(_
M1Y<RTY!&7\<ASD%9WR8"8YGJ!A@G'>6C,@($#6?/JSR9@9!?A\BXK8HX6-8K
ML_# /1O^J/I&J@B#S.5]R>8*ZY%YWN7Y,:8\3FB!DL;-X95[J"]O+@A1IA%B
M"W2"7&P(^74Q#'B1I"1QHYC.(]#60X,"C16(X %* 7ZSQHR" XL+ZV801MS^
MF+7LHA4>H'%B!>$F(ZWLV2/X]/BYT1CO]01AX(A3[9:(Q=KBE+(BO].L04%5
M[?2NF<H/BU=;"Y!-T\US6[+"*L=O-,>=O+,UY663,_%;,VC+M]"1^-WB29YB
M&\2=M W0"#R9UL#H9(XM*&K5C"\\0^TZZ,8;L/&W>&8Z26@"&/7^&$#+IFZ;
M*?X!9*?<UCA !R7SZ2,!-M4R77DYGMP77.AMO(A+W]Z [ ]+C?5W%NM!\1<*
M-D;N;2R9<JUIDMRS_V?HBOW'R0WG5V^W>2#0A5&##S@M4X50Q_&;O_(R\$VC
M7?.0;?.<5@OH;*0X0Y$21A;6)/\@3SNM6J^U4@GX*<3\/CTH37 ]>"O@T9'%
M%"EZCFC: 8\N]0^"H!5'V&!%LZP59_!!U#_(]O9=XTS\\TJE9G!.:JP  C.L
M'QQ<?SHC+-KJ4_K=TYY.MU=8,9MC[AS8]4_3?N;[$,4=;1+H1]",W[]F(=-X
MK#O)$N0*J%J1K'ZFV:%Y[>+*:_^^L[A0IG-'8TK]NW@/%"]'FJE<7E..[GVN
MQZ9GJ7:@C:*E3!T*?C@RBN,M;=LT?SC2^-4KDEZ'Q?P77.3*ZTU 0.?FPY'K
M3Q^QF/38V)EEMOINC]O3<^9%8T5W_#.L"F %3U5:CMH^FDZ;U:FF3:WJCOK?
M-RX\@DNC,G<\@L^V*MRT_.\/:6GL4G,G?I&8RKW'+*1IG94SXQ9>X46Q7H)5
M/"-._0#[A*+?1 D8&U4(4)&A="/+M:9>C[MWVM7\,/!>B-&Z9&&.RES:2PD*
M/-[,W0K45I24_SVS%QZ>[UM+TOL"W](HO(86;^7;@@DR>@8/.(-,[J<$J'.P
MD7@(Y:$RR%60\&:JBU U#<2(1KN*K8:Q$3P=:(4,UVT?TKTI6+5W=#P0!YU;
M$0B\78*-8XPA+9O\-!"EV0QY^/6SC ,W5G3=I44/JXQI'4>THZ&/6;9KT"PH
M1\H<-U"L!N*T,&BK6;=*&4Y9"^9W8>GXE1RB'&NT3-Z7(U['W1DT[>J2H975
MZZ&\=Z.*5'4VA40P24*[@+8_%1Z'<"%2DE%XL?X(N\WAE=@W2;5"^90WD'\!
MR/F8%EH[[>M50[[V_@0+1!3]6ET3X%!2X5YF-I$SYGNFZH"-ES(P*>7H@%7Y
M<1DO%3N>IH@=PDK^M01C4>]+:"*F9MWWTNHO ?'LL!R?%."7B=E,28 2Y/ -
ME'/UH)]0EV1";A(*Q&N_OD!;2PO_Y&R[40*Y]G6XBM-JF*R'N QD5T#;W*OG
M90'A=[OCU2^@:GX^U09P25=97Y0EA'6.:K8"Q?72'JPI1*B]HCHL[6GS\W@V
M:*_"/7([;'V_KK',^]>"NM\%DU[G4;42&Y.,Z\A_2)IU:;(EV#)-5_$.=;YF
M%<5+F]656N,3Z=R7'>#2CEI&=CP#"&<#"5*Z!90O_#0!R04M^%3NCZJ+9F_+
MVUBT#9J=Q(%IC.[K1T'Q9T8Y1PF2>%WR%:;#KH]L.P ^,0]95E-^*M2L;57N
MGE2%,^0)\_2O>#A9>+YEF$:P\%V"G8,FF.1H/^B^W-VC/=@:2E,_&<!_6!S-
MX.A$2VLI9-]W\<U 3EXY49K":<TZX96!/5G]N4>SUEN>8RO#S>HJ,=#\ 2A#
M>5IU_K4*5T9N]AF@;J..-;78Y\\A940=*%'VK'8>LVT<NOEN_CC>>KO2)!4Q
M(,,Y=AJWK,]?&>343DU]K2/$-GG,8H%HQ1@0E2;MRW IQ@"T#,XVFO-"(L:.
MLAU*EF-3&(:J#06U@H+B78,4K!RWG#B)& GIIQ ?3_'YDSOZH^H^QM1ZX>[;
MY/4I#PE/M;(^,[7Y?X+YQE$VFH+1A\R[L<MJOGQ_@+46N,18SUE60C81B#=J
MS,9XG5FMM=C3(YB-D%RC]9Y9*A>7KB58"M5JB-6JY]>-@4%W49D<1UE0P%IG
M;^*I-AZ'^ZQ%K?OX%N8,E*/<0.UA&']EI(OZND@IKG&9:=VT1"I"74B)+A$3
MJ3O2.LT8'?/KR'0_,"Q5Y7A1,FX1-<A';.&^5AVLG8S09J+*N9R <!A\E^:M
MM'F^;LKL/$O&L=="J%1]1V6K=*<<5>?/:8PN:$7;.HS#3*V,E[E"BP307:V"
M3J>Z@]G1X8U35&<0*T":0LT7H/HJJ(^_ATSDVW9,_I OH(T7ZR/,@$7H%^4)
M,_>TNPL6ALLD^,:TV6X@4.$-);CPL8F3QFW ?!H;OHF(<02-2YCDZFXN%F1F
MJ\)D)HELWF;HL\R$_K7/@/Q>B-@Y5,IN8#\;Y9R3Z06>5:Y*+:H07D4P*L?&
M#TZH?GKNA5TVT[R)<JH9VG>W-I5J.4%?9T[3CQJ:?>V4+%",%F_6ROJ[%\M0
MBB).<L*B.C]R?FPB8=TS? 9>A =2B/@Q)/S+?&; G7%4(V3B.\1*L,2-XA0Y
ME0^:S>ZT$>/+QK/6<'I/.<9%[K@7Z)2YM?&%P1.==D9]<-7*20<H[0J/??FA
MW.\9- Q6O*6:=O+6K!+2S["/706-5SR:JB=7SRXFT>>ZEV"W;\K&^8&&ZH*Q
M*\M\U<[,WKXW0LTF.N3)M4IH5EP#A+>_B*%@I)GV4GJ-RD=2..'1T4)7M'XK
M7MTP&#.!$/MQGS84FAV*,$L8,KOT6S/#J$$D<U5;/EJN!?S_8WN.70=9\H-U
M\[L=R=$XXEHT0=;K(=!87F[EM"AI&;%$;U?!$NSTF3BT;/ARTT!-B'%>DNX^
MU3WP -VJ1AWZ_UW&Y269U($Q _)*Y'H^!YX2[<0(Z '$ZW8T;^VY^P2Z]>$F
M*DUO6AB+[A]C*CS2OA3B&_VMV^HBLS4XAM,GS^'^HS CCY\&OO1&GQR*"2*>
MJA_^DA LF/<:9A6='1"?'G3V=CS=?&]@"79JZ(J#O&!$(5",$"+KYAQ^R9M\
M-^F_K< E9\Q[>@?!:="SHH!0-NCM]!]_VL\5@]Y["_X/_V>\6J'8K[YKN H_
MAE?\N@X&@R=J">(6;#T,!@C^XSC6LUJ'8T']D_>%B&RD:[0IE(I7_>77/^3G
M,@30ONC<7H)UGD0MP1RWX,<>AJEUKXE5+J%:-=I.T2Z1];%*2UI_#?45%@K1
MF-(^[\;GB('3.&AK6,<\'3F.-\1>&GW-74$)OA_EK"M>85_%AISEA<.KSVP>
M<((LN$BBR=GE6540=21RM:<I9D+ZNM=^<0EV^(M?\]UW;SYNZ>+X>I_=O'/H
M^R[]#_V+=7ONEQ6MCS(9.Y;JD%VZ7WBO;?\S0;0BNN*M \D2+?EH*MNUZF2K
MTXNGSN&G/J6<V'P% S=*K;Y<BM?-ZKP(?/W@F_+E][!]G@X!K(B.9XQ.DQ2L
MI%3,ZE,95':72I@"QILLQ>DA*I9B^?QX+68[N5!*3T-;@"<&O8:<!.Q!5&ZW
M6,])Z07?&!C1<F14[Z)<STD4-%,0-%OUI"?.[N_C2[!1N,J@45$)HN9*E):J
MW>K'Z(M2;WA'L!58,_DC>QCM+FT=5Q\^S"KD(_:,<G9O:4D0/'F\!'O):1ZX
MV$*NT\(5X5).:,PZXC^H\<.:-45*C&8<BW3FB0R$-$/JCV2O;LQ6X'V*:O^3
M<,W&%H"N6)/<>7T/8<1D;S\18SK$+"F.]\.S[8(]#5ZF'A_Y\:W.!_ALLM(!
M<E0XJQFJC4HT><4%$)6!WBW)0!]V+VZ63;&FV#/?5%XR=[^NT7FRZ%SJPY^K
M+#[6HO?6CX\)+-F91G?+?T<SOZH\'_QZS&U[!\[JY8\/PS;Z=ET$36M^-(V]
MHJ^_)P_1(#B4\X?ZW""9_LO4'V0R!I\BV'V5MJJ=LE_X+_>NA\4F>_\*S9:\
MW'<E=/U]W^[0V*OG0K><,@J%LL_M0@3>[N*<Z#C&=AV^:C3C-9$=MO.Y1^Y4
MYH['/ SVE_]9]&\_R?RO)@T<=)J3;^8B:@)L2BW)[VBSA^&WD\:/X]*M$5:I
M"3!AN7SNBO.#T,&K&Y47(O4!FALM1._L6LX-<.\$+4+M**!'@T(9NY.R+X,*
MSZ)GG(B9V+\$D_X\3KLX=9?\K\!7&Z9#-!N)622]^P/C/4V!.'8I-0L2SM&
M3"AK%F'" MGS"O<EV!AZ&RWNXL5062"]\<7;\&:_EC(3U]@RLRR9R"MKYD;M
M+_ZZO>:/?J!A>"%XZ 1-ZJR5SGUC/#["<#!-^/WU#!'&M1'T2T(YPY=%(,<6
M+\^O(BQ>+RSM^&-Z[^D7;PE:T7*BI6GPY,WL!MVKZWTL;U%_'VTOME(GJ73
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M5=N +"\H6:H7XCN$OB'GI4_JOG8Z'DM*]U5,;@'^6=2P]PU_-?=V[4S )].
M8ZAD[$;*"MN<)1B)MPKRD)G,[92+,Q@;N6@H22SQR*#^2.WCZ7+704*Y7RIF
M2SAO Q5!L7H*!8*!QT8=.(YDL1[:/4$FWD"F=[F^JI8OP3;3HLB-I^_9#'>S
M8C$FM YKS0[-2W%C\VR(5/SFLYS$Y\$T [R&O<D@EI]/W0W52ACI8F.,GBJP
M7^,ZQ35G0?45Y+1.%YI1# -)CGH5%-V!607RM")_M[S'WHXOTB:@P2DSIQ:;
MYW\$_@9_0EFA3(B(0P+>2'/-W[1-'(-2@C8SW(%1>?D2K&L^36,X7/<1[1@-
M^BANC%)($MSF\&##$9(T]S1N/3E7H%G=BC%O'?J%<;JQWYFXXDG"XT]K1;@,
MCH^20A73&B:861AC:O\(KQ'531(9R,0=XB2Q 2VTNB\-803.\TEIDV;07;!1
MWI>(#;/WD@B[U':^(/-.[+PQ.40:ELVUA5#=>VF;8MQQG8O-=+2=2<:N.@I*
M6ALP*3C\]7TB35*,V .,MFLQ)81N0+E6#S;/MLFQ8V%R;.=\]O5F'KSVRQ(L
M:])=7<K=#[WW >-R:.%Z6,%OQ%P"PKS_,F87R"F@\5, 3:4^HVK:U:FG[N_
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M$7U?/VL;<%[-+M;]TYYM1_1WJ*E,4KSQ)CKY8&5QVF!JE9%F;8CRA%;:@\K
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M*B^1-VKSPHLW-M_9<DET_:Z,+G*3NZ2RB5H)6,[,>@^Z9-3:8H'?^J()L=)
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MYGVO7!GAVSRR#2&B='ZX_=X]O1QW^^C ?L'.:L@Q#-A?7C;^C9+#.>O4UW/
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MX.O7MROF429P $#,%]J0P[+JB@_M4[%,W_S9YG%W-K-%'I% ]P3.Y%3B\Y]
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M\)50T-2@%NN+CD'&YXJ*]TW] 1>5+BQ9Z-TZ$<:/[6=$N86T"(U[$+18"?N
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MH&>]KN 1O,V;I'E>ESU.&GSX19D:H;LZE46IT546JR?UI'NM$:TOPD,1K#]
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M?V@>9>#\AZA4MLE@?O#_ %!+ P04    " "H@-):O+_.1L,"  !O P  #0
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MLMN^K$^G3"QX(;LS=KJ *;!?.7U&</@5SN3^9(A$*8ZJE^!4]ZV28D #DY1
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M75]>G'_^+<(+/MHB9R@_AYM;2'J$=2 7M6LF*&I8C?!>RT9:_9KF./"]1/X
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MBE=A@A" @5A?" 44-%BY+=N+(@ZY'DF4GF8)?/P7?-+Z-<"YU82&9E<4/5!
MJE ST\BB! .)!ASNJ2^H]UN+Z0%#Q.OA7/<.2IK];J(#"D(8)F;:CJ,  _$V
M(N".A3'G'!+!XR2-U@J7>L]="4%)JQ) YV$0%:]B--A+5V&  /FJYB-(8X+D
M*Z_)CP[,>:4K2 [JOH4)2P)#8GHEM+".7_X7]]NEF*)0O,DVCUR][O?)5._Y
MU>_>*UA!IE^IB^@)W%,1S5>8;,0A-7"$:)QBFA,(/DE3US,\%>4E?&2_\@2_
M&-QJ85Q7^X!>O_YK0%!"Z+,:H8A"!D!8 FGJ6A&'^!JF,&8P.8>14*;BG=&
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M              "  7H+ @!F;W)M9&5F8S$T85\P,#(N:G!G4$L! A0#%
M  @ J(#26NTP#-2&&P  ;1P  !,              ( !#!0" &9O<FUD969C
M,31A7S P,RYJ<&=02P$"% ,4    " "H@-):3DU"#M3F   L"0$ $P
M        @ '#+P( 9F]R;61E9F,Q-&%?,# T+FIP9U!+ 0(4 Q0    ( *B
MTEI7ZC"]%><  "H* 0 3              "  <@6 P!F;W)M9&5F8S$T85\P
M,#4N:G!G4$L! A0#%     @ J(#26KR_SD;# @  ;P,   T
M ( !#OX# '!R;WAY7S P,2YJ<&=02P$"% ,4    " "H@-):9),@4"L#  #1
M P  #0              @ '\  0 <')O>'E?,# R+FIP9U!+ 0(4 Q0    (
M *B TEK#H5#YJ@4  , (   -              "  5($! !P<F]X>5\P,#,N
M:G!G4$L! A0#%     @ J(#26JX.>_$B P  Q@,   T              ( !
M)PH$ '!R;WAY7S P-"YJ<&=02P$"% ,4    " "H@-):<JB;%) $  #V%@
M$0              @ %T#00 <V]N;2TR,#(T,3(S,2YX<V102P$"% ,4
M" "H@-):##W_/^P$  "()P  %0              @ $S$@0 <V]N;2TR,#(T
M,3(S,5]D968N>&UL4$L! A0#%     @ J(#26IZ*4T*J$P  B/T  !4
M         ( !4A<$ '-O;FTM,C R-#$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M *B TEIL>&)<:PT  *:O   5              "  2\K! !S;VYM+3(P,C0Q
A,C,Q7W!R92YX;6Q02P4&      X #@!V P  S3@$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>formdefc14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SONM="http://sonimtech.com/20241231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sonm-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0001178697</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011">DEFC14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000012">Sonim Technologies, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000013">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000015">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
    Year&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Summary Compensation Table Total
    for PEO&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
    Actually Paid to PEO &lt;sup id="xdx_F5A_zoC5cfgHytsc"&gt;(2)(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Average Summary Compensation Table
    Total for non-PEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
    Compensation Actually Paid to non-PEO NEOs&lt;sup id="xdx_F53_z2S7G13evcl3"&gt;(2)(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value of Initial Fixed $100 Investment
    Based on Total Shareholder Return&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Income $(M)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;2024 &lt;span id="xdx_F49_ztKsO747mKM5" style="display: none"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;672,918&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(134,334&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;624,083&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;513,490&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;34.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(33.65&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023 &lt;span id="xdx_F42_z1MDmElWV8X8" style="display: none"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;677,266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,136,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;626,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;688,442&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;79.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2022 &lt;span id="xdx_F4F_z0K51fsW4TSd" style="display: none"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,986,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,975,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;420,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;409,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;46.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000016"
      unitRef="USD">672918</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">-134334</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000018"
      unitRef="USD">624083</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000019"
      unitRef="USD">513490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="2"
      id="Fact000020"
      unitRef="USD">34.23</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-4"
      id="Fact000021"
      unitRef="USD">-33650000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">677266</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">2136138</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000024"
      unitRef="USD">626135</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000025"
      unitRef="USD">688442</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="2"
      id="Fact000026"
      unitRef="USD">79.72</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-4"
      id="Fact000027"
      unitRef="USD">-90000.00</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">1986962</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">1975045</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">420553</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">409019</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000032"
      unitRef="USD">46.08</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-4"
      id="Fact000033"
      unitRef="USD">-14090000.00</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000038">&lt;p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    PEO in all reporting years is &lt;span id="xdx_902_eecd--PeoName_c20240101__20241231_zLaRAxIJNNWa"&gt;&lt;span id="xdx_90F_eecd--PeoName_c20230101__20231231_zJN3VjvnASK2"&gt;&lt;span id="xdx_904_eecd--PeoName_c20220101__20221231_zoKdZEallga6"&gt;Hao (Peter) Liu&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2024-01-01to2024-12-31" id="Fact000039">Hao (Peter) Liu</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-01-012023-12-31" id="Fact000040">Hao (Peter) Liu</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000041">Hao (Peter) Liu</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000043">&lt;p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PEO: Liu, Hao (Peter)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Prior Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;SCT Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$1,986,962&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$677,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$672,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,501,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,445,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,346&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;681,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(610,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,046&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(801&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;777,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(197,203&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zLIFV5UcRD41" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; padding-bottom: 1pt"&gt;Adjustment to Compensation Amount&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Compensation Actually Paid&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,975,045&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,136,138&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(134,334&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000045"
      unitRef="USD">1986962</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000046"
      unitRef="USD">677266</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000047"
      unitRef="USD">672918</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000049"
      unitRef="USD">-1501393</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000053"
      unitRef="USD">1445577</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">-2346</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">681465</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">-610049</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000061"
      unitRef="USD">47046</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000062"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000065"
      unitRef="USD">-801</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000066"
      unitRef="USD">777407</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">-197203</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000069"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000077"
      unitRef="USD">1975045</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000078"
      unitRef="USD">2136138</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000079"
      unitRef="USD">-134334</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000081">&lt;p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-PEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Prior Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;SCT Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$420,553&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$626,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$624,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(87,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(78,760&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(44,676&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;48,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;91,269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;19,886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in
    Prior Fiscal Years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,262&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;38,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,049&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(50,540&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards
    Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zzTNdSMsZ8ng" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; padding-bottom: 1pt"&gt;Adjustment to Compensation Amount&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; display: none; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; display: none; text-align: right"&gt;0&lt;/td&gt;&lt;td style="display: none; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Compensation Actually Paid&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;409,019&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;688,442&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;513,490&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000083"
      unitRef="USD">420553</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">626135</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000085"
      unitRef="USD">624083</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000087"
      unitRef="USD">-87981</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">-78760</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000089"
      unitRef="USD">-44676</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">48383</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">91269</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">19886</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">37406</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">-35262</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000099"
      unitRef="USD">38115</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000103"
      unitRef="USD">-10049</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">12392</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">-50540</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">409019</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000116"
      unitRef="USD">688442</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">513490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000119">&lt;p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Relationship
between CAP and TSR&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#x2019;s cumulative indexed Total Shareholder
Return (&#x201c;TSR&#x201d;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdefc14a_004.jpg"/&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000121">&lt;p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Relationship
between CAP and net income (loss)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#x2019;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdefc14a_005.jpg"/&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000016"
          xlink:label="Fact000016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
    reflect Summary Compensation Table (&#x201c;SCT&#x201d;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</link:footnote>
        <link:footnote id="Footnote000036" xlink:label="Footnote000036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
